
<html lang="en"     class="pb-page"  data-request-id="aaabc587-1dc4-4432-97a3-a384a6320c02"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-24;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.9b01304;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile" /></meta><meta name="dc.Creator" content="Stefan  Werner" /></meta><meta name="dc.Creator" content="Stefanie  Mesch" /></meta><meta name="dc.Creator" content="Roman C.  Hillig" /></meta><meta name="dc.Creator" content="Antonius  ter Laak" /></meta><meta name="dc.Creator" content="Julie  Klint" /></meta><meta name="dc.Creator" content="Ioana  Neagoe" /></meta><meta name="dc.Creator" content="Alexis  Laux-Biehlmann" /></meta><meta name="dc.Creator" content="Henrik  Dahllöf" /></meta><meta name="dc.Creator" content="Nico  Bräuer" /></meta><meta name="dc.Creator" content="Vera  Puetter" /></meta><meta name="dc.Creator" content="Reinhard  Nubbemeyer" /></meta><meta name="dc.Creator" content="Simone  Schulz" /></meta><meta name="dc.Creator" content="Michaela  Bairlein" /></meta><meta name="dc.Creator" content="Thomas M.  Zollner" /></meta><meta name="dc.Creator" content="Andreas  Steinmeyer" /></meta><meta name="dc.Description" content="The P2X4 receptor is a ligand-gated ion channel that is expressed on a variety of cell types, especially those involved in inflammatory and immune processes. High-throughput screening led to a new ..." /></meta><meta name="Description" content="The P2X4 receptor is a ligand-gated ion channel that is expressed on a variety of cell types, especially those involved in inflammatory and immune processes. High-throughput screening led to a new ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 20, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01304" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01304" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01304" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01304" /></link>
        
    
    

<title>Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01304" /></meta><meta property="og:title" content="Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0010.jpeg" /></meta><meta property="og:description" content="The P2X4 receptor is a ligand-gated ion channel that is expressed on a variety of cell types, especially those involved in inflammatory and immune processes. High-throughput screening led to a new class of P2X4 inhibitors with substantial CYP 3A4 induction in human hepatocytes. A structure-guided optimization with respect to decreased pregnane X receptor (PXR) binding was started. It was found that the introduction of larger and more polar substituents on the ether linker led to less PXR binding while maintaining the P2X4 inhibitory potency. This translated into significantly reduced CYP 3A4 induction for compounds 71 and 73. Unfortunately, the in vivo pharmacokinetic (PK) profiles of these compounds were insufficient for the desired profile in humans. However, BAY-1797 (10) was identified and characterized as a potent and selective P2X4 antagonist. This compound is suitable for in vivo studies in rodents, and the anti-inflammatory and anti-nociceptive effects of BAY-1797 were demonstrated in a mouse complete Freund’s adjuvant (CFA) inflammatory pain model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01304"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01304">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01304&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01304&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01304&amp;href=/doi/10.1021/acs.jmedchem.9b01304" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 11194-11217</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01294" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01393" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Stefan Werner</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan Werner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#ea999e8f8c8b84c49d8f98848f98aa888b938f98c4898587"><span class="__cf_email__" data-cfemail="4d3e39282b2c23633a283f23283f0d2f2c34283f632e2220">[email protected]</span></a> (S.W.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Werner">Stefan Werner</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7115-6350" title="Orcid link">http://orcid.org/0000-0001-7115-6350</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefanie Mesch</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefanie Mesch</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#067572636067686f63286b6375656e4664677f63742865696b"><span class="__cf_email__" data-cfemail="dba8afbebdbab5b2bef5b6bea8b8b39bb9baa2bea9f5b8b4b6">[email protected]</span></a> (S.M.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefanie++Mesch">Stefanie Mesch</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roman C. Hillig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roman C. Hillig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roman+C.++Hillig">Roman C. Hillig</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Antonius ter Laak</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Antonius ter Laak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Antonius++ter+Laak">Antonius ter Laak</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Julie Klint</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julie Klint</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Evotec SE, 22419 Hamburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Klint">Julie Klint</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ioana Neagoe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ioana Neagoe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Evotec SE, 22419 Hamburg, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ioana++Neagoe">Ioana Neagoe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexis Laux-Biehlmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexis Laux-Biehlmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexis++Laux-Biehlmann">Alexis Laux-Biehlmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Henrik Dahllöf</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Henrik Dahllöf</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Henrik++Dahll%C3%B6f">Henrik Dahllöf</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nico Bräuer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nico Bräuer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nico++Br%C3%A4uer">Nico Bräuer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vera Puetter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vera Puetter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vera++Puetter">Vera Puetter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Reinhard Nubbemeyer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Reinhard Nubbemeyer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Reinhard++Nubbemeyer">Reinhard Nubbemeyer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Simone Schulz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Simone Schulz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Simone++Schulz">Simone Schulz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michaela Bairlein</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michaela Bairlein</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michaela++Bairlein">Michaela Bairlein</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas M. Zollner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas M. Zollner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+M.++Zollner">Thomas M. Zollner</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Andreas Steinmeyer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andreas Steinmeyer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bayer AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andreas++Steinmeyer">Andreas Steinmeyer</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01304&amp;href=/doi/10.1021%2Facs.jmedchem.9b01304" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 11194–11217</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 20, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>9 August 2019</li><li><span class="item_label"><b>Published</b> online</span>20 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 December 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01304" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01304</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D11194%26pageCount%3D24%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DStefan%2BWerner%252C%2BStefanie%2BMesch%252C%2BRoman%2BC.%2BHillig%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D24%26contentID%3Dacs.jmedchem.9b01304%26title%3DDiscovery%2Band%2BCharacterization%2Bof%2Bthe%2BPotent%2Band%2BSelective%2BP2X4%2BInhibitor%2BN-%255B4-%25283-Chlorophenoxy%2529-3-sulfamoylphenyl%255D-2-phenylacetamide%2B%2528BAY-1797%2529%2Band%2BStructure-Guided%2BAmelioration%2Bof%2BIts%2BCYP3A4%2BInduction%2BProfile%26numPages%3D24%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D11217%26publicationDate%3DDecember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01304"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1639</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01304" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery and Characterization of the Potent and Selective P2X4 Inhibitor N-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Werner&quot;},{&quot;first_name&quot;:&quot;Stefanie&quot;,&quot;last_name&quot;:&quot;Mesch&quot;},{&quot;first_name&quot;:&quot;Roman&quot;,&quot;last_name&quot;:&quot;C. Hillig&quot;},{&quot;first_name&quot;:&quot;Antonius&quot;,&quot;last_name&quot;:&quot;ter Laak&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Klint&quot;},{&quot;first_name&quot;:&quot;Ioana&quot;,&quot;last_name&quot;:&quot;Neagoe&quot;},{&quot;first_name&quot;:&quot;Alexis&quot;,&quot;last_name&quot;:&quot;Laux-Biehlmann&quot;},{&quot;first_name&quot;:&quot;Henrik&quot;,&quot;last_name&quot;:&quot;Dahllöf&quot;},{&quot;first_name&quot;:&quot;Nico&quot;,&quot;last_name&quot;:&quot;Bräuer&quot;},{&quot;first_name&quot;:&quot;Vera&quot;,&quot;last_name&quot;:&quot;Puetter&quot;},{&quot;first_name&quot;:&quot;Reinhard&quot;,&quot;last_name&quot;:&quot;Nubbemeyer&quot;},{&quot;first_name&quot;:&quot;Simone&quot;,&quot;last_name&quot;:&quot;Schulz&quot;},{&quot;first_name&quot;:&quot;Michaela&quot;,&quot;last_name&quot;:&quot;Bairlein&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;M. Zollner&quot;},{&quot;first_name&quot;:&quot;Andreas&quot;,&quot;last_name&quot;:&quot;Steinmeyer&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;20&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;11194-11217&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01304&quot;},&quot;abstract&quot;:&quot;The P2X4 receptor is a ligand-gated ion channel that is expressed on a variety of cell types, especially those involved in inflammatory and immune processes. High-throughput screening led to a new class of P2X4 inhibitors with substantial CYP 3A4 induction in human hepatocytes. A structure-guided optimization with respect to decreased pregnane X receptor (PXR) binding was started. It was found that the introduction of larger and more polar substituents on the ether linker led to less PXR binding while maintaining the P2X4 inhibitory potency. This translated into significantly reduced CYP 3A4 induction for compounds 71 and 73. Unfortunately, the in vivo pharmacokinetic (PK) profiles of these compounds were insufficient for the desired profile in humans. However, BAY-1797 (10) was identified and characterized as a potent and selective P2X4 antagonist. This compound is suitable for in vivo studies in rodents, and the anti-inflammatory and anti-nociceptive effects of BAY-1797 were demonstrated in a mouse complete&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01304&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01304" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01304&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01304" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01304&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01304" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01304&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01304&amp;href=/doi/10.1021/acs.jmedchem.9b01304" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01304" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01304" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01304%26sid%3Dliteratum%253Aachs%26pmid%3D31746599%26genre%3Darticle%26aulast%3DWerner%26date%3D2019%26atitle%3DDiscovery%2Band%2BCharacterization%2Bof%2Bthe%2BPotent%2Band%2BSelective%2BP2X4%2BInhibitor%2BN-%255B4-%25283-Chlorophenoxy%2529-3-sulfamoylphenyl%255D-2-phenylacetamide%2B%2528BAY-1797%2529%2Band%2BStructure-Guided%2BAmelioration%2Bof%2BIts%2BCYP3A4%2BInduction%2BProfile%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D24%26spage%3D11194%26epage%3D11217%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292461" title="Neurophysiology">Neurophysiology</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292304" title="Optimization">Optimization</a>,</li><li><a href="/action/doSearch?ConceptID=291161" title="Inflammation">Inflammation</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/jmcmar.2019.62.issue-24/20191226/jmcmar.2019.62.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The P2X4 receptor is a ligand-gated ion channel that is expressed on a variety of cell types, especially those involved in inflammatory and immune processes. High-throughput screening led to a new class of P2X4 inhibitors with substantial CYP 3A4 induction in human hepatocytes. A structure-guided optimization with respect to decreased pregnane X receptor (PXR) binding was started. It was found that the introduction of larger and more polar substituents on the ether linker led to less PXR binding while maintaining the P2X4 inhibitory potency. This translated into significantly reduced CYP 3A4 induction for compounds <b>71</b> and <b>73</b>. Unfortunately, the in vivo pharmacokinetic (PK) profiles of these compounds were insufficient for the desired profile in humans. However, BAY-1797 (<b>10</b>) was identified and characterized as a potent and selective P2X4 antagonist. This compound is suitable for in vivo studies in rodents, and the anti-inflammatory and anti-nociceptive effects of BAY-1797 were demonstrated in a mouse complete Freund’s adjuvant (CFA) inflammatory pain model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46437" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46437" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Adenosine triphosphate (ATP) is widely recognized as an important neurotransmitter implicated in various physiological and pathophysiological roles by acting through different subtypes of purinergic receptors.<a onclick="showRef(event, 'ref1 ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4">(1−4)</a> To date, seven members of the P2X family have been cloned, comprising P2X1-7.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> The P2X4 receptor is a ligand-gated ion channel that is expressed on a variety of cell types, largely those known to be involved in inflammatory and immune processes, specifically including monocytes, macrophages, mast cells, and microglia.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> Activation of P2X4 by extracellular ATP is known to release proinflammatory cytokines and prostaglandins such as prostaglandin E2 (PGE2).<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> There is growing evidence indicating the potential of P2X4 as an attractive therapeutic target in multiple pathologies, especially in chronic inflammation and neuropathic pain. Numerous lines of evidence in the literature using animal models implicate a key role of the P2X4 receptor in nociception and pain. Mice lacking the P2X4 receptor do not develop pain hypersensitivity in response to numerous inflammatory challenges such as Complete Freund’s Adjuvant (CFA), carrageenan or formalin.<a onclick="showRef(event, 'ref8 ref11'); return false;" href="javascript:void(0);" class="ref ref8 ref11">(8,11)</a> In addition, mice lacking the P2X4 receptor do not develop mechanical allodynia after peripheral nerve injury, indicating an important role of P2X4 also in neuropathic pain conditions.<a onclick="showRef(event, 'ref12 ref8'); return false;" href="javascript:void(0);" class="ref ref12 ref8">(12,8)</a> It has been described that P2X4 expression on microglial cells is upregulated in chronic pain conditions and is a central player in mechanisms of neuropathic and inflammatory pain.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> Besides the prominent role of P2X4 in acute and chronic pain-related diseases, P2X4 is considered as a critically important mediator of neuroinflammatory and neurodegenerative diseases, respiratory diseases (e.g., asthma), and lung diseases, including fibrosis, bone metabolism, cardiovascular diseases, immunomodulation in transplantation, and atherosclerosis.<a onclick="showRef(event, 'ref14 ref16 ref17 ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref14 ref16 ref17 ref18 ref19 ref20 ref21">(14,16−21)</a></div><div class="NLM_p">The first P2X4 inhibitor 5-BDBD (<b>1</b>) was described in 2004 by Bayer<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and has been used as in vitro probe since then (see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Until now, most reported inhibitors<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> show activity only in the high nanomolar or even micromolar range and even fewer have been described to be suitable for in vivo studies in rodents. For example, it has been shown that the antidepressive paroxetine (<b>2</b>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> acts as P2X4 inhibitor in the micromolar range in humans and rats. Müller et al. published several human selective P2X4 inhibitors like PSB-12054<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<b>3</b>) and the structurally related urea <b>4</b>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Another submicromolar urea BX-430 (<b>5</b>) was reported by Séguéla et al.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> More potent P2X4 inhibitors like <b>6</b>, <b>7</b>, or <b>8</b> (NP-1815-PX) have been published by Nippon Chemiphar.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In 2016, Nippon Chemiphar announced the start of Phase 1 clinical trials for the treatment of neuropathic pain for their P2X4 antagonist NC-2600 (structure unpublished) together with Kyushu University.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Structurally related compounds like tetrazole <b>9</b> have also been disclosed by Sunovion.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected published structures of P2X4 antagonists with reported P2X4 IC<sub>50</sub>s (# in-house potency data from the assays of this study).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Here, we report the identification and optimization of a novel class of P2X4 antagonists. This structural class shows activity on P2X4 across species, which led to the identification of <b>BAY-1797</b> (compound <b>10</b>) that will be discussed in detail.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75216" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75216" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The pharmacological hypothesis that P2X4 plays a crucial role in inflammation, sensory nerve sensitization, and proliferation (in-house and published data; for reviews, see refs <a onclick="showRef(event, 'ref9 ref14'); return false;" href="javascript:void(0);" class="ref ref9 ref14">(9,14)</a>) motivated us to screen the Bayer compound collection with the aim to identify a small-molecule inhibitor of the P2X4 ion channel. Out of the 800 000 compounds that were tested in a primary high-throughput screening (HTS, Ca-flux fluorescence Imaging Plate Reader (FLIPR) assay), we identified 183 confirmed hits. After careful evaluation, two hit clusters of P2X4 antagonists were chosen for further optimization. One cluster with the most prominent member 5-BDBD (<b>1</b>) was already published a few years ago.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> The current report focuses on the second cluster with compound <b>10</b> as a representative starting point for our optimization program. In this program, we used a P2X4 screening assay, evaluating the ability to inhibit ATP-induced calcium influx in human embryonic kidney (HEK) cells that were stably transfected with the human P2X4 receptor. Sulfonamide <b>10</b> is a structurally novel antagonist which is 17 times more potent (IC<sub>50</sub> = 211 nM) than 5-BDBD (IC<sub>50</sub> = 3710 nM) in the above-mentioned HEK cell-based human P2X4 assay (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0014.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. P2X4 inhibition activity of <b>10</b> (<b>BAY-1797</b>) in the FLIPR assay (human P2X4 HEK cells, IC<sub>50</sub> = 211 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the overall technical profile was already a good starting point with only moderate in vitro blood clearance (Cl<sub>blood</sub>) of 1.88 L/(h kg) in rat hepatocytes (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), this compound showed CYP3A4 induction in human hepatocytes. However, hepatocytes are not suitable for high-throughput assays to guide structure-based optimization. The primary mechanism of cytochrome P450 induction is due to increased gene transcription, which typically occurs through nuclear receptor activation. The most common nuclear receptor involved in the induction of drug metabolizing enzymes is the pregnane X receptor (PXR). To evaluate PXR nuclear receptor transactivation, a screening luciferase reporter gene assay in a human hepatoma cell line was included early in the medicinal chemistry optimization program.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Selected in Vitro Data for Compounds <b>10</b> (<b>BAY-1797</b>) and <b>16–30</b> (Optimization of Western Part)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0018.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">racemic.</p></div></div><div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">Commercially available sulfuryl chloride <b>11a</b> was treated with 1-(2,4-dimethoxyphenyl)methanamine under basic conditions to give the protected sulfonamide <b>12a</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Afterwards, aryl ether <b>13</b> was obtained by nucleophilic aromatic substitution reaction with 3-chlorophenol and cesium carbonate in dimethylformamide (DMF). Subsequently, the nitro group was reduced under mild conditions with platinum/vanadium (1%/2%) on activated carbon under hydrogen atmosphere to <b>14.</b> Acylation of aniline <b>14</b> was performed using standard amide coupling conditions with 1-[Bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate (HATU) and <i>N</i>,<i>N-</i>diisopropylethylamine (DIPEA) in DMF. Final deprotection with trifluoroacetic acid in dichloromethane (DCM) yielded antagonists <b>10</b> and <b>16–30</b> in good overall yields.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Sulfonamides <b>10</b> and <b>16</b>–<b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-(2,4-dimethoxyphenyl)methanamine, NaHCO<sub>3</sub>, DCM; (b): R<sup>2</sup>-OH, Cs<sub>2</sub>CO<sub>3</sub>, MeCN; (c) H<sub>2</sub>, Pt/V (1%/2%) on charcoal, toluene; (d) R-COOH, HATU, DIPEA, DMF; (e) TFA, DCM, rt.</p></p></figure><div class="NLM_p">For further optimization of the so-called eastern ether moiety, protected sulfonamide <b>12a</b> was reacted with the corresponding phenols or alcohols in the presence of cesium carbonate or sodium hydride, respectively, to nitro aryl ethers <b>31a</b>–<b>u</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). After reduction and acylation, the final products <b>33</b>–<b>40, 42, 43, 45, 47, 49</b>, and <b>51</b>–<b>62</b> were obtained by removing the 2,4-dimethoxy-benzyl group under acidic conditions.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Sulfonamides <b>33</b>–<b>40</b>, <b>42</b>, <b>43</b>, <b>45</b>, <b>47</b>, <b>49</b>, and <b>51</b>–<b>62</b><sup>a</sup><sup>b</sup><sup>c</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>2</sup>-OH, Cs<sub>2</sub>CO<sub>3</sub>, MeCN (for R<sup>2</sup> = aryl/hetaryl) or NaH, DMF (for R<sup>2</sup> = alkyl); (b) H<sub>2</sub>, Pd/C, THF or SnCl<sub>2</sub>·2H<sub>2</sub>O, dioxane, 70 °C; (c) R-COOH, HATU, DIPEA, DMF; (d) TFA, DCM, rt; (e) morpholine-3-one, Cs<sub>2</sub>CO<sub>3</sub>, Xanthphos, Pd<sub>2</sub>(dba)<sub>3</sub>, dioxane, 105 °C; (f) MeMgBr, THF, −78 °C.</p><p><span class="fn-label"><sup>b</sup></span>Synthesis of <b>55</b> was started with fluoronitroaryl <b>12b</b>.</p><p class="last"><span class="fn-label"><sup>c</sup></span>Synthesis of <b>57</b> was performed without 2,4-dimethoxybenzyl-protecting group.</p></p></figure><div class="NLM_p">Esters <b>46</b>, <b>48</b>, and <b>50</b> were reduced with MeMgBr in THF to the corresponding tertiary alcohols <b>47</b>, <b>49</b>, and <b>51</b>. Deprotection with trifluoroacetic acid had to be performed at the ester stage because elimination was observed when we tried to deprotect the tertiary alcohols as final step.</div><div class="NLM_p">Some of the alkyl and benzyl ethers were synthesized via alkylation of the phenol (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). 2-Hydroxy-5-nitrobenzenesulfonamide <b>63</b> was reduced under acidic conditions with Pd/C under hydrogen atmosphere. The aniline <b>64</b> was subsequently acylated with the different phenylacetic acids to yield phenols <b>65a–d.</b> Final alkylation was performed at 0 °C by addition of sodium hydride and the corresponding benzyl- or alkylbromide in DMF yielding sulfonamides <b>66</b>–<b>74</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Sulfonamides <b>66</b>–<b>74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>, Pd/C, 2N aq. HCl, MeOH; (b) HATU, DIPEA, DMF; (c) NaH, R<sup>2</sup>-Br, DMF, 0 °C.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Optimization and Structure–Activity Relationships (I)</h3><div class="NLM_p">We started to explore the structure–activity relationship (SAR) towards P2X4 inhibition at the so-called western part of the molecule by applying differently substituted phenylacetic acids, as summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. From an initial methyl scan, we got the first hint that substitution in the ortho-position (<b>16</b>) leads to a very significant boost in activity (IC<sub>50</sub> = 10 nM) while substitution in the para-position is particularly not very well tolerated (<b>18</b>, IC<sub>50</sub> = 317 nM). Introduction of further ortho-substituents such as fluorine (<b>19</b>, IC<sub>50</sub> = 76 nM), chlorine (<b>20</b>, IC<sub>50</sub> = 92 nM), trifluoromethyl (<b>21</b>, IC<sub>50</sub> = 24 nM), or methoxy (<b>22</b>) all improved the human P2X4 IC<sub>50</sub>, with <b>22</b> being the most potent compound in this series (IC<sub>50</sub> = 2 nM). However, the in vitro clearance in rat hepatocytes was significantly increased for these potent ortho-substituted compounds (MeO, Me, F with Cl<sub>blood</sub> = 3.42, 2.82, 2.89 L/(h kg), respectively) and as trifluoromethyl added too much lipophilicity, chlorine was selected as the ortho-substituent with the overall best profile (log D(<b>21</b>) = 3.3 vs log D(<b>20</b>) = 3.0).</div><div class="NLM_p">Additional halogen substitution in the remaining ortho-position as in the cases of <b>23</b> (IC<sub>50</sub> = 9 nM) and <b>24</b> (IC<sub>50</sub> = 15 nM) improved potency even by factors of 10 and 6, respectively, but resulted also in compounds exhibiting higher clearance in most cases. In addition, the extra halogen burden decreased the aqueous solubility significantly (aqueous solubility of 7 mg/L for compound <b>20</b> versus 0.7 mg/L for compound <b>23</b>).</div><div class="NLM_p">Addition of a methyl group in the benzylic position (<b>25</b>, IC<sub>50</sub> = 1242 nM) clearly decreased human P2X4 potency, although in combination with chlorine in the ortho-position (<b>26</b>) still led to an IC<sub>50</sub> of 134 nM. Cyclopropyl in the same position even led to a compound with no measurable activity (<b>27,</b> IC<sub>50</sub> > 25 μM).</div><div class="NLM_p last">With the improved potency and our better SAR understanding, we now turned our focus on the CYP 3A4 induction potential. With exception of fluorine derivative <b>19</b>, all synthesized compounds so far exhibited a low minimum efficacious concentration (MEC) of 0.1–1.7 μM in the PXR transactivation assay (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Based on our HTS hit <b>10</b>, a good correlation between PXR assay and human hepatocytes was anticipated. Therefore, low MEC values in the PXR assay would most likely translate into a significant risk for CYP3A4 induction in human hepatocytes.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> PXR Co-Crystal Structure and Docking</h3><div class="NLM_p">To understand the molecular basis of the recognition of our molecules by the PXR protein and to guide the optimization, several compounds were selected for a co-crystallization with the PXR protein. Candidates for co-crystallization were prioritized using the thermal shift assay (TSA). For compounds that stabilized the PXR by a shift in the melting temperature Δ<i>Tm</i> of larger than 4 K, co-crystallization experiments were initiated. This resulted in a PXR co-crystal structure with the 2-phenylpropionic acid derivative <b>25</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The compound binds to PXR with the methylbenzyl moiety inserting in a hydrophobic subpocket forming a π–π stacking interaction with Trp299 and T-stacking interactions with Phe288 and Tyr306. The sulfonamide group is coordinated via three H bonds to the side chains of Ser247, Gln285, and His407.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding mode of compound <b>25</b> in the PXR (protein data bank (PDB) accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HTY">6HTY</a>). (A) View into the fully solvent-excluded ligand binding pocket of the PXR (chain B), side-chain residues shown in stick representation, protein shown additionally in surface representation. (B) View rotated by 90°. The dotted lines show H-bond interactions. Figure generated using Pymol (The PyMOL Molecular Graphics System, Version 1.3 Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Constraint docking of HTS hit <b>10</b> and of <i>para</i>-methyl derivative <b>18</b> using the X-ray structure of compound <b>25</b> as guidance revealed a good fit in the PXR pocket explaining the low MEC values in the PXR assay. <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A shows that the phenylacetic acid substituent forms a π–π stacking with Trp299 and a T stacking with Phe288. We figured out that a larger para-substituent should disturb the stacking due to a steric clash with Tyr306 leading overall to the desired looser fit in the PXR pocket, which results in a higher MEC value. We therefore also docked the series of <i>para</i>-fluorine (<b>28</b>), <i>para</i>-chlorine (<b>29</b>), and <i>para</i>-trifluoromethyl (<b>30</b>) derivatives (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). Subsequent testing of these compounds in the PXR assay supported this hypothesis. With increasing size of the para-substituent, these compounds showed weaker PXR binding translating into increasing MEC values (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A shows that especially <b>30</b> cannot be accommodated with the same binding mode as <b>10</b> and <b>18</b> anymore, leading to the observed increased MEC value in the PXR assay. Unfortunately, such large substituents were not tolerated by the P2X4 SAR, leading to loss of activity as, for example, for compound <b>30</b> (IC<sub>50</sub> = 1718 nM).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Constraint docking of analogues, using the energy-minimized binding site of PXR co-crystallized with <b>25</b> as a template (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HTY">6HTY</a>), led to a qualitative understanding of the SAR roughly defined by the boundaries of the PXR binding site. To this end, it is assumed that the binding modes in PXR of close analogues of <b>25</b> are very similar. (A) Variations in the para-position including compounds <b>10</b>, <b>18</b>, <b>28</b>, and <b>29</b> (PXR assay: low MEC values, in orange), and <b>30</b> (PXR assay: high MEC values, in green). Large groups such as <i>para</i>-CF<sub>3</sub><b>30</b> (green ligand) and <i>para</i>-chloro <b>29</b> (yellow ligand) appear to accommodate less well in PXR between the stacking (blue dashed lines) residues Trp299 and Phe288, which then results in a loss of optimal H-bonding with Gln285. (B) Compounds showing low MEC values in the PXR assay are docked well into the PXR binding site: <b>66</b>, <b>69</b>, <b>67</b>, and <b>47</b> (C) Compounds with reduced PXR transactivation potential have close steric contacts with the PXR protein surface: <b>39</b>, <b>40</b>, <b>45</b>, and <b>70</b>. (D) Compounds with no or weak effects in the PXR assay cannot accommodate PXR in a similar binding mode because of severe steric hindrance with the protein: <b>43</b>, <b>51</b>, 4<b>2</b>, and <b>71</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Optimization and Structure–Activity Relationships (II)</h3><div class="NLM_p">Altogether, our understanding of PXR docking based on the PXR-co-crystal structure of <b>25</b> was in line with our experimental findings but did not fulfill the SAR requirements for human P2X4 inhibition. Consequently, we directed our attention on the eastern SAR while keeping the ortho-chlorine substituent (compound <b>20</b>) constant. We started by variations with different phenols that were prepared in nucleophilic aromatic substitution reactions, as summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Selected in Vitro Data for Compounds <b>33–40</b>, <b>42</b>, <b>43</b>, <b>45</b>, <b>47</b>, <b>49</b>, <b>51–58</b>, and <b>66–71</b> (Optimization of Eastern Part)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0001.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0017.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0002.gif" alt="" id="fx5" /></img><div></div></div><div class="NLM_p">Unsubstituted phenol (<b>33</b>) as well as small substituents in ortho- (<b>34</b>) or meta-position (<b>36</b>) led to very good human P2X4 potencies with IC<sub>50</sub> values of 10, 13, and 8 nM. Comparing the pair of <b>34</b> (IC<sub>50</sub> = 13 nM) and <b>35</b> (IC<sub>50</sub> = 1250 nM) demonstrated again the highly beneficial effect of the ortho-substituent of the phenylacetic acid on potency. However, PXR binding was maintained, which was in good accordance with the PXR co-crystal structure of <b>25.</b></div><div class="NLM_p">Having a closer look at the PXR co-crystal structure of <b>25</b>, we postulated that a larger and especially more polar substituent in meta- or para-position of the eastern aryl should weaken PXR binding and by that improving the CYP induction profile. Therefore, sulfonamides <b>37</b>–<b>40, 42, 43</b>, and <b>45</b> were synthesized and while the first four (<b>37</b>–<b>40</b>) showed higher MEC values (range: 8.4–11 μM) (with human P2X4 IC<sub>50</sub>’s of 30, 75, 67, and 93 nM, respectively), the latter and slightly larger ones (<b>42, 43</b>, and <b>45</b>) showed no transactivation of PXR up to the highest tested concentration (MEC values > 50 μM), well in line with our hypothesis. Among these three compounds, the morpholinylamide <b>43</b> showed a very promising human P2X4 IC<sub>50</sub> of 45 nM but later had to be discontinued due to increased clearance in rat hepatocytes (Cl<sub>blood</sub> = 2.25 L/(h kg)). On first glance, compounds <b>37</b> and <b>39</b> also looked promising regardless of the still only moderate MEC for PXR binding. But despite low in vitro clearance in rat hepatocytes, <b>37</b> showed medium in vitro clearance in human liver microsomes (0.62 L/(h kg)) and a low aqueous solubility of only around 1 mg/L. The combination of these two parameters led to the deprioritization of this compound. Triazole <b>39</b>, on the other hand, had an efflux ratio in the Caco-2 assay of 70 and therefore was no alternative.</div><div class="NLM_p">A hydroxyisopropyl scan further supported our PXR-binding hypothesis. While ortho and meta derivatives <b>47</b> (IC<sub>50</sub> = 242 nM) and <b>49</b> (IC<sub>50</sub> = 474 nM) showed PXR binding, the para-substituted derivative <b>51</b> (IC<sub>50</sub> = 376 nM) showed a significantly weaker transactivation of PXR (MEC = 33 μM), matching well with the docking study as highlighted in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B–D.</div><div class="NLM_p">To further expand the SAR understanding regarding human P2X4 inhibition, the right aryl was then replaced by various heterocycles. Among those heterocycles, especially 5-chloro-3-pyridyl (<b>54</b>, IC<sub>50</sub> = 27 nM) and 1-methyl-4-pyrazolyl (<b>56</b>, IC<sub>50</sub> = 185 nM) were potent, but most likely due to their small size, they still showed significant PXR binding.</div><div class="NLM_p">Not surprisingly, cyclohexyl ether <b>57</b> also strongly transactivated PXR, but had a human P2X4 IC<sub>50</sub> of 39 nM, which shows that also nonaromatic substituents were well tolerated.</div><div class="NLM_p">In parallel, we decided to increase the size of the right substituent and synthesized benzyl derivative <b>66</b>. While <b>66</b> was extremely potent with an IC<sub>50</sub> of 2 nM, significant PXR transactivation was maintained. In addition, this compound showed a very low aqueous solubility. Switching to 2-pyridylmethyl (<b>67</b>, IC<sub>50</sub> = 26 nM) and phenethyl (<b>68</b>, IC<sub>50</sub> = 19 nM) slightly decreased potency but did not improve PXR interaction.</div><div class="NLM_p">Encouraged by the above-described findings that aliphatic as well as larger substituents are well tolerated, and based on our increasing understanding of the PXR binding, we synthesized a set of elongated aliphatic ethers, from a small cyclobutylmethyl (<b>69</b>, IC<sub>50</sub> = 5 nM) over 2-oxetanylmethyl (<b>70</b>, IC<sub>50</sub> = 784 nM) towards larger and especially more polar 2-dioxanylmethyl (<b>58</b>, IC<sub>50</sub> = 258 nM) and 4-tetrahydropyranylmethyl (<b>71</b>, IC<sub>50</sub> = 139 nM). While the smaller and more lipophilic substituents in <b>57</b> and <b>69</b> transactivated PXR, oxetane derivative <b>70</b> showed a reduced effect (MEC = 11.4 μM), and the larger and more polar variants <b>58</b> and <b>71</b> did not significantly transactivate PXR (MEC > 25 μM). With the tetrahydropyrane derivative <b>71</b>, we had finally arrived at an inhibitor with an overall improved profile, combining potency against human P2X4 (IC<sub>50</sub> just above 100 nM), a higher MEC value of 35.6 μM, and low clearance in rat hepatocytes (Cl<sub>blood</sub> 0.95 L/(h kg)). We therefore selected this compound as the starting point for the next round of optimization and went back to modify the left 2-chlorophenyl acetic acid moiety, as shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Selected in Vitro Data for Compounds <b>59</b>–<b>62</b> and <b>72</b>–<b>74</b> (Fine-Tuning of Western Part)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0008.gif" alt="" id="fx6" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">cmpd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center" char=".">hum P2X4 IC<sub>50</sub> [nM] (HEK, Ca<sup>2+</sup>)</th><th class="colsep0 rowsep0" align="center">PXR binding MEC [μM]</th><th class="colsep0 rowsep0" align="center" char=".">rat Heps CL<sub>blood</sub> [L/(h kg)]</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub>-C<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="left">16.8</td><td class="colsep0 rowsep0" align="char" char=".">1.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>2</sub><i>H-</i>C<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">111</td><td class="colsep0 rowsep0" align="left">27.6</td><td class="colsep0 rowsep0" align="char" char=".">0.57</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">2-F-C<sub>6</sub>H<sub>4</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">597</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">3-F-2-Cl-C<sub>6</sub>H<sub>3</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">37</td><td class="colsep0 rowsep0" align="left">17.2</td><td class="colsep0 rowsep0" align="char" char=".">1.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">4-F-2-Cl-C<sub>6</sub>H<sub>3</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">173</td><td class="colsep0 rowsep0" align="left">5.51</td><td class="colsep0 rowsep0" align="char" char=".">1.73</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">3-F-6-Cl-C<sub>6</sub>H<sub>3</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="left">33.2</td><td class="colsep0 rowsep0" align="char" char=".">0.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">2-F-6-Cl-C<sub>6</sub>H<sub>3</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="left">14.2</td><td class="colsep0 rowsep0" align="char" char=".">1.40</td></tr></tbody></table></div></div><div class="NLM_p last">First, the chlorine was replaced again by trifluoromethyl (<b>59</b>, IC<sub>50</sub> = 88 nM), difluoromethyl (<b>60</b>, IC<sub>50</sub> = 111 nM), and fluorine (<b>61</b>, IC<sub>50</sub> = 597 nM). While compound <b>59</b> resulted in reduced PXR transactivation, the ortho-fluorine led to a significant decrease in potency, leaving only difluoromethyl derivative <b>60</b> as an interesting candidate. Next, disubstituted phenylacetic acids were synthesized, maintaining the ortho-chlorine. Among these, compounds <b>72</b>–<b>74</b> showed potencies below 100 nM, with the 3-fluoro-6-chloro derivative <b>73</b> having the best overall technical profile as it showed significantly reduced PXR transactivation with an MEC value of 33 μM and displayed low in vitro clearance in rat hepatocytes (0.53 L/(h kg)). Consequently, we chose compound <b>73</b> for further profiling together with the original HTS hit <b>10</b> and the first candidate <b>71</b>.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Technical Profile of Key Compounds <b>10</b>, <b>71</b>, and <b>73</b></h3><div class="NLM_p">During the optimization process starting from HTS hit <b>10</b>, the potency against human P2X4 could be improved from 211 nM to IC<sub>50</sub> = 139 and 84 nM for candidates <b>71</b> and <b>73</b>, respectively. The physicochemical and pharmacokinetic parameters of these compounds are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. While log D could be reduced from 2.8 to 2.2 during this process, total polar surface area (TPSA) and solubility slightly increased. Most importantly, due to the better understanding of the PXR binding based on the co-crystal structure with <b>25</b>, the new candidates <b>71</b> and <b>73</b> had MEC values in the high micromolar range, indicating an improved CYP 3A4 induction profile, which was confirmed in human hepatocytes. While hit <b>10</b> showed an onset of CYP3A4 induction above 41 μg/L, this increased significantly to >10 000 and 3333 μg/L for compounds <b>71</b> and <b>73</b>, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Potency, PhysChem, DMPK, and Selectivity Data for Compounds <b>10</b>, <b>71</b>, and <b>73</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0012.gif" alt="" id="fx7" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center">cmpd <b>10</b></th><th class="colsep0 rowsep0" align="center">cmpd <b>71</b></th><th class="colsep0 rowsep0" align="center">cmpd <b>73</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hum P2X4 IC<sub>50</sub> (HEK, Ca<sup>2+</sup>) [nM]</td><td class="colsep0 rowsep0" align="left">211</td><td class="colsep0 rowsep0" align="left">139</td><td class="colsep0 rowsep0" align="left">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mol. weight [g/mol]/TPSA</td><td class="colsep0 rowsep0" align="left">417/98</td><td class="colsep0 rowsep0" align="left">439/108</td><td class="colsep0 rowsep0" align="left">457/108</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">log D pH 7.5 (exp)</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">aqu. solubility (thermodynamic, pH6.5) [mg/L]</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PXR binding MEC [μM]</td><td class="colsep0 rowsep0" align="left">1.66</td><td class="colsep0 rowsep0" align="left">35.6</td><td class="colsep0 rowsep0" align="left">33.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP 3A4 induction NOEL [μg/L]</td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">3333</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Caco Papp A-B [nm/s]/efflux ratio</td><td class="colsep0 rowsep0" align="left">132/0.6</td><td class="colsep0 rowsep0" align="left">53/4.3</td><td class="colsep0 rowsep0" align="left">43/5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vitro rat Heps CL<sub>blood</sub> [L/(h kg)]<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1.88</td><td class="colsep0 rowsep0" align="left">0.95</td><td class="colsep0 rowsep0" align="left">0.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo rat AUC<sub>norm</sub> [kg h/L]</td><td class="colsep0 rowsep0" align="left">1.06<a class="ref internalNav" href="#t4fn4" aria-label="dS">dS</a></td><td class="colsep0 rowsep0" align="left">0.37<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">1.11<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo rat <i>V</i><sub>SS</sub>[L/kg]</td><td class="colsep0 rowsep0" align="left">2.77<a class="ref internalNav" href="#t4fn4" aria-label="dS">dS</a></td><td class="colsep0 rowsep0" align="left">1.23<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">0.82<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo rat <i>t</i><sub>1/2</sub> [h]</td><td class="colsep0 rowsep0" align="left">2.64<a class="ref internalNav" href="#t4fn4" aria-label="dS">dS</a></td><td class="colsep0 rowsep0" align="left">0.37<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">0.77<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo rat CL<sub>blood</sub> [L/(h kg)]</td><td class="colsep0 rowsep0" align="left">0.48<a class="ref internalNav" href="#t4fn4" aria-label="dS">dS</a></td><td class="colsep0 rowsep0" align="left">2.70<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">1.31<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo rat F [%]</td><td class="colsep0 rowsep0" align="left">43<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">21<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">44<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhib. IC<sub>50</sub> (3A4/2D6/2C9/2C8/1A2) [μM]</td><td class="colsep0 rowsep0" align="left">>20/4.9/4.6/1.8/>20</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">fu (human/rat/mouse) [%]<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">1.2/2.2/3.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">In vitro LM CL<sub>blood</sub> (human/rat/mouse) [L/(h kg)]<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t4fn2" aria-label="b">b</a><sup>,</sup><a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.02/0.89/1.10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hum/rat/mouse P2X4 IC<sub>50</sub> (1321N1, Ca<sup>2+</sup>) [nM]</td><td class="colsep0 rowsep0" align="left">108/233/112</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hum P2X4 IC<sub>50</sub> (1321N1, Ephys) [nM]</td><td class="colsep0 rowsep0" align="left">320</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hum P2X1/P2X23/P2X3/P2X7 IC<sub>50</sub> [μM]</td><td class="colsep0 rowsep0" align="left">>50/>30/8.3/10.6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG/carbonic anhydrase II IC<sub>50</sub> [μM]</td><td class="colsep0 rowsep0" align="left">>10/>10</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stability plasma human/rat (4 h) [%]</td><td class="colsep0 rowsep0" align="left">94/stable</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">stability pH 1/7/10 (24 h)</td><td class="colsep0 rowsep0" align="left">stable</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ames/MNT/cytotox</td><td class="colsep0 rowsep0" align="left">all negative</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Rat male Wistar.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Human mix Caucasian.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Mouse female NMRI.</p></div><div class="footnote" id="t4fn4"><sup><sup>dS</sup></sup><p class="last">ingle-dose administration of a PEG400/water/ethanol vehicle (50/40/10) at 1.0 mg/kg by i.v. bolus in male Wistar rats.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">Single-dose administration of a PEG400/water/ethanol vehicle (50/40/10) at 0.5 mg/kg by i.v. bolus in male Wistar rats.</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Single-dose administration of a PEG400/water/ethanol vehicle (50/40/10) at 2.0 mg/kg p.o. in male Wistar rats.</p></div></div></div><div class="NLM_p">In summary, the improved CYP interaction profile was obtained by introduction of more polar substituents on the eastern part of the molecules. However, we observed a negative impact on the apparent permeability (53 and 43 nm/s for <b>71</b> and <b>73</b>, respectively, vs 132 nm/s for hit <b>10</b>) and also a slight increase in efflux (efflux ratio in the Caco-2 permeability assay of 4.3 and 5.5 for <b>71</b> and <b>73</b>, respectively) compared to <b>10</b> (efflux ratio of 0.6).</div><div class="NLM_p">In the next step, the in vivo pharmacokinetic properties of these three compounds were evaluated by a single-dose i.v. and p.o. administration in rats. Unfortunately, candidates <b>71</b> (Cl<sub>blood</sub> = 2.70 L/(h kg); <i>t</i><sub>1/2</sub> = 0.37 h, <i>F</i> = 21%) and <b>73</b> (Cl<sub>blood</sub> = 1.31 L/(h kg); <i>t</i><sub>1/2</sub> = 0.77 h, <i>F</i> = 44%) displayed higher clearance, shorter half-life times, and lower or equal bioavailability compared to the starting point <b>10</b> (Cl<sub>blood</sub> = 0.48 L/(h kg); <i>t</i><sub>1/2</sub> = 2.64 h, <i>F</i> = 43%). It appeared that despite an improved in vitro metabolic stability in rat hepatocytes, the increased efflux ratio and lower permeability led to an overall suboptimal in vivo PK profile for the anticipated once daily/twice daily dosing regimen especially due to the significantly lower half-life times for compounds <b>71</b> and <b>73</b>. We therefore discontinued derivatives <b>71</b> and <b>73</b> and further profiled the HTS hit <b>10</b> in depth as it displayed the best overall pharmacokinetic (PK) profile. The backup compound <b>60</b> also showed a comparable efflux ratio of 4.5 and was therefore discontinued as well.</div><div class="NLM_p">Compound <b>10</b> (<b>BAY-1797</b>) was profiled in further P2X4 assays. It was equipotent over various species in calcium influx based assays in overexpressing 1321N1 cells (human P2X4 IC<sub>50</sub> = 108 nM, mouse P2X4 IC<sub>50</sub> = 112 nM, and rat P2X4 IC<sub>50</sub> = 233 nM), as shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>. IC<sub>50</sub> was confirmed in patch-clamp experiments on human P2X4 in 1321N1 cells (320 nM, QPatch) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. P2X4 inhibition activity of <b>10</b> (<b>BAY-1797</b>) in the FLIPR assay (human, mouse, and rat P2X4 1321N1 cells, IC<sub>50</sub> = 108 nM human), 112 nM (mouse), and 233 nM (rat).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0015.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. P2X4 inhibition activity of <b>10</b> (<b>BAY-1797</b>) by electrophysiology on the QPatch (human P2X4 1321N1 cells, IC<sub>50</sub> = 320 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Sulfonamide <b>10</b> is a very selective P2X4 antagonist with no or very weak activity on the other P2X ion channels (human P2X1 IC<sub>50</sub> > 50 μM; human P2X23 IC<sub>50</sub> > 30 μM; human P2X3 IC<sub>50</sub> = 8.3 μM; and human P2X7 IC<sub>50</sub> = 10.6 μM). No measurable activity was seen on hERG and carbonic anhydrase II (both IC<sub>50</sub> > 10 μM). Compound <b>10</b> was also tested against a panel of off-targets, including G-protein coupled receptors (GPCRs), ion channels, kinases, and transporters at 10 μM. An inhibitory activity against the dopamine transporter (DAT, IC<sub>50</sub> 2.17 μM) was revealed as the only hit.</div><div class="NLM_p">The compound has an acceptable CYP inhibition profile with IC<sub>50</sub>’s against CYP3A4, CYP2D6, CYP2C9, CYP2C8, and CYP 1A2 of >20, 4.9, 4.6, 1.8, and >20 μM, respectively.</div><div class="NLM_p last">Compound <b>10</b> shows a slight degradation in human plasma (6% degradation after 4 h) and is stable in rat plasma as well as in aqueous buffered media between pH 1 and 10. Ames, micronucleus test (MNT), and Cytotox tests were negative.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Antinociceptive and Anti-Inflammatory Effects of Compound <b>10</b> in a Model of Inflammatory Pain</h3><div class="NLM_p">Inflammatory pain can be induced in rodents by intraplantar injection of Complete Freund’s Adjuvant (CFA). This model is well characterized in the literature and is routinely used for assessing antinociceptive and anti-inflammatory effects of new compounds.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In this inflammatory pain model, P2X4 expression in the spinal cord is described to be upregulated and P2X4 knock-out (KO) mice exhibited decreased pain hypersensitivity to mechanical stimuli.<a onclick="showRef(event, 'ref12 ref33'); return false;" href="javascript:void(0);" class="ref ref12 ref33">(12,33)</a> These observations support the use of the mouse CFA inflammatory pain model to assess the in vivo efficacy of P2X4 antagonists. In a first study, the anti-inflammatory effect of compound <b>10</b> was evaluated by measuring intraplantar levels of PGE2. <b>10</b> was administered once per os (p.o.) at doses of 12.5, 25, and 50 mg/kg. Treatment with CFA showed a significant induction of PGE2 levels in the inflamed paw in comparison to the contralateral paw (mean ± standard deviation (SD); contraleral paw, 298 ± 167 mg/mL; CFA, 955 ± 340 mg/mL; <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). At the two highest tested doses (25 and 50 mg/kg), compound <b>10</b> significantly reduced intraplantar PGE2 levels (mean ± SD; 12.5 mg/kg, 890 ± 458 mg/mL; 25 mg/kg, 554 ± 289 mg/mL; 50 mg/kg, 337 ± 74 mg/mL; <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). Plasma levels of <b>10</b> one hour after dosing (<i>C</i><sub>ub</sub>; mean ± SD; 12.5 mg/kg, 186 ± 43 nM; 25 mg/kg, 374 ± 70 nM; 50 mg/kg, 672 ± 154 nM) indicated that unbound plasma levels should exceed the mouse IC<sub>80</sub> (mouse IC<sub>80</sub> = 490 nM in 1321N1 cells) to observe a significant efficacy on PGE2 levels. The observed efficacy was then comparable to the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib (mean ± SD; rofecoxib, 327 ± 76 mg/mL; <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A).</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0016.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Anti-inflammatory and antinociceptive effects of compound <b>10</b> (<b>BAY-1797</b>) evaluated in the mouse CFA inflammatory pain model, 48 h following intraplantar CFA injection. (A) Following a single administration, <b>10</b> or rofecoxib dose-dependently reduces PGE2 concentration in inflamed paw. (B) Reduction of nonevoked inflammatory hyperalgesia observed using dynamic weight bearing following daily administration of <b>10</b> or rofecoxib. One-way analysis of variance (ANOVA) followed by Holm–Sidak’s multiple comparisons test and was performed vs vehicle group (*, <i>p</i> < 0.05; **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001) or vs baseline values (##, <i>p</i> < 0.01; ###, <i>p</i> < 0.001). <i>n</i> = 8 per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Changes in pain-related spontaneous behavior were evaluated in the mouse CFA model over 48 h following multiple p.o. administrations of compound <b>10</b> (50 mg/kg, once daily). As previously described, we evaluated nonevoked inflammatory hyperalgesia using the dynamic weight bearing (DWB) system.<a onclick="showRef(event, 'ref32 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref32 ref34 ref35 ref36">(32,34−36)</a> DWB quantifies whether a relief posture is taken by animals to avoid pain. We observed that treatment with CFA induced a significant reduction of the ipsilateral paw load 24 and 48 h after CFA injection compared to baseline values (mean ± SD; baseline, 94 ± 19%; 24h, 38 ± 23%; 48h, 49 ± 22%; <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). Daily treatment with <b>10</b> or rofecoxib significantly reduced nonevoked pain-related behavior by increasing paw load on the ipsilateral paw. While the effect of <b>10</b> was not significant and inferior to the effect of rofecoxib at 24 h (mean ± SD; compound <b>10</b>, 63 ± 11%; rofecoxib, 90 ± 32%; <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), a comparable efficacy was observed at 48 h (mean ± SD; compound <b>10</b>, 80 ± 32%; rofecoxib, 87 ± 37%; <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B). Relevant unbound plasma levels of compound <b>10</b> were measured 80 min after dosing (C<sub>ub</sub>; mean ± SD; 50 mg/kg, 548 ± 32 nM).</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08015" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08015" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, we have identified and characterized <b>10</b> (<b>BAY-1797</b>) as potent and selective P2X4 inhibitor. Anti-inflammatory and antinociceptive effects of <b>10</b> were demonstrated in mouse CFA inflammatory pain models.</div><div class="NLM_p"><b>BAY-1797</b> together with the negative control <b>BAY-207</b> (compound <b>27</b>) are available at the Structure Genomics Center (SGC) within their chemical probe program.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Chemical probes are chemical biology tool compounds, where a selective small-molecule modulator of a protein’s function allows answering research questions about a specific target and hence improving the understanding of the physiological or pathological role of a target.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a></div><div class="NLM_p last">Due to its high risk for CYP 3A4 induction in the clinic, compound <b>10</b> was not considered for further profiling toward clinical testing. In the course of the optimization program, we performed a structure-guided optimization to abolish PXR binding by introduction of longer and more polar substituents on the ether linker and larger groups in para-position on the phenylacetic acid group. This translated into significantly improved CYP induction profiles for tetrahydropyranmethyl ethers <b>71</b> and <b>73</b>. Unfortunately, the in vivo PK profiles of these compounds were insufficient for the desired profile of once or twice daily oral dosing in humans and these compounds had to be terminated. Further optimization work focused on maintaining this favorable CYP induction profile and combining it with further improved PK and potency profiles will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86053" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86053" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General</h4><div class="NLM_p">All reagents and solvents were used as purchased, unless otherwise specified. Intermediates <b>11a</b>, <b>11b</b>, and <b>63</b> were purchased, and all others were prepared as described below. All air- and moisture-sensitive reactions were carried out in oven-dried (at 120 °C) glassware under an inert atmosphere of argon. The purity of most final compounds was ≥ 95%, determined by liquid chromatography mass spectrometry (LC–MS) and <sup>1</sup>H NMR. Reactions were monitored by thin-layer chromatography (TLC) and ultraperformance liquid chromatography (UPLC) analysis with a Waters Acquity UPLC MS Single Quad system; column: Acquity UPLC BEH C18 1.7 μm, 50 × 2.1 mm; eluent A: water (H<sub>2</sub>O) + 0.2 vol % aqueous (aq) ammonia (NH<sub>3</sub>, 32%) and eluent B: acetonitrile (MeCN); gradient: 0–1.6 min 1–99% B, 1.6–2.0 min 99% B; flow: 0.8 mL/min; temperature: 60 °C; diode array detector (DAD) scan: 210–400 nm. Flash chromatography was carried out using a Biotage Isolera One system with a 200–400 nm variable detector, using Biotage SNAP KP-Sil or KP-NH cartridges. Preparative high-performance liquid chromatography (HPLC) was carried out with a Waters AutoPurification MS Single Quad system; column: Waters XBridge C18 5 μm, 100 mm × 30 mm; eluent A: H<sub>2</sub>O + 0.2 vol % aq NH3 (32%) and eluent B: MeCN; gradient: 0–5.5 min 5–100% B; flow: 70 mL/min; temperature: 25 °C; DAD scan: 210–400 nm. Analytical TLC was carried out on aluminum-backed plates coated with Merck Kieselgel 60 F254, with visualization under UV light at 254 nm. All NMR spectra were recorded on Bruker Avance III HD spectrometers. <sup>1</sup>H NMR spectra were obtained at 300, 400, 500, or 600 MHz and referenced to the residual solvent signal (2.49 ppm for DMSO-<i>d</i><sub>6</sub>).</div><div class="NLM_p last"><sup>13</sup>C NMR spectra were obtained at 101 or 151 MHz and also referenced to the residual solvent signal (39.7 ppm for DMSO-<i>d</i><sub>6</sub>). All spectra were obtained at ambient temperature (22 ± 1 °C). <sup>1</sup>H NMR data are reported as follows: chemical shift (δ) in ppm, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), and integration. Mass spectra were recorded on LC-MS instruments. Analytical LC-MS and UPLC-MS conditions are reported in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure for Nucleophilic Aromatic Substitution</h4><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i22" class="anchor-spacer"></div><h5 class="article-section__title" id="_i22"> GP1.1</h5><div class="NLM_p last">Sulfonamide <b>12</b> (1.29 mmol) was dissolved in acetonitrile (10 mL) and cesium carbonate (1.29 mmol, 1.0 eq), and the corresponding alcohols (1.29 mmol, 1.0 eq) were added. Stirring was continued at 85–100 °C until TLC showed consumption of starting material. The solvent was removed under reduced pressure, followed by addition of water and dichloromethane. Afterward, the phases were separated, the organic phase was dried, and concentrated in vacuo. The crude product was either used without further purification or purified as indicated in the examples.</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i23" class="anchor-spacer"></div><h5 class="article-section__title" id="_i23"> GP1.2</h5><div class="NLM_p last">Sulfonamide <b>12</b> (1.29 mmol) was dissolved in dimethylformamide (20 mL) and the corresponding alcohol (1.94 mmol, 1.5 eq) was added followed by the addition of sodium hydride (9.05 mmol, 1.5 eq). Stirring was continued for aliphatic alcohols at room temperature and for phenols at 110 °C until TLC showed consumption of starting material. The reaction mixture was cooled to 0 °C and water and ethyl acetate was carefully added. Afterward, the phases were separated and the aqueous phase was extracted three times with ethyl acetate. The combined organic phases were dried and concentrated in vacuo. The crude was either used without further purification or purified as indicated in the examples.</div></div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> General Procedure for Reduction of Nitro Compounds</h4><div id="sec4_1_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> GP2.1</h5><div class="NLM_p last">Nitro compound <b>13</b>, <b>31</b>, or <b>63</b> (0.85 mmol) was dissolved in tetrahydrofuran (25 mL) and Pd/C (0.09 mmol, 0.1 eq) was added. The flask was evacuated three times and flushed with hydrogen (1 bar) and stirring was continued at room temperature. After completion of the reaction, the mixture was filtered and concentrated in vacuo. The crude was used without further purification.</div></div><div id="sec4_1_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> GP2.2</h5><div class="NLM_p last">Nitro compound <b>13</b>, <b>31a–u</b>, or <b>63</b> (1.29 mmol) was dissolved in dioxane (6 mL) and tinn(II)chloride dihydrate (6.46 mmol, 5.0 eq) was added, and the reaction mixture was stirred for 2 h at 70 °C. After cooling to room temperature, the reaction mixture was filtered and concentrated in vacuo. The filtrate was either used without further purification or purified as indicated in the examples.</div></div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> General Procedure for Acylation of Anilines</h4><div id="sec4_1_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i28" class="anchor-spacer"></div><h5 class="article-section__title" id="_i28"> GP3.1</h5><div class="NLM_p last">Aniline <b>14</b>, <b>32a–u</b>, or <b>64</b> (0.17 mmol) was dissolved in dimethylformamide (5 mL) followed by the addition of the corresponding acid chloride (0.6 mmol), potassium carbonate (0.5 mmol). The reaction mixture was stirred at room at 100 °C until TLC showed consumption of starting material. After cooling to r.t., dichloromethane and water were added to the reaction mixture and phases were separated. The aqueous phase was extracted three times with ethyl acetate, the combined organic phase was dried, and the solvent was removed under reduced pressure. The crude was used without further purification.</div></div><div id="sec4_1_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i29" class="anchor-spacer"></div><h5 class="article-section__title" id="_i29"> GP3.2</h5><div class="NLM_p last">Aniline <b>14</b>, <b>32</b>, or <b>64</b> (1.29 mmol) was dissolved in dimethylformamide (6 mL) followed by the addition of the corresponding acid (1.42 mmol, 1.1 eq), <i>N</i>,<i>N-</i>diisopropylethylamine (6.46 mmol, 5.0 eq), and HATU (2.07 mmol, 1.6 eq). The reaction mixture was either stirred overnight at room temperature or heated at 50 °C until TLC showed consumption of starting material. After cooling to room temperature, the reaction mixture was concentrated in vacuo. Ethyl acetate and water were added, and the organic phase was dried and concentrated in vacuo. The crude was used without further purification.</div></div><div id="sec4_1_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i30" class="anchor-spacer"></div><h5 class="article-section__title" id="_i30"> GP3.3</h5><div class="NLM_p last">Aniline <b>14</b>, <b>32</b>, or <b>64</b> (0.25 mmol), the corresponding acid (0.50 mmol, 2.0 eq), HATU (0.50 mmol, 2.0 eq), and <i>N</i>-methylmorpholine (1.0 mmol, 2.0 eq) were dissolved in NMP (2.83 mL, containing 2.5% DMAP) and stirred for 2 h at room temperature, followed by stirring overnight at 60 °C. The reaction mixture was concentrated in vacuo, and the crude was used without further purification.</div></div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> General Procedure for Deprotection of 2,4-Dimethoxybenzyl Sulfonamides</h4><div id="sec4_1_5_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> GP4</h5><div class="NLM_p last">Crude amide (1.29 mmol) was dissolved in dichloromethane (5–10 mL), trifluoroacetic acid (64.5 mmol, 50 eq) was added, and the reaction mixture was stirred at room temperature until TLC showed consumption of starting material. The reaction mixture was concentrated in vacuo, ethyl acetate and water were added to the crude, the organic phase was dried, and the solvent was removed under reduced pressure. The resulting residue was purified as indicated in the examples. Purification without aqueous extraction was also possible but made the HPLC purification more difficult.</div></div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> General Procedue Alkylation of Phenols</h4><div id="sec4_1_6_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> GP5</h5><div class="NLM_p last">Phenol <b>65</b> (0.20 mmol) was dissolved in dimethylformamide (3–5 mL), cooled in an ice bath, and treated with sodium hydride (55% purity, 0.24 mmol, 1.2 eq). After stirring for 20 min, the corresponding alkyl or benzyl halide (0.30 mmol, 1.5 eq) was added and the reaction mixture was allowed to warm up and stirred at room temperature (if not indicated otherwise) until TLC showed consumption of starting material. Water and ethyl acetate were added, the organic phase was washed twice with water, dried, and concentrated in vacuo. The crude was purified as indicated in the examples to yield pure final compound.</div></div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (<b>10</b>, <b>BAY-1797</b>)</h4><div class="NLM_p last"><b>15a</b> (150 mg, 0.264 mmol) was converted according to GP4 to <b>10</b>. The pure compound was obtained after preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (28 mg, 0.066 mmol, 25% yield, 95% purity). LC-MS (method B): Rt = 1.12 min; MS (ESIpos): <i>m</i>/<i>z</i> = 417 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.65 (s, 2H), 6.92–7.00 (m, 1H), 7.04–7.11 (m, 2H), 7.15–7.22 (m, 1H), 7.22–7.30 (m, 1H), 7.30–7.45 (m, 7H), 7.77–7.85 (m, 1H), 8.16–8.23 (m, 1H), 10.46 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 43.3, 117.0, 118.6, 118.7, 121.5, 123.3, 123.9, 126.6, 128.4, 129.1, 131.1, 133.6, 135.2, 135.3, 135.7, 147.5, 158.0, 169.3.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 2-Chloro-<i>N</i>-(2,4-dimethoxybenzyl)-5-nitrobenzenesulfonamide (<b>12a</b>)</h4><div class="NLM_p last">To a solution of <b>11a</b> (10.8 g, 42.2 mmol) in dichloromethane (108 mL) were added sodium bicarbonate (7.09 g, 84.4 mmol) and 1-(2,4-dimethoxyphenyl)methanamine (7.05 g, 42.2 mmol). The mixture was stirred overnight. The reaction mixture was concentrated in vacuo, followed by addition of water (75 mL) and ethyl acetate (75 mL). After stirring for 10 min, the resulting precipitate was separated by filtration, and it was dried at 40 °C overnight in vacuo to yield <b>12a</b> (14.1 g, 36.5 mmol, 86% yield). LC-MS (method A): Rt = 1.17 min; MS (ESIneg): <i>m</i>/<i>z</i> = 385 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.56 (s, 3H), 3.61 (s, 3H), 4.08 (s, 2H), 6.10 (d, 1H), 6.26 (dd, 1H), 7.04 (d, 1H), 7.79 (d, 1H), 8.19 (d, 1H), 8.28 (dd, 1H), 8.45 (s, 1H).</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> <i>N</i>-(2,4-Dimethoxybenzyl)-2-fluoro-5-nitrobenzenesulfonamide (<b>12b</b>)</h4><div class="NLM_p last">To a solution of 1-(2,4-dimethoxyphenyl)methanamine (0.669 g, 4.00 mmol) in dichloromethane (40 mL) was added under ice cooling <i>N-</i>ethyl-<i>N-</i>isopropylpropan-2-amine (1.29 g, 10.0 mmol). Over 25 min, a solution of <b>11b</b> (0.958 g, 4.00 mmol) in dichloromethane (10 mL) was slowly added. Stirring was continued under ice cooling for 2 h, followed by stirring at room temperature overnight. It was washed with water, dried over sodium sulfate, and concentrated in vacuo. Column chromatography on a Biotage Isolera system (silica gel, gradient <i>n</i>-hexane/ethyl acetate) gave <b>12b</b> (400 mg, 1.08 mmol, 27% yield, purity 70%). LC-MS (method A): Rt = 1.12 min; MS (ESIneg): <i>m</i>/<i>z</i> = 369 (M – H)<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 2-(3-Chlorophenoxy)-<i>N</i>-[(2,4-dimethoxyphenyl)methyl]-5-nitrobenzene-1-sulfonamide (<b>13</b>)</h4><div class="NLM_p last"><b>12a</b> (49.9 g, 129 mmol) was dissolved in acetonitrile (500 mL) under nitrogen atmosphere. Cesium carbonate (42.0 g, 129 mmol) and 3-chlorophenol (14 mL, 130 mmol) were added successively under stirring. The reaction was heated overnight at 110 °C. After completion of the reaction, the mixture was cooled to r.t. and DCM (500 mL) was added. The suspension was filtered and the precipitate was washed with DCM. Afterward, the solid was suspended in water and filtered. The filtrate was evaporated and DCM/water (250 mL/250 mL) was added, and the precipitate was filtered off and washed with water. The combined product (<b>13</b>) was used without further purification in the next step (83.6 g, 84%). LC-MS (method B): Rt = 1.38 min; MS (ESIpos): <i>m</i>/<i>z</i> = 496 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ [ppm]= 3.57 (s, 3H), 3.65 (s, 3H), 4.13 (s, 2H), 6.23 (d, 1H), 6.32–6.37 (m, 1H), 6.95–7.02 (m, 1H), 7.08–7.14 (m, 2H), 7.16–7.21 (m, 1H), 7.36–7.45 (m, 1H), 7.49–7.59 (m, 1H), 8.20 (s, 1H), 8.27–8.37 (m, 2H).</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-Amino-2-(3-chlorophenoxy)-<i>N</i>-(2,4-dimethoxybenzyl)benzenesulfonamide (<b>14</b>)</h4><div class="NLM_p last">The reaction was performed in an autoclave reactor. <b>13</b> (13.0 g, 27.1 mmol) was suspended in toluene (150 mL) and water (150 mL) was added. The pH was adjusted to 3 by addition of phosphoric acid (85%, 40 μL). Afterward, platinum/vanadium (1%/2%) on activated carbon (ca. 50% wetted powder) (3.34 g, 1% purity, 136 μmol) was added. The reaction mixture was set under hydrogen atmosphere (6.48 bar), the temperature was adjusted to 100 °C, and stirred for 4 h (caution: raise in pressure observed). After completion of the reaction, the catalyst was filtered off. The phases were separated, and the aqueous phase was extracted three times with ethyl acetate. The combined organic phases were washed with half-saturated aq. NaCl and dried over sodium sulfate. After filtration, the solvent was removed under reduced pressure to yield <b>14</b> (12.4 g, 102%). The crude was used without further purification in the next step. LC-MS (method A): Rt = 1.26 min; MS (ESIpos): <i>m</i>/<i>z</i> = 449 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ [ppm]= 3.67–3.74 (m, 6H), 3.98 (d, 2H), 5.47 (s, 2H), 6.39–6.48 (m, 2H), 6.70–6.77 (m, 1H), 6.78–6.85 (m, 2H), 6.87–6.94 (m, 1H), 7.03–7.10 (m, 2H), 7.11–7.15 (m, 1H), 7.27–7.37 (m, 1H), 7.41–7.48 (m, 1H).</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-{4-(3-Chlorophenoxy)-3-[(2,4-dimethoxybenzyl)sulfamoyl]phenyl}-2-phenylacetamide (<b>15a</b>)</h4><div class="NLM_p last"><b>14</b> (500 mg, 1.14 mmol) was converted according to GP3.2 to <b>15a</b>. The crude was purified by column chromatography on a Biotage Isolera system (silica gel, gradient <i>n</i>-hexane/ethyl acetate) (550 mg, 631 mmol, 87% yield, 99% purity). LC-MS (method A): Rt = 1.39 min; MS (ESIpos): <i>m</i>/<i>z</i> = 567 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.54–3.73 (m, 8H), 4.01 (d, 2H), 6.30–6.42 (m, 2H), 6.80–6.92 (m, 1H), 6.92–7.03 (m, 2H), 7.04–7.15 (m, 1H), 7.15–7.23 (m, 1H), 7.23–7.31 (m, 1H), 7.31–7.39 (m, 5H), 7.63–7.75 (m, 1H), 7.75–7.85 (m, 1H), 8.08 (d, 1H), 10.44 (s, 1H).</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-(2-methylphenyl)acetamide (<b>16</b>)</h4><div class="NLM_p last">According to GP3.1 and GP4, aniline <b>14</b> (150 mg, 0.267 mmol) was reacted with (2-methylphenyl)acetyl chloride (50 mg, 0.294 mmol) to give <b>16</b>. The pure compound was obtained after preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (15 mg, 0.034 mmol, 13% yield over two steps, 95% purity). LC-MS (method B): Rt = 1.17 min; MS (ESIneg): <i>m</i>/<i>z</i> = 429 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 2.30 (s, 3H), 3.68 (s, 2H), 6.93–7.03 (m, 1H), 7.05–7.28 (m, 7H), 7.34–7.45 (m, 3H), 7.76–7.86 (m, 1H), 8.16–8.25 (m, 1H), 10.44 (s, 1H).</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-(3-methylphenyl)acetamide (<b>17</b>)</h4><div class="NLM_p last">According to GP3.1 and GP4, aniline <b>14</b> (150 mg, 0.267 mmol) was reacted with (3-methylphenyl)acetyl chloride (50 mg, 0.294 mmol) to give <b>17</b>. The pure compound was obtained after preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (22 mg, 0.052 mmol, 20% yield over two steps, 95% purity). LC-MS (method B): Rt = 1.18 min; MS (ESIneg): <i>m</i>/<i>z</i> = 429 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 2.28 (s, 3H), 3.59 (s, 2H), 6.92–7.01 (m, 1H), 7.03–7.26 (m, 7H), 7.33–7.44 (m, 3H), 7.77–7.87 (m, 1H), 8.15–8.24 (m, 1H), 10.44 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 21.0, 43.3, 117.0, 118.6, 118.7, 121.5, 123.3, 123.9, 126.1, 127.3, 128.3, 129.7, 131.1, 133.6, 135.2, 135.3, 135.6, 137.4, 147.5, 158.0, 169.4.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-(4-methylphenyl)acetamide (<b>18</b>)</h4><div class="NLM_p last">According to GP3.1 and GP4, aniline <b>14</b> (150 mg, 0.267 mmol) and (4-methylphenyl)acetyl chloride (50 mg, 0.294 mmol) were reacted to give <b>18</b>. The pure compound was obtained after purification by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (23 mg, 0.053 mmol, 21% yield over two steps, 95% purity). LC-MS (method B): Rt = 1.18 min; MS (ESIpos): <i>m</i>/<i>z</i> = 431 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 2.27 (s, 3H), 3.59 (s, 2H), 6.94–7.00 (m, 1H), 7.05–7.09 (m, 2H), 7.11–7.15 (m, 2H), 7.17–7.24 (m, 3H), 7.32–7.43 (m, 3H), 7.75–7.85 (m, 1H), 8.15–8.23 (m, 1H), 10.39 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 20.7, 42.9, 117.0, 118.6, 118.7, 121.5, 123.3, 123.9, 128.9, 131.1, 132.7, 133.6, 135.2, 135.3, 135.7, 147.5, 158.0, 169.5.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-(2-fluorophenyl)acetamide (<b>19</b>)</h4><div class="NLM_p last">According to GP3.2 and GP4, aniline <b>14</b> (300 mg, 0.668 mmol) and (2-fluorophenyl)acetic acid (124 mg, 0.802 mmol) were reacted to give <b>19</b>. The pure compound was obtained after preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid). (246 mg, 0.56 mmol, 85% yield, 95% purity). LC-MS (method A): Rt = 1.18 min; MS (ESIneg): <i>m</i>/<i>z</i> = 433 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.74 (s, 2H), 6.94–7.01 (m, 1H), 7.05–7.10 (m, 2H), 7.14–7.22 (m, 4H), 7.29–7.42 (m, 4H), 7.79 (dd, 1H), 8.20 (d, 1H), 10.52 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 36.4, 115.0, 115.2, 117.0, 118.6, 118.8, 121.6, 122.7, 122.9, 123.3, 123.9, 124.3, 124.4, 128.9, 129.0, 131.2, 132.0, 132.1, 133.7, 135.3, 135.4, 147.6, 158.1, 159.5, 161.9, 168.3.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-(2-chlorophenyl)acetamide (<b>20</b>)</h4><div class="NLM_p last">According to GP3.1 and GP4, aniline <b>14</b> (175 mg, 0.292 mmol) and (2-chlorophenyl)acetyl chloride (66 mg, 0.350 mmol) were reacted to give <b>20</b>. The pure compound was obtained after preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (34 mg, 0.075 mmol, 26% yield, 95% purity). LC-MS (method B): Rt = 1.16 min; MS (ESIneg): <i>m</i>/<i>z</i> = 449 (M – H)<sup>+</sup>.<sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.86 (s, 2H), 6.92–7.14 (m, 3H), 7.17–7.23 (m, 1H), 7.27–7.52 (m, 7H), 7.73–7.86 (m, 1H), 8.17–8.28 (m, 1H), 10.53 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.8, 117.0, 118.6, 118.7, 121.6, 123.3, 123.9, 127.1, 128.7, 129.0, 131.2, 132.3, 133.6, 133.7, 133.8, 135.2, 135.3, 147.5, 158.0, 168.2.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-[2-(trifluoromethyl)phenyl]acetamide (<b>21</b>)</h4><div class="NLM_p last">According to general procedures GP3.2 and GP4, purified <b>14</b> (70.0 mg, 0.156 mmol) and [2-(trifluoromethyl)phenyl]acetic acid (35.0 mg, 0.172 mmol) were converted to <b>21</b> and were purified by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (62 mg, 0.128 mmol, 82% yield, 97% purity). LC-MS (method A): Rt = 1.28 min; MS (ESIpos): <i>m</i>/<i>z</i> = 485 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.94 (s, 2H), 6.98 (ddd, 1H), 7.07–7.11 (m, 2H), 7.19 (ddd, 1H), 7.37–7.42 (m, 3H), 7.47–7.56 (m, 2H), 7.63–7.69 (m, 1H), 7.72 (d, 1H), 7.78 (dd, 1H), 8.20 (d, 1H), 10.52 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 117.0, 118.6, 118.7, 121.5, 123.3, 123.9, 125.6, 125.7, 127.3, 127.4, 131.1, 132.3, 133.5, 133.6, 135.2, 147.6, 158.0, 168.2 (one signal below solvent).</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-(2-methoxyphenyl)acetamide (<b>22</b>)</h4><div class="NLM_p last">According to GP3.2 and GP4, aniline <b>14</b> (175 mg, 0.29 mmol) was converted to <i>N-</i>[4-(3-chlorophenoxy)-3-sulfamoylphenyl]-2-(2-methoxyphenyl)acetamide. The pure compound was obtained after preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (40 mg, 0.090 mmol, 34% over two steps, 95% purity). LC-MS (method B): Rt = 1.11 min; MS (ESIneg): <i>m</i>/<i>z</i> = 445 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.63 (s, 2H), 3.77 (s, 3H), 6.86–6.95 (m, 1H), 6.95–7.03 (m, 2H), 7.06–7.13 (m, 2H), 7.14–7.31 (m, 3H), 7.34–7.44 (m, 3H), 7.80 (dd, 1H), 8.22 (d, 1H), 10.36 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 37.7, 55.4, 110.7, 116.9, 118.5, 118.6, 120.2, 121.5, 123.2, 123.8, 123.9, 128.1, 130.8, 131.1, 133.6, 135.2, 135.5, 147.3, 157.2, 158.1, 169.4.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 2-(2-Chloro-6-fluorophenyl)-<i>N</i>-[4-(3-chlorophenoxy)-3-sulfamoylphenyl]acetamide (<b>23</b>)</h4><div class="NLM_p last">According to general procedures GP3.2 and GP4, purified <b>14</b> (50.0 mg, 0.111 mmol) and (2-chloro-6-fluorophenyl)acetic acid (23.1 mg, 0.123 mmol) were converted to <b>23</b> and were purified by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (12 mg, 0.0256 mmol, 23% yield, 98% purity). LC-MS (method A): Rt = 1.21 min; MS (ESIpos): <i>m</i>/<i>z</i> = 469 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, dichloromethane-<i>d</i><sub>2</sub>) δ [ppm]: 3.95 (d, 2H), 5.14 (s, 2H), 6.98 (d, 1H), 7.01 (ddd, 1H), 7.10–7.15 (m, 2H), 7.22 (ddd, 1H), 7.30–7.38 (m, 3H), 7.43 (s, 1H), 7.87 (dd, 1H), 7.94 (d, 1H).</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-(2,6-dichlorophenyl)acetamide (<b>24</b>)</h4><div class="NLM_p last">According to general procedures GP3.2 and GP4, purified <b>14</b> (50.0 mg, 0.111 mmol) and (2,6-dichlorophenyl)acetic acid (25.1 mg, 0.123 mmol) were converted to <b>24</b> and were purified by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (11 mg, 0.0268 mmol, 20% yield, 95% purity). LC-MS (method A): Rt = 1.25 min; MS (ESIpos): <i>m</i>/<i>z</i> = 486 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 4.06 (s, 2H), 6.98 (ddd, 1H), 7.08–7.11 (m, 2H), 7.18–7.22 (m, 1H), 7.33–7.40 (m, 2H), 7.41 (s, 2H), 7.50 (d, 2H), 7.76 (dd, 1H), 8.21 (d, 1H), 10.64 (s, 1H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.0, 117.0, 118.6, 121.6, 123.3, 123.9, 128.2, 129.6, 131.2, 132.0, 133.6, 135.2, 135.2, 135.6, 147.6, 158.0, 166.8.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylpropanamide (<b>25</b>)</h4><div class="NLM_p last">According to GP3.1 and GP4, aniline <b>14</b> (170 mg, 0.284 mmol) and 2-phenylpropanoyl chloride (57 mg, 0.340 mmol) were reacted to give <b>25</b>. The pure compound was obtained after preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (17 mg, 0.038 mmol, 15% yield over two steps, 95% yield). LC-MS (method E): Rt = 1.17 min; MS (ESIneg): <i>m</i>/<i>z</i> = 429 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.42 (d, 3H), 3.82 (q, 1H), 6.96 (dd, 1H), 7.03–7.10 (m, 2H), 7.16–7.20 (m, 1H), 7.21–7.27 (m, 1H), 7.31–7.43 (m, 7H), 7.81 (dd, 1H), 8.20 (d, 1H), 10.35 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 18.6, 46.0, 117.0, 118.6, 118.7, 121.5, 123.3, 123.9, 126.8, 127.2, 128.4, 131.1, 133.6, 135.1, 135.3, 141.6, 147.5, 158.0, 172.4.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-(2-chlorophenyl)propanamide (<b>26</b>)</h4><div class="NLM_p last">According to GP3.2 and GP4, aniline <b>14</b> (170 mg, 0.379 mmol) was reacted with 2-(2-chlorophenyl)propanoic acid (84 mg, 0.454 mmol) to give <b>26</b>, and it was purified by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (24 mg, 0.048 mmol, 13% yield, 95% purity). LC-MS (method E): Rt = 1.26 min; MS (ESIneg): <i>m</i>/<i>z</i> = 463 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.45 (d, 3H), 4.20 (q, 1H), 6.94–7.00 (m, 1H), 7.05–7.11 (m, 2H), 7.19 (ddd, 1H), 7.27–7.42 (m, 5H), 7.46 (dd, 2H), 7.83 (dd, 1H), 8.22 (d, 1H), 10.43 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 17.9, 43.2, 117.0, 118.6, 118.9, 121.5, 123.3, 124.1, 127.5, 128.5, 129.3, 131.1, 132.9, 133.6, 135.1, 135.3, 138.8, 147.6, 158.0, 171.7.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-1-(2-chlorophenyl)cyclopropane-1-carboxamide (<b>27, BAY-207</b>)</h4><div class="NLM_p last">According to GP3.2 and GP4, aniline <b>14</b> (300 mg, 668 μmol) and 1-(2-chlorophenyl)cyclopropane-1-carboxylic acid (145 mg, 735 μmol) were converted to <b>27</b>. The crude was purified by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) to yield 20 mg of final compound (6% yield, 95% purity). LC-MS (method B): Rt = 1.28 min; MS (ESIpos): <i>m</i>/<i>z</i> = 477 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.12–1.17 (m, 2H), 1.61–1.66 (m, 2H), 6.96 (ddd, 1H), 7.02 (d, 1H), 7.07 (t, 1H), 7.19 (ddd, 1H), 7.34 (s, 2H), 7.36–7.43 (m, 3H), 7.45–7.57 (m, 2H), 7.74 (dd, 1H), 8.07 (d, 1H), 9.00 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 16.3, 29.8, 117.1, 118.7, 120.8, 121.0, 123.3, 126.3, 127.4, 129.3, 129.4, 131.1, 132.7, 133.6, 134.6, 134.9, 136.1, 137.0, 148.0, 157.9, 170.7.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-(4-fluorophenyl)acetamide (<b>28</b>)</h4><div class="NLM_p last">According to general procedures GP3.3 and GP4, purified <b>14</b> (112 mg, 0.25 mmol) and (4-fluorophenyl)acetic acid (77.0 mg, 0.50 mmol) were converted to <b>28</b> and were purified by HPLC (12.9 mg, 0.297 mmol, 12% yield, 99% purity). LC-MS (method A): Rt = 1.12 min; MS (ESIpos): <i>m</i>/<i>z</i> = 435 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.65 (s, 2H), 6.97 (ddd, 1H), 7.07–7.11 (m, 2H), 7.18 (d, 3H), 7.34–7.43 (m, 5H), 7.81 (dd, 1H), 8.20 (d, 1H), 10.48 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 42.2, 115.0, 115.2, 117.0, 118.6, 118.7, 121.5, 123.3, 124.0, 130.9, 131.0, 131.1, 131.9, 131.9, 133.6, 135.2, 135.2, 147.6, 158.0, 159.9, 162.4, 169.2.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-(4-chlorophenyl)acetamide (<b>29</b>)</h4><div class="NLM_p last">According to GP3.1 and GP4, aniline <b>14</b> (150 mg, 0.267 mmol) and (4-chlorophenyl)acetyl chloride (56 mg, 0.294 mmol) were reacted to give <b>29</b>. The pure compound was obtained after preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (24 mg, 0.054 mmol, 22% yield over two steps, 95% purity). LC-MS (method B): Rt = 1.20 min; MS (ESIpos): <i>m</i>/<i>z</i> = 451 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.66 (s, 2H), 6.90–7.02 (m, 1H), 7.05–7.13 (m, 2H), 7.14–7.23 (m, 1H), 7.35–7.42 (m, 7H), 7.77–7.84 (m, 1H), 8.14–8.23 (m, 1H), 10.48 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 42.4, 117.0, 118.6, 118.7, 121.5, 123.3, 124.0, 128.3, 131.0, 131.1, 131.4, 133.6, 134.7, 135.2, 135.2, 147.6, 158.0, 169.0.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-[4-(trifluoromethyl)phenyl]acetamide (<b>30</b>)</h4><div class="NLM_p last">According to general procedures GP3.2 and GP4, purified <b>14</b> (70.0 mg, 0.156 mmol) and [4-(trifluoromethyl)phenyl]acetic acid (35.0 mg, 0.172 mmol) were converted to <b>30</b> and were purified by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (28 mg, 0.0577 mmol, 37% yield, 99% purity). LC-MS (method A): Rt = 1.27 min; MS (ESIpos): <i>m</i>/<i>z</i> = 485 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.78 (s, 2H), 6.97 (ddd, 1H), 7.06–7.12 (m, 2H), 7.19 (ddd, 1H), 7.34–7.45 (m, 3H), 7.56 (d, 2H), 7.71 (d, 2H), 7.80 (dd, 1H), 8.19 (d, 1H), 10.55 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 42.8, 117.0, 118.6, 118.8, 121.5, 123.3, 124.0, 125.2, 127.4, 130.1, 131.1, 133.6, 135.1, 135.2, 140.5, 140.6, 147.7, 157.9, 168.6.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(2,4-Dimethoxybenzyl)-5-nitro-2-(tetrahydro-2<i>H</i>-pyran-4-ylmethoxy)benzenesulfonamide (<b>31u</b>)</h4><div class="NLM_p last"><b>12a</b> (2.00 g, 5.17 mmol) was dissolved in dimethylformamide (10 mL), treated with tetrahydro-2<i>H</i>-pyran-4-ylmethanol (901 mg, 7.76 mmol) and sodium hydride (1.58 g, 36.2 mmoL), and stirred for 2 h at room temperature. It was quenched under ice cooling with water/ethyl acetate. The phases were separated, the aqueous phase was three times reextracted with ethyl acetate, and all organic phases were combined, dried, and concentrated in vacuo. It was then stirred with ethyl acetate/methyl tert. butyl ether (1/2) until a white solid precipitated. Filtration led to <b>31u</b> (2.20 g, 4.75 mmol, 91% yield, 95% purity). LC-MS (method A): Rt = 1.16 min; MS (ESIneg): <i>m</i>/<i>z</i> = 465 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.23–1.36 (m, 2H), 1.70–1.77 (m, 2H), 2.09–2.23 (m, 1H), 3.29–3.39 (m, 2H), 3.59 (s, 3H), 3.65 (s, 3H), 3.89 (dd, 2H), 3.99 (d, 2H), 4.08 (s, 2H), 6.21 (d, 1H), 6.30 (dd, 1H), 7.01 (d, 1H), 7.25 (d, 1H), 7.42 (s, 1H), 8.23 (d, 1H), 8.31 (dd, 1H).</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 5-Amino-<i>N</i>-(2,4-dimethoxybenzyl)-2-(tetrahydro-2<i>H</i>-pyran-4-ylmethoxy)benzenesulfonamide (<b>32u</b>)</h4><div class="NLM_p last"><b>31u</b> (2.20 g, 4.75 mmol) was dissolved in methanol, treated with Pd/C (10% loading), and stirred under a hydrogen atmosphere for 3 days at room temperature. After filtration, the filtrate was concentrated in vacuo to give <b>32u</b> (1.55 g, 3.54 mmol, 75% yield), which was used without further purification in the following steps. LC-MS (method A): Rt = 0.92 min; MS (ESIpos): <i>m</i>/<i>z</i> = 437 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.25 (ddd, 2H), 1.63–1.70 (m, 2H), 1.90–2.03 (m, 1H), 3.25–3.33 (m, 2H), 3.68–3.74 (m, 8H), 3.85 (dd, 2H), 3.94 (d, 2H), 5.10 (s, 2H), 6.40 (dd, 1H), 6.46 (d, 1H), 6.54 (t, 1H), 6.72 (dd, 1H), 6.84 (d, 1H), 7.01 (d, 1H), 7.05 (d, 1H).</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 2-(2-Chlorophenyl)-<i>N</i>-(4-phenoxy-3-sulfamoylphenyl)acetamide (<b>33</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), phenol (127 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (240 mg, 1.41 mmol) were converted without purification of intermediates to <b>33</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (67 mg, 0.161 mmol, 12% yield over four steps, 98% purity). LC-MS (method A): Rt = 1.12 min; MS (ESIpos): <i>m</i>/<i>z</i> = 417 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.83 (s, 2H), 6.92 (d, 1H), 7.02–7.08 (m, 2H), 7.14 (tt, 1H), 7.26–7.35 (m, 4H), 7.35–7.47 (m, 4H), 7.74 (dd, 1H), 8.18 (d, 1H), 10.45 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>): δ [ppm]: 40.7, 118.7, 119.2, 120.2, 123.8, 123.9, 127.1, 128.7, 129.0, 129.8, 132.2, 133.7, 133.8, 134.3, 134.4, 149.0, 156.6, 168.1.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-[4-(2-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (<b>34</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), 2-chlorophenol (166 mg, 1.29 mmol), and phenylacetic acid (193 mg, 1.42 mmol) were converted without purification of intermediates to <b>34</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (28 mg, 0.0672 mmol, 5% yield over four steps, 98% purity). LC-MS (method A): Rt = 1.11 min; MS (ESIpos): <i>m</i>/<i>z</i> = 417 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.62 (s, 2H), 6.71 (d, 1H), 7.09 (dd, 1H), 7.20–7.41 (m, 9H), 7.59 (dd, 1H), 7.71 (dd, 1H), 8.18 (d, 1H), 10.41 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.7, 118.2, 119.0, 122.2, 124.0, 125.2, 126.0, 127.1, 128.7, 128.8, 129.0, 130.6, 132.2, 133.2, 133.7, 133.8, 134.2, 148.9, 151.4, 168.0.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-[4-(2-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (<b>35</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), 2-chlorophenol (166 mg, 1.29 mmol), and phenylacetic acid (193 mg, 1.42 mmol) were converted without purification of intermediates to <b>35</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (28 mg, 0.0672 mmol, 5% yield over four steps, 98% purity). LC-MS (method A): Rt = 1.11 min; MS (ESIpos): <i>m</i>/<i>z</i> = 417 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.62 (s, 2H), 6.71 (d, 1H), 7.09 (dd, 1H), 7.20–7.41 (m, 9H), 7.59 (dd, 1H), 7.71 (dd, 1H), 8.18 (d, 1H), 10.41 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 43.3, 118.2, 119.0, 122.2, 124.1, 125.2, 126.0, 126.6, 128.4, 128.9, 129.1, 130.6, 133.2, 134.3, 135.8, 148.9, 151.4, 169.2.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 2-(2-Chlorophenyl)-<i>N</i>-[4-(3-methoxyphenoxy)-3-sulfamoylphenyl]acetamide (<b>36</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), 3-methoxyphenol (160 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (242 mg, 1.42 mmol) were converted without purification of intermediates to <b>36</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (42 mg, 0.0940 mmol, 7% yield over four steps, 97% purity). LC-MS (method A): Rt = 1.13 min; MS (ESIpos): <i>m</i>/<i>z</i> = 447 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.75 (s, 3H), 3.85 (s, 2H), 6.60 (ddd, 1H), 6.67 (t, 1H), 6.74 (ddd, 1H), 6.99 (d, 1H), 7.25–7.36 (m, 5H), 7.41–7.49 (m, 2H), 7.76 (dd, 1H), 8.20 (d, 1H), 10.48 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.7, 55.3, 105.3, 109.4, 111.0, 118.7, 120.4, 123.9, 127.1, 128.7, 129.0, 130.3, 132.2, 133.7, 133.8, 134.3, 134.4, 148.7, 157.7, 160.5, 168.1.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 2-(2-Chlorophenyl)-<i>N</i>-{3-sulfamoyl-4-[4-(1,3-thiazol-2-yl)phenoxy]phenyl}acetamide (<b>37</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b>(500 mg, 1.29 mmol), 4-(1,3-thiazol-2-yl)phenol (229 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (248 mg, 1.46 mmol) were converted without purification of intermediates to <b>37</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (69 mg, 0.138 mmol, 11% yield over four steps, 98% purity). LC-MS (method A): Rt = 1.15 min; MS (ESIpos): <i>m</i>/<i>z</i> = 500 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.86 (s, 2H), 7.10–7.17 (m, 3H), 7.30–7.36 (m, 2H), 7.40–7.48 (m, 4H), 7.76 (d, 1H), 7.81 (dd, 1H), 7.91 (d, 1H), 7.95–7.99 (m, 2H), 8.24 (d, 1H), 10.55 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.8, 118.7, 119.1, 120.1, 121.5, 123.9, 127.1, 127.8, 128.4, 128.7, 129.0, 132.2, 133.6, 133.7, 135.1, 135.2, 143.8, 147.8, 158.6, 166.5, 168.1.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 2-(2-Chlorophenyl)-<i>N</i>-{3-sulfamoyl-4-[4-(tetrahydrofuran-3-yl)phenoxy]phenyl}acetamide (<b>38</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), 4-(tetrahydrofuran-3-yl)phenol (212 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (242 mg, 1.42 mmol) were converted without purification of intermediates to <b>38</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (45 mg, 0.0924 mmol, 7% yield over four steps, 98% purity). LC-MS (method A): Rt = 1.12 min; MS (ESIpos): <i>m</i>/<i>z</i> = 487 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.86–1.96 (m, 1H), 2.25–2.35 (m, 1H), 3.38 (quin, 1H), 3.53 (t, 1H), 3.80 (q, 1H), 3.84 (s, 2H), 3.95 (td, 1H), 4.03 (t, 1H), 6.94 (d, 1H), 6.98–7.03 (m, 2H), 7.28–7.36 (m, 6H), 7.41–7.47 (m, 2H), 7.74 (dd, 1H), 8.19 (d, 1H), 10.48 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 34.0, 40.7, 43.6, 67.6, 73.9, 118.7, 119.2, 120.1, 123.9, 127.1, 128.6, 128.7, 129.0, 132.2, 133.7, 133.8, 134.2, 134.3, 137.9, 149.1, 155.0, 168.0.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> 2-(2-Chlorophenyl)-<i>N</i>-{3-sulfamoyl-4-[3-(4H-1,2,4-triazol-4-yl)phenoxy]phenyl}acetamide (<b>39</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), 3-(4<i>H-</i>1,2,4-triazol-4-yl)phenol (208 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (242 mg, 1.42 mmol) were converted without purification of intermediates to <b>39</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (17 mg, 0.0351 mmol, 3% yield over four steps, 98% purity). LC-MS (method A): Rt = 0.92 min; MS (ESIpos): <i>m</i>/<i>z</i> = 484 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.84 (s, 2H), 6.99 (ddd, 1H), 7.09 (d, 1H), 7.27–7.34 (m, 2H), 7.36 (s, 2H), 7.40–7.46 (m, 2H), 7.46–7.50 (m, 1H), 7.51–7.57 (m, 2H), 7.79 (dd, 1H), 8.22 (d, 1H), 9.13 (s, 2H), 10.50 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.8, 112.0, 116.0, 117.6, 118.7, 121.0, 123.9, 127.1, 128.7, 129.0, 131.2, 132.2, 133.6, 133.7, 134.9, 135.0, 135.1, 141.3, 147.8, 157.8, 168.1.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i>-[4-(3-Acetamidophenoxy)-3-sulfamoylphenyl]-2-(2-chlorophenyl)acetamide (<b>40</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), <i>N-</i>(3-hydroxyphenyl)acetamide (195 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (242 mg, 1.42 mmol) were converted without purification of intermediates to <b>40</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (0.0317 mmol, 2% yield over four steps, two fractions were obtained with 8 mg 90% purity and 7 mg 98% purity). LC-MS (method A): Rt = 0.99 min; MS (ESIpos): <i>m</i>/<i>z</i> = 474 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 2.02 (s, 3H), 3.85 (s, 2H), 6.71–6.77 (m, 1H), 6.96 (d, 1H), 7.26–7.40 (m, 7H), 7.41–7.48 (m, 2H), 7.75 (dd, 1H), 8.19 (d, 1H), 10.00 (s, 1H), 10.48 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 24.1, 40.8,9.4, 113.7, 114.1, 118.7, 120.4, 123.9, 127.1, 128.7, 129.1, 129.8, 132.2, 133.7, 133.8, 134.4, 134.5, 140.7, 148.8, 156.9, 168.1, 168.4.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-{4-(4-Bromophenoxy)-3-[(2,4-dimethoxybenzyl)sulfamoyl]phenyl}-2-(2-chlorophenyl)acetamide (<b>41</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, and GP3.2, <b>12a</b> (2.90 g, 7.50 mmol), 4-bromophenol (1.30 g, 7.50 mmol), and (2-chlorophenyl)acetic acid (1.15 g, 6.75 mmol) were converted without purification of intermediates to <b>41</b>. A small amount was purified at the end by column chromatography on a Biotage Isolera system (silica gel, gradient dichloromethane/ethyl acetate) for NMR characterization, and the rest was used in the next step without further purification (purity 40%). LC-MS (method A): Rt = 1.45 min; MS (ESIneg): <i>m</i>/<i>z</i> = 645 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.65 (s, 3H), 3.71 (s, 3H), 3.85 (s, 2H), 4.03 (d, 2H), 6.39–6.43 (m, 2H), 6.89–6.94 (m, 2H), 6.96 (d, 1H), 7.10–7.14 (m, 1H), 7.29–7.36 (m, 2H), 7.42–7.49 (m, 2H), 7.52–7.58 (m, 2H), 7.73 (t, 1H), 7.77 (dd, 1H), 8.12 (d, 1H), 10.50 (s, 1H).</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> 2-(2-Chlorophenyl)-<i>N</i>-{4-[4-(3-oxomorpholin-4-yl)phenoxy]-3-sulfamoylphenyl}acetamide (<b>42</b>)</h4><div class="NLM_p last"><b>41</b> (129 mg, 0.20 mmol), cesium carbonate (97.7 mg, 0.30 mmol), morpholin-3-one (24.3 mg, 0.24 mmol), Xanthphos (2.3 mg, 0.004 mmol), and tris(dibenzylideneacetone)dipalladium(0) (9.2 mg, 0.01 mmol) were dissolved in dioxane (5 mL), flushed with argon, and stirred in a sealed vessel at 105 °C for 2.5 h. Then, the same amount of Xanthphos and tris(dibenzylideneacetone)-dipalladium(0) was added and stirring at 105 °C was continued overnight. After cooling to room temperature, the solvents were removed under reduced pressure and the residue was treated with water and dichloromethane. The organic phase was dried over sodium sulfate and concentrated, followed by chromatography over a Biotage Isolera system (silica gel, dichloromethane/ethyl acetate gradient). Then, the residue was redissolved in dichloromethane (10 mL), treated with trifluoroacetic acid (0.25 mL), and stirred overnight at room temperature. All volatile components were removed under reduced pressure, followed by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) leading to <b>42</b> (1.3 mg, 0.00252 mmol, 1% yield, 98% purity). LC-MS (method A): Rt = 0.95 min; MS (ESIpos): <i>m</i>/<i>z</i> = 516 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, methanol<i>-d</i><sub>4</sub>) δ [ppm]: 3.77–3.82 (m, 2H), 3.90 (s, 2H), 4.04–4.09 (m, 2H), 4.30 (s, 2H), 7.01 (d, 1H), 7.16–7.21 (m, 2H), 7.27–7.34 (m, 2H), 7.37–7.45 (m, 4H), 7.79 (dd, 1H), 8.22 (d, 1H).</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 2-(2-Chlorophenyl)-<i>N</i>-{4-[3-(morpholin-4-ylcarbonyl)phenoxy]-3-sulfamoylphenyl}-acetamide (<b>43</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), (3-hydroxyphenyl)(morpholin-4-yl)methanone (268 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (242 mg, 1.42 mmol) were converted without purification of intermediates to <b>43</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (65 mg, 0.123 mmol, 10% yield over four steps, 90% purity). LC-MS (method A): Rt = 0.99 min; MS (ESIpos): <i>m</i>/<i>z</i> = 530 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.44–3.70 (m, 8H), 3.85 (s, 2H), 7.02 (dd, 1H), 7.06 (s, 1H), 7.13 (ddd, 1H), 7.18 (dt, 1H), 7.28–7.35 (m, 2H), 7.39 (s, 2H), 7.42–7.47 (m, 3H), 7.78 (dd, 1H), 8.22 (d, 1H), 10.52 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.8, 66.0, 117.3, 118.7, 119.8, 121.1, 122.0, 123.9, 127.1, 128.7, 129.0, 130.0, 132.2, 133.6, 133.7, 134.9, 135.0, 137.0, 148.2, 156.8, 168.1, 168.2.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>N</i>-[4-(3-Bromophenoxy)-3-sulfamoylphenyl]-2-(2-chlorophenyl)acetamide (<b>44</b>)</h4><div class="NLM_p last">According to general procedures GP3.1 and GP4, aniline <b>14</b> (2.47g, 5 mmol) was converted to <i>N-</i>[4-(3-bromophenoxy)-3-sulfamoylphenyl]-2-(2-chlorophenyl)acetamide, and it was purified by two column chromatographies on a Biotage Isolera system (silica gel, gradient dichloromethane/ethyl acetate and dichloromethane/dichloromethane-methanol) (30 mg, 97% purity). LC-MS (method A): Rt = 1.23 min; MS (ESIpos): <i>m</i>/<i>z</i> = 497 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.86 (s, 2H), 7.00–7.06 (m, 1H), 7.10 (d, 1H), 7.22–7.24 (m, 1H), 7.29–7.37 (m, 4H), 7.39 (s, 2H), 7.42–7.49 (m, 2H), 7.80 (dd, 1H), 8.22 (d, 1H), 10.53 (s, 1H).</div></div><div id="sec4_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 2-(2-Chlorophenyl)-<i>N</i>-{4-[3-(3-oxomorpholin-4-yl)phenoxy]-3-sulfamoylphenyl}acetamide (<b>45</b>)</h4><div class="NLM_p last"><b>44</b> (129 mg, 0.20 mmol), cesium carbonate (97.7 mg, 0.30 mmol), morpholin-3-one (24.3 mg, 0.24 mmol), Xanthphos (2.3 mg, 0.004 mmol), and tris(dibenzylideneacetone)dipalladium(0) (9.2 mg, 0.01 mmol) were dissolved in dioxane (5 mL), flushed with argon, and stirred in a sealed vessel at 105 °C for 2.5 h. Then, the same amount of Xanthphos and tris(dibenzylideneacetone)-dipalladium(0) was added and stirring at 105 °C was continued overnight. After cooling to room temperature, the solvents were removed under reduced pressure and the residue was treated with water and dichloromethane. The organic phase was dried over sodium sulfate and concentrated, followed by chromatography over a Biotage Isolera system (silica gel, gradient dichloromethane/ethyl acetate). Then, the residue was redissolved in dichloromethane (10 mL), treated with trifluoroacetic acid (0.25 mL), and stirred overnight at room temperature. All volatile components were removed under reduced pressure followed by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) leading to <b>45</b> (5.2 mg, 0.0102 mmol, 5% yield, 98% purity). LC-MS (method A): Rt = 0.97 min; MS (ESIpos): <i>m</i>/<i>z</i> = 516 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.69–3.76 (m, 2H), 3.84 (s, 2H), 3.91–4.03 (m, 2H), 4.19 (s, 2H), 6.91–6.95 (m, 1H), 7.00 (d, 1H), 7.16–7.22 (m, 2H), 7.29–7.34 (m, 2H), 7.37 (s, 2H), 7.39–7.47 (m, 3H), 7.76 (dd, 1H), 8.20 (d, 1H), 10.51 (s, 1H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.0, 48.8, 63.4, 67.7, 116.3, 116.8, 118.7, 120.4, 120.4, 123.9, 127.1, 128.7, 129.0, 129.8, 132.2, 133.7, 133.8, 134.5, 134.6, 142.8, 148.5, 156.7, 166.0, 168.1.</div></div><div id="sec4_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Methyl 2-(4-{[(2-chlorophenyl)acetyl]amino}-2-sulfamoylphenoxy)benzoate (<b>46</b>)</h4><div class="NLM_p"><b>12a</b> (484 mg, 1.25 mmol) was dissolved in acetonitrile (17.5 mL), and cesium carbonate (407 mg, 1.25 mmol) and methyl 3-hydroxybenzoate (190 mg, 1.25 mmol) were added. The mixtures was stirred in a sealed vial overnight at 110 °C. After cooling to room temperature, the solvent was removed under reduced pressure and the crude was treated with dichloromethane and brine solution, the organic phase was separated, dried over sodium sulfate, and concentrated in vacuo. Chromatography on a Biotage Isolera System (silica gel, gradient ethyl acetate to dichloromethane/methanol) led to <b>31k</b> (350 mg, 0.697 mmol, 56% yield, 98% purity). LC-MS (method A): Rt = 1.34 min; MS (ESIneg): <i>m</i>/<i>z</i> = 501 (M – H)<sup>+</sup>.</div><div class="NLM_p"><b>31k</b> (350 mg, 0.70 mmol) was dissolved in dioxane (5 mL) and treated with tin(II)chloride dihydrate (786 mg, 3.48 mmol). The reaction mixture was stirred in a sealed vial at 70 °C for 3 h, cooled to room temperature, and filtered over a poly(tetrafluoroethylene) (PTFE) membrane. The filtrate was concentrated and redissolved in tetrahydrofuran (14 mL). (2-Chlorophenyl)acetic acid (179 mg, 1.05 mmol), <i>N</i>,<i>N-</i>diisopropylethylamine (1.36 g, 10.5 mmol), and HATU (399 mg, 1.05 mmol) were added and stirred overnight at room temperature. The solvent was removed in vacuo, and the residue was extracted and washed with water and dichloromethane. The organic phase was separated, dried over sodium sulfate, and concentrated in vacuo. Chromatography on a Biotage Isolera system (silica gel, gradient dichloromethane/ethyl acetate) led to methyl 2-(4-{[(2-chlorophenyl)acetyl]amino}-2-[(2,4-dimethoxybenzyl)sulfamoyl]phenoxy)benzoate (100 mg, 0.160 mmol, 23% yield, 98% purity). LC-MS (method A): Rt = 1.36 min; MS (pos): <i>m</i>/<i>z</i> = 625 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ [ppm]= 3.64 (s, 3H), 3.70 (s, 3H), 3.75 (s, 3H), 3.86 (s, 2H), 3.97–4.05 (m, 2H), 6.35–6.44 (m, 2H), 6.82–6.87 (m, 1H), 6.99 (d, 1H), 7.10–7.15 (m, 1H), 7.22–7.28 (m, 1H), 7.31–7.36 (m, 2H), 7.42–7.50 (m, 2H), 7.52–7.59 (m, 1H), 7.77–7.83 (m, 1H), 7.84–7.89 (m, 1H), 8.05–8.11 (m, 1H), 10.50 (s, 1H).</div><div class="NLM_p last">According to GP4, methyl 2-(4-{[(2-chlorophenyl)acetyl]amino}-2-[(2,4-dimethoxybenzyl)sulfamoyl]phenoxy)benzoate (350 mg, 0.56 mmol) was converted to <b>46</b>, and it was purified by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (54 mg, 0.114 mmol, 20% yield, 97% purity). LC-MS (method A): Rt = 1.14 min; MS (ESIpos): <i>m</i>/<i>z</i> = 475 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.79 (s, 3H), 3.85 (s, 2H), 6.97 (d, 1H), 7.05 (d, 1H), 7.21–7.38 (m, 5H), 7.38–7.50 (m, 2H), 7.53–7.63 (m, 1H), 7.74–7.82 (m, 1H), 7.87–7.92 (m, 1H), 8.22 (d, 1H), 10.52 (s, 1H).</div></div><div id="sec4_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 2-(2-Chlorophenyl)-<i>N</i>-{4-[2-(2-hydroxypropan-2-yl)phenoxy]-3-sulfamoylphenyl}-acetamide (<b>47</b>)</h4><div class="NLM_p last"><b>46</b> (54 mg, 0.11 mmol) was dissolved in tetrahydrofuran (2.5 mL), and a solution of methyl magnesium bromide (0.81 mL, 1.4 M) was added under a nitrogen atmosphere slowly at 0 °C. The mixture was stirred at 0 °C for 2 h, followed by stirring at room temperature overnight. Then, again a solution of methyl magnesium bromide (0.3 mL, 1.4 M) was added at 0 °C. Stirring was continued at 0 °C for 2 h and quenched at the same temperature with saturated aqueous ammonium chloride solution and extracted twice with ethyl acetate. The combined ethyl acetate phases were washed with brine, dried over sodium sulfate, and concentrated in vacuo. Purification by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% aqueous ammonia (32%)) led to <b>47</b> (22 mg, 0.0463, 42% yield, 95% purity). LC-MS (method B): Rt = 1.06 min; MS (ESIneg): <i>m</i>/<i>z</i> = 473 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.50 (s, 6H), 3.83 (s, 2H), 5.30 (s, 1H), 6.77–6.85 (m, 2H), 7.10–7.19 (m, 1H), 7.22–7.36 (m, 3H), 7.36–7.48 (m, 4H), 7.65 (dd, 1H), 7.71 (dd, 1H), 8.19 (d, 1H), 10.44 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 30.1, 40.7, 70.3, 118.2, 118.8, 120.0, 123.8, 124.0, 127.0, 127.1, 128.1, 128.7, 129.0, 132.2, 133.5, 133.6, 133.7, 133.8, 140.3, 149.5, 152.6, 168.0.</div></div><div id="sec4_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Methyl 3-(4-{[(2-chlorophenyl)acetyl]amino}-2-sulfamoylphenoxy)benzoate (<b>48</b>)</h4><div class="NLM_p">According to general procedures GP1.1, GP2.1 (with methanol as solvent), and GP3.2, <b>12a</b> (1.00 g mg, 2.59 mmol), methyl 3-hydroxybenzoate (393 mg, 2.59 mmol), and (2-chlorophenyl)acetic acid (324 mg, 1.90 mmol) were converted without purification of intermediates to methyl 3-(4-{[(2-chlorophenyl)acetyl]amino}-2-[(2,4-dimethoxybenzyl)sulfamoyl]phenoxy)benzoate and were purified at the end by column chromatography on a Biotage Isolera system (silica gel, gradient <i>n</i>-hexane/ethyl acetate) (497 mg, 0.795 mmol, 31% yield over three steps). LC-MS (method A): Rt = 1.34 min; MS (ESIneg): <i>m</i>/<i>z</i> = 623 (M – H)+. <sup>1</sup>H NMR (400 MHz, CD<sub>2</sub>Cl<sub>2</sub>): δ [ppm]= 3.72 (s, 3H), 3.75 (s, 3H), 3.89–3.90 (s, 2H), 3.91 (s, 3H), 4.16 (d, 2H), 5.56–5.62 (m, 1H), 6.24 (dd, 1H), 6.31–6.33 (m, 1H), 6.76 (d, 1H), 6.91 (d, 1H), 7.13–7.18 (m, 1H), 7.27–7.34 (m, 1H), 7.36–7.40 (m, 2H), 7.43–7.55 (m, 3H), 7.60–7.62 (m, 1H), 7.65–7.67 (m, 1H), 7.77–7.89 (m, 2H).</div><div class="NLM_p last">According to GP4 methyl 3-(4-{[(2-chlorophenyl)acetyl]amino}-2-[(2,4-dimethoxybenzyl)sulfamoyl]phenoxy)benzoate (281 mg, 0.45 mmol) was converted to <b>48</b> and was used without further purification in the next step (226 mg). LC-MS (method A): Rt = 1.11 min; MS (ESIpos): <i>m</i>/<i>z</i> = 475 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ [ppm]= 3.84 (s, 3H), 3.86 (s, 2H), 7.07 (d, 1H), 7.29–7.39 (m, 3H), 7.41–7.49 (m, 4H), 7.52–7.58 (m, 2H), 7.69–7.76 (m, 1H), 7.78–7.82 (m, 1H), 8.23 (d, 1H), 10.48–10.62 (m, 1H).</div></div><div id="sec4_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 2-(2-Chlorophenyl)-<i>N</i>-{4-[3-(2-hydroxypropan-2-yl)phenoxy]-3-sulfamoylphenyl}-acetamide (<b>49</b>)</h4><div class="NLM_p last"><b>48</b> (50 mg, 0.11 mmol) was dissolved in tetrahydrofuran (2.5 mL) and a solution of methyl magnesium bromide (0.9 mL, 1.4 M) was added under a nitrogen atmosphere slowly at 0 °C. It was stirred at 0 °C for 2 h, followed by stirring at room temperature overnight. Then, again a solution of methyl magnesium bromide (0.75 mL, 1.4 M) was added at 0 °C. Stirring was continued at 0 °C for 2 h and quenched at the same temperature with saturated aqueous ammonium chloride solution and extracted twice with ethyl acetate. The combined ethyl acetate phases were washed with brine, dried over sodium sulfate, and concentrated in vacuo. Purification by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% aqueous ammonia (32%)) led to <b>49</b> (24 mg, 0.0505, 46% yield, 98% purity). LC-MS (method B): Rt = 1.04 min; MS (ESIneg): <i>m</i>/<i>z</i> = 473 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.41 (s, 6H), 3.84 (s, 2H), 5.08 (s, 1H), 6.79–6.92 (m, 2H), 7.18–7.37 (m, 7H), 7.40–7.49 (m, 2H), 7.69–7.78 (m, 1H), 8.14–8.21 (m, 1H), 10.47 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 31.9, 40.7, 70.6, 115.9, 116.7, 118.7, 119.6, 120.2, 123.9, 127.1, 128.7, 129.0, 129.1, 132.2, 133.7, 133.8, 134.0, 134.0, 149.3, 152.9, 156.0, 168.0.</div></div><div id="sec4_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Methyl 4-(4-{[(2-chlorophenyl)acetyl]amino}-2-sulfamoylphenoxy)benzoate (<b>50</b>)</h4><div class="NLM_p">According to general procedures GP1.1, GP2.1 (with methanol as solvent), and GP3.2, <b>12a</b> (1.00 g mg, 2.59 mmol), methyl 4-hydroxybenzoate (393 mg, 2.59 mmol), and (2-chlorophenyl)acetic acid (527 mg, 3.09 mmol) were converted without purification of intermediates to methyl 4-(4-{[(2-chlorophenyl)acetyl]amino}-2-[(2,4-dimethoxybenzyl)sulfamoyl]phenoxy)benzoate and were purified at the end by column chromatography on a Biotage Isolera system (silica gel, gradient <i>n</i>-hexane/ethyl acetate) (441 mg, 0.705 mmol, 27% yield over three steps). LC-MS (method A): Rt = 1.33 min; MS (ESIneg): <i>m</i>/<i>z</i> = 623 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ [ppm] = 3.67 (s, 3H), 3.71 (s, 3H), 3.84 (s, 3H), 3.87 (s, 2H), 4.01–4.05 (m, 2H), 6.37–6.43 (m, 2H), 7.00–7.13 (m, 4H), 7.29–7.38 (m, 2H), 7.42–7.51 (m, 2H), 7.76 (t, 1H), 7.82 (dd, 1H), 7.92–7.99 (m, 2H), 8.14 (d, 1H), 10.54 (s, 1H).</div><div class="NLM_p last">According to GP4, methyl 4-(4-{[(2-chlorophenyl)acetyl]amino}-2-[(2,4-dimethoxybenzyl)sulfamoyl]phenoxy)benzoate (441 mg, 0.705 mmol) was converted to <b>50</b>, and it was purified by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (53 mg, 0.112 mmol, 16% yield, 97% purity). LC-MS (method A): Rt = 1.11 min; MS (ESIpos): <i>m</i>/<i>z</i> = 475 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.84 (s, 3H), 3.86 (s, 2H), 7.04–7.16 (m, 3H), 7.26–7.38 (m, 2H), 7.39–7.50 (m, 4H), 7.83 (dd, 1H), 7.92–8.01 (m, 2H), 8.23 (d, 1H), 10.55 (s, 1H).</div></div><div id="sec4_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 2-(2-Chlorophenyl)-<i>N</i>-{4-[4-(2-hydroxypropan-2-yl)phenoxy]-3-sulfamoylphenyl}-acetamide (<b>51</b>)</h4><div class="NLM_p last"><b>50</b> (60 mg, 0.13 mmol) was dissolved in tetrahydrofuran (2.5 mL) and a solution of methyl magnesium bromide (0.9 mL, 1.4M) was added under a nitrogen atmosphere slowly at 0 °C. The mixture was stirred at 0 °C for 2 h, followed by stirring at room temperature overnight. Then, again a solution of methyl magnesium bromide (0.3 mL, 1.4M) was added at 0 °C. Stirring was continued at 0 °C for 2 h and quenched at the same temperature with saturated aqueous ammonium chloride solution and extracted twice with ethyl acetate. The combined ethyl acetate phases were washed with brine, dried over sodium sulfate, and concentrated in vacuo. Purification by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% aqueous ammonia (32%)) led to <b>51</b> (23 mg, 0.0484, 37% yield, 99% purity). LC-MS (method B): Rt = 1.01 min; MS (ESIneg): <i>m</i>/<i>z</i> = 473 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.42 (s, 6H), 3.83 (s, 2H), 5.02 (s, 1H), 6.92 (d, 1H), 6.95–6.99 (m, 2H), 7.31 (m, 4H), 7.40–7.51 (m, 4H), 7.73 (dd, 1H), 8.18 (d, 1H), 10.48 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 32.0, 40.7, 70.4, 118.4, 118.7, 120.0, 124.0, 126.0, 127.1, 128.7, 129.0, 132.2, 133.7, 133.8, 134.1, 134.2, 146.1, 149.3, 154.6, 168.0.</div></div><div id="sec4_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 2-(2-Chlorophenyl)-<i>N</i>-[4-(pyridin-2-yloxy)-3-sulfamoylphenyl]acetamide (<b>52</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), pyridin-2-ol (123 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (239 mg, 1.40 mmol) were converted without purification of intermediates to <b>52</b> (among other isomers) and were purified at the end twice by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid), (27 mg, 0.646 mmol, 5% yield over four steps, 98% purity). LC-MS (method A): Rt = 0.99 min; MS (ESIpos): <i>m</i>/<i>z</i> = 418 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.85 (s, 2H), 7.11 (ddd, 1H), 7.15 (d, 1H), 7.23 (d, 1H), 7.26–7.34 (m, 4H), 7.39–7.47 (m, 2H), 7.79 (dd, 1H), 7.83 (ddd, 1H), 8.07 (ddd, 1H), 8.17 (d, 1H), 10.49 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.8, 112.2, 118.3, 119.1, 123.2, 124.7, 127.1, 128.7, 129.0, 132.2, 133.7, 133.8, 135.5, 135.7, 139.8, 145.4, 146.8, 162.8, 168.1.</div></div><div id="sec4_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> 2-(2-Chlorophenyl)-<i>N</i>-[4-(pyridin-3-yloxy)-3-sulfamoylphenyl]acetamide (<b>53</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), pyridin-3-ol (123 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (242 mg, 1.42 mmol) were converted without purification of intermediates to <b>53</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (45 mg, 0.108 mmol, 8% yield over four steps, 95% purity). LC-MS (method A): Rt = 0.89 min; MS (ESIneg): <i>m</i>/<i>z</i> = 416 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.85 (s, 2H), 7.07 (d, 1H), 7.26–7.46 (m, 8H), 7.80 (dd, 1H), 8.22 (d, 1H), 8.35 (dd, 1H), 8.38 (d, 1H), 10.52 (s, 1H).</div></div><div id="sec4_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> 2-(2-Chlorophenyl)-<i>N</i>-{4-[(5-chloropyridin-3-yl)oxy]-3-sulfamoylphenyl}acetamide (<b>54</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), 5-chloropyridin-3-ol (167 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (242 mg, 1.42 mmol) were converted without purification of intermediates to <b>54</b> and were purified at the end by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) followed by another preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (11.2 mg, 0.0248 mmol, 2% yield over four steps, 95% purity). LC-MS (method B): Rt = 0.99 min; MS (ESIpos): <i>m</i>/<i>z</i> = 452 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.86 (s, 2H), 7.23 (d, 1H), 7.29–7.35 (m, 2H), 7.42–7.47 (m, 2H), 7.49 (s, 2H), 7.51–7.53 (m, 1H), 7.83 (dd, 1H), 8.24 (d, 1H), 8.32 (d, 1H), 8.40 (d, 1H), 10.60 (s, 1H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.8, 118.7, 122.1, 124.0, 125.0, 127.1, 128.7, 129.1, 130.9, 132.3, 133.7, 135.6, 136.0, 138.8, 142.6, 146.6, 154.3, 168.3.</div></div><div id="sec4_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>N</i>-{4-[(5-Chloropyridin-3-yl)oxy]-3-sulfamoylphenyl}-2-phenylacetamide (<b>55</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.2, GP3.2, and GP4, <b>12b</b> (185 mg, 0.50 mmol), 2-chloropyrimidin-5-ol (65.3 mg, 0.50 mmol), and (2-chlorophenyl)acetic acid (51.2 mg, 0.30 mmol) were converted with purification of intermediates on a Biotage Isolera system to <b>55</b> and were purified at the end by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (10 mg, 0.0221 mmol, 4% yield over four steps, 95% purity). LC-MS (method A): Rt = 1.03 min; MS (ESIpos): <i>m</i>/<i>z</i> = 453 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.80 (s, 2H), 6.89 (d, 1H), 7.27–7.36 (m, 2H), 7.39–7.48 (m, 2H), 7.61 (dd, 1H), 8.07 (d, 1H), 8.43 (s, 2H), 10.25 (s, 1H), 10.80 (s, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.6, 117.5, 120.0, 126.2, 127.1, 128.6, 129.0, 130.7, 132.2, 133.7, 133.8, 150.0, 150.9, 167.7.</div></div><div id="sec4_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 2-(2-Chlorophenyl)-<i>N</i>-{4-[(1-methyl-1<i>H</i>-pyrazol-4-yl)oxy]-3-sulfamoylphenyl}acetamide (<b>56</b>)</h4><div class="NLM_p last">According to general procedures GP1.3, GP2.1, GP3.2, and GP4, <b>12a</b> (200 mg, 0.5 mmol), 1-methyl-1<i>H-</i>pyrazol-4-ol (152 mg, 1.6 mmol), and (2-chlorophenyl)acetic acid (127 mg, 0.7 mmol) were converted without purification of intermediates to <b>56</b>. The pure compound was obtained after preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (24 mg, 0.058 mmol, 6% yield over four steps, 96% purity). LC-MS (method B): Rt =0.83 min; MS (ESIneg): <i>m</i>/<i>z</i> = 419 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.79–3.84 (m, 5H), 7.04 (d, 1H), 7.28–7.33 (m, 4H), 7.36 (d, 1H), 7.40–7.46 (m, 2H), 7.69–7.75 (m, 2H), 8.12 (d, 1H), 10.40 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.7, 116.7, 118.8, 122.0, 123.9, 127.1, 128.7, 129.0, 130.4, 132.2, 132.4, 133.5, 133.7, 133.8, 139.2, 150.8, 168.0.</div></div><div id="sec4_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 2-(2-Chlorophenyl)-<i>N</i>-[4-(cyclohexyloxy)-3-sulfamoylphenyl]acetamide (<b>57</b>)</h4><div class="NLM_p">Step 1. (2-(Cyclohexyloxy)-5-nitrobenzenesulfonamide): According to GP1.2, 2-chloro-5-nitrobenzenesulfonamide (500 mg, 2.1 mmol) was reacted with cyclohexanol (254 mg, 2.5 mmol) and sodium hydride (0.3 g, 7.4 mmol, 60% purity). The crude was purified by column chromatography on a Biotage Isolera (silica gel, gradient <i>n</i>-hexane/ethyl acetate) to yield pure 2-(cyclohexyloxy)-5-nitrobenzenesulfonamide (430 mg, 1.43 mmol, 68% yield). LC-MS (method A): Rt = 1.08 min; MS (ESIneg): <i>m</i>/<i>z</i> = 299 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>6): δ [ppm]= 1.25–1.44 (m, 3H), 1.47–1.56 (m, 1H), 1.64–1.81 (m, 4H), 1.84–1.97 (m, 2H), 4.73–4.84 (m, 1H), 7.24 (s, 2H), 7.49 (d, 1H), 8.38 (dd, 1H), 8.52 (d, 1H).</div><div class="NLM_p">Step 2. (5-Amino-2-(cyclohexyloxy)benzenesulfonamide): According to GP2.1, 2-(cyclohexyloxy)-5-nitrobenzenesulfonamide (430 mg, 1.43 mmol) was converted to 5-amino-2-(cyclohexyloxy)benzenesulfonamide (360 mg, 1.3 mmol, 93% yield) and used in the next step without further purification. LC-MS (method A): Rt = 0.80 min; MS (ESIpos): <i>m</i>/<i>z</i> = 271 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i>6): δ [ppm]= 1.15–1.33 (m, 3H), 1.41–1.64 (m, 3H), 1.65–1.80 (m, 2H), 1.80–1.93 (m, 2H), 4.20–4.36 (m, 1H), 4.99 (s, 2H), 6.55 (s, 2H), 6.65–6.75 (m, 1H), 6.89–6.95 (m, 1H), 6.99–7.04 (m, 1H).</div><div class="NLM_p last">Step 3. (2-(2-Chlorophenyl)-<i>N</i>-[4-(cyclohexyloxy)-3-sulfamoylphenyl]acetamide): According to GP3.2, 5-amino-2-(cyclohexyloxy)benzenesulfonamide (180 mg, 0.7 mmol) and (2-chlorophenyl)acetic acid (136 mg, 0.8 mmol) were converted to <b>57</b>. Pure <b>57</b> was obtained after preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (155 mg, 0.37 mmol, 55% yield, 99% purity). LC-MS (method A): Rt = 1.16 min; MS (ESIpos): <i>m</i>/<i>z</i> = 422 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.16–1.42 (m, 3H), 1.44–1.56 (m, 1H), 1.57–1.69 (m, 2H), 1.69–1.82 (m, 2H), 1.83–1.96 (m, 2H), 3.81 (s, 2H), 4.41–4.57 (m, 1H), 6.76 (s, 2H), 7.20 (d, 1H), 7.26–7.36 (m, 2H), 7.38–7.51 (m, 2H), 7.74 (dd, 1H), 8.03 (d, 1H), 10.29 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 23.0, 25.1, 30.8, 40.7, 75.8, 115.1, 118.9, 124.0, 127.1, 128.6, 129.0, 131.4, 131.7, 132.2, 133.7, 133.9, 149.8, 167.7.</div></div><div id="sec4_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 2-(2-Chlorophenyl)-<i>N</i>-[4-(1,4-dioxan-2-ylmethoxy)-3-sulfamoylphenyl]acetamide (<b>58</b>)</h4><div class="NLM_p last">According to general procedures GP1.1, GP2.1 (but with methanol as solvent), GP3.2, and GP4, <b>12a</b> (500 mg, 1.29 mmol), 1,4-dioxan-2-ylmethanol (153 mg, 1.29 mmol), and (2-chlorophenyl)acetic acid (154 mg, 0.90 mmol) were converted without purification of intermediates to <b>58</b> and were purified at the end twice by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (7 mg, 0.0159 mmol, 1% yield over four steps, 98% purity). LC-MS (method B): Rt = 0.89 min; MS (ESIneg): <i>m</i>/<i>z</i> = 439 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.37–3.52 (m, 2H), 3.61–3.70 (m, 2H), 3.71–3.85 (m, 3H), 3.85–3.92 (m, 1H), 3.91–4.03 (m, 1H), 4.06–4.15 (m, 2H), 6.92 (s, 2H), 7.19 (d, 1H), 7.25–7.36 (m, 2H), 7.38–7.50 (m, 2H), 7.77 (dd, 1H), 8.02 (d, 1H), 10.35 (s, 1H).</div></div><div id="sec4_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>N</i>-[3-Sulfamoyl-4-(tetrahydro-2<i>H</i>-pyran-4-ylmethoxy)phenyl]-2-[2-(trifluoromethyl)-phenyl]acetamide (<b>59</b>)</h4><div class="NLM_p last">According to general procedures GP3.2 and GP4, <b>32u</b> (54.0 mg, 0.124 mmol) and [2-(trifluoromethyl)phenyl]acetic acid (30.3 mg, 0.148 mmol) were converted to <b>59</b> and were purified by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (35 mg, 0.0741 mmol, 60% yield, 98% purity). LC-MS (method A): Rt = 1.05 min; MS (ESIpos): <i>m</i>/<i>z</i> = 473 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.27 (ddd, 2H), 1.69–1.74 (m, 2H), 2.09–2.19 (m, 1H), 3.27–3.34 (m, 2H), 3.83–3.88 (m, 2H), 3.88 (s, 2H), 3.92 (d, 2H), 6.90 (s, 2H), 7.15 (d, 1H), 7.45–7.53 (m, 2H), 7.64 (t, 1H), 7.70 (d, 1H), 7.73 (d, 1H), 8.00 (d, 1H), 10.29 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 29.2, 33.9, 66.7, 73.1, 113.7, 119.0, 124.1, 125.6, 127.3, 127.4, 131.0, 131.5, 132.2, 133.4, 133.8, 151.0, 167.8.</div></div><div id="sec4_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 2-[2-(Difluoromethyl)phenyl]-<i>N</i>-[3-sulfamoyl-4-(tetrahydro-2<i>H</i>-pyran-4-ylmethoxy)-phenyl]acetamide (<b>60</b>)</h4><div class="NLM_p last">According to general procedures GP3.2 and GP4, <b>32u</b> (55.0 mg, 0.126 mmol) and [2-(difluoromethyl)phenyl]acetic acid (28.1 mg, 0.151 mmol) were converted to <b>60</b> and were purified by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (30 mg, 0.0660 mmol, 52% yield, 98% purity). LC-MS (method A): Rt = 1.00 min; MS (ESIpos): <i>m</i>/<i>z</i> = 455 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.26 (ddd, 2H), 1.71 (dd, 2H), 2.09–2.19 (m, 1H), 3.27–3.33 (m, 2H), 3.82–3.89 (m, 4H), 3.92 (d, 2H), 6.90 (s, 2H), 7.15 (d, 1H), 7.23 (t, 1H), 7.38–7.43 (m, 2H), 7.47–7.51 (m, 1H), 7.58 (d, 1H), 7.75 (dd, 1H), 7.99 (d, 1H), 10.29 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 29.2, 33.9, 66.7, 73.1, 113.7, 114.3, 119.0, 124.1, 125.7, 127.2, 130.8, 131.0, 131.4, 131.5, 132.6, 134.0, 151.1, 168.2.</div></div><div id="sec4_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 2-(2-Fluorophenyl)-<i>N</i>-[3-sulfamoyl-4-(tetrahydro-2<i>H</i>-pyran-4-ylmethoxy)phenyl]acetamide (<b>61</b>)</h4><div class="NLM_p last">According to general procedures GP3.2 and GP4, <b>32u</b> (54.0 mg, 0.124 mmol) and (2-fluorophenyl)acetic acid (22.9 mg, 0.148 mmol) were converted to <b>61</b> and were purified by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (27 mg, 0.0639 mmol, 52% yield, 98% purity). LC-MS (method A): Rt = 0.94 min; MS (ESIpos): <i>m</i>/<i>z</i> = 423 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: d [ppm]= 1.27 (ddd, 2H), 1.67–1.75 (m, 2H), 2.09–2.20 (m, 1H), 3.27–3.35 (m, 2H), 3.69 (s, 2H), 3.86 (dd, 2H), 3.93 (d, 2H), 6.90 (s, 2H), 7.12–7.19 (m, 3H), 7.27–7.34 (m, 1H), 7.37 (td, 1H), 7.75 (dd, 1H), 8.01 (d, 1H), 10.29 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 29.2, 33.9, 36.2, 66.7, 73.1, 113.7, 114.9, 115.1, 119.0, 122.8, 123.0, 124.1, 124.2, 124.3, 128.8, 128.9, 131.0, 131.5, 131.9, 132.0, 151.0, 159.4, 161.9, 167.9.</div></div><div id="sec4_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> 2-(2-Chloro-4-fluorophenyl)-<i>N</i>-[3-sulfamoyl-4-(tetrahydro-2<i>H</i>-pyran-4-ylmethoxy)-phenyl]acetamide (<b>62</b>)</h4><div class="NLM_p last">According to general procedures GP3.2 and GP4, <b>32u</b> (55.0 mg, 0.126 mmol) and (2-chloro-4-fluorophenyl)acetic acid (28.5 mg, 0.151 mmol) were converted to <b>62</b> and were purified by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (11 mg, 0.0241 mmol, 19% yield, 97% purity). LC-MS (method A): Rt = 1.02 min; MS (ESIpos): <i>m</i>/<i>z</i> = 457 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.27 (ddd, 2H), 1.70–1.76 (m, 2H), 2.09–2.22 (m, 1H), 3.28–3.37 (m, 2H), 3.80 (s, 2H), 3.84–3.91 (m, 2H), 3.94 (d, 2H), 6.92 (s, 2H), 7.17 (d, 1H), 7.22 (td, 1H), 7.42–7.50 (m, 2H), 7.76 (dd, 1H), 8.02 (d, 1H), 10.31 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 29.2, 33.9, 66.7, 73.1, 113.7, 114.1, 114.3, 116.1, 116.4, 119.0, 124.1, 130.2, 130.3, 131.0, 131.5, 133.9, 151.0, 159.7, 162.2, 167.6.</div></div><div id="sec4_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> 5-Amino-2-hydroxybenzenesulfonamide Hydrochloride (<b>64</b>)</h4><div class="NLM_p last">To a solution of <b>63</b> (10.9 g, 50.0 mmol) in methanol (250 mL) were added under argon aqueous 2M-HCl (25 mL, 50 mmol) and 10% Pd/C (1.5 g). After stirring under an atmosphere of hydrogen for 20 h, the catalyst was removed by filtration over a PTFE membrane and the filtrate was concentrated in vacuo affording crude <b>64</b> that was used in the next steps without further purification (11.2 g, 0.499 mmol, 99% yield, 95% purity). LC-MS (method C): Rt = 0.20 min; MS (ESIneg): <i>m</i>/<i>z</i> = 187 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, deuterium oxide) δ [ppm]: 7.23 (d, 1H), 7.57 (dd, 1H), 7.83 (d, 1H).</div></div><div id="sec4_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> 2-(2-Chlorophenyl)-<i>N</i>-(4-hydroxy-3-sulfamoylphenyl)acetamide (<b>65a</b>)</h4><div class="NLM_p last">To a suspension of <b>64</b> (2.25 g, 10.0 mmol) in tetrahydrofuran (75 mL) were added (2-chlorophenyl)acetic acid (1.88 g, 11 mmol), <i>N</i>,<i>N-</i>diisopropylethylamine (6.46 g, 50 mmol), and HATU (4.18 g, 11 mmol). The reaction mixture was stirred overnight at room temperature. Then, it was concentrated in vacuo, followed by extraction from ethyl acetate/water. The organic phase was washed with water, dried over sodium sulfate, and concentrated in vacuo. Column chromatography on a Biotage Isolera system (silica gel, gradient dichloromethane to dichloromethane/methanol 80/20) led to <b>65a</b> (1.60 g, 4.70 mmol, 47% yield, 90% purity). LC-MS (method A): Rt = 0.85 min; MS (ESIpos): <i>m</i>/<i>z</i> = 341 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.78 (s, 2H), 6.85–6.95 (m, 3H), 7.25–7.33 (m, 2H), 7.36–7.46 (m, 2H), 7.59 (dd, 1H), 7.93 (d, 1H), 10.17 (s, 1H), 10.39 (s, 1H).</div></div><div id="sec4_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> 2-(2-Chloro-3-fluorophenyl)-<i>N</i>-(4-hydroxy-3-sulfamoylphenyl)acetamide (<b>65b</b>)</h4><div class="NLM_p last">To a suspension of <b>64</b> (0.450 g, 2.00 mmol) in tetrahydrofuran (20 mL) were added (2-chloro-3-fluorophenyl)acetic acid (0.415 g, 2.20 mmol), <i>N</i>,<i>N-</i>diisopropylethylamine (1.29 g, 10.0 mmol), and HATU (0.837 g, 2.20 mmol). The reaction mixture was stirred overnight at room temperature, followed by concentration in vacuo and extraction from ethyl acetate/water. The organic phase was washed with water, dried over sodium sulfate, and concentrated in vacuo. As LC-MS showed mostly bisacylated product, the residue was redissolved in tetrahydrofuran and treated for 24 h with aqueous 1 M NaOH (15 mL). After removing tetrahydrofuran in vacuo, it was neutralized with diluted hydrochloric acid, followed by extraction with ethyl acetate. The organic phase was washed with water, dried over sodium sulfate, and concentrated in vacuo. Purification by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) led to <b>65b</b> (240 mg, 0.669 mmol, 33% yield, 99% purity). LC-MS (method A): Rt = 0.86 min; MS (ESIpos): <i>m</i>/<i>z</i> = 359 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.86 (s, 2H), 6.90–7.00 (m, 3H), 7.24–7.41 (m, 3H), 7.60 (dd, 1H), 7.94 (d, 1H), 10.24 (s, 1H), 10.45 (s, 1H).</div></div><div id="sec4_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> 2-(2-Chloro-5-fluorophenyl)-<i>N</i>-(4-hydroxy-3-sulfamoylphenyl)acetamide (<b>65c</b>)</h4><div class="NLM_p last">To <b>64</b> (1.24 g, 5.50 mmol) in tetrahydrofuran (55 mL) were added (2-chloro-5-fluorophenyl)acetic acid (1.14 g, 6.05 mmol) and <i>N</i>,<i>N</i>-diisopropylethylamine (4.8 mL, 28 mmol) at 0 °C. Afterward, HATU (2.30 g, 6.05 mmol) was added and the reaction mixture was stirred for 1 h at 0 °C. The reaction was allowed to come to room temperature and stirring was continued overnight. Afterward, the solvent was removed under reduced pressure and the crude was partitioned in ethyl acetate/water. The organic phase was washed with water, dried over sodium sulfate, and concentrated in vacuo. The crude was suspended in DCM, warmed up, and stirring was continued at room temperature overnight. The precipitate was filtered off and washed with DCM to yield <b>65c</b> (0.35 g, 18% yield, 99% purity). LC-MS (method A): Rt = 0.89 min; MS (ESIpos): <i>m</i>/<i>z</i> = 359 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i>6): δ [ppm] = 3.81 (s, 2H), 6.88–6.99 (m, 3H), 7.14–7.23 (m, 1H), 7.31 (dd, 1H), 7.47–7.52 (m, 1H), 7.60 (dd, 1H), 7.88–7.99 (m, 1H), 10.21 (s, 1H), 10.43 (s, 1H).</div></div><div id="sec4_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> 2-(2-Chloro-6-fluorophenyl)-<i>N</i>-(4-hydroxy-3-sulfamoylphenyl)acetamide (<b>65d</b>)</h4><div class="NLM_p last">To a suspension of <b>64</b> (1.24 g, 5.50 mmol) in tetrahydrofuran (55 mL) were added (2-chloro-6-fluorophenyl)acetic acid (1.14 g, 6.05 mmol), <i>N</i>,<i>N-</i>diisopropylethylamine (3.55 g, 27.5 mmol), and HATU (2.3 g, 6.05 mmol). The reaction mixture was stirred over a weekend at room temperature, followed by concentration in vacuo and extraction from ethyl acetate/water. The organic phase was washed with water, dried over sodium sulfate, and concentrated in vacuo. As LC-MS showed mostly bisacylated product, the residue was redissolved in tetrahydrofuran and treated for 24 h with aqueous 1 M NaOH (30 mL). After removing tetrahydrofuran in vacuo, it was neutralized with diluted hydrochloric acid, followed by extraction with ethyl acetate. The organic phase was washed with water, dried over sodium sulfate, and concentrated in vacuo. Purification by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) led to <b>65d</b> (55 mg, 0.153 mmol, 3% yield, 99% purity). LC-MS (method A): Rt = 0.85 min; MS (ESIpos): <i>m</i>/<i>z</i> = 359 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.85 (d, 2H), 6.80–7.05 (m, 3H), 7.21–7.27 (m, 1H), 7.32–7.42 (m, 2H), 7.58 (dd, 1H), 7.93 (d, 1H), 10.29 (s, 1H), 10.35–10.68 (m, 1H).</div></div><div id="sec4_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>N</i>-[4-(Benzyloxy)-3-sulfamoylphenyl]-2-(2-chlorophenyl)acetamide (<b>66</b>)</h4><div class="NLM_p last">According to general procedure GP5, <b>65a</b> (102 mg, 0.30 mmol) and (bromomethyl)benzene (61.6 mg, 0.36 mmol) were converted to <b>66</b>, and it was purified by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid), followed by column chromatography on a Biotage Isolera system (silica gel, gradient dichloromethane/ethyl acetate) (20 mg, 0.0464 mmol, 15% yield, 99% purity). LC-MS (method B): Rt = 1.12 min; MS (ESIpos): <i>m</i>/<i>z</i> = 431 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, METHANOL-d<sub>4</sub>) δ [ppm]: 3.87 (s, 2H), 5.35 (s, 2H), 7.16 (d, 1H), 7.26–7.36 (m, 3H), 7.36–7.45 (m, 4H), 7.51–7.56 (m, 2H), 7.75 (dd, 1H), 8.08 (d, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.7, 69.5, 114.4, 118.9, 123.8, 127.1, 127.6, 128.4, 128.6, 129.0, 131.5, 131.8, 132.2, 133.6, 133.8, 136.8, 150.2, 167.8.</div></div><div id="sec4_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 2-(2-Chlorophenyl)-<i>N</i>-[4-(pyridin-2-ylmethoxy)-3-sulfamoylphenyl]acetamide (<b>67</b>)</h4><div class="NLM_p last">According to general procedure GP5, <b>65a</b> (102 mg, 0.30 mmol) and 2-(bromomethyl)pyridine hydrobromide (114 mg, 0.45 mmol)/<i>N-</i>ethyl-<i>N-</i>isopropylpropan-2-amine (116 mg, 0.90 mmol) were converted to <b>67</b> (stirring overnight at room temperature was followed by stirring at 65 °C for 3 h) and it was purified by preparative HPLC (Waters XBridge C18 5 μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (45 mg, 0.104 mmol, 35% yield, 99% purity). LC-MS (method B): Rt = 0.94 min; MS (ESIpos): <i>m</i>/<i>z</i> = 432 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.80 (s, 2H), 5.35 (s, 2H), 7.20 (d, 1H), 7.27–7.33 (m, 2H), 7.33–7.38 (m, 3H), 7.39–7.45 (m, 2H), 7.57 (d, 1H), 7.73 (dd, 1H), 7.84 (td, 1H), 8.06 (d, 1H), 8.56–8.59 (m, 1H), 10.32 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 40.7, 70.6, 114.5, 118.7, 121.6, 123.1, 123.9, 127.1, 128.6, 129.0, 131.7, 132.2, 132.3, 133.7, 133.8, 137.2, 149.0, 150.3, 156.1, 167.8.</div></div><div id="sec4_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> 2-(2-Chlorophenyl)-<i>N</i>-[4-(2-phenylethoxy)-3-sulfamoylphenyl]acetamide (<b>68</b>)</h4><div class="NLM_p last">According to general procedure GP5, <b>65a</b> (102 mg, 0.30 mmol) and (2-bromoethyl)benzene (83.3 mg, 0.45 mmol) were converted to <b>68</b>, and it was purified by preparative HPLC (Waters XBridge C18 5 μ 100 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (35 mg, 0.0787 mmol, 26% yield, 98% purity). LC-MS (method A): Rt = 1.17 min; MS (ESIpos): <i>m</i>/<i>z</i> = 445 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 3.13 (t, 2H), 3.81 (s, 2H), 4.31 (t, 2H), 6.69 (s, 2H), 7.19–7.26 (m, 2H), 7.28–7.39 (m, 6H), 7.40–7.47 (m, 2H), 7.77 (dd, 1H), 8.03 (d, 1H), 10.32 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 34.6, 40.7, 69.5, 113.9, 118.8, 124.1, 126.4, 127.1, 128.4, 128.6, 129.0, 129.1, 131.1, 131.8, 132.2, 133.7, 133.9, 138.2, 150.7, 167.8.</div></div><div id="sec4_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> 2-(2-Chlorophenyl)-<i>N</i>-[4-(cyclobutylmethoxy)-3-sulfamoylphenyl]acetamide (<b>69</b>)</h4><div class="NLM_p last">According to general procedure GP5, <b>65a</b> (51.1 mg, 0.15 mmol) and (bromomethyl)cyclobutane (33.5 mg, 0.23 mmol) were converted to <b>69</b>, and it was purified by preparative HPLC (Waters XBridge C18 5 μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (10 mg, 0.0245 mmol, 16% yield, 98% purity). LC-MS (method B): Rt = 1.13 min; MS (ESIpos): <i>m</i>/<i>z</i> = 409 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.78–1.93 (m, 4H), 1.97–2.08 (m, 2H), 2.73–2.87 (m, 1H), 3.80 (s, 2H), 4.08 (d, 2H), 6.77 (s, 2H), 7.16 (d, 1H), 7.26–7.34 (m, 2H), 7.38–7.45 (m, 2H), 7.75 (dd, 1H), 8.01 (d, 1H), 10.28 (s, 1H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 18.1, 24.4, 33.7, 40.0, 40.7, 72.7, 114.2, 118.8, 124.1, 127.1, 128.6, 129.0, 131.2, 131.7, 132.2, 133.7, 133.9, 151.1, 167.8.</div></div><div id="sec4_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 2-(2-Chlorophenyl)-<i>N</i>-[4-(oxetan-2-ylmethoxy)-3-sulfamoylphenyl]acetamide (<b>70</b>)</h4><div class="NLM_p last">According to general procedure GP5, <b>65a</b> (51.1 mg, 0.15 mmol) and 2-(bromomethyl)oxetane (40.0 mg, 0.23 mmol) were converted to <b>70</b>, and it was purified by preparative HPLC (Waters XBridge C18 5μ 100 mm × 30 mm, acetonitrile/water + 0.2% aqueous ammonia (32%)) (6 mg, 0.0146 mmol, 10% yield, 95% purity). LC-MS (method B): Rt = 0.90 min; MS (ESIpos): <i>m</i>/<i>z</i> = 411 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 2.61–2.71 (m, 2H), 3.81 (s, 2H), 4.18 (dd, 1H), 4.29 (dd, 1H), 4.48–4.60 (m, 2H), 5.05–5.14 (m, 1H), 6.90 (s, 2H), 7.25 (d, 1H), 7.27–7.34 (m, 2H), 7.39–7.46 (m, 2H), 7.77 (dd, 1H), 8.03 (d, 1H), 10.33 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 22.8, 40.7, 68.0, 72.1, 79.4, 115.4, 118.3, 124.0, 127.1, 128.6, 129.0, 131.8, 132.2, 132.4, 133.7, 133.8, 150.8, 167.9.</div></div><div id="sec4_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 2-(2-Chlorophenyl)-<i>N</i>-[3-sulfamoyl-4-(tetrahydro-2<i>H</i>-pyran-4-ylmethoxy)phenyl]-acetamide (<b>71</b>)</h4><div class="NLM_p last">According to general procedure GP5, <b>65a</b> (307 mg, 0.90 mmol) and 4-(bromomethyl)tetrahydro-2<i>H-</i>pyran (242 mg, 1.35 mmol) were converted to <b>71</b> (stirring overnight at room temperature was followed by stirring at 65 °C for 5 h), and it was purified by normal phase chromatography (Biotage system, puri Flash Interchim column, dichloromethane/methanol gradient) (150 mg, 0.34 mmol, 38% yield, 99% purity). LC-MS (method A): Rt = 1.02 min; MS (ESIneg): <i>m</i>/<i>z</i> = 437 (M – H)<sup>+</sup>. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.22–1.34 (m, 2H), 1.70–1.77 (m, 2H), 2.10–2.23 (m, 1H), 3.27–3.35 (m, 2H), 3.80 (s, 2H), 3.83–3.88 (m, 2H), 3.93 (d, 2H), 6.88 (s, 2H), 7.16 (d, 1H), 7.27–7.33 (m, 2H), 7.42 (s, 2H), 7.73–7.77 (m, 1H), 8.01 (d, 1H), 10.28 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 29.2, 33.9, 40.7, 66.7, 73.1, 113.7, 119.0, 124.1, 127.1, 128.6, 129.0, 131.0, 131.6, 132.2, 133.7, 133.9, 151.0, 167.8.</div></div><div id="sec4_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 2-(2-Chloro-3-fluorophenyl)-<i>N</i>-[3-sulfamoyl-4-(tetrahydro-2<i>H</i>-pyran-4-ylmethoxy)phenyl]acetamide (<b>72</b>)</h4><div class="NLM_p last">According to general procedure GP5, <b>65b</b> (233 mg, 0.65 mmol) and 4-(bromomethyl)tetrahydro-2<i>H-</i>pyran (175 mg, 0.98 mmol) were converted to <b>72</b> (stirring over the weekend at room temperature), and it was purified by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (35 mg, 0.0766 mmol, 12% yield, 99% purity). LC-MS (method B): Rt = 1.00 min; MS (ESIpos): <i>m</i>/<i>z</i> = 457 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.22–1.35 (m, 2H), 1.67–1.78 (m, 2H), 2.10–2.24 (m, 1H), 3.28–3.36 (m, 2H), 3.88 (m, 4H), 3.94 (d, 2H), 6.92 (s, 2H), 7.18 (d, 1H), 7.26–7.41 (m, 3H), 7.76 (dd, 1H), 8.03 (d, 1H), 10.36 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 29.2, 33.9, 40.3, 66.7, 73.1, 113.7, 115.0, 115.2, 119.0, 120.3, 120.5, 124.1, 127.6, 127.7, 128.0, 128.1, 131.0, 131.4, 136.5, 151.1, 156.2, 158.7, 167.3.</div></div><div id="sec4_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 2-(2-Chloro-5-fluorophenyl)-<i>N</i>-[3-sulfamoyl-4-(tetrahydro-2<i>H</i>-pyran-4-ylmethoxy)phenyl]acetamide (<b>73</b>)</h4><div class="NLM_p last">According to general procedure GP5, <b>65c</b> (144 mg, 0.40 mmol) and 4-(bromomethyl)tetrahydro-2<i>H-</i>pyran (107 mg, 0.60 mmol) were converted to <b>73</b> (stirring overnight at room temperature was followed by stirring at 50 °C for 6 h), and it was purified by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (40 mg, 0.0875 mmol, 22% yield, 95% purity). LC-MS (method A): Rt = 1.04 min; MS (ESIpos): <i>m</i>/<i>z</i> = 457 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.29 (ddd, 2H), 1.69–1.77 (m, 2H), 2.10–2.24 (m, 1H), 3.28–3.36 (m, 2H), 3.83 (s, 2H), 3.84–3.91 (m, 2H), 3.95 (d, 2H), 6.92 (s, 2H), 7.15–7.23 (m, 2H), 7.34 (dd, 1H), 7.50 (dd, 1H), 7.76 (dd, 1H), 8.02 (d, 1H), 10.33 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 29.2, 33.9, 40.5, 66.7, 73.1, 113.7, 115.4, 115.6, 118.9, 119.0, 119.2, 124.1, 129.0, 129.0, 130.5, 130.6, 131.0, 131.4, 136.1, 136.2, 151.1, 159.3, 161.7, 167.2.</div></div><div id="sec4_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 2-(2-Chloro-6-fluorophenyl)-<i>N</i>-[3-sulfamoyl-4-(tetrahydro-2<i>H</i>-pyran-4-ylmethoxy)phenyl]acetamide (<b>74</b>)</h4><div class="NLM_p last">According to general procedure GP5, <b>65d</b> (53.8 mg, 0.15 mmol) and 4-(bromomethyl)tetrahydro-2<i>H-</i>pyran (40.3 mg, 0.23 mmol) were converted to <b>74</b> (stirring over the weekend at room temperature), and it was purified by preparative HPLC (Chromatorex C-18 10 μm, 125 mm × 30 mm, acetonitrile/water + 0.1% formic acid) (3 mg, 0.00657 mmol, 4% yield, 99% purity). LC-MS (method A): Rt = 1.02 min; MS (ESIpos): <i>m</i>/<i>z</i> = 457 (M + H)<sup>+</sup>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ [ppm]: 1.22–1.37 (m, 2H), 1.68–1.79 (m, 2H), 2.09–2.24 (m, 1H), 3.26–3.36 (m, 2H), 3.87 (s, 4H), 3.94 (d, 2H), 6.92 (s, 2H), 7.17 (d, 1H), 7.25 (ddd, 1H), 7.33–7.42 (m, 2H), 7.74 (dd, 1H), 8.02 (d, 1H), 10.41 (s, 1H).</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> In Vivo Models: Animals</h3><div class="NLM_p last">Female adult C57BL/6N mice (≈20 g; Taconic) were acclimatized for 2 weeks and maintained in a 12 h light/dark cycle with access to food and water ad libitum. The animals were randomized and housed in groups of six per cage. All experiments were performed in strict compliance with company, regional, and federal guidelines for the use of laboratory animals. The experiments were approved and executed in accordance with policies and directives of LAGESO (Landesamt für Gesundheit und Soziales Berlin; Germany; A0195/13). All efforts were made to minimize suffering.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> CFA Inflammatory Pain Model</h3><div class="NLM_p last">Female adult C57BL/6N mice received intraplantar injection of Complete Freund’s Adjuvant (CFA) (30 μL, 1 mg/mL, Sigma) into the left hind paw under isoflurane anesthesia.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> Drugs and Vehicles</h3><div class="NLM_p last">Both BAY-1797 and rofecoxib were formulated in EtOH/Solutol/NaCl (1:5:94%). For dynamic weight bearing evaluation, Rofecoxib (10 mg/kg), BAY-1797 (50 mg/kg), and vehicle are administered in a volume of 5 mL/kg once daily for 2 days starting 1 day after CFA injection. Rofecoxib is administered for 3 h and BAY-1797 is given 1 h prior to behavioral testing in DWB on days 1 and 2, respectively. For the determination of intraplantar PGE2 concentrations, Rofecoxib (10 mg/kg), BAY-1797 (12.5, 25, or 50 mg/kg), and vehicle are administered in a volume of 5 mL/kg once on day 2 after CFA injection. Rofecoxib is administered for 3 h, and BAY-1797 is given 1 h prior to paw samples collection.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> Determination of PGE2 Concentrations</h3><div class="NLM_p last">As PGE2 in biologically active matrices is rapidly converted to its metabolites, very low PGE2 concentrations are detectable in tissue, urine, or blood samples. For this reason, measurement of PGE2 metabolites is advisable to provide a reliable estimate of actual PGE2 production. Paw biopsy samples taken 1 h after oral dosing with BAY-1797 or rofecoxib were used in PGE2 metabolite enzyme immunoassay (EIA) kit (Cayman Chemicals, Ann Arbor; #514531) converting 13,14-dihydro-15-keto PGA2 and 13,14-dihydro-15-keto PGE2 to a stable derivative that can be easily quantified by EIA. The detection limit of this kit is 2 pg/mL. The assay was performed according to manufacturer’s protocol.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> Dynamic Weight Bearing Evaluation</h3><div class="NLM_p last">The automated DWB device (Bioseb, Boulogne, France) consists of a Plexiglas enclosure (11 cm × 11 cm), a floor sensor composed of 44 × 44 captors detecting pressure variation, and a camera placed above the enclosure to validate the animal position during the analysis. DWB recording took place 24 and 48 h after intraplantar CFA injection and 1 h after oral administration of BAY-1797 or rofecoxib. The mice were able to move freely in the enclosure during a total time of 10 min, starting with a habituation phase of 5 min followed by a recording phase of 5 min, in which the weight distribution and the video were recorded. We analyzed the recordings during the entire time period using the DWB software (v1.4.1.28.), as previously described.<a onclick="showRef(event, 'ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref39 ref40">(39,40)</a> We considered a zone as valid when the following parameters were detected: ≥0.8 g on one captor with minimum of two adjacent captors recording ≥1.0 g. A time segment was considered as valid if greater than or equal to three stable pictures were detected. We validated, in a semiautomated way, for each sequence, the position of the paws according to the video recording. At the end of analysis, we extracted the mean over the time of the weight value applied by each paw on the floor.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i107" class="anchor-spacer"></div><h3 class="article-section__title" id="_i107"> Human P2X4 FLIPR Assay in HEK Cells</h3><div class="NLM_p last">HEK293 cells stably expressing human P2X4 were plated in poly-<span class="smallcaps smallerCapital">d</span>-lysine-coated 384-well plates at a seeding density of 30 000 cells/well and incubated overnight. P2X4 function was assessed by measuring intracellular calcium changes using the calcium-chelating dye Fluo8-AM (Molecular Devices) on a fluorescent imaging plate reader (FLEX/FLIPR station; Molecular Devices). On the day of the assay, the medium was removed and the cells were incubated for 30 min at 37 °C and 5% CO<sub>2</sub> in 30 μL of dye buffer (Hank’s balanced salt solution, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 1.8 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 2 mM probenecid, 5 mM <span class="smallcaps smallerCapital">d</span>-glucose monohydrate, 5 μM Fluo8-AM, pH = 7.4). Compounds diluted in probenecid buffer (Hank’s balanced salt solution, 10 mM HEPES, 1.8 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 2 mM probenecid, 5 mM <span class="smallcaps smallerCapital">d</span>-glucose monohydrate, pH = 7.4) were added in a volume of 10 μL and allowed to incubate for 30 min at room temperature. The final assay dimethyl sulfoxide (DMSO) concentration was 0.5%. The agonist, Bz-ATP (Tocris), was added in a volume of 10 μL at a concentration representing the EC80 value. The EC80 value of Bz-ATP was determined each assay day prior to compound profiling. The fluorescence was measured for an interval of 120 at 2 s intervals. The excitation and emission wavelengths used to monitor fluorescence were 470–495 and 515–575 nm, respectively. The data were analyzed based on the increase in peak relative fluorescence units (RFU) compared to the basal fluorescence and normalized to the agonist control. The compounds were tested in triplicates per plate, and mean values were plotted in Excel XLFit to determine IC<sub>50</sub> values, percentage of maximal inhibition, and the Hill coefficients.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Investigation of in Vitro Metabolic Stability in Rat Hepatocytes</h3><div class="NLM_p last">Hepatocytes from Han/Wistar rats were isolated via a two-step perfusion method. After perfusion, the liver was carefully removed from the rat: the liver capsule was opened and the hepatocytes were gently shaken out into a Petri dish with ice-cold Williams’ medium E (WME). The resulting cell suspension was filtered through sterile gaze in 50 mL falcon tubes and centrifuged at 50<i>g</i> for 3 min at room temperature. The cell pellet was resuspended in 30 mL of WME and centrifuged twice through a Percoll gradient at 100<i>g</i>. The hepatocytes were washed again with WME and resuspended in medium containing 5% fetal calf serum (FCS). Cell viability was determined by trypan blue exclusion. For the metabolic stability assay, liver cells were distributed in WME containing 5% FCS to glass vials at a density of 1.0 × 106 vital cells/mL. The test compound was added to a final concentration of 1 μM. During incubation, the hepatocyte suspensions were continuously shaken at 580 rpm and aliquots were taken at 2, 8, 16, 30, 45, and 90 min, to which equal volumes of cold methanol were immediately added. Samples were frozen at −20 °C overnight, subsequently centrifuged for 15 min at 3000 rpm, and the supernatant was analyzed with an Agilent 1200 HPLC-system with LC/MS-MS detection. The half-life of a test compound was determined from the concentration–time plot. From the half-life, the intrinsic clearances and the hepatic in vivo blood clearance (CL) and maximal oral bioavailability (<i>F</i><sub>max</sub>) were calculated using the “well stirred” liver model together with the additional parameters liver blood flow, specific liver weight, and amount of liver cells in vivo and in vitro. The following parameter values were used: Liver blood flow, 4.2 L/(h kg); specific liver weight, 32 g/kg; liver cells in vivo, 1.1 × 108 cells/g liver; liver cells in vitro, 1.0 × 106/mL.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> PXR Transactivation Assay</h3><div class="NLM_p last">To evaluate PXR nuclear receptor transactivation, a screening luciferase reporter gene assay in human HepG2 cells was applied. Transiently co-transfected HepG2 cells or stably transfected DPX-2 cells (Puracyp, Carlsbad, CA) containing the human PXR gene and a luciferase reporter gene under control of the human CYP3A4 promotor were used. The cells were seeded in 384-well plates and cultivated at 37 °C in humidified air with 5% CO<sub>2</sub>. Co-transfections with the two vectors were performed using FuGENE HD transfection reagent (Promega, Madison, WI) according to the manufacturer’s instructions; 24 h after seeding, the cells were treated with test compound (2 nM–50 μM, 0.5% DMSO) prepared by serial dilution of 1:3. Rifampicin was incubated in the same manner as positive control. In addition, for the normalization of the luminescence signal, the cells were incubated with rifampicin at a concentration of 16.5 μM corresponding to 100% activation, as well as DMSO for background luminescence corresponding to 0% activation (<i>n</i> = 32 wells each). The cells were lyzed and incubated with the luciferase substrate ONE-Glo Reagent (Promega, Madison, WI) according to the manufacturer’s instructions, and luminescence signal was detected in a plate reader. The transient assay was validated with a standard set of inducers (e.g., bosentan, carbamazepine) and noninducers (e.g., penicilin V, fluconazole). In addition, transiently transfected HepG2 cells and stably transfected DPX-2 cells were cross-validated using a set of 30 test compounds with different PXR transactivation potentials. From the dose–response curves, a concentration-dependent increase of the luciferase activity above a certain threshold (4-fold standard deviation of the DMSO background for transiently transfected cells and >10% of the rifampicin control for DPX-2 cells) was classified as PXR transactivation.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> CYP Induction Assay</h3><div class="NLM_p last">Human hepatocytes are seeded at a density of ∼40 000 cells/96 well in a collagen sandwich and cultured for 1 day before compound treatment. The cells are treated with a 1:3 serial dilution of 8 concentrations for two consecutive days with media change every day. After 48 h of compound treatment, the cells are lysed and mRNA is prepared by the state-of-the-art magnetic beads technique. Briefly, approximately 24 h after the last treatment, hepatocytes were harvested for mRNA isolation. Thus, cell culture medium was removed from each well, cells were washed with 150 μL supplement free cell culture medium prior to cell lysis, cells were lysed with 100 μL lysis buffer containing proteinase K (50 μg/μL; final concentration in well 30 ng/μL), and final cell lysates were stored at −80 °C. mRNA was isolated using the Dynabeads mRNA Direct Kit (Life Technologies); 150 μL of each cell lysate was mixed with 100 μg magnetic beads, incubated for a few minutes, then the supernatant was removed and beads were washed twice with Washing Buffer A and twice with Washing Buffer B with 200 and 100 μL per well, respectively. Single-stranded cDNA was prepared from mRNA with the High Capacity RNA to cDNA Kit (Life Technologies). RT Master Mix (20 μL) was added to each well and transcribed for 60 min at 37 °C using the Gene Amp PCR System 9700 thermocycling program (Biometra). The RT Master Mix is composed of 10× RT buffer, 25× deoxyNTPs, 10× Random hexamers, RNase Inhibitor (20 U/μL), MultiScribe reverse transcriptase (50 U/μL), and RNase-free water. The prepared cDNA samples were stored at −80 °C prior to analysis by quantitative real-time polymerase chain reaction (qRT-PCR). Quantitative RT-PCR was carried out on a QuantStudio7 Flex PCR system (Applied Biosystems) according to manufacturer’s protocol. A primer mix was prepared for each gene expression assay. A typical primer mix contained TaqMan Fast Advanced Master Mix (1×), Gene Expression Assay (1×, 900 nM forward and reverse primers), and RNase-free water and was added to the cDNA. The relative quantity of the target cDNA compared to that of the control cDNA (Actin, Tubulin) was determined by the ΔΔCt method. Relative quantification measures the change in mRNA expression in a test sample relative to that in a control sample (e.g., vehicle-treated). In summary, CYP induction is calculated based on the ΔΔCt method and expressed as fold induction over vehicle-treated control.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> PXR Protein Production and Co-crystal Structure Determination</h3><div class="NLM_p last">An expression construct similar to the one reported by Wang et al.,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> coding for a peptide of the Nuclear Receptor Coactivator NCOA1 (residues 678-700) fused via a Gly-Gly-Ser-Gly-Gly linker to the C-terminus of the ligand binding domain of PXR (residues 129 to 434), was expressed in <i>Escherichia coli</i>, purified via affinity chromatography (His-Trap, 5 mL), ion-exchange chromatography (Mono S HR 10/10), and gelfiltration (Superdex75 26/60, buffer 20 mM Tris pH 7.8, 250 mM NaCl, 2.5 mM EDTA, 5% (v/v) glycerol, 5 mM dithiothreitol (DTT)), concentrated to 12.1 mg/mL, and shock-frozen in liquid nitrogen. Compounds were selected for co-crystallization based on their stabilizing effect in the thermal shift assay (TSA; for assay details, see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_001.pdf" class="ext-link">Supporting Information</a>). For co-crystallization with compound <b>25</b>, PXR was thawn, supplemented with 10 mM compound (from a 200 mM stock solution in DMSO) and incubated at 277 K for 24 h. Crystals were set up using the vapor diffusion method in hanging drops made of 1 μL of protein–ligand solution and 1 μL of reservoir (100 mM imidazole pH 8.0, 17% (v/v) 2-methyl-2,4-pentanediol). Crystals were additionally soaked in 20 mM compound <b>25</b> prior to data collection. For data collection, crystals were briefly immerged in cryo buffer (100 mM imidazole pH 8.0, 34% (v/v) 2-methyl-2,4-pentanediol, supplemented with 20 mM compound <b>25</b>) and shock-frozen in liquid nitrogen. A diffraction data set to 2.2 Å resolution was collected on beamline BL14.1 operated by Helmholtz-Zentrum Berlin (HZB) at the BESSY II electron storage ring (Berlin-Adlershof, Germany)<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and processed using XDS<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> via the graphical user interface XDSAPP.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> The structure was solved by rigid-body refinement with REFMAC5<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> with PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HVL">3HVL</a> as starting model. The initial model was rebuilt in COOT<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> and refined using REFMAC5. Difference electron density indicated binding of the ligand only in one of the two PXR molecules of this crystal form (chain B). The ligand parameters were calculated using PRODRG,<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> and the ligand was fitted to the electron density using COOT. The remaining weak unexplained difference density suggested that a small fraction of the compound may also be bound in an alternative second conformation where the benzyl moiety may be flipped, but the density was too weak to justify, including this possible second conformation into the final model. Data collection and refinement statistics are summarized in Table 1 in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_001.pdf" class="ext-link">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i112"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01304" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01304?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01304</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Analytical LC-MS and UPLC-MS conditions; FLIPR methods for human, mouse, and rat P2X4 1321N1 astrocytoma cells; QPatch methods for hP2X4 1321N1 cells; Caco-2 Permeability Assay; inhibition of CYP450 metabolism; TSA assay; stability of compounds in solution (pH 10, 7, and 1 at 37 °C); stability of compounds in plasma (rat, human at 37 °C); LogD measurement; off-target assay panels; HPLC traces of lead compounds <b>10</b>, <b>71</b>, and <b>73</b>;and data collection and refinement statistics (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_001.pdf">jm9b01304_si_001.pdf (335.56 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_002.csv">jm9b01304_si_002.csv (16.16 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factors of the crystal structure of PXR in complex with compound <b>25</b> have been deposited to the protein data bank (PDB) with PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HTY">6HTY</a>. The authors will release them upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.9b01304" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05052" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05052" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Werner</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7115-6350" title="Orcid link">http://orcid.org/0000-0001-7115-6350</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#88fbfcedeee9e6a6ffedfae6edfac8eae9f1edfaa6ebe7e5"><span class="__cf_email__" data-cfemail="e192958487808fcf9684938f8493a18380988493cf828e8c">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefanie Mesch</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#1162657477707f78743f7c746272795173706874633f727e7c"><span class="__cf_email__" data-cfemail="1467607172757a7d713a797167777c5476756d71663a777b79">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roman C. Hillig</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Antonius ter Laak</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Klint</span> - <span class="hlFld-Affiliation affiliation">Evotec
SE, 22419 Hamburg, Germany</span>; 
    <span>Present Address:
                        Lundbeck, 2500 Kopenhagen, Denmark (J.K.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ioana Neagoe</span> - <span class="hlFld-Affiliation affiliation">Evotec
SE, 22419 Hamburg, Germany</span>; 
    <span>Present Address:
                        Galapagos, 2800 Mechelen, Belgium (I.N.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexis Laux-Biehlmann</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henrik Dahllöf</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span>; 
    <span>Present Address:
                        Swedish Medical Products Agency, SE-751 03 Uppsala, Sweden (H.D.)</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nico Bräuer</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vera Puetter</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reinhard Nubbemeyer</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simone Schulz</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michaela Bairlein</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas M. Zollner</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andreas Steinmeyer</span> - <span class="hlFld-Affiliation affiliation">Bayer
AG, Research & Development, Pharmaceuticals, 13353 Berlin, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): With the exception of I.N. and J.K., who were employees of Evotec AG, all authors are current or former employees of Bayer AG. All authors were members of the respective research labs involved in the generation of these results.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5589-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i118">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02831" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02831" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Werner Behrendt, Anh-Thu Ngyuen, Florian Elflein, Giannina Rotzoll, and Thorsten Unger (Medicinal Chemistry, Berlin), and Ulrike Efiloglu and Stefan Wisniewski (Preclinical research, Berlin) for their technical assistance throughout the whole project. Dr. Stephan Gründemann and Bernd Undeutsch are acknowledged for analytical support. The authors would like to thank Petra Rothhaupt and Ivonne Herms for technical support with PXR purification and crystallization and the beamline staff at beamline BL14.1 at Helmholtz-Zentrum Berlin (HZB) for support during data collection. Dr. Glauco Tarozzo is acknowledged for additional P2X4 measurements, and Dr. Stephen Hess is acknowledged for careful manuscript proof reading. They also want to express their greatest gratitude to Prof. Dr. Christa E. Müller (University of Bonn) for providing them with the P2X4 1321N astrocytoma cell lines (human, mouse, and rat)</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">Complete Freund’s Adjuvant</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DWB</td><td class="NLM_def"><p class="first last">dynamic weight bearing</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorescence imaging plate reader</p></td></tr><tr><td class="NLM_term">GP</td><td class="NLM_def"><p class="first last">general procedure</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">1-[Bis(dimethylamino)methylene]-1<i>H</i>-1,2,3-triazolo[4,5-<i>b</i>]pyridinium 3-oxide hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human Ether-à-go-go-Related Gene</p></td></tr><tr><td class="NLM_term">MEC</td><td class="NLM_def"><p class="first last">minimum effective concentration</p></td></tr><tr><td class="NLM_term">MNT</td><td class="NLM_def"><p class="first last">micronucleus test</p></td></tr><tr><td class="NLM_term">P2X</td><td class="NLM_def"><p class="first last">purinoreceptor</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PGE2</td><td class="NLM_def"><p class="first last">prostaglandin E2</p></td></tr><tr><td class="NLM_term">PTFE</td><td class="NLM_def"><p class="first last">poly(tetrafluoroethylene)</p></td></tr><tr><td class="NLM_term">PXR</td><td class="NLM_def"><p class="first last">pregnane X receptor</p></td></tr><tr><td class="NLM_term">Rt</td><td class="NLM_def"><p class="first last">retention time</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr><tr><td class="NLM_term">TSA</td><td class="NLM_def"><p class="first last">thermal shift assay</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultraperformance liquid chromatography</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i120">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 47 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span> <span> </span><span class="NLM_article-title">P2X ion channel receptors and inflammation</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1007/s11302-015-9493-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1007%2Fs11302-015-9493-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26739702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=59-67&author=G.+Burnstock&title=P2X+ion+channel+receptors+and+inflammation&doi=10.1007%2Fs11302-015-9493-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">P2X ion channel receptors and inflammation</span></div><div class="casAuthors">Burnstock, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-67</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuroinflammation limits tissue damage in response to pathogens or injury and promotes repair.  There are two stages of inflammation, initiation and resoln.  P2X receptors are gaining attention in relation to immunol. and inflammation.  The P2X7 receptor in particular appears to be an essential immunomodulatory receptor, although P2X1 and P2X4 receptors also appear to be involved.  ATP released from damaged or infected cells causes inflammation by release of inflammatory cytokines via P2X7 receptors and acts as a danger signal by occupying upregulated P2X receptors on immune cells to increase immune responses.  The purinergic involvement in inflammation is being explored for the development of novel therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRKcDsxubzrVg90H21EOLACvtfcHk0liSPL9Pg3MXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslGmug%253D%253D&md5=c8ce49c3caa010bb73e33ec75b931abd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11302-015-9493-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-015-9493-0%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DP2X%2520ion%2520channel%2520receptors%2520and%2520inflammation%26jtitle%3DPurinergic%2520Signalling%26date%3D2016%26volume%3D12%26spage%3D59%26epage%3D67%26doi%3D10.1007%2Fs11302-015-9493-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span> <span> </span><span class="NLM_article-title">Purinergic mechanisms and pain</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/bs.apha.2015.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fbs.apha.2015.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26920010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsFSjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2016&pages=91-137&author=G.+Burnstock&title=Purinergic+mechanisms+and+pain&doi=10.1016%2Fbs.apha.2015.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Purinergic mechanisms and pain</span></div><div class="casAuthors">Burnstock, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">Pharmacological Mechanisms and the Modulation of Pain</span>),
    <span class="NLM_cas:pages">91-137</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">There is a brief introductory summary of purinergic signaling involving ATP storage, release, and ectoenzymic breakdown, and the current classification of receptor subtypes for purines and pyrimidines.  The review then describes purinergic mechanosensory transduction involved in visceral, cutaneous, and musculoskeletal nociception and on the roles played by receptor subtypes in neuropathic and inflammatory pain.  Multiple purinoceptor subtypes are involved in pain pathways both as an initiator and modulator.  Activation of homomeric P2X3 receptors contributes to acute nociception and activation of heteromeric P2X2/3 receptors appears to modulate longer-lasting nociceptive sensitivity assocd. with nerve injury or chronic inflammation.  In neuropathic pain activation of P2X4, P2X7, and P2Y12 receptors on microglia may serve to maintain nociceptive sensitivity through complex neural-glial cell interactions and antagonists to these receptors reduce neuropathic pain.  Potential therapeutic approaches involving purinergic mechanisms will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowoVefyC4mLLVg90H21EOLACvtfcHk0liSPL9Pg3MXWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsFSjsLw%253D&md5=e69a7b8343ff587d61ebac0af1b62787</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fbs.apha.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.apha.2015.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DPurinergic%2520mechanisms%2520and%2520pain%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2016%26volume%3D75%26spage%3D91%26epage%3D137%26doi%3D10.1016%2Fbs.apha.2015.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span> <span> </span><span class="NLM_article-title">Triphosphate, the key structure of the ATP molecule responsible for interaction with P2X-purinoceptors</span>. <i>Gen. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1016/0306-3623(93)90223-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2F0306-3623%2893%2990223-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=8365644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADyaK3sXltV2hs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1993&pages=637-640&author=X.+Boauthor=G.+Burnstock&title=Triphosphate%2C+the+key+structure+of+the+ATP+molecule+responsible+for+interaction+with+P2X-purinoceptors&doi=10.1016%2F0306-3623%2893%2990223-K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Triphosphate, the key structure of the ATP molecule responsible for interaction with P2X-purinoceptors</span></div><div class="casAuthors">Bo, Xuenong; Burnstock, Goeffrey</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">637-40</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    </div><div class="casAbstract">A radioligand binding assay was carried out to explore the key structure in mols. of ATP and its analogs responsible for the binding to P2X-purinoceptors.  It was found that adenosine, adenine and xanthine had no effect on [3H]α,β-methylene ATP binding to membrane fractions prepd. from rat urinary bladder, while pentasodium triphosphate and disodium pyrophosphate could effectively displace the binding.  Na orthophosphate was shown to displace the binding only at much higher concn.  Apart from ATP, several other nucleotides could also fully displace the specific binding, but with potencies lower than that of ATP.  The results indicate that the phosphate side chain in mols. of ATP and its analogs is the key structure responsible for the binding to P2X-purinoceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbE0zzS_hQ0LVg90H21EOLACvtfcHk0ljkMkOwYIUfPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltV2hs7c%253D&md5=503f55f3b601201a482524e3d8bd54b0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2893%2990223-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252893%252990223-K%26sid%3Dliteratum%253Aachs%26aulast%3DBo%26aufirst%3DX.%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DTriphosphate%252C%2520the%2520key%2520structure%2520of%2520the%2520ATP%2520molecule%2520responsible%2520for%2520interaction%2520with%2520P2X-purinoceptors%26jtitle%3DGen.%2520Pharmacol.%26date%3D1993%26volume%3D24%26spage%3D637%26epage%3D640%26doi%3D10.1016%2F0306-3623%2893%2990223-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rassendren, F.</span></span> <span> </span><span class="NLM_article-title">P2X receptors: an emerging channel family</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2221</span>– <span class="NLM_lpage">2228</span>, <span class="refDoi"> DOI: 10.1111/j.1460-9568.1996.tb00745.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1111%2Fj.1460-9568.1996.tb00745.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=8921315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADyaK2s%252FnvFKjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=2221-2228&author=G.+Buellauthor=G.+Colloauthor=F.+Rassendren&title=P2X+receptors%3A+an+emerging+channel+family&doi=10.1111%2Fj.1460-9568.1996.tb00745.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">P2X receptors: an emerging channel family</span></div><div class="casAuthors">Buell G; Collo G; Rassendren F</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2221-8</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxnqTOAOvv4xWfpMXQLRstfW6udTcc2ebognBwaSch_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FnvFKjtg%253D%253D&md5=931b513dbae97dd799ebefbe4ab676dc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.1996.tb00745.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.1996.tb00745.x%26sid%3Dliteratum%253Aachs%26aulast%3DBuell%26aufirst%3DG.%26aulast%3DCollo%26aufirst%3DG.%26aulast%3DRassendren%26aufirst%3DF.%26atitle%3DP2X%2520receptors%253A%2520an%2520emerging%2520channel%2520family%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1996%26volume%3D8%26spage%3D2221%26epage%3D2228%26doi%3D10.1111%2Fj.1460-9568.1996.tb00745.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span> <span> </span><span class="NLM_article-title">Introduction and perspective, historical note</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>, <span class="NLM_elocation-id">227</span> <span class="refDoi"> DOI: 10.3389/fncel.2013.00227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.3389%2Ffncel.2013.00227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=24312014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKisrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=G.+Burnstock&title=Introduction+and+perspective%2C+historical+note&doi=10.3389%2Ffncel.2013.00227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction and perspective, historical note</span></div><div class="casAuthors">Burnstock, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">Nov.</span>),
    <span class="NLM_cas:pages">227/1-227/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  P2 nucleotide receptors were proposed to consist of two subfamilies based on pharmacol. in 1985, named P2X and P2Y receptors.  Later, this was confirmed following cloning of the receptors for nucleotides and studies of transduction mechanisms in the early 1990s.  P2X receptors are ion channels and seven subtypes are recognized that form trimeric homomultimers or heteromultimers.  P2X receptors are involved in neuromuscular and synaptic neurotransmission and neuromodulation.  They are also expressed on many types of non-neuronal cells to mediate smooth muscle contraction, secretion, and immune modulation.  The emphasis in this review will be on the pathophysiol. of P2X receptors and therapeutic potential of P2X receptor agonists and antagonists for neurodegenerative and inflammatory disorders, visceral and neuropathic pain, irritable bowel syndrome, diabetes, kidney failure, bladder incontinence and cancer, as well as disorders if the special senses, airways, skin, cardiovascular, and musculoskeletal systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlPN8XDxfm-rVg90H21EOLACvtfcHk0ljkMkOwYIUfPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKisrjE&md5=c4c24c343dd28aaa673ff0dc50c9e7bc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2013.00227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2013.00227%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DIntroduction%2520and%2520perspective%252C%2520historical%2520note%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2013%26doi%3D10.3389%2Ffncel.2013.00227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nori, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">North, R. A.</span></span> <span> </span><span class="NLM_article-title">Tissue distribution of P2X4 receptors studied with an ectodomain antibody</span>. <i>Cell Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1007/s00441-003-0758-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1007%2Fs00441-003-0758-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=12845522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1ajurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2003&pages=159-165&author=X.+Boauthor=M.+Kimauthor=S.+L.+Noriauthor=R.+Schoepferauthor=G.+Burnstockauthor=R.+A.+North&title=Tissue+distribution+of+P2X4+receptors+studied+with+an+ectodomain+antibody&doi=10.1007%2Fs00441-003-0758-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution of P2X4 receptors studied with an ectodomain antibody</span></div><div class="casAuthors">Bo, Xuenong; Kim, Miran; Nori, Stefania L.; Schoepfer, Ralf; Burnstock, Geoffrey; North, R. Alan</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-165</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A monoclonal antibody was developed to the extracellular domain of the rat P2X4 receptor.  The antibody was highly selective among all rat P2X receptor subunits, and recognized only the oligomeric, non-denatured form of the P2X4 receptor.  Immunohistochem. showed an extensive pattern of distribution throughout the central and peripheral nervous systems, the epithelia of ducted glands and airways, smooth muscle of bladder, gastrointestinal tract, uterus, and arteries, uterine endometrium and fat cells.  The protein was identified by Western blotting in membrane exts. of these tissues, and the ectodomain antibody immunopptd. a protein that was recognized with a P2X4 receptor C terminus antibody.  The findings indicate that the P2X4 receptor subunit has a very extensive distribution among mammalian tissues, and this suggests possible new functional roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZDYPBDy6tkrVg90H21EOLACvtfcHk0ljJU7cY6CE6Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1ajurw%253D&md5=8d1bbec06f2079383860eb7ce477a084</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00441-003-0758-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-003-0758-5%26sid%3Dliteratum%253Aachs%26aulast%3DBo%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DNori%26aufirst%3DS.%2BL.%26aulast%3DSchoepfer%26aufirst%3DR.%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DNorth%26aufirst%3DR.%2BA.%26atitle%3DTissue%2520distribution%2520of%2520P2X4%2520receptors%2520studied%2520with%2520an%2520ectodomain%2520antibody%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2003%26volume%3D313%26spage%3D159%26epage%3D165%26doi%3D10.1007%2Fs00441-003-0758-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bengtsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlinge, D.</span></span> <span> </span><span class="NLM_article-title">P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells</span>. <i>BMC Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.1186/1471-2172-5-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1186%2F1471-2172-5-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=15291969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BD2cvgs1ShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=16&author=L.+Wangauthor=S.+E.+Jacobsenauthor=A.+Bengtssonauthor=D.+Erlinge&title=P2+receptor+mRNA+expression+profiles+in+human+lymphocytes%2C+monocytes+and+CD34%2B+stem+and+progenitor+cells&doi=10.1186%2F1471-2172-5-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells</span></div><div class="casAuthors">Wang Lingwei; Jacobsen Sten Eirik W; Bengtsson Anders; Erlinge David</div><div class="citationInfo"><span class="NLM_cas:title">BMC immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Extracellular nucleotides (ATP, ADP, UTP and UDP) exert a wide range of biological effects in blood cells mediated by multiple ionotropic P2X receptors and G protein-coupled P2Y receptors.  Although pharmacological experiments have suggested the presence of several P2 receptor subtypes on monocytes and lymphocytes, some results are contradictory.  Few physiological functions have been firmly established to a specific receptor subtype, partly because of a lack of truly selective agonists and antagonists.  This stimulated us to investigate the expression of P2X and P2Y receptors in human lymphocytes and monocytes with a newly established quantitative mRNA assay for P2 receptors.  In addition, we describe for the first time the expression of P2 receptors in CD34+ stem and progenitor cells implicating a potential role of P2 receptors in hematopoietic lineage and progenitor/stem cell function.  RESULTS:  Using a quantitative mRNA assay, we assessed the hypothesis that there are specific P2 receptor profiles in inflammatory cells.  The P2X4 receptor had the highest expression in lymphocytes and monocytes.  Among the P2Y receptors, P2Y12 and P2Y2 had highest expression in lymphocytes, while the P2Y2 and P2Y13 had highest expression in monocytes.  Several P2 receptors were expressed (P2Y2, P2Y1, P2Y12, P2Y13, P2Y11, P2X1, P2X4) in CD34+ stem and progenitor cells.  CONCLUSIONS:  The most interesting findings were the high mRNA expression of P2Y12 receptors in lymphocytes potentially explaining the anti-inflammatory effects of clopidogrel, P2Y13 receptors in monocytes and a previously unrecognised expression of P2X4 in lymphocytes and monocytes.  In addition, for the first time P2 receptor mRNA expression patterns was studied in CD34+ stem and progenitor cells.  Several P2 receptors were expressed (P2Y2, P2Y1, P2Y12, P2Y13, P2Y11, P2X1, P2X4), indicating a role in differentiation and proliferation.  Thus, it is possible that specific antibodies to P2 receptors could be used to identify progenitors for monocytes, lymphocytes and megakaryocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-XS29us3wqa-9TkgmBqTqfW6udTcc2eb2eP9iUGhz4bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvgs1ShtA%253D%253D&md5=ce8e74144c12d078458d8eb8430132e1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1186%2F1471-2172-5-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2172-5-16%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DJacobsen%26aufirst%3DS.%2BE.%26aulast%3DBengtsson%26aufirst%3DA.%26aulast%3DErlinge%26aufirst%3DD.%26atitle%3DP2%2520receptor%2520mRNA%2520expression%2520profiles%2520in%2520human%2520lymphocytes%252C%2520monocytes%2520and%2520CD34%252B%2520stem%2520and%2520progenitor%2520cells%26jtitle%3DBMC%2520Immunol.%26date%3D2004%26volume%3D5%26spage%3D16%26doi%3D10.1186%2F1471-2172-5-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaumont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conquet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buell, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeve, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessell, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rassendren, F.</span></span> <span> </span><span class="NLM_article-title">Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">11263</span>– <span class="NLM_lpage">11268</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2308-08.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1523%2FJNEUROSCI.2308-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=18971468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGltrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=11263-11268&author=L.+Ulmannauthor=J.+P.+Hatcherauthor=J.+P.+Hughesauthor=S.+Chaumontauthor=P.+J.+Greenauthor=F.+Conquetauthor=G.+N.+Buellauthor=A.+J.+Reeveauthor=I.+P.+Chessellauthor=F.+Rassendren&title=Up-regulation+of+P2X4+receptors+in+spinal+microglia+after+peripheral+nerve+injury+mediates+BDNF+release+and+neuropathic+pain&doi=10.1523%2FJNEUROSCI.2308-08.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain</span></div><div class="casAuthors">Ulmann, Lauriane; Hatcher, Jon P.; Hughes, Jane P.; Chaumont, Severine; Green, Paula J.; Conquet, Francois; Buell, Gary N.; Reeve, Alison J.; Chessell, Iain P.; Rassendren, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11263-11268</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">ATP is a known mediator of inflammatory and neuropathic pain.  However, the mechanisms by which specific purinergic receptors contribute to chronic pain states are still poorly characterized.  Here, we demonstrate that in response to peripheral nerve injury, P2X4 receptors (P2X4R) are expressed de novo by activated microglia in the spinal cord.  Using in vitro and in vivo models, we provide direct evidence that P2X4R stimulation leads to the release of BDNF from activated microglia and, most likely phosphorylation of the NR1 subunit of NMDA receptors in dorsal horn neurons of the spinal cord.  Consistent with these findings, P2X4-deficient mice lack mech. hyperalgesia induced by peripheral nerve injury and display impaired BDNF signaling in the spinal cord.  Furthermore, ATP stimulation is unable to stimulate BDNF release from P2X4-deficient mice microglia in primary cultures.  These results indicate that P2X4R contribute to chronic pain through a central inflammatory pathway.  P2X4R might thus represent a potential therapeutic target to limit microglia-mediated inflammatory responses assocd. with brain injury and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeL5JMDsIicbVg90H21EOLACvtfcHk0ljJU7cY6CE6Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGltrfL&md5=7446b0242bc30ef950d77c57f873c7c7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2308-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2308-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DUlmann%26aufirst%3DL.%26aulast%3DHatcher%26aufirst%3DJ.%2BP.%26aulast%3DHughes%26aufirst%3DJ.%2BP.%26aulast%3DChaumont%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DP.%2BJ.%26aulast%3DConquet%26aufirst%3DF.%26aulast%3DBuell%26aufirst%3DG.%2BN.%26aulast%3DReeve%26aufirst%3DA.%2BJ.%26aulast%3DChessell%26aufirst%3DI.%2BP.%26aulast%3DRassendren%26aufirst%3DF.%26atitle%3DUp-regulation%2520of%2520P2X4%2520receptors%2520in%2520spinal%2520microglia%2520after%2520peripheral%2520nerve%2520injury%2520mediates%2520BDNF%2520release%2520and%2520neuropathic%2520pain%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D11263%26epage%3D11268%26doi%3D10.1523%2FJNEUROSCI.2308-08.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suurväli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudinot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanellopoulos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rüütel Boudinot, S.</span></span> <span> </span><span class="NLM_article-title">P2X4: A fast and sensitive purinergic receptor</span>. <i>Biomed J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1016/j.bj.2017.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.bj.2017.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=29179879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC1M3lsVWktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2017&pages=245-256&author=J.+Suurv%C3%A4liauthor=P.+Boudinotauthor=J.+Kanellopoulosauthor=S.+R%C3%BC%C3%BCtel+Boudinot&title=P2X4%3A+A+fast+and+sensitive+purinergic+receptor&doi=10.1016%2Fj.bj.2017.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">P2X4: A fast and sensitive purinergic receptor</span></div><div class="casAuthors">Suurvali Jaanus; Boudinot Pierre; Kanellopoulos Jean; Ruutel Boudinot Sirje</div><div class="citationInfo"><span class="NLM_cas:title">Biomedical journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">245-256</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Extracellular nucleotides have been recognized as important mediators of activation, triggering multiple responses via plasma membrane receptors known as P2 receptors.  P2 receptors comprise P2X ionotropic receptors and G protein-coupled P2Y receptors.  P2X receptors are expressed in many tissues, where they are involved in a number of functions including synaptic transmission, muscle contraction, platelet aggregation, inflammation, macrophage activation, differentiation and proliferation, neuropathic and inflammatory pain.  P2X4 is one of the most sensitive purinergic receptors (at nanomolar ATP concentrations), about one thousand times more than the archetypal P2X7.  P2X4 is widely expressed in central and peripheral neurons, in microglia, and also found in various epithelial tissues and endothelial cells.  It localizes on the plasma membrane, but also in intracellular compartments.  P2X4 is preferentially localized in lysosomes, where it is protected from proteolysis by its glycosylation.  High ATP concentration in the lysosomes does not activate P2X4 at low pH; P2X4 gets activated by intra-lysosomal ATP only in its fully dissociated tetra-anionic form, when the pH increases to 7.4.  Thus, P2X4 is functioning as a Ca(2+)-channel after the fusion of late endosomes and lysosomes.  P2X4 modulates major neurotransmitter systems and regulates alcohol-induced responses in microglia.  P2X4 is one of the key receptors mediating neuropathic pain.  However, injury-induced upregulation of P2X4 expression is gender dependent and plays a key role in pain difference between males and females.  P2X4 is also involved in inflammation.  Extracellular ATP being a pro-inflammatory molecule, P2X4 can trigger inflammation in response to high ATP release.  It is therefore involved in multiple pathologies, like post-ischemic inflammation, rheumatoid arthritis, airways inflammation in asthma, neurodegenerative diseases and even metabolic syndrome.  Although P2X4 remains poorly characterized, more studies are needed as it is likely to be a potential therapeutic target in these multiple pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRLP8XyTkQo3GK_SFaaT9INfW6udTcc2eYqcQUbjbzXvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3lsVWktw%253D%253D&md5=0fab046d18ddeed93b1c8b90aa060f38</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bj.2017.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bj.2017.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DSuurv%25C3%25A4li%26aufirst%3DJ.%26aulast%3DBoudinot%26aufirst%3DP.%26aulast%3DKanellopoulos%26aufirst%3DJ.%26aulast%3DR%25C3%25BC%25C3%25BCtel%2BBoudinot%26aufirst%3DS.%26atitle%3DP2X4%253A%2520A%2520fast%2520and%2520sensitive%2520purinergic%2520receptor%26jtitle%3DBiomed%2520J.%26date%3D2017%26volume%3D40%26spage%3D245%26epage%3D256%26doi%3D10.1016%2Fj.bj.2017.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namaka, M.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor-4/p38 MAPK signaling in the dorsal horn contributes to P2X4 receptor activation and BDNF over-secretion in cancer induced bone pain</span>. <i>Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.neures.2017.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.neures.2017.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=28668500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1CmsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=37-45&author=X.+W.+Mengauthor=J.+L.+Gaoauthor=J.+L.+Zuoauthor=L.+N.+Wangauthor=S.+L.+Liuauthor=X.+H.+Jinauthor=M.+Yaoauthor=M.+Namaka&title=Toll-like+receptor-4%2Fp38+MAPK+signaling+in+the+dorsal+horn+contributes+to+P2X4+receptor+activation+and+BDNF+over-secretion+in+cancer+induced+bone+pain&doi=10.1016%2Fj.neures.2017.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptor-4/p38 MAPK signaling in the dorsal horn contributes to P2X4 receptor activation and BDNF over-secretion in cancer induced bone pain</span></div><div class="casAuthors">Meng, Xiao-wen; Gao, Jian-ling; Zuo, Jian-Ling; Wang, Li-Na; Liu, Si-lan; Jin, Xiao-Hong; Yao, Ming; Namaka, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-45</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Our previous research suggested that the P2X4 receptor (P2X4R) expression in microglia was involved in the activation of toll-like receptor-4 (TLR4) in the dorsal horn in the rat model of cancer induced bone pain (CIBP).  In this study, we focused on whether TLR4- mitogen-activated protein kinases, p38 (p38 MAPK) contributes to P2X4R activation and brain-derived neurotrophic factor (BDNF) over-secretion in CIBP.  In in vitro expt., the results showed that BDNF expression evoked by ATP stimulation was dependent on TLR4-p38.  In in vivo expt., the results demonstrated that an intrathecal injection of TLR4 siRNA alleviated nociception induced by lipopolysaccharide (LPS) plus ATP or CIBP with decreased expression of P2X4R, TLR4, BDNF, interleukin-6 (IL-6) and phosphorylated-p38 MAPK (p-p38 MAPK).  Moreover, injection with p38MAPK inhibitor SB203580 resulted in an identical pattern compared with treatment with TLR4 siRNA.  Our results demonstrate that the activation of TLR4-p38MAPK-P2X4R signaling in microglial possibility plays an important role in the process of nociceptive transmission in CIBP, suggesting new mechanism and potential therapeutic targets for CIBP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE4hiRJHm2H7Vg90H21EOLACvtfcHk0ljB9J6JERz-jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1CmsLbF&md5=8affb046a15324a315222a92637c6d36</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.neures.2017.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neures.2017.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%2BW.%26aulast%3DGao%26aufirst%3DJ.%2BL.%26aulast%3DZuo%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DL.%2BN.%26aulast%3DLiu%26aufirst%3DS.%2BL.%26aulast%3DJin%26aufirst%3DX.%2BH.%26aulast%3DYao%26aufirst%3DM.%26aulast%3DNamaka%26aufirst%3DM.%26atitle%3DToll-like%2520receptor-4%252Fp38%2520MAPK%2520signaling%2520in%2520the%2520dorsal%2520horn%2520contributes%2520to%2520P2X4%2520receptor%2520activation%2520and%2520BDNF%2520over-secretion%2520in%2520cancer%2520induced%2520bone%2520pain%26jtitle%3DNeurosci.%2520Res.%26date%3D2017%26volume%3D125%26spage%3D37%26epage%3D45%26doi%3D10.1016%2Fj.neures.2017.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, M. W.</span></span> <span> </span><span class="NLM_article-title">P2X4 purinoceptor signaling in chronic pain</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1007/s11302-012-9306-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1007%2Fs11302-012-9306-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=22528681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=621-628&author=T.+Trangauthor=M.+W.+Salter&title=P2X4+purinoceptor+signaling+in+chronic+pain&doi=10.1007%2Fs11302-012-9306-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">P2X4 purinoceptor signaling in chronic pain</span></div><div class="casAuthors">Trang, Tuan; Salter, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621-628</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  ATP, acting via P2 purinergic receptors, is a known mediator of inflammatory and neuropathic pain.  There is increasing evidence that the ATP-gated P2X4 receptor (P2X4R) subtype is a locus through which activity of spinal microglia and peripheral macrophages instigate pain hypersensitivity caused by inflammation or by injury to a peripheral nerve.  The present article highlights the recent advances in our understanding of microglia-neuron interactions in neuropathic pain by focusing on the signaling and regulation of the P2X4R.  We will also develop a framework for understanding converging lines of evidence for involvement of P2X4Rs expressed on macrophages in peripheral inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp25UzCgKxYk7Vg90H21EOLACvtfcHk0ljB9J6JERz-jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVCmt7g%253D&md5=e951d7ec39460a4b09a7834ffab5b2c5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs11302-012-9306-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-012-9306-7%26sid%3Dliteratum%253Aachs%26aulast%3DTrang%26aufirst%3DT.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26atitle%3DP2X4%2520purinoceptor%2520signaling%2520in%2520chronic%2520pain%26jtitle%3DPurinergic%2520Signalling%26date%3D2012%26volume%3D8%26spage%3D621%26epage%3D628%26doi%3D10.1007%2Fs11302-012-9306-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuboyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozaki-Saitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span> <span> </span><span class="NLM_article-title">Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1744</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-5-28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1186%2F1744-8069-5-28" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=1744&author=M.+Tsudaauthor=K.+Kuboyamaauthor=T.+Inoueauthor=K.+Nagataauthor=H.+Tozaki-Saitohauthor=K.+Inoue&title=Behavioral+phenotypes+of+mice+lacking+purinergic+P2X4+receptors+in+acute+and+chronic+pain+assays&doi=10.1186%2F1744-8069-5-28"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-5-28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-5-28%26sid%3Dliteratum%253Aachs%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DKuboyama%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DTozaki-Saitoh%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DK.%26atitle%3DBehavioral%2520phenotypes%2520of%2520mice%2520lacking%2520purinergic%2520P2X4%2520receptors%2520in%2520acute%2520and%2520chronic%2520pain%2520assays%26jtitle%3DMol.%2520Pain%26date%3D2009%26volume%3D5%26spage%3D1744%26doi%3D10.1186%2F1744-8069-5-28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, M.</span></span> <span> </span><span class="NLM_article-title">Microglia in the spinal cord and neuropathic pain</span>. <i>J. Diabetes Invest.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1111/jdi.12379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1111%2Fjdi.12379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26813032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvFGgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=17-26&author=M.+Tsuda&title=Microglia+in+the+spinal+cord+and+neuropathic+pain&doi=10.1111%2Fjdi.12379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia in the spinal cord and neuropathic pain</span></div><div class="casAuthors">Tsuda, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Diabetes Investigation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-26</span>CODEN:
                <span class="NLM_cas:coden">JDIOAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-1124</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In contrast to physiol. pain, pathol. pain is not dependent on the presence of tissue-damaging stimuli.  One type of pathol. pain - neuropathic pain - is often a consequence of nerve injury or of diseases such as diabetes.  Neuropathic pain can be agonizing, can persist over long periods and is often resistant to known painkillers.  A growing body of evidence shows that many pathol. processes within the central nervous system are mediated by complex interactions between neurons and glial cells.  In the case of painful peripheral neuropathy, spinal microglia react and undergo a series of changes that directly influence the establishment of neuropathic pain states.  After nerve damage, purinergic P2X4 receptors (non-selective cation channels activated by extracellular ATP) are upregulated in spinal microglia in a manner that depends on the transcription factors interferon regulatory factor 8 and 5, both of which are expressed in microglia after peripheral nerve injury.  P2X4 receptor expression on the cell surface of microglia is also regulated at the post-translational level by signaling from CC chemokine receptor chemotactic cytokine receptor 2.  Furthermore, spinal microglia in response to extracellular stimuli results in signal transduction through intracellular signaling cascades, such as mitogen-activated protein kinases, p38 and extracellular signal-regulated protein kinase.  Importantly, inhibiting the function or expression of these microglial mols. suppresses the aberrant excitability of dorsal horn neurons and neuropathic pain.  These findings show that spinal microglia are a central player in mechanisms for neuropathic pain, and might be a potential target for treating the chronic pain state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyRrA1amipMrVg90H21EOLACvtfcHk0lgH5D35-pmCqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjvFGgsw%253D%253D&md5=f16454ad118dcf2350115a4c1877dc17</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fjdi.12379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjdi.12379%26sid%3Dliteratum%253Aachs%26aulast%3DTsuda%26aufirst%3DM.%26atitle%3DMicroglia%2520in%2520the%2520spinal%2520cord%2520and%2520neuropathic%2520pain%26jtitle%3DJ.%2520Diabetes%2520Invest.%26date%3D2016%26volume%3D7%26spage%3D17%26epage%3D26%26doi%3D10.1111%2Fjdi.12379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layhadi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fountain, S. J.</span></span> <span> </span><span class="NLM_article-title">P2X4 receptor function in the nervous system and current breakthroughs in pharmacology</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">291</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.3389%2Ffphar.2017.00291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=28588493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFentbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=291&author=L.+Stokesauthor=J.+A.+Layhadiauthor=L.+Bibicauthor=K.+Dhunaauthor=S.+J.+Fountain&title=P2X4+receptor+function+in+the+nervous+system+and+current+breakthroughs+in+pharmacology&doi=10.3389%2Ffphar.2017.00291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">P2X4 receptor function in the nervous system and current breakthroughs in pharmacology</span></div><div class="casAuthors">Stokes, Leanne; Layhadi, Janice A.; Bibic, Lucka; Dhuna, Kshitija; Fountain, Samuel J.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291/1-291/15</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Adenosine 50-triphosphate is a well-known extracellular signaling mol. and neurotransmitter known to activate purinergic P2X receptors.  Information has been elucidated about the structure and gating of P2X channels following the detn. of the crystal structure of P2X4 (zebrafish), however, there is still much to discover regarding the role of this receptor in the central nervous system (CNS).  In this review we provide an overview of what is known about P2X4 expression in the CNS and discuss evidence for pathophysiol. roles in neuroinflammation and neuropathic pain.  Recent advances in the development of pharmacol. tools including selective antagonists (5-BDBD, PSB-12062, BX430) and pos. modulators (ivermectin, avermectins, divalent cations) of P2X4 will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo-UCoTfoDkLVg90H21EOLACvtfcHk0lhpsQdcNzlH5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFentbzI&md5=c1b3ee43fe3de52d966ad345c078bf74</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00291%26sid%3Dliteratum%253Aachs%26aulast%3DStokes%26aufirst%3DL.%26aulast%3DLayhadi%26aufirst%3DJ.%2BA.%26aulast%3DBibic%26aufirst%3DL.%26aulast%3DDhuna%26aufirst%3DK.%26aulast%3DFountain%26aufirst%3DS.%2BJ.%26atitle%3DP2X4%2520receptor%2520function%2520in%2520the%2520nervous%2520system%2520and%2520current%2520breakthroughs%2520in%2520pharmacology%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D291%26doi%3D10.3389%2Ffphar.2017.00291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beggs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, M. W.</span></span> <span> </span><span class="NLM_article-title">P2X4R+ microglia drive neuropathic pain</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1068</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1038/nn.3155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1038%2Fnn.3155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=22837036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2itLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=1068-1073&author=S.+Beggsauthor=T.+Trangauthor=M.+W.+Salter&title=P2X4R%2B+microglia+drive+neuropathic+pain&doi=10.1038%2Fnn.3155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">P2X4R+ microglia drive neuropathic pain</span></div><div class="casAuthors">Beggs, Simon; Trang, Tuan; Salter, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1068-1073</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain, the most debilitating of all clin. pain syndromes, may be a consequence of trauma, infection or pathol. from diseases that affect peripheral nerves.  Here we provide a framework for understanding the spinal mechanisms of neuropathic pain as distinct from those of acute pain or inflammatory pain.  Recent work suggests that a specific microglia response phenotype characterized by de novo expression of the purinergic receptor P2X4 is crit. for the pathogenesis of pain hypersensitivity caused by injury to peripheral nerves.  Stimulating P2X4 receptors initiates a core pain signaling pathway mediated by release of brain-derived neurotrophic factor, which produces a disinhibitory increase in intracellular chloride in nociceptive (pain-transmitting) neurons in the spinal dorsal horn.  The changes caused by signaling from P2X4R+ microglia to nociceptive transmission neurons may account for the main symptoms of neuropathic pain in humans, and they point to specific interventions to alleviate this debilitating condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomFRlAEtpyXrVg90H21EOLACvtfcHk0lhpsQdcNzlH5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2itLfP&md5=6f25fbac78f20f4932556ff77abfa66b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnn.3155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3155%26sid%3Dliteratum%253Aachs%26aulast%3DBeggs%26aufirst%3DS.%26aulast%3DTrang%26aufirst%3DT.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26atitle%3DP2X4R%252B%2520microglia%2520drive%2520neuropathic%2520pain%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D1068%26epage%3D1073%26doi%3D10.1038%2Fnn.3155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Virgilio, F.</span></span> <span> </span><span class="NLM_article-title">P2X receptors and inflammation</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">866</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.2174/0929867322666141210155311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.2174%2F0929867322666141210155311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25524252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislensbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=866-877&author=F.+Di%0AVirgilio&title=P2X+receptors+and+inflammation&doi=10.2174%2F0929867322666141210155311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">P2X Receptors and Inflammation</span></div><div class="casAuthors">Di Virgilio, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">866-877</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Until recently, P2X receptors have not received much attention in the context of immunol. and inflammation.  While this is justified to a certain extent for P2X1, P2X2, P2X3, P2X5 and P2X6, which still await identification of a convincing role in the pathophysiol. of immune cells, it is clearly not any more the case for P2X4 and even more so for P2X7, a mol. that has achieved the status of an essential, nonredundant, immunomodulatory receptor.  In this review I will highlight the most important inflammatory responses participated by P2X receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrRmCnHNH0obVg90H21EOLACvtfcHk0lhpsQdcNzlH5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislensbk%253D&md5=ac21cea24dca2b31d45a86648f81937b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F0929867322666141210155311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666141210155311%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26atitle%3DP2X%2520receptors%2520and%2520inflammation%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D866%26epage%3D877%26doi%3D10.2174%2F0929867322666141210155311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayata, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlaich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dürk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoßfeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idzko, M.</span></span> <span> </span><span class="NLM_article-title">P2RX4 deficiency in mice alleviates allergen-induced airway inflammation</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">80288</span>– <span class="NLM_lpage">80297</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.18632%2Foncotarget.13375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=27863396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC2snotVakuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=80288-80297&author=A.+Zechauthor=B.+Wieslerauthor=C.+K.+Ayataauthor=T.+Schlaichauthor=T.+D%C3%BCrkauthor=M.+Ho%C3%9Ffeldauthor=N.+Ehratauthor=S.+Cickoauthor=M.+Idzko&title=P2RX4+deficiency+in+mice+alleviates+allergen-induced+airway+inflammation&doi=10.18632%2Foncotarget.13375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">P2rx4 deficiency in mice alleviates allergen-induced airway inflammation</span></div><div class="casAuthors">Zech Andreas; Wiesler Benjamin; Ayata Cemil Korcan; Schlaich Tilmann; Durk Thorsten; Hossfeld Madelon; Ehrat Nicolas; Cicko Sanja; Idzko Marco</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">80288-80297</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Compelling evidences point out a crucial role for extracellular nucleotides such as adenosine triphosphate (ATP) during inflammatory conditions.  Once released into the extracellular space, ATP modulates migration, maturation and function of various inflammatory cells via activating of purinergic receptors of the P2Y- and P2X- family.  P2RX4 is an ATP-guided ion channel expressed on structural cells such as alveolar epithelial and smooth muscle cells as well as inflammatory cells including macrophages, dendritic cells (DCs) and T cells.  P2RX4 has been shown to interact with P2RX7 and promote NLRP3 inflammasome activation.  Although P2RX7 has already been implicated in allergic asthma, the role of P2RX4 in airway inflammation has not been elucidated yet.  Therefore, we used a selective pharmacological antagonist and genetic ablation to investigate the role of P2RX4 in an ovalbumin (OVA) driven model of allergen-induced airway inflammation (AAI).  Both, P2RX4 antagonist 5-BDBD treatment and P2rx4 deficiency resulted in an alleviated broncho alveolar lavage fluid eosinophilia, peribronchial inflammation, Th2 cytokine production and bronchial hyperresponsiveness.  Furthermore, P2rx4-deficient bone marrow derived DCs (BMDCs) showed a reduced IL-1ss production in response to ATP accompanied by a decreased P2rx7 expression and attenuated Th2 priming capacity compared to wild type (WT) BMDCs in vitro.  Moreover, mice adoptively transferred with P2rx4-deficient BMDCs exhibit a diminished AAI in vivo.  In conclusion our data suggests that P2RX4-signaling contributes to AAI pathogenesis by regulating DC mediated Th2 cell priming via modulating IL-1ss secretion and selective P2RX4-antagonists might be a new therapeutic option for allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9a1Ej-CIqi9NTrvPZP1IpfW6udTcc2ebwDRH0o4uECLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snotVakuw%253D%253D&md5=a21500fd3364250eade3b9161385fe98</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13375%26sid%3Dliteratum%253Aachs%26aulast%3DZech%26aufirst%3DA.%26aulast%3DWiesler%26aufirst%3DB.%26aulast%3DAyata%26aufirst%3DC.%2BK.%26aulast%3DSchlaich%26aufirst%3DT.%26aulast%3DD%25C3%25BCrk%26aufirst%3DT.%26aulast%3DHo%25C3%259Ffeld%26aufirst%3DM.%26aulast%3DEhrat%26aufirst%3DN.%26aulast%3DCicko%26aufirst%3DS.%26aulast%3DIdzko%26aufirst%3DM.%26atitle%3DP2RX4%2520deficiency%2520in%2520mice%2520alleviates%2520allergen-induced%2520airway%2520inflammation%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D80288%26epage%3D80297%26doi%3D10.18632%2Foncotarget.13375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, X.</span></span> <span> </span><span class="NLM_article-title">Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.3892/mmr.2015.4622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.3892%2Fmmr.2015.4622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26648454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVyjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=697-704&author=H.+Chenauthor=Q.+Xiaauthor=X.+Fengauthor=F.+Caoauthor=H.+Yuauthor=Y.+Songauthor=X.+Ni&title=Effect+of+P2X4R+on+airway+inflammation+and+airway+remodeling+in+allergic+airway+challenge+in+mice&doi=10.3892%2Fmmr.2015.4622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice</span></div><div class="casAuthors">Chen, Hongxia; Xia, Qingqing; Feng, Xiaoqian; Cao, Fangyuan; Yu, Hang; Song, Yinli; Ni, Xiuqin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1, Pt. B</span>),
    <span class="NLM_cas:pages">697-704</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">P2X4 receptor (P2X4R) is the most widely expressed subtype of the P2XRs in the purinergic receptor family.  ATP (ATP), a ligand for this receptor, has been implicated in the pathogenesis of asthma.  ATP-P2X4R signaling is involved in pulmonary vascular remodeling, and in the proliferation and differentiation of airway and alveolar epithelial cell lines.  However, the role of P2X4R in asthma remains to be elucidated.  This aim of the present study was to investigate the effects of P2X4R in a murine exptl. asthma model.  The asthmatic model was established by the inhalation of ovalbumin (OVA) in BALB/c mice.  The mice were treated with P2X4R-specific agonists and antagonists to investigate the role of this receptor in vivo.  Pathol. changes in the bronchi and lung tissues were examd. using hematoxylin and eosin staining, Masson's trichrome staining and Alcian blue staining.  The inflammatory cells in the bronchoalveolar lavage fluid were counted, and the expression levels of P2X4R, α-smooth muscle actin (α-SMA) and proliferating cell nuclear antigen (PCNA) were detected using western blotting.  In the OVA-challenged mice, inflammation, infiltration, collagen deposition, mucus prodn., and the expression levels of P2X4R and PCNA were all increased; however, the expression of α-SMA was decreased, compared with the mice in the control group.  Whereas treatment with the P2X4R agonist, ATP, enhanced the allergic reaction, treatment with the P2X4R antagonist, 5-BDBD, attenuated the allergic reaction.  The results suggested that ATP-P2X4R signaling may not only contribute to airway inflammation, but it may also contribute to airway remodeling in allergic asthma in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeh4hfRqnMsbVg90H21EOLACvtfcHk0lge-ErsQlz70g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVyjsLg%253D&md5=2c5689ddd5c0617a09440271e9d011cd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2015.4622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2015.4622%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DQ.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DX.%26atitle%3DEffect%2520of%2520P2X4R%2520on%2520airway%2520inflammation%2520and%2520airway%2520remodeling%2520in%2520allergic%2520airway%2520challenge%2520in%2520mice%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2016%26volume%3D13%26spage%3D697%26epage%3D704%26doi%3D10.3892%2Fmmr.2015.4622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ralevic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, W. R.</span></span> <span> </span><span class="NLM_article-title">Purinergic transmission in blood vessels</span>. <i>Auton. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.autneu.2015.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.autneu.2015.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26004513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2015&pages=48-66&author=V.+Ralevicauthor=W.+R.+Dunn&title=Purinergic+transmission+in+blood+vessels&doi=10.1016%2Fj.autneu.2015.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Purinergic transmission in blood vessels</span></div><div class="casAuthors">Ralevic, Vera; Dunn, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Autonomic Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-66</span>CODEN:
                <span class="NLM_cas:coden">ANUEB2</span>;
        ISSN:<span class="NLM_cas:issn">1566-0702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  There are nineteen different receptor proteins for adenosine, adenine and uridine nucleotides, and nucleotide sugars, belonging to three families of G protein-coupled adenosine and P2Y receptors, and ionotropic P2X receptors.  The majority are functionally expressed in blood vessels, as purinergic receptors in perivascular nerves, smooth muscle and endothelial cells, and roles in regulation of vascular contractility, immune function and growth have been identified.  The endogenous ligands for purine receptors, ATP, ADP, UTP, UDP and adenosine, can be released from different cell types within the vasculature, as well as from circulating blood cells, including erythrocytes and platelets.  Many purine receptors can be activated by two or more of the endogenous ligands.  Further complexity arises because of interconversion between ligands, notably adenosine formation from the metab. of ATP, leading to complex integrated responses through activation of different subtypes of purine receptors.  The enzymes responsible for this conversion, ectonucleotidases, are present on the surface of smooth muscle and endothelial cells, and may be coreleased with neurotransmitters from nerves.  What selectivity there is for the actions of purines/pyrimidines comes from differential expression of their receptors within the vasculature.  P2X1 receptors mediate the vasocontractile actions of ATP released as a neurotransmitter with noradrenaline (NA) from sympathetic perivascular nerves, and are located on the vascular smooth muscle adjacent to the nerve varicosities, the sites of neurotransmitter release.  The relative contribution of ATP and NA as functional cotransmitters varies with species, type and size of blood vessel, neuronal firing pattern, the tone/pressure of the blood vessel, and in aging and disease.  ATP is also a neurotransmitter in non-adrenergic non-cholinergic perivascular nerves and mediates vasorelaxation via smooth muscle P2Y-like receptors.  ATP and adenosine can act as neuromodulators, with the most robust evidence being for prejunctional inhibition of neurotransmission via A1 adenosine receptors, but also prejunctional excitation and inhibition of neurotransmission via P2X and P2Y receptors, resp.  P2Y2, P2Y4 and P2Y6 receptors expressed on the vascular smooth muscle are coupled to vasocontraction, and may have a role in pathophysiol. conditions, when purines are released from damaged cells, or when there is damage to the protective barrier that is the endothelium.  Adenosine is released during hypoxia to increase blood flow via vasodilator A2A and A2B receptors expressed on the endothelium and smooth muscle.  ATP is released from endothelial cells during hypoxia and shear stress and can act at P2Y and P2X4 receptors expressed on the endothelium to increase local blood flow.  Activation of endothelial purine receptors leads to the release of nitric oxide, hyperpolarizing factors and prostacyclin, which inhibits platelet aggregation and thus ensures patent blood flow.  Vascular purine receptors also regulate endothelial and smooth muscle growth, and inflammation, and thus are involved in the underlying processes of a no. of cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbeULIrF09MrVg90H21EOLACvtfcHk0lge-ErsQlz70g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOhu7k%253D&md5=4093d360d3282fed51863bfe01de02ee</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.autneu.2015.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autneu.2015.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DRalevic%26aufirst%3DV.%26aulast%3DDunn%26aufirst%3DW.%2BR.%26atitle%3DPurinergic%2520transmission%2520in%2520blood%2520vessels%26jtitle%3DAuton.%2520Neurosci.%26date%3D2015%26volume%3D191%26spage%3D48%26epage%3D66%26doi%3D10.1016%2Fj.autneu.2015.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ledderose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slubowski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dertnig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denicoló, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konrad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junger, W. G.</span></span> <span> </span><span class="NLM_article-title">Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">3583</span>– <span class="NLM_lpage">3594</span>, <span class="refDoi"> DOI: 10.1172/JCI120972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1172%2FJCI120972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=29894310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC1MbmsFSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=3583-3594&author=C.+Ledderoseauthor=K.+Liuauthor=Y.+Kondoauthor=C.+J.+Slubowskiauthor=T.+Dertnigauthor=S.+Denicol%C3%B3author=M.+Arbabauthor=J.+Hubnerauthor=K.+Konradauthor=M.+Fakhariauthor=J.+A.+Ledererauthor=S.+C.+Robsonauthor=G.+A.+Visnerauthor=W.+G.+Junger&title=Purinergic+P2X4+receptors+and+mitochondrial+ATP+production+regulate+T+cell+migration&doi=10.1172%2FJCI120972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration</span></div><div class="casAuthors">Ledderose Carola; Kondo Yutaka; Slubowski Christian J; Dertnig Thomas; Denicolo Sara; Arbab Mona; Hubner Johannes; Konrad Kirstin; Fakhari Mahtab; Junger Wolfgang G; Liu Kaifeng; Visner Gary A; Lederer James A; Robson Simon C; Junger Wolfgang G</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3583-3594</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">T cells must migrate in order to encounter antigen-presenting cells (APCs) and to execute their varied functions in immune defense and inflammation.  ATP release and autocrine signaling through purinergic receptors contribute to T cell activation at the immune synapse that T cells form with APCs.  Here, we show that T cells also require ATP release and purinergic signaling for their migration to APCs.  We found that the chemokine stromal-derived factor-1α (SDF-1α) triggered mitochondrial ATP production, rapid bursts of ATP release, and increased migration of primary human CD4+ T cells.  This process depended on pannexin-1 ATP release channels and autocrine stimulation of P2X4 receptors.  SDF-1α stimulation caused localized accumulation of mitochondria with P2X4 receptors near the front of cells, resulting in a feed-forward signaling mechanism that promotes cellular Ca2+ influx and sustains mitochondrial ATP synthesis at levels needed for pseudopod protrusion, T cell polarization, and cell migration.  Inhibition of P2X4 receptors blocked the activation and migration of T cells in vitro.  In a mouse lung transplant model, P2X4 receptor antagonist treatment prevented the recruitment of T cells into allograft tissue and the rejection of lung transplants.  Our findings suggest that P2X4 receptors are therapeutic targets for immunomodulation in transplantation and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4HkcvkZTMrNts4TFFB11gfW6udTcc2earmoydW-2x9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbmsFSmug%253D%253D&md5=de5d429950992944510b704e353bd52c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1172%2FJCI120972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI120972%26sid%3Dliteratum%253Aachs%26aulast%3DLedderose%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DY.%26aulast%3DSlubowski%26aufirst%3DC.%2BJ.%26aulast%3DDertnig%26aufirst%3DT.%26aulast%3DDenicol%25C3%25B3%26aufirst%3DS.%26aulast%3DArbab%26aufirst%3DM.%26aulast%3DHubner%26aufirst%3DJ.%26aulast%3DKonrad%26aufirst%3DK.%26aulast%3DFakhari%26aufirst%3DM.%26aulast%3DLederer%26aufirst%3DJ.%2BA.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DVisner%26aufirst%3DG.%2BA.%26aulast%3DJunger%26aufirst%3DW.%2BG.%26atitle%3DPurinergic%2520P2X4%2520receptors%2520and%2520mitochondrial%2520ATP%2520production%2520regulate%2520T%2520cell%2520migration%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26spage%3D3583%26epage%3D3594%26doi%3D10.1172%2FJCI120972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ralevic, V.</span></span> <span> </span><span class="NLM_article-title">P2X receptors in the cardiovascular system and their potential as therapeutic targets in disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">865</span>, <span class="refDoi"> DOI: 10.2174/0929867321666141215094050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.2174%2F0929867321666141215094050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25515516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislelsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=851-865&author=V.+Ralevic&title=P2X+receptors+in+the+cardiovascular+system+and+their+potential+as+therapeutic+targets+in+disease&doi=10.2174%2F0929867321666141215094050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">P2X Receptors in the Cardiovascular System and their Potential as Therapeutic Targets in Disease</span></div><div class="casAuthors">Ralevic, Vera</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">851-865</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review considers the expression and roles of P2X receptors in the cardiovascular system in health and disease and their potential as therapeutic targets.  P2X receptors are ligand gated ion channels which are activated by the endogenous ligand ATP.  They are formed from the assembly of three P2X subunit proteins from the complement of seven (P2X1-7), which can assoc. to form homomeric or heteromeric P2X receptors.  The P2X1 receptor is widely expressed in the cardiovascular system, being located in the heart, in the smooth muscle of the majority of blood vessels and in platelets.  P2X1 receptors expressed in blood vessels can be activated by ATP coreleased with noradrenaline as a sympathetic neurotransmitter, leading to smooth muscle depolarisation and contraction.  There is evidence that the purinergic component of sympathetic neurotransmission is increased in hypertension, identifying P2X1 receptors as a possible therapeutic target in this disorder.  P2X3 and P2X2/3 receptors are expressed on cardiac sympathetic neurons and may, through pos. feedback of neuronal ATP at this prejunctional site, amplify sympathetic neurotransmission.  Activation of P2X receptors expressed in the heart increases cardiac myocyte contractility, and an important role of the P2X4 receptor in this has been identified.  Deletion of P2X4 receptors in the heart depresses contractile performance in models of heart failure, while overexpression of P2X4 receptors has been shown to be cardioprotective, thus P2X4 receptors may be therapeutic targets in the treatment of heart disease.  P2X receptors have been identified on endothelial cells.  Although immunoreactivity for all P2X1-7 receptor proteins has been shown on the endothelium, relatively little is known about their function, with the exception of the endothelial P2X4 receptor, which has been shown to mediate endothelium-dependent vasodilatation to ATP released during shear stress.  The potential of P2X receptors as therapeutic targets in the treatment of cardiovascular disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppU7eFgynPOrVg90H21EOLACvtfcHk0lggz5jynqiaMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislelsr8%253D&md5=825263e596aff3a3588cc40cae14541d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F0929867321666141215094050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666141215094050%26sid%3Dliteratum%253Aachs%26aulast%3DRalevic%26aufirst%3DV.%26atitle%3DP2X%2520receptors%2520in%2520the%2520cardiovascular%2520system%2520and%2520their%2520potential%2520as%2520therapeutic%2520targets%2520in%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D851%26epage%3D865%26doi%3D10.2174%2F0929867321666141215094050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span>; <span class="NLM_string-name">Kalthof, B.</span>; <span class="NLM_string-name">Grützmann, R.</span>; <span class="NLM_string-name">Woltering, E.</span>; <span class="NLM_string-name">Stelte-Ludwig, B.</span>; <span class="NLM_string-name">Wuttke, M.</span></span> <span> </span><span class="NLM_article-title">Bayer Healthcare AG. Benzofuro-1,4-diazepin-2-one Derivatives</span>. <span class="NLM_patent">WO2004085440</span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+Fischer&author=B.+Kalthof&author=R.+Gr%C3%BCtzmann&author=E.+Woltering&author=B.+Stelte-Ludwig&author=M.+Wuttke&title=Bayer+Healthcare+AG.+Benzofuro-1%2C4-diazepin-2-one+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DR.%26atitle%3DBayer%2520Healthcare%2520AG.%2520Benzofuro-1%252C4-diazepin-2-one%2520Derivatives%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Emerging structures and ligands for P2X3 and P2X4 receptors – towards novel treatments of neuropathic pain</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1007/s11302-010-9182-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1007%2Fs11302-010-9182-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=20806006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFSrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=145-148&author=C.+E.+M%C3%BCller&title=Emerging+structures+and+ligands+for+P2X3+and+P2X4+receptors+%E2%80%93+towards+novel+treatments+of+neuropathic+pain&doi=10.1007%2Fs11302-010-9182-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging structures and ligands for P2X3 and P2X4 receptors-towards novel treatments of neuropathic pain</span></div><div class="casAuthors">Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-148</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGQFjAaEKcybVg90H21EOLACvtfcHk0ljpgL7M86EhIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFSrtrg%253D&md5=296b4340724c0c75160bde886b783255</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1007%2Fs11302-010-9182-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-010-9182-y%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DEmerging%2520structures%2520and%2520ligands%2520for%2520P2X3%2520and%2520P2X4%2520receptors%2520%25E2%2580%2593%2520towards%2520novel%2520treatments%2520of%2520neuropathic%2520pain%26jtitle%3DPurinergic%2520Signalling%26date%3D2010%26volume%3D6%26spage%3D145%26epage%3D148%26doi%3D10.1007%2Fs11302-010-9182-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gunosewoyo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">P2X purinergic receptor ligands: recently patented compounds</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1517/13543771003702424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1517%2F13543771003702424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=20205618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=625-646&author=H.+Gunosewoyoauthor=M.+Kassiou&title=P2X+purinergic+receptor+ligands%3A+recently+patented+compounds&doi=10.1517%2F13543771003702424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">P2X purinergic receptor ligands: recently patented compounds</span></div><div class="casAuthors">Gunosewoyo, Hendra; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-646</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: P2X channels are ionotropic purinergic receptors that are currently under scrutiny as attractive targets for novel therapeutics in areas including chronic inflammation, pain and depression.  Their wide expression in the CNS, recent advances in the biochem. and pharmacol. properties as well as increasing nos. of patents published in this research domain demand a review in this field.  Areas covered in this review: The patent literature covering novel drug-like antagonists for each P2X receptor subtype (P2X1R to P2X7R) up to Dec. 2009 is described in this review article together with their recent highlights in pharmacol.  What the reader will gain: Readers will gain an up-to-date overview of patents covering drug-like antagonists for seven P2X receptor subtypes within the last 4 years.  Take home message: P2X7R antagonists and other P2X inhibitors will probably be on the market for combating rheumatoid arthritis and other diseases.  Some P2X7R antagonists are already in Phase I and II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-8wN9lvn6XrVg90H21EOLACvtfcHk0ljpgL7M86EhIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWhtro%253D&md5=368c6d47ee49616986f80db5be326ab0</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1517%2F13543771003702424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543771003702424%26sid%3Dliteratum%253Aachs%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DP2X%2520purinergic%2520receptor%2520ligands%253A%2520recently%2520patented%2520compounds%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D625%26epage%3D646%26doi%3D10.1517%2F13543771003702424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry of P2X receptors: allosteric modulators</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">941</span>, <span class="refDoi"> DOI: 10.2174/0929867322666141210155610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.2174%2F0929867322666141210155610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25524251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislemtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=929-941&author=C.+E.+M%C3%BCller&title=Medicinal+chemistry+of+P2X+receptors%3A+allosteric+modulators&doi=10.2174%2F0929867322666141210155610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal Chemistry of P2X Receptors: Allosteric Modulators</span></div><div class="casAuthors">Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">929-941</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  P2X receptors are trimeric ligand-gated ion channels whose potential as novel drug targets for a no. of diseases has been recognized.  They are mainly involved in inflammatory processes, including neuroinflammation, and pain sensation.  The orthosteric binding site is lined by basic amino acid residues that bind the neg. charged agonist ATP.  Therefore it is not easy to develop orthosteric ligands that possess drug-like properties for such a highly polar binding site.  However, ligand-gated ion channels offer multiple addnl. binding sites for allosteric ligands, pos. or neg. allosteric modulators enhancing or blocking receptor function.  So far, the P2X3 (and P2X2/3), as well as the P2X7 receptor subtype have been the main focus of drug development efforts.  A no. of potent and selective allosteric antagonists have been developed to block these receptors.  We start to see the development of novel allosteric ligands also for the other P2X receptor subtypes, P2X1, P2X2 and esp. P2X4.  The times when only poor, non-selective, non-drug-like tools for studying P2X receptor function were available have been overcome.  The first clin. studies with allosteric P2X3 and P2X7 antagonists suggest that P2X therapeutics may soon become a reality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBp9rwzLCJ3bVg90H21EOLACvtfcHk0ljpgL7M86EhIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislemtbY%253D&md5=be1838c9ea9de083e946065f3c72650e</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.2174%2F0929867322666141210155610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666141210155610%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMedicinal%2520chemistry%2520of%2520P2X%2520receptors%253A%2520allosteric%2520modulators%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D929%26epage%3D941%26doi%3D10.2174%2F0929867322666141210155610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit23d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry of adenosine, P2Y and P2X receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.neuropharm.2015.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26686393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2016&pages=31-49&author=K.+A.+Jacobsonauthor=C.+E.+M%C3%BCller&title=Medicinal+chemistry+of+adenosine%2C+P2Y+and+P2X+receptors&doi=10.1016%2Fj.neuropharm.2015.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23dR"><div class="casContent"><span class="casTitleNuber">23d</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine, P2Y and P2X receptors</span></div><div class="casAuthors">Jacobson, Kenneth A.; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-49</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pharmacol. tool compds. are now available to define action at the adenosine (ARs), P2Y and P2X receptors.  We present a selection of the most commonly used agents to study purines in the nervous system.  Some of these compds., including A1 and A3 AR agonists, P2Y1R and P2Y12R antagonists, and P2X3, P2X4 and P2X7 antagonists, are potentially of clin. use in treatment of disorders of the nervous system, such as chronic pain, neurodegeneration and brain injury.  Agonists of the A2AAR and P2Y2R are already used clin., P2Y12R antagonists are widely used antithrombotics and an antagonist of the A2AAR is approved in Japan for treating Parkinson's disease.  The selectivity defined for some of the previously introduced compds. has been revised with updated pharmacol. characterization, for example, various AR agonists and antagonists were deemed A1AR or A3AR selective based on human data, but species differences indicated a redn. in selectivity ratios in other species.  Also, many of the P2R ligands still lack bioavailability due to charged groups or hydrolytic (either enzymic or chem.) instability.  X-ray crystallog. structures of AR and P2YRs have shifted the mode of ligand discovery to structure-based approaches rather than previous empirical approaches.  The X-ray structures can be utilized either for in silico screening of chem. diverse libraries for the discovery of novel ligands or for enhancement of the properties of known ligands by chem. modification.  Although X-ray structures of the zebrafish P2X4R have been reported, there is scant structural information about ligand recognition in these trimeric ion channels.  In summary, there are definitive, selective agonists and antagonists for all of the ARs and some of the P2YRs; while the pharmacochem. of P2XRs is still in nascent stages.  The therapeutic potential of selectively modulating these receptors is continuing to gain interest in such fields as cancer, inflammation, pain, diabetes, ischemic protection and many other conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfj6lh6K1FbLVg90H21EOLACvtfcHk0li29zWaq_s6Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF&md5=ffcb23c7e271df86ef6b24d88aef2d82</span></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMedicinal%2520chemistry%2520of%2520adenosine%252C%2520P2Y%2520and%2520P2X%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D104%26spage%3D31%26epage%3D49%26doi%3D10.1016%2Fj.neuropharm.2015.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozaki-Saitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span> <span> </span><span class="NLM_article-title">Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1744</span>– <span class="NLM_lpage">8069</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-5-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1186%2F1744-8069-5-20" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=1744-8069&author=K.+Nagataauthor=T.+Imaiauthor=T.+Yamashitaauthor=M.+Tsudaauthor=H.+Tozaki-Saitohauthor=K.+Inoue&title=Antidepressants+inhibit+P2X4+receptor+function%3A+a+possible+involvement+in+neuropathic+pain+relief&doi=10.1186%2F1744-8069-5-20"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-5-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-5-20%26sid%3Dliteratum%253Aachs%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DTozaki-Saitoh%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DK.%26atitle%3DAntidepressants%2520inhibit%2520P2X4%2520receptor%2520function%253A%2520a%2520possible%2520involvement%2520in%2520neuropathic%2520pain%2520relief%26jtitle%3DMol.%2520Pain%26date%3D2009%26volume%3D5%26spage%3D1744%26epage%3D8069%26doi%3D10.1186%2F1744-8069-5-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Olmos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freudendahl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinhausen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">N-Substituted phenoxazine and acridone derivatives: Structure-activity relationships of potent P2X4 receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9576</span>– <span class="NLM_lpage">9588</span>, <span class="refDoi"> DOI: 10.1021/jm300845v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300845v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9576-9588&author=V.+Hernandez-Olmosauthor=A.+Abdelrahmanauthor=A.+El-Tayebauthor=D.+Freudendahlauthor=S.+Weinhausenauthor=C.+E.+M%C3%BCller&title=N-Substituted+phenoxazine+and+acridone+derivatives%3A+Structure-activity+relationships+of+potent+P2X4+receptor+antagonists&doi=10.1021%2Fjm300845v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">N-Substituted Phenoxazine and Acridone Derivatives: Structure-Activity Relationships of Potent P2X4 Receptor Antagonists</span></div><div class="casAuthors">Hernandez-Olmos, Victor; Abdelrahman, Aliaa; El-Tayeb, Ali; Freudendahl, Diana; Weinhausen, Stephanie; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9576-9588</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">P2X4 receptor antagonists have potential as drugs for the treatment of neuropathic pain and neurodegenerative diseases.  In the present study the discovery of phenoxazine derivs. as potent P2X4 antagonists is described.  N-Substituted phenoxazine and related acridone and benzoxazine derivs. were synthesized and optimized with regard to their potency to inhibit ATP-induced calcium influx in 1321N1 astrocytoma cells stably transfected with the human P2X4 receptor.  In addn., species selectivity (rat, mouse, human) and receptor subtype selectivity (vs. P2X1,2,3,7) were investigated.  The most potent P2X4 antagonist of the present series was N-(benzyloxycarbonyl)phenoxazine (PSB-12054) with an IC50 of 0.189 μM and good selectivity vs. the other human P2X receptor subtypes.  N-(p-Methylphenylsulfonyl)phenoxazine (PSB-12062) was identified as a selective P2X4 antagonist that was equally potent in all three species (IC50: 0.928-1.76 μM).  The compds. showed an allosteric mechanism of action.  The present study represents the first structure-activity relationship anal. of P2X4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxJVfTTe0warVg90H21EOLACvtfcHk0li29zWaq_s6Wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrL&md5=44d6b170092e37329f9dd82cac8e3dfb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300845v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300845v%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Olmos%26aufirst%3DV.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DFreudendahl%26aufirst%3DD.%26aulast%3DWeinhausen%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DN-Substituted%2520phenoxazine%2520and%2520acridone%2520derivatives%253A%2520Structure-activity%2520relationships%2520of%2520potent%2520P2X4%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9576%26epage%3D9588%26doi%3D10.1021%2Fjm300845v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinhausen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dosa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Carbamazepine derivatives with P2X4 receptor-blocking activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.bmc.2013.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=24411477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktFymtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1077-1088&author=M.+Tianauthor=A.+Abdelrahmanauthor=S.+Weinhausenauthor=S.+Hinzauthor=S.+Weyerauthor=S.+Dosaauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCller&title=Carbamazepine+derivatives+with+P2X4+receptor-blocking+activity&doi=10.1016%2Fj.bmc.2013.12.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamazepine derivatives with P2X4 receptor-blocking activity</span></div><div class="casAuthors">Tian, Maoqun; Abdelrahman, Aliaa; Weinhausen, Stephanie; Hinz, Sonja; Weyer, Stefanie; Dosa, Stefan; El-Tayeb, Ali; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1077-1088</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Antagonists for the P2 receptor subtype P2X4, an ATP-activated cation channel receptor, have potential as novel drugs for the treatment of neuropathic pain and other inflammatory diseases.  In the present study, a series of 47 carbamazepine derivs. including 32 novel compds. were designed, synthesized, and evaluated as P2X4 receptor antagonists.  Their potency to inhibit ATP-induced calcium influx in 1321N1 astrocytoma cells stably transfected with the human P2X4 receptor was detd.  Addnl., species selectivity (human, rat, mouse) and receptor subtype selectivity (P2X4 vs P2X1, 2, 3, 7) were investigated for selected derivs.  The most potent compd. of the present series, which exhibited an allosteric mechanism of P2X4 inhibition, was N,N-diisopropyl-5H-dibenz[b,f]azepine-5-carboxamide (34, IC50 of 3.44 μM).  The present study extends the so far very limited knowledge on structure-activity relationships of P2X4 receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlNUgOfw-YE7Vg90H21EOLACvtfcHk0li114DSTqCA9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktFymtw%253D%253D&md5=2d9bd84b87ea809455af4d8fff8599ef</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DM.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DWeinhausen%26aufirst%3DS.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DWeyer%26aufirst%3DS.%26aulast%3DDosa%26aufirst%3DS.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DCarbamazepine%2520derivatives%2520with%2520P2X4%2520receptor-blocking%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1077%26epage%3D1088%26doi%3D10.1016%2Fj.bmc.2013.12.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ase, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaghdane, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Séguéla, P.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1124/mol.114.096222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1124%2Fmol.114.096222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25597706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktlaksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2015&pages=606-616&author=A.+R.+Aseauthor=N.+S.+Honsonauthor=H.+Zaghdaneauthor=T.+A.+Pfeiferauthor=P.+S%C3%A9gu%C3%A9la&title=Identification+and+characterization+of+a+selective+allosteric+antagonist+of+human+P2X4+receptor+channels&doi=10.1124%2Fmol.114.096222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels</span></div><div class="casAuthors">Ase, Ariel R.; Honson, Nicolette S.; Zaghdane, Helmi; Pfeifer, Tom A.; Seguela, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">606-616</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P2X4 is an ATP-gated nonselective cation channel highly permeable to calcium.  There is increasing evidence that this homomeric purinoceptor, which is expressed in several neuronal and immune cell types, is involved in chronic pain and inflammation.  The current paucity of unambiguous pharmacol. tools available to interrogate or modulate P2X4 function led us to pursue the search for selective antagonists.  In the high-throughput screen of a compd. library, we identified the phenylurea BX430 (1-(2,6-dibromo-4-isopropyl-phenyl)-3-(3-pyridyl)urea, mol. wt. = 413), with antagonist properties on human P2X4-mediated calcium uptake.  Patch-clamp electrophysiol. confirmed direct inhibition of P2X4 currents by extracellular BX430, with submicromolar potency (IC50 = 0.54 μM).  BX430 is highly selective, having virtually no functional impact on all other P2X subtypes, namely, P2X1-P2X3, P2X5, and P2X7, at 10-100 times its IC50.  Unexpected species differences were noticed, as BX430 is a potent antagonist of zebrafish P2X4 but has no effect on rat andmouse P2X4 orthologs.  The concn.-response curve for ATP on human P2X4 in the presence of BX430 shows an insurmountable blockade, indicating a noncompetitive allosteric mechanism of action.  Using a fluorescent dye uptake assay, we obsd. that BX430 also effectively suppresses ATP-evoked and ivermectin-potentiated membrane permeabilization induced by P2X4 pore dilation.  Finally, in single-cell calcium imaging, we validated its selective inhibitory effects on native P2X4 channels at the surface of human THP-1 cells that were differentiated into macrophages.  In summary, this ligand provides a novel mol. probe to assess the specific role of P2X4 in inflammatory and neuropathic conditions, where ATP signaling has been shown to be dysfunctional.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWlqYNj9h6IrVg90H21EOLACvtfcHk0li114DSTqCA9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktlaksb0%253D&md5=5c3359c14f615d964142a61ad1bfad2f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.096222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.096222%26sid%3Dliteratum%253Aachs%26aulast%3DAse%26aufirst%3DA.%2BR.%26aulast%3DHonson%26aufirst%3DN.%2BS.%26aulast%3DZaghdane%26aufirst%3DH.%26aulast%3DPfeifer%26aufirst%3DT.%2BA.%26aulast%3DS%25C3%25A9gu%25C3%25A9la%26aufirst%3DP.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520selective%2520allosteric%2520antagonist%2520of%2520human%2520P2X4%2520receptor%2520channels%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D87%26spage%3D606%26epage%3D616%26doi%3D10.1124%2Fmol.114.096222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Ushioda, M.</span>; <span class="NLM_string-name">Kobayashi, K.</span>; <span class="NLM_string-name">Saito, D.</span>; <span class="NLM_string-name">Sakuma, S.</span>; <span class="NLM_string-name">Imai, T.</span>; <span class="NLM_string-name">Inoue, K.</span></span> <span> </span><span class="NLM_article-title">Preparation of Benzodiazepine Derivatives P2X4 Receptor Antagonists</span>. <span class="NLM_patent">WO2013105608</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Ushioda&author=K.+Kobayashi&author=D.+Saito&author=S.+Sakuma&author=T.+Imai&author=K.+Inoue&title=Preparation+of+Benzodiazepine+Derivatives+P2X4+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUshioda%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Benzodiazepine%2520Derivatives%2520P2X4%2520Receptor%2520Antagonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozaki-Saitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuraishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span> <span> </span><span class="NLM_article-title">A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">32461</span> <span class="refDoi"> DOI: 10.1038/srep32461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1038%2Fsrep32461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=27576299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKjtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=Y.+Matsumuraauthor=T.+Yamashitaauthor=A.+Sasakiauthor=E.+Nakataauthor=K.+Kohnoauthor=T.+Masudaauthor=H.+Tozaki-Saitohauthor=T.+Imaiauthor=Y.+Kuraishiauthor=M.+Tsudaauthor=K.+Inoue&title=A+novel+P2X4+receptor-selective+antagonist+produces+anti-allodynic+effect+in+a+mouse+model+of+herpetic+pain&doi=10.1038%2Fsrep32461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain</span></div><div class="casAuthors">Matsumura, Yuta; Yamashita, Tomohiro; Sasaki, Atsushi; Nakata, Eriko; Kohno, Keita; Masuda, Takahiro; Tozaki-Saitoh, Hidetoshi; Imai, Toshiyasu; Kuraishi, Yasushi; Tsuda, Makoto; Inoue, Kazuhide</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32461</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulating evidence indicates that purinergic P2X4 receptors (P2X4R: cation channels activated by extracellular ATP) expressed in spinal microglia are crucial for pathol. chronic pain caused by nerve damage, suggesting a potential target for drug discovery.  We identified NP-1815-PX (5-[3-(5-thioxo-4H-[1,2,4]oxadiazol-3-yl)phenyl]-1H-naphtho[1, 2-b][1,4]diazepine-2,4(3H,5H)-dione) as a novel antagonist selective for P2X4R with high potency and selectivity compared with other P2XR subtypes.  In in vivo assay for acute and chronic pain, intrathecal administration of NP-1815-PX produced an anti-allodynic effect in mice with traumatic nerve damage without affecting acute nociceptive pain and motor function (although its oral administration did not produce the effect).  Furthermore, in a mouse model of herpetic pain, P2X4R upregulation in the spinal cord exclusively occurred in microglia, and intrathecal NP-1815-PX suppressed induction of mech. allodynia.  This model also showed K+/Cl- cotransporter 2 (KCC2) downregulation, which is implicated in dorsal horn neuron hyperexcitability; this downregulation was restored by intrathecal treatment with NP-1815-PX or by interfering with brain-derived neurotrophic factor (BDNF) signaling, a P2X4R-activated microglial factor implicated in KCC2 downregulation.  Taken together, the newly developed P2X4R antagonist NP-1815-PX produces anti-allodynic effects in chronic pain models without altering acute pain sensitivity, suggesting that microglial P2X4R could be an attractive target for treating chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs9wa0Z9o767Vg90H21EOLACvtfcHk0liB48lSOI3xKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKjtrzM&md5=e7f89cd6fd1c8eb45e95d61384ca9cea</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1038%2Fsrep32461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep32461%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DA.%26aulast%3DNakata%26aufirst%3DE.%26aulast%3DKohno%26aufirst%3DK.%26aulast%3DMasuda%26aufirst%3DT.%26aulast%3DTozaki-Saitoh%26aufirst%3DH.%26aulast%3DImai%26aufirst%3DT.%26aulast%3DKuraishi%26aufirst%3DY.%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26atitle%3DA%2520novel%2520P2X4%2520receptor-selective%2520antagonist%2520produces%2520anti-allodynic%2520effect%2520in%2520a%2520mouse%2520model%2520of%2520herpetic%2520pain%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fsrep32461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29a"><span><span class="NLM_label">(a) </span>Announcement see: <a href="https://adisinsight.springer.com/drugs/800038339" class="extLink">https://adisinsight.springer.com/drugs/800038339</a> (accessed Oct 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Announcement+see%3A+https%3A%2F%2Fadisinsight.springer.com%2Fdrugs%2F800038339+%28accessed+Oct+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span>; <span class="NLM_string-name">Sakuma, S.</span>; <span class="NLM_string-name">Nakata, E.</span>; <span class="NLM_string-name">Kawasaki, T.</span>; <span class="NLM_string-name">Ogawa, T.</span>; <span class="NLM_string-name">Inoue, K.</span>; <span class="NLM_string-name">Yamakawa, T.</span></span> <i>Novel P2X4 Receptor Antagonist NC-2600 Attenuated Allodynia Induced by Sciatic Nerve Injury</i>, 16th World Congress on Pain, <span class="NLM_publisher-name">IASP</span>: <span class="NLM_publisher-loc">Yokohama</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+Imai&author=S.+Sakuma&author=E.+Nakata&author=T.+Kawasaki&author=T.+Ogawa&author=K.+Inoue&author=T.+Yamakawa&title=Novel+P2X4+Receptor+Antagonist+NC-2600+Attenuated+Allodynia+Induced+by+Sciatic+Nerve+Injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DT.%26jtitle%3DNovel%2520P2X4%2520Receptor%2520Antagonist%2520NC-2600%2520Attenuated%2520Allodynia%2520Induced%2520by%2520Sciatic%2520Nerve%2520Injury%26pub%3DIASP%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Newcom, J.</span>; <span class="NLM_string-name">Spear, K. L.</span></span> <span> </span><span class="NLM_article-title">Sunovion Pharmaceuticals Inc. P2X4 Receptor Modulating Compounds</span>. <span class="NLM_patent">WO2015088564</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Newcom&author=K.+L.+Spear&title=Sunovion+Pharmaceuticals+Inc.+P2X4+Receptor+Modulating+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNewcom%26aufirst%3DJ.%26atitle%3DSunovion%2520Pharmaceuticals%2520Inc.%2520P2X4%2520Receptor%2520Modulating%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Newcom, J.</span>; <span class="NLM_string-name">Spear, K. L.</span></span> <span> </span><span class="NLM_article-title">Sunovion Pharmaceuticals Inc. P2X4 Receptor Modulating Compounds and Methods of Use Thereof</span>. <span class="NLM_patent">WO2015088565</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Newcom&author=K.+L.+Spear&title=Sunovion+Pharmaceuticals+Inc.+P2X4+Receptor+Modulating+Compounds+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNewcom%26aufirst%3DJ.%26atitle%3DSunovion%2520Pharmaceuticals%2520Inc.%2520P2X4%2520Receptor%2520Modulating%2520Compounds%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Werner, S.</span>; <span class="NLM_string-name">Mesch, S.</span>; <span class="NLM_string-name">Bräuer, N.</span>; <span class="NLM_string-name">Pook, E.</span>; <span class="NLM_string-name">Dahllöf, H.</span>; <span class="NLM_string-name">Nubbemeyer, R.</span>; <span class="NLM_string-name">Osmers, M.</span>; <span class="NLM_string-name">Kalthof, B.</span></span> <span> </span><span class="NLM_article-title">Aromatic Sulfonamide Derivatives</span>. <span class="NLM_patent">WO2016198374</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Werner&author=S.+Mesch&author=N.+Br%C3%A4uer&author=E.+Pook&author=H.+Dahll%C3%B6f&author=R.+Nubbemeyer&author=M.+Osmers&author=B.+Kalthof&title=Aromatic+Sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWerner%26aufirst%3DS.%26atitle%3DAromatic%2520Sulfonamide%2520Derivatives%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dernetz, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C. L.</span></span> <span> </span><span class="NLM_article-title">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span>. <i>Nurs. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1097/NNR.0000000000000082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1097%2FNNR.0000000000000082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25738619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=81-87&author=M.+A.+Griffioenauthor=V.+H.+Dernetzauthor=G.+S.+Yangauthor=K.+A.+Griffithauthor=S.+G.+Dorseyauthor=C.+L.+Renn&title=Evaluation+of+dynamic+weight+bearing+for+measuring+nonevoked+inflammatory+hyperalgesia+in+mice&doi=10.1097%2FNNR.0000000000000082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span></div><div class="casAuthors">Griffioen Mari A; Dernetz Valerie H; Yang Gee Su; Griffith Kathleen A; Dorsey Susan G; Renn Cynthia L</div><div class="citationInfo"><span class="NLM_cas:title">Nursing research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Animal models in pain research have suggested that inclusion of both evoked and nonevoked behavioral measures is needed to better reflect the human pain experience.  Individuals with chronic pain are known to experience spontaneous pain, in addition to pain after exposure to an external stimulus.  Recently, the dynamic weight bearing (DWB) apparatus was developed to assess for nonevoked hyperalgesia by capturing weight bearing and surface distribution in the paws of mice after acute inflammation.  OBJECTIVES:  The aim of this study was to evaluate the DWB test as a measure of nonevoked hyperalgesia.  METHODS:  The experimental group received an intraplantar injection in the left hind paw of the inflammatory agent--complete Freund's adjuvant (CFA)--whereas the vehicle control group received a saline injection and the naive control group had no treatment.  Calipers and a plethysmometer were used to verify inflammation and the hot-plate test was used as a measure for stimulus-evoked hyperalgesia.  Data were collected at baseline; 3 hours; and 1, 3, and 7 days after injection.  RESULTS:  Mice injected with CFA showed a statistically significant higher mean paw thickness and volume displacement compared with the vehicle and naive control groups.  In the hot-plate testing, CFA-treated mice showed lower response temperature at 7 days compared with the other groups.  On the DWB test, CFA-treated mice showed a reduction in the ipsilateral paw load and surface area compared with the contralateral paw load at Days 1, 3, and 7.  DISCUSSION:  Mice with inflammation showed alterations in weight bearing as well as increased thermal hyperalgesia in comparison with control groups.  These findings support the use of the DWB test as a tool for measuring nonevoked inflammatory hyperalgesia in a mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHfIzmZeNC_GhHGZei4OW9fW6udTcc2eYld2HzIDzcjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D&md5=f9c78e7f44e84894440969c91f5d0554</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1097%2FNNR.0000000000000082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNNR.0000000000000082%26sid%3Dliteratum%253Aachs%26aulast%3DGriffioen%26aufirst%3DM.%2BA.%26aulast%3DDernetz%26aufirst%3DV.%2BH.%26aulast%3DYang%26aufirst%3DG.%2BS.%26aulast%3DGriffith%26aufirst%3DK.%2BA.%26aulast%3DDorsey%26aufirst%3DS.%2BG.%26aulast%3DRenn%26aufirst%3DC.%2BL.%26atitle%3DEvaluation%2520of%2520dynamic%2520weight%2520bearing%2520for%2520measuring%2520nonevoked%2520inflammatory%2520hyperalgesia%2520in%2520mice%26jtitle%3DNurs.%2520Res.%26date%3D2015%26volume%3D64%26spage%3D81%26epage%3D87%26doi%3D10.1097%2FNNR.0000000000000082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dernetz, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C. L.</span></span> <span> </span><span class="NLM_article-title">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span>. <i>Nurs. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1097/NNR.0000000000000082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1097%2FNNR.0000000000000082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25738619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=81-87&author=M.+A.+Griffioenauthor=V.+H.+Dernetzauthor=G.+S.+Yangauthor=K.+A.+Griffithauthor=S.+G.+Dorseyauthor=C.+L.+Renn&title=Evaluation+of+dynamic+weight+bearing+for+measuring+nonevoked+inflammatory+hyperalgesia+in+mice&doi=10.1097%2FNNR.0000000000000082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span></div><div class="casAuthors">Griffioen Mari A; Dernetz Valerie H; Yang Gee Su; Griffith Kathleen A; Dorsey Susan G; Renn Cynthia L</div><div class="citationInfo"><span class="NLM_cas:title">Nursing research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Animal models in pain research have suggested that inclusion of both evoked and nonevoked behavioral measures is needed to better reflect the human pain experience.  Individuals with chronic pain are known to experience spontaneous pain, in addition to pain after exposure to an external stimulus.  Recently, the dynamic weight bearing (DWB) apparatus was developed to assess for nonevoked hyperalgesia by capturing weight bearing and surface distribution in the paws of mice after acute inflammation.  OBJECTIVES:  The aim of this study was to evaluate the DWB test as a measure of nonevoked hyperalgesia.  METHODS:  The experimental group received an intraplantar injection in the left hind paw of the inflammatory agent--complete Freund's adjuvant (CFA)--whereas the vehicle control group received a saline injection and the naive control group had no treatment.  Calipers and a plethysmometer were used to verify inflammation and the hot-plate test was used as a measure for stimulus-evoked hyperalgesia.  Data were collected at baseline; 3 hours; and 1, 3, and 7 days after injection.  RESULTS:  Mice injected with CFA showed a statistically significant higher mean paw thickness and volume displacement compared with the vehicle and naive control groups.  In the hot-plate testing, CFA-treated mice showed lower response temperature at 7 days compared with the other groups.  On the DWB test, CFA-treated mice showed a reduction in the ipsilateral paw load and surface area compared with the contralateral paw load at Days 1, 3, and 7.  DISCUSSION:  Mice with inflammation showed alterations in weight bearing as well as increased thermal hyperalgesia in comparison with control groups.  These findings support the use of the DWB test as a tool for measuring nonevoked inflammatory hyperalgesia in a mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHfIzmZeNC_GhHGZei4OW9fW6udTcc2eaXnNwZQtgyd7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D&md5=f9c78e7f44e84894440969c91f5d0554</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1097%2FNNR.0000000000000082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNNR.0000000000000082%26sid%3Dliteratum%253Aachs%26aulast%3DGriffioen%26aufirst%3DM.%2BA.%26aulast%3DDernetz%26aufirst%3DV.%2BH.%26aulast%3DYang%26aufirst%3DG.%2BS.%26aulast%3DGriffith%26aufirst%3DK.%2BA.%26aulast%3DDorsey%26aufirst%3DS.%2BG.%26aulast%3DRenn%26aufirst%3DC.%2BL.%26atitle%3DEvaluation%2520of%2520dynamic%2520weight%2520bearing%2520for%2520measuring%2520nonevoked%2520inflammatory%2520hyperalgesia%2520in%2520mice%26jtitle%3DNurs.%2520Res.%26date%3D2015%26volume%3D64%26spage%3D81%26epage%3D87%26doi%3D10.1097%2FNNR.0000000000000082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tétreault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansereau, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré-Savard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats</span>. <i>Physiol. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.1016/j.physbeh.2011.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.physbeh.2011.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=21620878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFSqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2011&pages=495-502&author=P.+T%C3%A9treaultauthor=M.+A.+Dansereauauthor=L.+Dor%C3%A9-Savardauthor=N.+Beaudetauthor=P.+Sarret&title=Weight+bearing+evaluation+in+inflammatory%2C+neuropathic+and+cancer+chronic+pain+in+freely+moving+rats&doi=10.1016%2Fj.physbeh.2011.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats</span></div><div class="casAuthors">Tetreault, Pascal; Dansereau, Marc-Andre; Dore-Savard, Louis; Beaudet, Nicolas; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Physiology & Behavior</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-502</span>CODEN:
                <span class="NLM_cas:coden">PHBHA4</span>;
        ISSN:<span class="NLM_cas:issn">0031-9384</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Preclin. pain assessment remains a key step for the development of new and potent painkillers.  Significant progress in pain evaluation has been achieved with the development of non-reflexive tools.  Seeking efficient and clin. relevant devices for pain-related quality of life assessment, we evaluated a new Dynamic Wt. Bearing (DWB) device based on pressure captors in three different preclin. chronic pain models.  Inflammatory (CFA), neuropathic (CCI) and bone cancer pain (femoral tumor) models were evaluated in Sprague Dawley rats for mech. allodynia using dynamic von Frey for pain-related behaviors and DWB for discomfort.  We obsd. similar impairment patterns in all of the models for both von Frey (allodynia) and DWB (wt. balance) during the complete observation period, starting at day 3 in CCI- and CFA-affected limbs and at day 14 in bone cancer-afflicted rats, indicating that the DWB could be a useful tool for supporting pain assessment.  Interestingly, we demonstrated that the main compensation, when animals experienced pain, was seen in the forepaws, ranging from 46% to 69% of increased load compared to normal.  Other pain-related coping behaviors were also measured, such as the time spent on each paw and the contact surface.  Our results revealed that CFA, CCI and cancerous rats decreased the use of their ipsilateral hind paws by 30% and showed a 50% redn. in paw surface pressed against the floor.  In conclusion, this new device improves methods for preclin. evaluation of discomfort and quality of life proxies and could be helpful in screening putative analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocZiNDP41SHbVg90H21EOLACvtfcHk0ljAJ7TZgVwvfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFSqsr4%253D&md5=0c6181a0e82193f6632b3bbf52fb67b5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.physbeh.2011.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.physbeh.2011.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DT%25C3%25A9treault%26aufirst%3DP.%26aulast%3DDansereau%26aufirst%3DM.%2BA.%26aulast%3DDor%25C3%25A9-Savard%26aufirst%3DL.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DWeight%2520bearing%2520evaluation%2520in%2520inflammatory%252C%2520neuropathic%2520and%2520cancer%2520chronic%2520pain%2520in%2520freely%2520moving%2520rats%26jtitle%3DPhysiol.%2520Behav.%26date%3D2011%26volume%3D104%26spage%3D495%26epage%3D502%26doi%3D10.1016%2Fj.physbeh.2011.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laux-Biehlmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyken, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahllöf, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollner, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, J.</span></span> <span> </span><span class="NLM_article-title">Dynamic weight bearing as a non-reflexive method for the measurement of abdominal pain in mice</span>. <i>Eur. J. Pain.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1002/ejp.800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1002%2Fejp.800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26684879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28Xltlajs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=742-752&author=A.+Laux-Biehlmannauthor=J.+Boykenauthor=H.+Dahll%C3%B6fauthor=N.+Schmidtauthor=T.+M.+Zollnerauthor=J.+Nagel&title=Dynamic+weight+bearing+as+a+non-reflexive+method+for+the+measurement+of+abdominal+pain+in+mice&doi=10.1002%2Fejp.800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic weight bearing as a non-reflexive method for the measurement of abdominal pain in mice</span></div><div class="casAuthors">Laux-Biehlmann, A.; Boyken, J.; Dahlloef, H.; Schmidt, N.; Zollner, T. M.; Nagel, J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pain (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-752</span>CODEN:
                <span class="NLM_cas:coden">EJPAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1532-2149</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: Chronic pelvic pain (CPP) is a high burden for patients and society.  It affects 15-24% of women in reproductive age and is an area of high unmet medical need.  CPP can be caused by a wide range of visceral diseases such as abdominal infections, gastrointestinal or gynaecol. diseases like endometriosis.  Despite the high medical need for this condition, pharmacol. approaches are hampered by the limited no. of available methods for the behavioral evaluation of pain in inflammation-driven animal models of pelvic pain.  Methods: The dynamic wt. bearing (DWB) system was used for the evaluation of spontaneous behavior changes in the zymosan-induced peritonitis mouse model.  Inflammatory mediator levels were evaluated in peritoneal lavage and their correlation with the behavioral endpoints was assessed.  We evaluated the effect on behavioral endpoints of the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib and the Nav1.8 blocker A-803467.  Results: The presence of a relief posture, characterized by a significantly increased wt. distribution towards the front paws, was obsd. following i.p. injection of zymosan.  A pos. correlation was detected between PGE2 levels in the peritoneal lavage and DWB endpoints.  In addn., zymosan-induced wt. bearing changes were reverted by celecoxib and A-803467.  Conclusions: This study described for the first time the use of DWB as a non-subjective and non-reflexive method for the evaluation of inflammatory-driven abdominal pain in a mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRgMcZqYylVrVg90H21EOLACvtfcHk0ljAJ7TZgVwvfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xltlajs70%253D&md5=87b7aaddcd30b018ca7eb6cb157a1b0f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fejp.800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejp.800%26sid%3Dliteratum%253Aachs%26aulast%3DLaux-Biehlmann%26aufirst%3DA.%26aulast%3DBoyken%26aufirst%3DJ.%26aulast%3DDahll%25C3%25B6f%26aufirst%3DH.%26aulast%3DSchmidt%26aufirst%3DN.%26aulast%3DZollner%26aufirst%3DT.%2BM.%26aulast%3DNagel%26aufirst%3DJ.%26atitle%3DDynamic%2520weight%2520bearing%2520as%2520a%2520non-reflexive%2520method%2520for%2520the%2520measurement%2520of%2520abdominal%2520pain%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Pain.%26date%3D2016%26volume%3D20%26spage%3D742%26epage%3D752%26doi%3D10.1002%2Fejp.800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gruen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laux-Biehlmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollner, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, J.</span></span> <span> </span><span class="NLM_article-title">Use of dynamic weight bearing as a novel end-point for the assessment of abdominal pain in the LPS-induced peritonitis model in the rat</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>232</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1016/j.jneumeth.2014.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.jneumeth.2014.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=24861422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC2cjlvF2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2014&pages=118-124&author=M.+Gruenauthor=A.+Laux-Biehlmannauthor=T.+M.+Zollnerauthor=J.+Nagel&title=Use+of+dynamic+weight+bearing+as+a+novel+end-point+for+the+assessment+of+abdominal+pain+in+the+LPS-induced+peritonitis+model+in+the+rat&doi=10.1016%2Fj.jneumeth.2014.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Use of dynamic weight bearing as a novel end-point for the assessment of abdominal pain in the LPS-induced peritonitis model in the rat</span></div><div class="casAuthors">Gruen Michael; Laux-Biehlmann Alexis; Zollner Thomas M; Nagel Jens</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">118-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Chronic pelvic pain (CPP) is defined as long-lasting and severe pelvic pain persisting over six months in cyclic or non-cyclic chronic manner.  Various pathologic conditions like endometriosis, abdominal infections, intra-peritoneal adhesions or infection, underlie CPP which is often the leading symptom of the associated diseases.  Pharmacological approaches addressing CPP are hampered by the absence of a straight-forward, objective, and reliable method for the assessment of CPP in rodents.  METHOD:  In the presented study, the dynamic weight bearing system (DWB) was employed for the first time for the evaluation of pelvic pain in a rat model of LPS-induced peritonitis.  Rats were pretreated with the COX-2 inhibitor rofecoxib and PGE2 levels were evaluated in peritoneal lavage.  RESULTS:  DWB analysis revealed that rats treated with LPS showed a relief posture by a significantly increased weight distribution to the front when compared to vehicle-treated animals.  This effect was prevented by rofecoxib treatment indicating the sensitivity of the model for pelvic pain related to peritonitis.  Analysis of the PGE2 levels in the peritoneal fluid indicated a correlation with the relief posture intensity.  COMPARISON WITH EXISTING METHOD(S):  In contrast to others weight bearing approaches, the use of DWB allows evaluation of spontaneous posture changes as a consequence of pelvic pain.  CONCLUSION:  Taken together, we were able to show, that DWB combined with LPS-induced peritonitis may deliver a new reliable animal model addressing pelvic pain with high construct validity (peritoneal inflammation), and face validity (pain related relief posture).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGu7FAT6EqDCXXDYhVZBdlfW6udTcc2eaPAVXjjEli0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjlvF2huw%253D%253D&md5=f27ca3eeb11072cc2551367ab8597617</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2014.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2014.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DGruen%26aufirst%3DM.%26aulast%3DLaux-Biehlmann%26aufirst%3DA.%26aulast%3DZollner%26aufirst%3DT.%2BM.%26aulast%3DNagel%26aufirst%3DJ.%26atitle%3DUse%2520of%2520dynamic%2520weight%2520bearing%2520as%2520a%2520novel%2520end-point%2520for%2520the%2520assessment%2520of%2520abdominal%2520pain%2520in%2520the%2520LPS-induced%2520peritonitis%2520model%2520in%2520the%2520rat%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2014%26volume%3D232%26spage%3D118%26epage%3D124%26doi%3D10.1016%2Fj.jneumeth.2014.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span>SGC chemical
probes: <a href="https://www.thesgc.org/chemical-probes" class="extLink">https://www.thesgc.org/chemical-probes</a> (accessed Oct 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SGC+chemical%0Aprobes%3A+https%3A%2F%2Fwww.thesgc.org%2Fchemical-probes+%28accessed+Oct+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser-Doepner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mader, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Fahrnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo-Sherman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">The promise and peril of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">536</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1038%2Fnchembio.1867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26196764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=536-541&author=C.+H.+Arrowsmithauthor=J.+E.+Audiaauthor=C.+Austinauthor=J.+Baellauthor=J.+Bennettauthor=J.+Blaggauthor=C.+Bountraauthor=P.+E.+Brennanauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=C.+Buser-Doepnerauthor=R.+M.+Campbellauthor=A.+J.+Carterauthor=P.+Cohenauthor=R.+A.+Copelandauthor=B.+Cravattauthor=J.+L.+Dahlinauthor=D.+Dhanakauthor=A.+M.+Edwardsauthor=M.+Frederiksenauthor=S.+V.+Fryeauthor=N.+Grayauthor=C.+E.+Grimshawauthor=D.+Hepworthauthor=T.+Howeauthor=K.+V.+M.+Huberauthor=J.+Jinauthor=S.+Knappauthor=J.+D.+Kotzauthor=R.+G.+Krugerauthor=D.+Loweauthor=M.+M.+Maderauthor=B.+Marsdenauthor=A.+Mueller-Fahrnowauthor=S.+M%C3%BCllerauthor=R.+C.+O%E2%80%99Haganauthor=J.+P.+Overingtonauthor=D.+R.+Owenauthor=S.+H.+Rosenbergauthor=R.+Rossauthor=B.+Rothauthor=M.+Schapiraauthor=S.+L.+Schreiberauthor=B.+Shoichetauthor=M.+Sundstr%C3%B6mauthor=G.+Superti-Furgaauthor=J.+Tauntonauthor=L.+Toledo-Shermanauthor=C.+Walpoleauthor=M.+A.+Waltersauthor=T.+M.+Willsonauthor=P.+Workmanauthor=R.+N.+Youngauthor=W.+J.+Zuercher&title=The+promise+and+peril+of+chemical+probes&doi=10.1038%2Fnchembio.1867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The promise and peril of chemical probes</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Muller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes are powerful reagents with increasing impacts on biomedical research.  However, probes of poor quality or that are used incorrectly generate misleading results.  To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-li4dxq487rVg90H21EOLACvtfcHk0lhib1tMHbA3Yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO&md5=d8c7a7af94921ab4cdcc871487cceadd</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1867%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBuser-Doepner%26aufirst%3DC.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKotz%26aufirst%3DJ.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DMader%26aufirst%3DM.%2BM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DR.%2BC.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DToledo-Sherman%26aufirst%3DL.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520promise%2520and%2520peril%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D536%26epage%3D541%26doi%3D10.1038%2Fnchembio.1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghasemlou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araldi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, C. J.</span></span> <span> </span><span class="NLM_article-title">Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2012.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.pain.2012.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=22341563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC38vjt1Kisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=876-884&author=E.+J.+Cobosauthor=N.+Ghasemlouauthor=D.+Araldiauthor=D.+Segalauthor=K.+Duongauthor=C.+J.+Woolf&title=Inflammation-induced+decrease+in+voluntary+wheel+running+in+mice%3A+a+nonreflexive+test+for+evaluating+inflammatory+pain+and+analgesia&doi=10.1016%2Fj.pain.2012.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia</span></div><div class="casAuthors">Cobos Enrique J; Ghasemlou Nader; Araldi Dioneia; Segal David; Duong Kelly; Woolf Clifford J</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">876-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammatory pain impacts adversely on the quality of life of patients, often resulting in motor disabilities.  Therefore, we studied the effect of peripheral inflammation induced by intraplantar administration of complete Freund's adjuvant (CFA) in mice on a particular form of voluntary locomotion, wheel running, as an index of mobility impairment produced by pain.  The distance traveled over 1 hour of free access to activity wheels decreased significantly in response to hind paw inflammation, peaking 24 hours after CFA administration.  Recovery of voluntary wheel running by day 3 correlated with the ability to support weight on the inflamed limb.  Inflammation-induced mechanical hypersensitivity, measured with von Frey hairs, lasted considerably longer than the impaired voluntary wheel running and is not driving; therefore, the change in voluntary behavior.  The CFA-induced decrease in voluntary wheel running was dose-dependently reversed by subcutaneous administration of antiinflammatory and analgesic drugs, including naproxen (10-80 mg/kg), ibuprofen (2.5-20mg/kg), diclofenac (1.25-10mg/kg), celecoxib (2.5-20mg/kg), prednisolone (0.62-5mg/kg), and morphine (0.06-0.5mg/kg), all at much lower doses than reported in most rodent models.  Furthermore, the doses that induced recovery in voluntary wheel running did not reduce CFA-induced mechanical allodynia, indicating a greater sensitivity of the former as a surrogate measure of inflammatory pain.  We conclude that monitoring changes in voluntary wheel running in mice during peripheral inflammation is a simple, observer-independent objective measure of functional changes produced by inflammation, likely more aligned to the global level of pain than reflexive measures, and much more sensitive to analgesic drug effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVTCC_7r7pdpPq5LRczm8ffW6udTcc2eb2k_Z8MR20hbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vjt1Kisw%253D%253D&md5=68a247f50365e78ec921d17657f208ac</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DGhasemlou%26aufirst%3DN.%26aulast%3DAraldi%26aufirst%3DD.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DDuong%26aufirst%3DK.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DInflammation-induced%2520decrease%2520in%2520voluntary%2520wheel%2520running%2520in%2520mice%253A%2520a%2520nonreflexive%2520test%2520for%2520evaluating%2520inflammatory%2520pain%2520and%2520analgesia%26jtitle%3DPain%26date%3D2012%26volume%3D153%26spage%3D876%26epage%3D884%26doi%3D10.1016%2Fj.pain.2012.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dernetz, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C. L.</span></span> <span> </span><span class="NLM_article-title">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span>. <i>Nurs Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1097/NNR.0000000000000082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1097%2FNNR.0000000000000082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25738619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=81-87&author=M.+A.+Griffioenauthor=V.+H.+Dernetzauthor=G.+S.+Yangauthor=K.+A.+Griffithauthor=S.+G.+Dorseyauthor=C.+L.+Renn&title=Evaluation+of+dynamic+weight+bearing+for+measuring+nonevoked+inflammatory+hyperalgesia+in+mice&doi=10.1097%2FNNR.0000000000000082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span></div><div class="casAuthors">Griffioen Mari A; Dernetz Valerie H; Yang Gee Su; Griffith Kathleen A; Dorsey Susan G; Renn Cynthia L</div><div class="citationInfo"><span class="NLM_cas:title">Nursing research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Animal models in pain research have suggested that inclusion of both evoked and nonevoked behavioral measures is needed to better reflect the human pain experience.  Individuals with chronic pain are known to experience spontaneous pain, in addition to pain after exposure to an external stimulus.  Recently, the dynamic weight bearing (DWB) apparatus was developed to assess for nonevoked hyperalgesia by capturing weight bearing and surface distribution in the paws of mice after acute inflammation.  OBJECTIVES:  The aim of this study was to evaluate the DWB test as a measure of nonevoked hyperalgesia.  METHODS:  The experimental group received an intraplantar injection in the left hind paw of the inflammatory agent--complete Freund's adjuvant (CFA)--whereas the vehicle control group received a saline injection and the naive control group had no treatment.  Calipers and a plethysmometer were used to verify inflammation and the hot-plate test was used as a measure for stimulus-evoked hyperalgesia.  Data were collected at baseline; 3 hours; and 1, 3, and 7 days after injection.  RESULTS:  Mice injected with CFA showed a statistically significant higher mean paw thickness and volume displacement compared with the vehicle and naive control groups.  In the hot-plate testing, CFA-treated mice showed lower response temperature at 7 days compared with the other groups.  On the DWB test, CFA-treated mice showed a reduction in the ipsilateral paw load and surface area compared with the contralateral paw load at Days 1, 3, and 7.  DISCUSSION:  Mice with inflammation showed alterations in weight bearing as well as increased thermal hyperalgesia in comparison with control groups.  These findings support the use of the DWB test as a tool for measuring nonevoked inflammatory hyperalgesia in a mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHfIzmZeNC_GhHGZei4OW9fW6udTcc2eb2k_Z8MR20hbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D&md5=f9c78e7f44e84894440969c91f5d0554</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1097%2FNNR.0000000000000082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNNR.0000000000000082%26sid%3Dliteratum%253Aachs%26aulast%3DGriffioen%26aufirst%3DM.%2BA.%26aulast%3DDernetz%26aufirst%3DV.%2BH.%26aulast%3DYang%26aufirst%3DG.%2BS.%26aulast%3DGriffith%26aufirst%3DK.%2BA.%26aulast%3DDorsey%26aufirst%3DS.%2BG.%26aulast%3DRenn%26aufirst%3DC.%2BL.%26atitle%3DEvaluation%2520of%2520dynamic%2520weight%2520bearing%2520for%2520measuring%2520nonevoked%2520inflammatory%2520hyperalgesia%2520in%2520mice%26jtitle%3DNurs%2520Res.%26date%3D2015%26volume%3D64%26spage%3D81%26epage%3D87%26doi%3D10.1097%2FNNR.0000000000000082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosise, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taremi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesburg, C. A.</span></span> <span> </span><span class="NLM_article-title">Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability</span>. <i>Protein Engineering, Design & Selection</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1093/protein/gzn017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1093%2Fprotein%2Fgzn017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=18456871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1Sks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=425-433&author=W.+Wangauthor=W.+W.+Prosiseauthor=J.+Chenauthor=S.+S.+Taremiauthor=H.+V.+Leauthor=V.+Madisonauthor=X.+Cuiauthor=A.+Thomasauthor=K.+C.+Chengauthor=C.+A.+Lesburg&title=Construction+and+characterization+of+a+fully+active+PXR%2FSRC-1+tethered+protein+with+increased+stability&doi=10.1093%2Fprotein%2Fgzn017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability</span></div><div class="casAuthors">Wang, Wenyan; Prosise, Winifred W.; Chen, Jun; Taremi, S. Shane; Le, Hung V.; Madison, Vincent; Cui, Xiaoming; Thomas, Ann; Cheng, K.-C.; Lesburg, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Engineering, Design & Selection</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">425-433</span>CODEN:
                <span class="NLM_cas:coden">PEDSBR</span>;
        ISSN:<span class="NLM_cas:issn">1741-0126</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The nuclear xenobiotic receptor PXR is a ligand-inducible transcription factor regulating drug-metabolizing enzymes and transporters and a master switch mediating potentially adverse drug-drug interactions.  In addn. to binding a coactivator protein such as SRC-1, the C-terminal ligand-binding domain (LBD) is solely responsible for ligand recognition and thus the ligand-dependent downstream effects.  In an effort to facilitate structural studies of PXR to understand and abolish the interactions between PXR and its ligands, several recombinant PXR/SRC-1 constructs were designed and evaluated for expression, stability and activity.  Expression strategies employing either dual expression or translationally coupled bicistronic expression were found to be unsuitable for producing stable PXR in a stoichiometric complex with a peptide derived from SRC-1 (SRC-1p).  A single polypeptide chain encompassing PXR and SRC-1p tethered with a peptidyl linker was designed to promote intramol. complex formation.  This tethered protein was overexpressed as a sol. protein and required no addnl. SRC-1p for further stabilization.  X-ray crystal structures in the presence and absence of the known PXR agonist SR-12813 were detd. to high resoln.  In addn., a CD-based binding assay was developed to allow rapid evaluation of PXR ligand affinity, making this tethered protein a convenient and effective reagent for the rational attenuation of drug-induced PXR-mediated metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaIAHYXZGyYLVg90H21EOLACvtfcHk0lh1bux5JKSfYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1Sks7s%253D&md5=87a30decb4445d6b713b55eedc2b7038</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fprotein%2Fgzn017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fprotein%252Fgzn017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DLe%26aufirst%3DH.%2BV.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26atitle%3DConstruction%2520and%2520characterization%2520of%2520a%2520fully%2520active%2520PXR%252FSRC-1%2520tethered%2520protein%2520with%2520increased%2520stability%26jtitle%3DProtein%2520Engineering%252C%2520Design%2520%2526%2520Selection%26date%3D2008%26volume%3D21%26spage%3D425%26epage%3D433%26doi%3D10.1093%2Fprotein%2Fgzn017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huschmann, F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malecki, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pühringer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Röwer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ühlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. S.</span></span> <span> </span><span class="NLM_article-title">2015. The macromolecular crystallography beamlines at BESSY II of the Helmholtz-Zentrum Berlin: Current status and perspectives</span>. <i>Eur. Phys. J. Plus</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1140/epjp/i2015-15141-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1140%2Fepjp%2Fi2015-15141-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2015&pages=141-150&author=U.+Muellerauthor=R.+F%C3%B6rsterauthor=M.+Hellmigauthor=F.+U.+Huschmannauthor=A.+Kastnerauthor=P.+Maleckiauthor=S.+P%C3%BChringerauthor=M.+R%C3%B6werauthor=K.+Spartaauthor=M.+Steffienauthor=M.+%C3%9Chleinauthor=P.+Wilkauthor=M.+S.+Weiss&title=2015.+The+macromolecular+crystallography+beamlines+at+BESSY+II+of+the+Helmholtz-Zentrum+Berlin%3A+Current+status+and+perspectives&doi=10.1140%2Fepjp%2Fi2015-15141-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1140%2Fepjp%2Fi2015-15141-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1140%252Fepjp%252Fi2015-15141-2%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DF%25C3%25B6rster%26aufirst%3DR.%26aulast%3DHellmig%26aufirst%3DM.%26aulast%3DHuschmann%26aufirst%3DF.%2BU.%26aulast%3DKastner%26aufirst%3DA.%26aulast%3DMalecki%26aufirst%3DP.%26aulast%3DP%25C3%25BChringer%26aufirst%3DS.%26aulast%3DR%25C3%25B6wer%26aufirst%3DM.%26aulast%3DSparta%26aufirst%3DK.%26aulast%3DSteffien%26aufirst%3DM.%26aulast%3D%25C3%259Chlein%26aufirst%3DM.%26aulast%3DWilk%26aufirst%3DP.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26atitle%3D2015.%2520The%2520macromolecular%2520crystallography%2520beamlines%2520at%2520BESSY%2520II%2520of%2520the%2520Helmholtz-Zentrum%2520Berlin%253A%2520Current%2520status%2520and%2520perspectives%26jtitle%3DEur.%2520Phys.%2520J.%2520Plus%26date%3D2015%26volume%3D130%26spage%3D141%26epage%3D150%26doi%3D10.1140%2Fepjp%2Fi2015-15141-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgba9KVirsK8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sparta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. S.</span></span> <span> </span><span class="NLM_article-title">XDSAPP2.0</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1107/S1600576716004416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1107%2FS1600576716004416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28Xosl2rtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2016&pages=1085-1092&author=K.+Spartaauthor=M.+Krugauthor=U.+Heinemannauthor=U.+Muellerauthor=M.+S.+Weiss&title=XDSAPP2.0&doi=10.1107%2FS1600576716004416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">XDSAPP2.0</span></div><div class="casAuthors">Sparta, Karine M.; Krug, Michael; Heinemann, Udo; Mueller, Uwe; Weiss, Manfred S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1085-1092</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">1600-5767</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">XDSAPP is an expert system and graphical user interface (GUI) for the automated processing of diffraction images using the XDS program suite and other programs.  The latest major update and the extension of the program are presented here.  The update includes new features, as well as improvements in the GUI and the underlying decision-making system.  XDSAPP is freely available for academic users.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ-TX0JPxrKrVg90H21EOLACvtfcHk0lgba9KVirsK8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xosl2rtLw%253D&md5=6f8dd41413be2d19cfee0e556da3cb0b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS1600576716004416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600576716004416%26sid%3Dliteratum%253Aachs%26aulast%3DSparta%26aufirst%3DK.%26aulast%3DKrug%26aufirst%3DM.%26aulast%3DHeinemann%26aufirst%3DU.%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26atitle%3DXDSAPP2.0%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2016%26volume%3D49%26spage%3D1085%26epage%3D1092%26doi%3D10.1107%2FS1600576716004416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papiz, M. Z.</span></span> <span> </span><span class="NLM_article-title">Macromolecular TLS refinement in REFMAC at moderate resolutions</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>374</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(03)74014-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2FS0076-6879%2803%2974014-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=14696379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2003&pages=300-321&author=M.+D.+Winnauthor=G.+N.+Murshudovauthor=M.+Z.+Papiz&title=Macromolecular+TLS+refinement+in+REFMAC+at+moderate+resolutions&doi=10.1016%2FS0076-6879%2803%2974014-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Macromolecular TLS refinement in REFMAC at moderate resolutions</span></div><div class="casAuthors">Winn, Martyn D.; Murshudov, Garib N.; Papiz, Miroslav Z.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part D</span>),
    <span class="NLM_cas:pages">300-321</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The translation, rotation, screw-rotation (TLS) model parameterization of anisotropic displacement parameters (ADPs) is described.  The phys. model applied is that the anisotropic displacements can be modeled as those of a set of rigid bodies.  For rigid groups of four atoms or larger, TLS parameterization represents a decrease in the no. of parameters over a full ADP description.  Some of the practical issues involved in running TLS refinement in refmac and its applications are discussed, as well as the anal. program tlsanl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpByvlfp34wMbVg90H21EOLACvtfcHk0lgba9KVirsK8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlynsg%253D%253D&md5=8240b81ce1b8f6d53cd8d61183c9e007</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2803%2974014-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252803%252974014-2%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPapiz%26aufirst%3DM.%2BZ.%26atitle%3DMacromolecular%2520TLS%2520refinement%2520in%2520REFMAC%2520at%2520moderate%2520resolutions%26jtitle%3DMethods%2520Enzymol.%26date%3D2003%26volume%3D374%26spage%3D300%26epage%3D321%26doi%3D10.1016%2FS0076-6879%2803%2974014-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lh0MuADgC97gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schüttelkopf, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Aalten, D. M. F.</span></span> <span> </span><span class="NLM_article-title">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span>. <i>Acta Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1363</span>, <span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVegtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-1363&author=A.+W.+Sch%C3%BCttelkopfauthor=D.+M.+F.+van+Aalten&title=PRODRG%3A+a+tool+for+high-throughput+crystallography+of+protein-ligand+complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuettelkopf, Alexander W.; van Aalten, Daan M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1355-1363</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The small-mol. topol. generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and mol. topologies suitable for x-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compds. from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the std. libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallog. R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbflrch0bs97Vg90H21EOLACvtfcHk0lh0MuADgC97gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVegtbY%253D&md5=f9bfdb14be7b04ea5c0db67feb39f72a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25BCttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%2BF.%26atitle%3DPRODRG%253A%2520a%2520tool%2520for%2520high-throughput%2520crystallography%2520of%2520protein-ligand%2520complexes%26jtitle%3DActa%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D1363%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23a','cit23b','cit23c','cit23d'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29a','cit29b'],'ref30':['cit30a','cit30b'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Adrian Hall, Hugues Chanteux, Karelle Ménochet, Marie Ledecq, <span class="NLM_string-name hlFld-ContribAuthor">Monika-Sarah E. D. Schulze</span>. </span><span class="cited-content_cbyCitation_article-title">Designing Out PXR Activity on Drug Discovery Projects: A Review of Structure-Based Methods, Empirical and Computational Approaches. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6413-6522. <a href="https://doi.org/10.1021/acs.jmedchem.0c02245" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c02245%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesigning%252BOut%252BPXR%252BActivity%252Bon%252BDrug%252BDiscovery%252BProjects%25253A%252BA%252BReview%252Bof%252BStructure-Based%252BMethods%25252C%252BEmpirical%252Band%252BComputational%252BApproaches%26aulast%3DHall%26aufirst%3DAdrian%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D27122020%26date%3D18052021%26volume%3D64%26issue%3D10%26spage%3D6413%26epage%3D6522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Illes</span>, <span class="hlFld-ContribAuthor ">Christa E.  Müller</span>, <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>, <span class="hlFld-ContribAuthor ">Thomas  Grutter</span>, <span class="hlFld-ContribAuthor ">Annette  Nicke</span>, <span class="hlFld-ContribAuthor ">Samuel J.  Fountain</span>, <span class="hlFld-ContribAuthor ">Charles  Kennedy</span>, <span class="hlFld-ContribAuthor ">Günther  Schmalzing</span>, <span class="hlFld-ContribAuthor ">Michael F.  Jarvis</span>, <span class="hlFld-ContribAuthor ">Stanko S.  Stojilkovic</span>, <span class="hlFld-ContribAuthor ">Brian F.  King</span>, <span class="hlFld-ContribAuthor ">Francesco  Di Virgilio</span>. </span><span class="cited-content_cbyCitation_article-title">Update of P2X receptor properties and their pharmacology: IUPHAR Review 30. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2021,</strong> <em>178 </em>
                                    (3)
                                     , 489-514. <a href="https://doi.org/10.1111/bph.15299" title="DOI URL">https://doi.org/10.1111/bph.15299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.15299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.15299%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DUpdate%252Bof%252BP2X%252Breceptor%252Bproperties%252Band%252Btheir%252Bpharmacology%25253A%252BIUPHAR%252BReview%252B30%26aulast%3DIlles%26aufirst%3DPeter%26date%3D2021%26date%3D2020%26volume%3D178%26issue%3D3%26spage%3D489%26epage%3D514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keita  Kohno</span>, <span class="hlFld-ContribAuthor ">Makoto  Tsuda</span>. </span><span class="cited-content_cbyCitation_article-title">Role of microglia and P2X4 receptors in chronic pain. </span><span class="cited-content_cbyCitation_journal-name">PAIN Reports</span><span> <strong>2021,</strong> <em>6 </em>
                                    (1)
                                     , e864. <a href="https://doi.org/10.1097/PR9.0000000000000864" title="DOI URL">https://doi.org/10.1097/PR9.0000000000000864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/PR9.0000000000000864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FPR9.0000000000000864%26sid%3Dliteratum%253Aachs%26jtitle%3DPAIN%2520Reports%26atitle%3DRole%252Bof%252Bmicroglia%252Band%252BP2X4%252Breceptors%252Bin%252Bchronic%252Bpain%26aulast%3DKohno%26aufirst%3DKeita%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D1%26spage%3De864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiangnan  Ma</span>, <span class="hlFld-ContribAuthor ">Jinzhao  Gao</span>, <span class="hlFld-ContribAuthor ">Mengyue  Niu</span>, <span class="hlFld-ContribAuthor ">Xiaona  Zhang</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Anmu  Xie</span>. </span><span class="cited-content_cbyCitation_article-title">P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Aging Neuroscience</span><span> <strong>2020,</strong> <em>12 </em><a href="https://doi.org/10.3389/fnagi.2020.580068" title="DOI URL">https://doi.org/10.3389/fnagi.2020.580068</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnagi.2020.580068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnagi.2020.580068%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Aging%2520Neuroscience%26atitle%3DP2X4R%252BOverexpression%252BUpregulates%252BInterleukin-6%252Band%252BExacerbates%252B6-OHDA-Induced%252BDopaminergic%252BDegeneration%252Bin%252Ba%252BRat%252BModel%252Bof%252BPD%26aulast%3DMa%26aufirst%3DJiangnan%26date%3D2020%26date%3D2020%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexia  Duveau</span>, <span class="hlFld-ContribAuthor ">Eléonore  Bertin</span>, <span class="hlFld-ContribAuthor ">Eric  Boué-Grabot</span>. </span><span class="cited-content_cbyCitation_article-title">Implication of Neuronal Versus Microglial P2X4 Receptors in Central Nervous System Disorders. </span><span class="cited-content_cbyCitation_journal-name">Neuroscience Bulletin</span><span> <strong>2020,</strong> <em>36 </em>
                                    (11)
                                     , 1327-1343. <a href="https://doi.org/10.1007/s12264-020-00570-y" title="DOI URL">https://doi.org/10.1007/s12264-020-00570-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12264-020-00570-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12264-020-00570-y%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroscience%2520Bulletin%26atitle%3DImplication%252Bof%252BNeuronal%252BVersus%252BMicroglial%252BP2X4%252BReceptors%252Bin%252BCentral%252BNervous%252BSystem%252BDisorders%26aulast%3DDuveau%26aufirst%3DAlexia%26date%3D2020%26date%3D2020%26volume%3D36%26issue%3D11%26spage%3D1327%26epage%3D1343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andreas H.  Göller</span>, <span class="hlFld-ContribAuthor ">Lara  Kuhnke</span>, <span class="hlFld-ContribAuthor ">Floriane  Montanari</span>, <span class="hlFld-ContribAuthor ">Anne  Bonin</span>, <span class="hlFld-ContribAuthor ">Sebastian  Schneckener</span>, <span class="hlFld-ContribAuthor ">Antonius  ter Laak</span>, <span class="hlFld-ContribAuthor ">Jörg  Wichard</span>, <span class="hlFld-ContribAuthor ">Mario  Lobell</span>, <span class="hlFld-ContribAuthor ">Alexander  Hillisch</span>. </span><span class="cited-content_cbyCitation_article-title">Bayer’s in silico ADMET platform: a journey of machine learning over the past two decades. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (9)
                                     , 1702-1709. <a href="https://doi.org/10.1016/j.drudis.2020.07.001" title="DOI URL">https://doi.org/10.1016/j.drudis.2020.07.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2020.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2020.07.001%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DBayer%2525E2%252580%252599s%252Bin%252Bsilico%252BADMET%252Bplatform%25253A%252Ba%252Bjourney%252Bof%252Bmachine%252Blearning%252Bover%252Bthe%252Bpast%252Btwo%252Bdecades%26aulast%3DG%25C3%25B6ller%26aufirst%3DAndreas%2BH.%26date%3D2020%26volume%3D25%26issue%3D9%26spage%3D1702%26epage%3D1709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selected published structures of P2X4 antagonists with reported P2X4 IC<sub>50</sub>s (# in-house potency data from the assays of this study).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0014.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. P2X4 inhibition activity of <b>10</b> (<b>BAY-1797</b>) in the FLIPR assay (human P2X4 HEK cells, IC<sub>50</sub> = 211 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Sulfonamides <b>10</b> and <b>16</b>–<b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) 1-(2,4-dimethoxyphenyl)methanamine, NaHCO<sub>3</sub>, DCM; (b): R<sup>2</sup>-OH, Cs<sub>2</sub>CO<sub>3</sub>, MeCN; (c) H<sub>2</sub>, Pt/V (1%/2%) on charcoal, toluene; (d) R-COOH, HATU, DIPEA, DMF; (e) TFA, DCM, rt.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Sulfonamides <b>33</b>–<b>40</b>, <b>42</b>, <b>43</b>, <b>45</b>, <b>47</b>, <b>49</b>, and <b>51</b>–<b>62</b><sup>a</sup><sup>b</sup><sup>c</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) R<sup>2</sup>-OH, Cs<sub>2</sub>CO<sub>3</sub>, MeCN (for R<sup>2</sup> = aryl/hetaryl) or NaH, DMF (for R<sup>2</sup> = alkyl); (b) H<sub>2</sub>, Pd/C, THF or SnCl<sub>2</sub>·2H<sub>2</sub>O, dioxane, 70 °C; (c) R-COOH, HATU, DIPEA, DMF; (d) TFA, DCM, rt; (e) morpholine-3-one, Cs<sub>2</sub>CO<sub>3</sub>, Xanthphos, Pd<sub>2</sub>(dba)<sub>3</sub>, dioxane, 105 °C; (f) MeMgBr, THF, −78 °C.</p><p><span class="fn-label"><sup>b</sup></span>Synthesis of <b>55</b> was started with fluoronitroaryl <b>12b</b>.</p><p class="last"><span class="fn-label"><sup>c</sup></span>Synthesis of <b>57</b> was performed without 2,4-dimethoxybenzyl-protecting group.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Sulfonamides <b>66</b>–<b>74</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) H<sub>2</sub>, Pd/C, 2N aq. HCl, MeOH; (b) HATU, DIPEA, DMF; (c) NaH, R<sup>2</sup>-Br, DMF, 0 °C.</p></p></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding mode of compound <b>25</b> in the PXR (protein data bank (PDB) accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HTY">6HTY</a>). (A) View into the fully solvent-excluded ligand binding pocket of the PXR (chain B), side-chain residues shown in stick representation, protein shown additionally in surface representation. (B) View rotated by 90°. The dotted lines show H-bond interactions. Figure generated using Pymol (The PyMOL Molecular Graphics System, Version 1.3 Schrödinger, LLC).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Constraint docking of analogues, using the energy-minimized binding site of PXR co-crystallized with <b>25</b> as a template (PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HTY">6HTY</a>), led to a qualitative understanding of the SAR roughly defined by the boundaries of the PXR binding site. To this end, it is assumed that the binding modes in PXR of close analogues of <b>25</b> are very similar. (A) Variations in the para-position including compounds <b>10</b>, <b>18</b>, <b>28</b>, and <b>29</b> (PXR assay: low MEC values, in orange), and <b>30</b> (PXR assay: high MEC values, in green). Large groups such as <i>para</i>-CF<sub>3</sub><b>30</b> (green ligand) and <i>para</i>-chloro <b>29</b> (yellow ligand) appear to accommodate less well in PXR between the stacking (blue dashed lines) residues Trp299 and Phe288, which then results in a loss of optimal H-bonding with Gln285. (B) Compounds showing low MEC values in the PXR assay are docked well into the PXR binding site: <b>66</b>, <b>69</b>, <b>67</b>, and <b>47</b> (C) Compounds with reduced PXR transactivation potential have close steric contacts with the PXR protein surface: <b>39</b>, <b>40</b>, <b>45</b>, and <b>70</b>. (D) Compounds with no or weak effects in the PXR assay cannot accommodate PXR in a similar binding mode because of severe steric hindrance with the protein: <b>43</b>, <b>51</b>, 4<b>2</b>, and <b>71</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. P2X4 inhibition activity of <b>10</b> (<b>BAY-1797</b>) in the FLIPR assay (human, mouse, and rat P2X4 1321N1 cells, IC<sub>50</sub> = 108 nM human), 112 nM (mouse), and 233 nM (rat).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0015.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. P2X4 inhibition activity of <b>10</b> (<b>BAY-1797</b>) by electrophysiology on the QPatch (human P2X4 1321N1 cells, IC<sub>50</sub> = 320 nM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/medium/jm9b01304_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0016.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Anti-inflammatory and antinociceptive effects of compound <b>10</b> (<b>BAY-1797</b>) evaluated in the mouse CFA inflammatory pain model, 48 h following intraplantar CFA injection. (A) Following a single administration, <b>10</b> or rofecoxib dose-dependently reduces PGE2 concentration in inflamed paw. (B) Reduction of nonevoked inflammatory hyperalgesia observed using dynamic weight bearing following daily administration of <b>10</b> or rofecoxib. One-way analysis of variance (ANOVA) followed by Holm–Sidak’s multiple comparisons test and was performed vs vehicle group (*, <i>p</i> < 0.05; **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001) or vs baseline values (##, <i>p</i> < 0.01; ###, <i>p</i> < 0.001). <i>n</i> = 8 per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-24/acs.jmedchem.9b01304/20191219/images/large/jm9b01304_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01304&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i120">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15652" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15652" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 47 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span> <span> </span><span class="NLM_article-title">P2X ion channel receptors and inflammation</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1007/s11302-015-9493-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1007%2Fs11302-015-9493-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26739702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28XjslGmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=59-67&author=G.+Burnstock&title=P2X+ion+channel+receptors+and+inflammation&doi=10.1007%2Fs11302-015-9493-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">P2X ion channel receptors and inflammation</span></div><div class="casAuthors">Burnstock, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-67</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Neuroinflammation limits tissue damage in response to pathogens or injury and promotes repair.  There are two stages of inflammation, initiation and resoln.  P2X receptors are gaining attention in relation to immunol. and inflammation.  The P2X7 receptor in particular appears to be an essential immunomodulatory receptor, although P2X1 and P2X4 receptors also appear to be involved.  ATP released from damaged or infected cells causes inflammation by release of inflammatory cytokines via P2X7 receptors and acts as a danger signal by occupying upregulated P2X receptors on immune cells to increase immune responses.  The purinergic involvement in inflammation is being explored for the development of novel therapeutic strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSRKcDsxubzrVg90H21EOLACvtfcHk0lieI1ux0xKUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjslGmug%253D%253D&md5=c8ce49c3caa010bb73e33ec75b931abd</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11302-015-9493-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-015-9493-0%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DP2X%2520ion%2520channel%2520receptors%2520and%2520inflammation%26jtitle%3DPurinergic%2520Signalling%26date%3D2016%26volume%3D12%26spage%3D59%26epage%3D67%26doi%3D10.1007%2Fs11302-015-9493-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span> <span> </span><span class="NLM_article-title">Purinergic mechanisms and pain</span>. <i>Adv. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">91</span>– <span class="NLM_lpage">137</span>, <span class="refDoi"> DOI: 10.1016/bs.apha.2015.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fbs.apha.2015.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26920010" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnsFSjsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2016&pages=91-137&author=G.+Burnstock&title=Purinergic+mechanisms+and+pain&doi=10.1016%2Fbs.apha.2015.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Purinergic mechanisms and pain</span></div><div class="casAuthors">Burnstock, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">Pharmacological Mechanisms and the Modulation of Pain</span>),
    <span class="NLM_cas:pages">91-137</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">There is a brief introductory summary of purinergic signaling involving ATP storage, release, and ectoenzymic breakdown, and the current classification of receptor subtypes for purines and pyrimidines.  The review then describes purinergic mechanosensory transduction involved in visceral, cutaneous, and musculoskeletal nociception and on the roles played by receptor subtypes in neuropathic and inflammatory pain.  Multiple purinoceptor subtypes are involved in pain pathways both as an initiator and modulator.  Activation of homomeric P2X3 receptors contributes to acute nociception and activation of heteromeric P2X2/3 receptors appears to modulate longer-lasting nociceptive sensitivity assocd. with nerve injury or chronic inflammation.  In neuropathic pain activation of P2X4, P2X7, and P2Y12 receptors on microglia may serve to maintain nociceptive sensitivity through complex neural-glial cell interactions and antagonists to these receptors reduce neuropathic pain.  Potential therapeutic approaches involving purinergic mechanisms will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowoVefyC4mLLVg90H21EOLACvtfcHk0lgHXtoGUAqmEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnsFSjsLw%253D&md5=e69a7b8343ff587d61ebac0af1b62787</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fbs.apha.2015.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fbs.apha.2015.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DPurinergic%2520mechanisms%2520and%2520pain%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2016%26volume%3D75%26spage%3D91%26epage%3D137%26doi%3D10.1016%2Fbs.apha.2015.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span> <span> </span><span class="NLM_article-title">Triphosphate, the key structure of the ATP molecule responsible for interaction with P2X-purinoceptors</span>. <i>Gen. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">640</span>, <span class="refDoi"> DOI: 10.1016/0306-3623(93)90223-K</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2F0306-3623%2893%2990223-K" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=8365644" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADyaK3sXltV2hs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1993&pages=637-640&author=X.+Boauthor=G.+Burnstock&title=Triphosphate%2C+the+key+structure+of+the+ATP+molecule+responsible+for+interaction+with+P2X-purinoceptors&doi=10.1016%2F0306-3623%2893%2990223-K"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Triphosphate, the key structure of the ATP molecule responsible for interaction with P2X-purinoceptors</span></div><div class="casAuthors">Bo, Xuenong; Burnstock, Goeffrey</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">637-40</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    </div><div class="casAbstract">A radioligand binding assay was carried out to explore the key structure in mols. of ATP and its analogs responsible for the binding to P2X-purinoceptors.  It was found that adenosine, adenine and xanthine had no effect on [3H]α,β-methylene ATP binding to membrane fractions prepd. from rat urinary bladder, while pentasodium triphosphate and disodium pyrophosphate could effectively displace the binding.  Na orthophosphate was shown to displace the binding only at much higher concn.  Apart from ATP, several other nucleotides could also fully displace the specific binding, but with potencies lower than that of ATP.  The results indicate that the phosphate side chain in mols. of ATP and its analogs is the key structure responsible for the binding to P2X-purinoceptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbE0zzS_hQ0LVg90H21EOLACvtfcHk0lgHXtoGUAqmEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXltV2hs7c%253D&md5=503f55f3b601201a482524e3d8bd54b0</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2893%2990223-K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252893%252990223-K%26sid%3Dliteratum%253Aachs%26aulast%3DBo%26aufirst%3DX.%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DTriphosphate%252C%2520the%2520key%2520structure%2520of%2520the%2520ATP%2520molecule%2520responsible%2520for%2520interaction%2520with%2520P2X-purinoceptors%26jtitle%3DGen.%2520Pharmacol.%26date%3D1993%26volume%3D24%26spage%3D637%26epage%3D640%26doi%3D10.1016%2F0306-3623%2893%2990223-K" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rassendren, F.</span></span> <span> </span><span class="NLM_article-title">P2X receptors: an emerging channel family</span>. <i>Eur. J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2221</span>– <span class="NLM_lpage">2228</span>, <span class="refDoi"> DOI: 10.1111/j.1460-9568.1996.tb00745.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1111%2Fj.1460-9568.1996.tb00745.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=8921315" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADyaK2s%252FnvFKjtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1996&pages=2221-2228&author=G.+Buellauthor=G.+Colloauthor=F.+Rassendren&title=P2X+receptors%3A+an+emerging+channel+family&doi=10.1111%2Fj.1460-9568.1996.tb00745.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">P2X receptors: an emerging channel family</span></div><div class="casAuthors">Buell G; Collo G; Rassendren F</div><div class="citationInfo"><span class="NLM_cas:title">The European journal of neuroscience</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2221-8</span>
        ISSN:<span class="NLM_cas:issn">0953-816X</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSxnqTOAOvv4xWfpMXQLRstfW6udTcc2eadOYYK2nXepbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252FnvFKjtg%253D%253D&md5=931b513dbae97dd799ebefbe4ab676dc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1111%2Fj.1460-9568.1996.tb00745.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1460-9568.1996.tb00745.x%26sid%3Dliteratum%253Aachs%26aulast%3DBuell%26aufirst%3DG.%26aulast%3DCollo%26aufirst%3DG.%26aulast%3DRassendren%26aufirst%3DF.%26atitle%3DP2X%2520receptors%253A%2520an%2520emerging%2520channel%2520family%26jtitle%3DEur.%2520J.%2520Neurosci.%26date%3D1996%26volume%3D8%26spage%3D2221%26epage%3D2228%26doi%3D10.1111%2Fj.1460-9568.1996.tb00745.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span> <span> </span><span class="NLM_article-title">Introduction and perspective, historical note</span>. <i>Front. Cell. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>, <span class="NLM_elocation-id">227</span> <span class="refDoi"> DOI: 10.3389/fncel.2013.00227</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.3389%2Ffncel.2013.00227" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=24312014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslKisrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=G.+Burnstock&title=Introduction+and+perspective%2C+historical+note&doi=10.3389%2Ffncel.2013.00227"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction and perspective, historical note</span></div><div class="casAuthors">Burnstock, Geoffrey</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Cellular Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">Nov.</span>),
    <span class="NLM_cas:pages">227/1-227/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">FCNRAH</span>;
        ISSN:<span class="NLM_cas:issn">1662-5102</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">A review.  P2 nucleotide receptors were proposed to consist of two subfamilies based on pharmacol. in 1985, named P2X and P2Y receptors.  Later, this was confirmed following cloning of the receptors for nucleotides and studies of transduction mechanisms in the early 1990s.  P2X receptors are ion channels and seven subtypes are recognized that form trimeric homomultimers or heteromultimers.  P2X receptors are involved in neuromuscular and synaptic neurotransmission and neuromodulation.  They are also expressed on many types of non-neuronal cells to mediate smooth muscle contraction, secretion, and immune modulation.  The emphasis in this review will be on the pathophysiol. of P2X receptors and therapeutic potential of P2X receptor agonists and antagonists for neurodegenerative and inflammatory disorders, visceral and neuropathic pain, irritable bowel syndrome, diabetes, kidney failure, bladder incontinence and cancer, as well as disorders if the special senses, airways, skin, cardiovascular, and musculoskeletal systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlPN8XDxfm-rVg90H21EOLACvtfcHk0lgDPgqdh2xIYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslKisrjE&md5=c4c24c343dd28aaa673ff0dc50c9e7bc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3389%2Ffncel.2013.00227&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffncel.2013.00227%26sid%3Dliteratum%253Aachs%26aulast%3DBurnstock%26aufirst%3DG.%26atitle%3DIntroduction%2520and%2520perspective%252C%2520historical%2520note%26jtitle%3DFront.%2520Cell.%2520Neurosci.%26date%3D2013%26doi%3D10.3389%2Ffncel.2013.00227" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nori, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoepfer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnstock, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">North, R. A.</span></span> <span> </span><span class="NLM_article-title">Tissue distribution of P2X4 receptors studied with an ectodomain antibody</span>. <i>Cell Tissue Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">159</span>– <span class="NLM_lpage">165</span>, <span class="refDoi"> DOI: 10.1007/s00441-003-0758-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1007%2Fs00441-003-0758-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=12845522" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1ajurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2003&pages=159-165&author=X.+Boauthor=M.+Kimauthor=S.+L.+Noriauthor=R.+Schoepferauthor=G.+Burnstockauthor=R.+A.+North&title=Tissue+distribution+of+P2X4+receptors+studied+with+an+ectodomain+antibody&doi=10.1007%2Fs00441-003-0758-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Tissue distribution of P2X4 receptors studied with an ectodomain antibody</span></div><div class="casAuthors">Bo, Xuenong; Kim, Miran; Nori, Stefania L.; Schoepfer, Ralf; Burnstock, Geoffrey; North, R. Alan</div><div class="citationInfo"><span class="NLM_cas:title">Cell & Tissue Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">159-165</span>CODEN:
                <span class="NLM_cas:coden">CTSRCS</span>;
        ISSN:<span class="NLM_cas:issn">0302-766X</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A monoclonal antibody was developed to the extracellular domain of the rat P2X4 receptor.  The antibody was highly selective among all rat P2X receptor subunits, and recognized only the oligomeric, non-denatured form of the P2X4 receptor.  Immunohistochem. showed an extensive pattern of distribution throughout the central and peripheral nervous systems, the epithelia of ducted glands and airways, smooth muscle of bladder, gastrointestinal tract, uterus, and arteries, uterine endometrium and fat cells.  The protein was identified by Western blotting in membrane exts. of these tissues, and the ectodomain antibody immunopptd. a protein that was recognized with a P2X4 receptor C terminus antibody.  The findings indicate that the P2X4 receptor subunit has a very extensive distribution among mammalian tissues, and this suggests possible new functional roles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZDYPBDy6tkrVg90H21EOLACvtfcHk0lgDPgqdh2xIYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1ajurw%253D&md5=8d1bbec06f2079383860eb7ce477a084</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1007%2Fs00441-003-0758-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00441-003-0758-5%26sid%3Dliteratum%253Aachs%26aulast%3DBo%26aufirst%3DX.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DNori%26aufirst%3DS.%2BL.%26aulast%3DSchoepfer%26aufirst%3DR.%26aulast%3DBurnstock%26aufirst%3DG.%26aulast%3DNorth%26aufirst%3DR.%2BA.%26atitle%3DTissue%2520distribution%2520of%2520P2X4%2520receptors%2520studied%2520with%2520an%2520ectodomain%2520antibody%26jtitle%3DCell%2520Tissue%2520Res.%26date%3D2003%26volume%3D313%26spage%3D159%26epage%3D165%26doi%3D10.1007%2Fs00441-003-0758-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobsen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bengtsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlinge, D.</span></span> <span> </span><span class="NLM_article-title">P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells</span>. <i>BMC Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">16</span>, <span class="refDoi"> DOI: 10.1186/1471-2172-5-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1186%2F1471-2172-5-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=15291969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BD2cvgs1ShtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2004&pages=16&author=L.+Wangauthor=S.+E.+Jacobsenauthor=A.+Bengtssonauthor=D.+Erlinge&title=P2+receptor+mRNA+expression+profiles+in+human+lymphocytes%2C+monocytes+and+CD34%2B+stem+and+progenitor+cells&doi=10.1186%2F1471-2172-5-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells</span></div><div class="casAuthors">Wang Lingwei; Jacobsen Sten Eirik W; Bengtsson Anders; Erlinge David</div><div class="citationInfo"><span class="NLM_cas:title">BMC immunology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Extracellular nucleotides (ATP, ADP, UTP and UDP) exert a wide range of biological effects in blood cells mediated by multiple ionotropic P2X receptors and G protein-coupled P2Y receptors.  Although pharmacological experiments have suggested the presence of several P2 receptor subtypes on monocytes and lymphocytes, some results are contradictory.  Few physiological functions have been firmly established to a specific receptor subtype, partly because of a lack of truly selective agonists and antagonists.  This stimulated us to investigate the expression of P2X and P2Y receptors in human lymphocytes and monocytes with a newly established quantitative mRNA assay for P2 receptors.  In addition, we describe for the first time the expression of P2 receptors in CD34+ stem and progenitor cells implicating a potential role of P2 receptors in hematopoietic lineage and progenitor/stem cell function.  RESULTS:  Using a quantitative mRNA assay, we assessed the hypothesis that there are specific P2 receptor profiles in inflammatory cells.  The P2X4 receptor had the highest expression in lymphocytes and monocytes.  Among the P2Y receptors, P2Y12 and P2Y2 had highest expression in lymphocytes, while the P2Y2 and P2Y13 had highest expression in monocytes.  Several P2 receptors were expressed (P2Y2, P2Y1, P2Y12, P2Y13, P2Y11, P2X1, P2X4) in CD34+ stem and progenitor cells.  CONCLUSIONS:  The most interesting findings were the high mRNA expression of P2Y12 receptors in lymphocytes potentially explaining the anti-inflammatory effects of clopidogrel, P2Y13 receptors in monocytes and a previously unrecognised expression of P2X4 in lymphocytes and monocytes.  In addition, for the first time P2 receptor mRNA expression patterns was studied in CD34+ stem and progenitor cells.  Several P2 receptors were expressed (P2Y2, P2Y1, P2Y12, P2Y13, P2Y11, P2X1, P2X4), indicating a role in differentiation and proliferation.  Thus, it is possible that specific antibodies to P2 receptors could be used to identify progenitors for monocytes, lymphocytes and megakaryocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-XS29us3wqa-9TkgmBqTqfW6udTcc2eZPResXTFQBa7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2cvgs1ShtA%253D%253D&md5=ce8e74144c12d078458d8eb8430132e1</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1186%2F1471-2172-5-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2172-5-16%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DJacobsen%26aufirst%3DS.%2BE.%26aulast%3DBengtsson%26aufirst%3DA.%26aulast%3DErlinge%26aufirst%3DD.%26atitle%3DP2%2520receptor%2520mRNA%2520expression%2520profiles%2520in%2520human%2520lymphocytes%252C%2520monocytes%2520and%2520CD34%252B%2520stem%2520and%2520progenitor%2520cells%26jtitle%3DBMC%2520Immunol.%26date%3D2004%26volume%3D5%26spage%3D16%26doi%3D10.1186%2F1471-2172-5-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatcher, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaumont, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conquet, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buell, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reeve, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chessell, I. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rassendren, F.</span></span> <span> </span><span class="NLM_article-title">Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">11263</span>– <span class="NLM_lpage">11268</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2308-08.2008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1523%2FJNEUROSCI.2308-08.2008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=18971468" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlGltrfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2008&pages=11263-11268&author=L.+Ulmannauthor=J.+P.+Hatcherauthor=J.+P.+Hughesauthor=S.+Chaumontauthor=P.+J.+Greenauthor=F.+Conquetauthor=G.+N.+Buellauthor=A.+J.+Reeveauthor=I.+P.+Chessellauthor=F.+Rassendren&title=Up-regulation+of+P2X4+receptors+in+spinal+microglia+after+peripheral+nerve+injury+mediates+BDNF+release+and+neuropathic+pain&doi=10.1523%2FJNEUROSCI.2308-08.2008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of P2X4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain</span></div><div class="casAuthors">Ulmann, Lauriane; Hatcher, Jon P.; Hughes, Jane P.; Chaumont, Severine; Green, Paula J.; Conquet, Francois; Buell, Gary N.; Reeve, Alison J.; Chessell, Iain P.; Rassendren, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">11263-11268</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">ATP is a known mediator of inflammatory and neuropathic pain.  However, the mechanisms by which specific purinergic receptors contribute to chronic pain states are still poorly characterized.  Here, we demonstrate that in response to peripheral nerve injury, P2X4 receptors (P2X4R) are expressed de novo by activated microglia in the spinal cord.  Using in vitro and in vivo models, we provide direct evidence that P2X4R stimulation leads to the release of BDNF from activated microglia and, most likely phosphorylation of the NR1 subunit of NMDA receptors in dorsal horn neurons of the spinal cord.  Consistent with these findings, P2X4-deficient mice lack mech. hyperalgesia induced by peripheral nerve injury and display impaired BDNF signaling in the spinal cord.  Furthermore, ATP stimulation is unable to stimulate BDNF release from P2X4-deficient mice microglia in primary cultures.  These results indicate that P2X4R contribute to chronic pain through a central inflammatory pathway.  P2X4R might thus represent a potential therapeutic target to limit microglia-mediated inflammatory responses assocd. with brain injury and neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeL5JMDsIicbVg90H21EOLACvtfcHk0liYue31rBh3SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlGltrfL&md5=7446b0242bc30ef950d77c57f873c7c7</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2308-08.2008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2308-08.2008%26sid%3Dliteratum%253Aachs%26aulast%3DUlmann%26aufirst%3DL.%26aulast%3DHatcher%26aufirst%3DJ.%2BP.%26aulast%3DHughes%26aufirst%3DJ.%2BP.%26aulast%3DChaumont%26aufirst%3DS.%26aulast%3DGreen%26aufirst%3DP.%2BJ.%26aulast%3DConquet%26aufirst%3DF.%26aulast%3DBuell%26aufirst%3DG.%2BN.%26aulast%3DReeve%26aufirst%3DA.%2BJ.%26aulast%3DChessell%26aufirst%3DI.%2BP.%26aulast%3DRassendren%26aufirst%3DF.%26atitle%3DUp-regulation%2520of%2520P2X4%2520receptors%2520in%2520spinal%2520microglia%2520after%2520peripheral%2520nerve%2520injury%2520mediates%2520BDNF%2520release%2520and%2520neuropathic%2520pain%26jtitle%3DJ.%2520Neurosci.%26date%3D2008%26volume%3D28%26spage%3D11263%26epage%3D11268%26doi%3D10.1523%2FJNEUROSCI.2308-08.2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Suurväli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boudinot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanellopoulos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rüütel Boudinot, S.</span></span> <span> </span><span class="NLM_article-title">P2X4: A fast and sensitive purinergic receptor</span>. <i>Biomed J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1016/j.bj.2017.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.bj.2017.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=29179879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC1M3lsVWktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2017&pages=245-256&author=J.+Suurv%C3%A4liauthor=P.+Boudinotauthor=J.+Kanellopoulosauthor=S.+R%C3%BC%C3%BCtel+Boudinot&title=P2X4%3A+A+fast+and+sensitive+purinergic+receptor&doi=10.1016%2Fj.bj.2017.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">P2X4: A fast and sensitive purinergic receptor</span></div><div class="casAuthors">Suurvali Jaanus; Boudinot Pierre; Kanellopoulos Jean; Ruutel Boudinot Sirje</div><div class="citationInfo"><span class="NLM_cas:title">Biomedical journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">245-256</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Extracellular nucleotides have been recognized as important mediators of activation, triggering multiple responses via plasma membrane receptors known as P2 receptors.  P2 receptors comprise P2X ionotropic receptors and G protein-coupled P2Y receptors.  P2X receptors are expressed in many tissues, where they are involved in a number of functions including synaptic transmission, muscle contraction, platelet aggregation, inflammation, macrophage activation, differentiation and proliferation, neuropathic and inflammatory pain.  P2X4 is one of the most sensitive purinergic receptors (at nanomolar ATP concentrations), about one thousand times more than the archetypal P2X7.  P2X4 is widely expressed in central and peripheral neurons, in microglia, and also found in various epithelial tissues and endothelial cells.  It localizes on the plasma membrane, but also in intracellular compartments.  P2X4 is preferentially localized in lysosomes, where it is protected from proteolysis by its glycosylation.  High ATP concentration in the lysosomes does not activate P2X4 at low pH; P2X4 gets activated by intra-lysosomal ATP only in its fully dissociated tetra-anionic form, when the pH increases to 7.4.  Thus, P2X4 is functioning as a Ca(2+)-channel after the fusion of late endosomes and lysosomes.  P2X4 modulates major neurotransmitter systems and regulates alcohol-induced responses in microglia.  P2X4 is one of the key receptors mediating neuropathic pain.  However, injury-induced upregulation of P2X4 expression is gender dependent and plays a key role in pain difference between males and females.  P2X4 is also involved in inflammation.  Extracellular ATP being a pro-inflammatory molecule, P2X4 can trigger inflammation in response to high ATP release.  It is therefore involved in multiple pathologies, like post-ischemic inflammation, rheumatoid arthritis, airways inflammation in asthma, neurodegenerative diseases and even metabolic syndrome.  Although P2X4 remains poorly characterized, more studies are needed as it is likely to be a potential therapeutic target in these multiple pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRLP8XyTkQo3GK_SFaaT9INfW6udTcc2eZm_I1rHL_-uLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3lsVWktw%253D%253D&md5=0fab046d18ddeed93b1c8b90aa060f38</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.bj.2017.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bj.2017.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DSuurv%25C3%25A4li%26aufirst%3DJ.%26aulast%3DBoudinot%26aufirst%3DP.%26aulast%3DKanellopoulos%26aufirst%3DJ.%26aulast%3DR%25C3%25BC%25C3%25BCtel%2BBoudinot%26aufirst%3DS.%26atitle%3DP2X4%253A%2520A%2520fast%2520and%2520sensitive%2520purinergic%2520receptor%26jtitle%3DBiomed%2520J.%26date%3D2017%26volume%3D40%26spage%3D245%26epage%3D256%26doi%3D10.1016%2Fj.bj.2017.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namaka, M.</span></span> <span> </span><span class="NLM_article-title">Toll-like receptor-4/p38 MAPK signaling in the dorsal horn contributes to P2X4 receptor activation and BDNF over-secretion in cancer induced bone pain</span>. <i>Neurosci. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">37</span>– <span class="NLM_lpage">45</span>, <span class="refDoi"> DOI: 10.1016/j.neures.2017.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.neures.2017.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=28668500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1CmsLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=37-45&author=X.+W.+Mengauthor=J.+L.+Gaoauthor=J.+L.+Zuoauthor=L.+N.+Wangauthor=S.+L.+Liuauthor=X.+H.+Jinauthor=M.+Yaoauthor=M.+Namaka&title=Toll-like+receptor-4%2Fp38+MAPK+signaling+in+the+dorsal+horn+contributes+to+P2X4+receptor+activation+and+BDNF+over-secretion+in+cancer+induced+bone+pain&doi=10.1016%2Fj.neures.2017.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Toll-like receptor-4/p38 MAPK signaling in the dorsal horn contributes to P2X4 receptor activation and BDNF over-secretion in cancer induced bone pain</span></div><div class="casAuthors">Meng, Xiao-wen; Gao, Jian-ling; Zuo, Jian-Ling; Wang, Li-Na; Liu, Si-lan; Jin, Xiao-Hong; Yao, Ming; Namaka, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Research (Shannon, Ireland)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">37-45</span>CODEN:
                <span class="NLM_cas:coden">NERADN</span>;
        ISSN:<span class="NLM_cas:issn">0168-0102</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Our previous research suggested that the P2X4 receptor (P2X4R) expression in microglia was involved in the activation of toll-like receptor-4 (TLR4) in the dorsal horn in the rat model of cancer induced bone pain (CIBP).  In this study, we focused on whether TLR4- mitogen-activated protein kinases, p38 (p38 MAPK) contributes to P2X4R activation and brain-derived neurotrophic factor (BDNF) over-secretion in CIBP.  In in vitro expt., the results showed that BDNF expression evoked by ATP stimulation was dependent on TLR4-p38.  In in vivo expt., the results demonstrated that an intrathecal injection of TLR4 siRNA alleviated nociception induced by lipopolysaccharide (LPS) plus ATP or CIBP with decreased expression of P2X4R, TLR4, BDNF, interleukin-6 (IL-6) and phosphorylated-p38 MAPK (p-p38 MAPK).  Moreover, injection with p38MAPK inhibitor SB203580 resulted in an identical pattern compared with treatment with TLR4 siRNA.  Our results demonstrate that the activation of TLR4-p38MAPK-P2X4R signaling in microglial possibility plays an important role in the process of nociceptive transmission in CIBP, suggesting new mechanism and potential therapeutic targets for CIBP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE4hiRJHm2H7Vg90H21EOLACvtfcHk0liHrLyhVwTPSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1CmsLbF&md5=8affb046a15324a315222a92637c6d36</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.neures.2017.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neures.2017.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DX.%2BW.%26aulast%3DGao%26aufirst%3DJ.%2BL.%26aulast%3DZuo%26aufirst%3DJ.%2BL.%26aulast%3DWang%26aufirst%3DL.%2BN.%26aulast%3DLiu%26aufirst%3DS.%2BL.%26aulast%3DJin%26aufirst%3DX.%2BH.%26aulast%3DYao%26aufirst%3DM.%26aulast%3DNamaka%26aufirst%3DM.%26atitle%3DToll-like%2520receptor-4%252Fp38%2520MAPK%2520signaling%2520in%2520the%2520dorsal%2520horn%2520contributes%2520to%2520P2X4%2520receptor%2520activation%2520and%2520BDNF%2520over-secretion%2520in%2520cancer%2520induced%2520bone%2520pain%26jtitle%3DNeurosci.%2520Res.%26date%3D2017%26volume%3D125%26spage%3D37%26epage%3D45%26doi%3D10.1016%2Fj.neures.2017.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, M. W.</span></span> <span> </span><span class="NLM_article-title">P2X4 purinoceptor signaling in chronic pain</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">621</span>– <span class="NLM_lpage">628</span>, <span class="refDoi"> DOI: 10.1007/s11302-012-9306-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1007%2Fs11302-012-9306-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=22528681" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC38XnsVCmt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=621-628&author=T.+Trangauthor=M.+W.+Salter&title=P2X4+purinoceptor+signaling+in+chronic+pain&doi=10.1007%2Fs11302-012-9306-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">P2X4 purinoceptor signaling in chronic pain</span></div><div class="casAuthors">Trang, Tuan; Salter, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">621-628</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  ATP, acting via P2 purinergic receptors, is a known mediator of inflammatory and neuropathic pain.  There is increasing evidence that the ATP-gated P2X4 receptor (P2X4R) subtype is a locus through which activity of spinal microglia and peripheral macrophages instigate pain hypersensitivity caused by inflammation or by injury to a peripheral nerve.  The present article highlights the recent advances in our understanding of microglia-neuron interactions in neuropathic pain by focusing on the signaling and regulation of the P2X4R.  We will also develop a framework for understanding converging lines of evidence for involvement of P2X4Rs expressed on macrophages in peripheral inflammatory pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp25UzCgKxYk7Vg90H21EOLACvtfcHk0liHrLyhVwTPSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnsVCmt7g%253D&md5=e951d7ec39460a4b09a7834ffab5b2c5</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1007%2Fs11302-012-9306-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-012-9306-7%26sid%3Dliteratum%253Aachs%26aulast%3DTrang%26aufirst%3DT.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26atitle%3DP2X4%2520purinoceptor%2520signaling%2520in%2520chronic%2520pain%26jtitle%3DPurinergic%2520Signalling%26date%3D2012%26volume%3D8%26spage%3D621%26epage%3D628%26doi%3D10.1007%2Fs11302-012-9306-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuboyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozaki-Saitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span> <span> </span><span class="NLM_article-title">Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1744</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-5-28</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1186%2F1744-8069-5-28" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=1744&author=M.+Tsudaauthor=K.+Kuboyamaauthor=T.+Inoueauthor=K.+Nagataauthor=H.+Tozaki-Saitohauthor=K.+Inoue&title=Behavioral+phenotypes+of+mice+lacking+purinergic+P2X4+receptors+in+acute+and+chronic+pain+assays&doi=10.1186%2F1744-8069-5-28"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-5-28&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-5-28%26sid%3Dliteratum%253Aachs%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DKuboyama%26aufirst%3DK.%26aulast%3DInoue%26aufirst%3DT.%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DTozaki-Saitoh%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DK.%26atitle%3DBehavioral%2520phenotypes%2520of%2520mice%2520lacking%2520purinergic%2520P2X4%2520receptors%2520in%2520acute%2520and%2520chronic%2520pain%2520assays%26jtitle%3DMol.%2520Pain%26date%3D2009%26volume%3D5%26spage%3D1744%26doi%3D10.1186%2F1744-8069-5-28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, M.</span></span> <span> </span><span class="NLM_article-title">Microglia in the spinal cord and neuropathic pain</span>. <i>J. Diabetes Invest.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">17</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1111/jdi.12379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1111%2Fjdi.12379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26813032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28XjvFGgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=17-26&author=M.+Tsuda&title=Microglia+in+the+spinal+cord+and+neuropathic+pain&doi=10.1111%2Fjdi.12379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Microglia in the spinal cord and neuropathic pain</span></div><div class="casAuthors">Tsuda, Makoto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Diabetes Investigation</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">17-26</span>CODEN:
                <span class="NLM_cas:coden">JDIOAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-1124</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">In contrast to physiol. pain, pathol. pain is not dependent on the presence of tissue-damaging stimuli.  One type of pathol. pain - neuropathic pain - is often a consequence of nerve injury or of diseases such as diabetes.  Neuropathic pain can be agonizing, can persist over long periods and is often resistant to known painkillers.  A growing body of evidence shows that many pathol. processes within the central nervous system are mediated by complex interactions between neurons and glial cells.  In the case of painful peripheral neuropathy, spinal microglia react and undergo a series of changes that directly influence the establishment of neuropathic pain states.  After nerve damage, purinergic P2X4 receptors (non-selective cation channels activated by extracellular ATP) are upregulated in spinal microglia in a manner that depends on the transcription factors interferon regulatory factor 8 and 5, both of which are expressed in microglia after peripheral nerve injury.  P2X4 receptor expression on the cell surface of microglia is also regulated at the post-translational level by signaling from CC chemokine receptor chemotactic cytokine receptor 2.  Furthermore, spinal microglia in response to extracellular stimuli results in signal transduction through intracellular signaling cascades, such as mitogen-activated protein kinases, p38 and extracellular signal-regulated protein kinase.  Importantly, inhibiting the function or expression of these microglial mols. suppresses the aberrant excitability of dorsal horn neurons and neuropathic pain.  These findings show that spinal microglia are a central player in mechanisms for neuropathic pain, and might be a potential target for treating the chronic pain state.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyRrA1amipMrVg90H21EOLACvtfcHk0liDZPK1EHuGew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjvFGgsw%253D%253D&md5=f16454ad118dcf2350115a4c1877dc17</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1111%2Fjdi.12379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjdi.12379%26sid%3Dliteratum%253Aachs%26aulast%3DTsuda%26aufirst%3DM.%26atitle%3DMicroglia%2520in%2520the%2520spinal%2520cord%2520and%2520neuropathic%2520pain%26jtitle%3DJ.%2520Diabetes%2520Invest.%26date%3D2016%26volume%3D7%26spage%3D17%26epage%3D26%26doi%3D10.1111%2Fjdi.12379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Layhadi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibic, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhuna, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fountain, S. J.</span></span> <span> </span><span class="NLM_article-title">P2X4 receptor function in the nervous system and current breakthroughs in pharmacology</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">291</span>, <span class="refDoi"> DOI: 10.3389/fphar.2017.00291</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.3389%2Ffphar.2017.00291" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=28588493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvFentbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=291&author=L.+Stokesauthor=J.+A.+Layhadiauthor=L.+Bibicauthor=K.+Dhunaauthor=S.+J.+Fountain&title=P2X4+receptor+function+in+the+nervous+system+and+current+breakthroughs+in+pharmacology&doi=10.3389%2Ffphar.2017.00291"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">P2X4 receptor function in the nervous system and current breakthroughs in pharmacology</span></div><div class="casAuthors">Stokes, Leanne; Layhadi, Janice A.; Bibic, Lucka; Dhuna, Kshitija; Fountain, Samuel J.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291/1-291/15</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Adenosine 50-triphosphate is a well-known extracellular signaling mol. and neurotransmitter known to activate purinergic P2X receptors.  Information has been elucidated about the structure and gating of P2X channels following the detn. of the crystal structure of P2X4 (zebrafish), however, there is still much to discover regarding the role of this receptor in the central nervous system (CNS).  In this review we provide an overview of what is known about P2X4 expression in the CNS and discuss evidence for pathophysiol. roles in neuroinflammation and neuropathic pain.  Recent advances in the development of pharmacol. tools including selective antagonists (5-BDBD, PSB-12062, BX430) and pos. modulators (ivermectin, avermectins, divalent cations) of P2X4 will be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo-UCoTfoDkLVg90H21EOLACvtfcHk0liDZPK1EHuGew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvFentbzI&md5=c1b3ee43fe3de52d966ad345c078bf74</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2017.00291&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2017.00291%26sid%3Dliteratum%253Aachs%26aulast%3DStokes%26aufirst%3DL.%26aulast%3DLayhadi%26aufirst%3DJ.%2BA.%26aulast%3DBibic%26aufirst%3DL.%26aulast%3DDhuna%26aufirst%3DK.%26aulast%3DFountain%26aufirst%3DS.%2BJ.%26atitle%3DP2X4%2520receptor%2520function%2520in%2520the%2520nervous%2520system%2520and%2520current%2520breakthroughs%2520in%2520pharmacology%26jtitle%3DFront.%2520Pharmacol.%26date%3D2017%26volume%3D8%26spage%3D291%26doi%3D10.3389%2Ffphar.2017.00291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beggs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, M. W.</span></span> <span> </span><span class="NLM_article-title">P2X4R+ microglia drive neuropathic pain</span>. <i>Nat. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1068</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1038/nn.3155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1038%2Fnn.3155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=22837036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2itLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2012&pages=1068-1073&author=S.+Beggsauthor=T.+Trangauthor=M.+W.+Salter&title=P2X4R%2B+microglia+drive+neuropathic+pain&doi=10.1038%2Fnn.3155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">P2X4R+ microglia drive neuropathic pain</span></div><div class="casAuthors">Beggs, Simon; Trang, Tuan; Salter, Michael W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1068-1073</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Neuropathic pain, the most debilitating of all clin. pain syndromes, may be a consequence of trauma, infection or pathol. from diseases that affect peripheral nerves.  Here we provide a framework for understanding the spinal mechanisms of neuropathic pain as distinct from those of acute pain or inflammatory pain.  Recent work suggests that a specific microglia response phenotype characterized by de novo expression of the purinergic receptor P2X4 is crit. for the pathogenesis of pain hypersensitivity caused by injury to peripheral nerves.  Stimulating P2X4 receptors initiates a core pain signaling pathway mediated by release of brain-derived neurotrophic factor, which produces a disinhibitory increase in intracellular chloride in nociceptive (pain-transmitting) neurons in the spinal dorsal horn.  The changes caused by signaling from P2X4R+ microglia to nociceptive transmission neurons may account for the main symptoms of neuropathic pain in humans, and they point to specific interventions to alleviate this debilitating condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGomFRlAEtpyXrVg90H21EOLACvtfcHk0liDZPK1EHuGew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2itLfP&md5=6f25fbac78f20f4932556ff77abfa66b</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fnn.3155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn.3155%26sid%3Dliteratum%253Aachs%26aulast%3DBeggs%26aufirst%3DS.%26aulast%3DTrang%26aufirst%3DT.%26aulast%3DSalter%26aufirst%3DM.%2BW.%26atitle%3DP2X4R%252B%2520microglia%2520drive%2520neuropathic%2520pain%26jtitle%3DNat.%2520Neurosci.%26date%3D2012%26volume%3D15%26spage%3D1068%26epage%3D1073%26doi%3D10.1038%2Fnn.3155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di
Virgilio, F.</span></span> <span> </span><span class="NLM_article-title">P2X receptors and inflammation</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">866</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.2174/0929867322666141210155311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.2174%2F0929867322666141210155311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25524252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislensbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=866-877&author=F.+Di%0AVirgilio&title=P2X+receptors+and+inflammation&doi=10.2174%2F0929867322666141210155311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">P2X Receptors and Inflammation</span></div><div class="casAuthors">Di Virgilio, Francesco</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">866-877</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Until recently, P2X receptors have not received much attention in the context of immunol. and inflammation.  While this is justified to a certain extent for P2X1, P2X2, P2X3, P2X5 and P2X6, which still await identification of a convincing role in the pathophysiol. of immune cells, it is clearly not any more the case for P2X4 and even more so for P2X7, a mol. that has achieved the status of an essential, nonredundant, immunomodulatory receptor.  In this review I will highlight the most important inflammatory responses participated by P2X receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrRmCnHNH0obVg90H21EOLACvtfcHk0liwfe1plUZUdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislensbk%253D&md5=ac21cea24dca2b31d45a86648f81937b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F0929867322666141210155311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666141210155311%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BVirgilio%26aufirst%3DF.%26atitle%3DP2X%2520receptors%2520and%2520inflammation%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D866%26epage%3D877%26doi%3D10.2174%2F0929867322666141210155311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zech, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayata, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlaich, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dürk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoßfeld, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cicko, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idzko, M.</span></span> <span> </span><span class="NLM_article-title">P2RX4 deficiency in mice alleviates allergen-induced airway inflammation</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">80288</span>– <span class="NLM_lpage">80297</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.13375</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.18632%2Foncotarget.13375" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=27863396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC2snotVakuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=80288-80297&author=A.+Zechauthor=B.+Wieslerauthor=C.+K.+Ayataauthor=T.+Schlaichauthor=T.+D%C3%BCrkauthor=M.+Ho%C3%9Ffeldauthor=N.+Ehratauthor=S.+Cickoauthor=M.+Idzko&title=P2RX4+deficiency+in+mice+alleviates+allergen-induced+airway+inflammation&doi=10.18632%2Foncotarget.13375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">P2rx4 deficiency in mice alleviates allergen-induced airway inflammation</span></div><div class="casAuthors">Zech Andreas; Wiesler Benjamin; Ayata Cemil Korcan; Schlaich Tilmann; Durk Thorsten; Hossfeld Madelon; Ehrat Nicolas; Cicko Sanja; Idzko Marco</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">80288-80297</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Compelling evidences point out a crucial role for extracellular nucleotides such as adenosine triphosphate (ATP) during inflammatory conditions.  Once released into the extracellular space, ATP modulates migration, maturation and function of various inflammatory cells via activating of purinergic receptors of the P2Y- and P2X- family.  P2RX4 is an ATP-guided ion channel expressed on structural cells such as alveolar epithelial and smooth muscle cells as well as inflammatory cells including macrophages, dendritic cells (DCs) and T cells.  P2RX4 has been shown to interact with P2RX7 and promote NLRP3 inflammasome activation.  Although P2RX7 has already been implicated in allergic asthma, the role of P2RX4 in airway inflammation has not been elucidated yet.  Therefore, we used a selective pharmacological antagonist and genetic ablation to investigate the role of P2RX4 in an ovalbumin (OVA) driven model of allergen-induced airway inflammation (AAI).  Both, P2RX4 antagonist 5-BDBD treatment and P2rx4 deficiency resulted in an alleviated broncho alveolar lavage fluid eosinophilia, peribronchial inflammation, Th2 cytokine production and bronchial hyperresponsiveness.  Furthermore, P2rx4-deficient bone marrow derived DCs (BMDCs) showed a reduced IL-1ss production in response to ATP accompanied by a decreased P2rx7 expression and attenuated Th2 priming capacity compared to wild type (WT) BMDCs in vitro.  Moreover, mice adoptively transferred with P2rx4-deficient BMDCs exhibit a diminished AAI in vivo.  In conclusion our data suggests that P2RX4-signaling contributes to AAI pathogenesis by regulating DC mediated Th2 cell priming via modulating IL-1ss secretion and selective P2RX4-antagonists might be a new therapeutic option for allergic asthma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9a1Ej-CIqi9NTrvPZP1IpfW6udTcc2eZqxE-kN8cgdLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2snotVakuw%253D%253D&md5=a21500fd3364250eade3b9161385fe98</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.13375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.13375%26sid%3Dliteratum%253Aachs%26aulast%3DZech%26aufirst%3DA.%26aulast%3DWiesler%26aufirst%3DB.%26aulast%3DAyata%26aufirst%3DC.%2BK.%26aulast%3DSchlaich%26aufirst%3DT.%26aulast%3DD%25C3%25BCrk%26aufirst%3DT.%26aulast%3DHo%25C3%259Ffeld%26aufirst%3DM.%26aulast%3DEhrat%26aufirst%3DN.%26aulast%3DCicko%26aufirst%3DS.%26aulast%3DIdzko%26aufirst%3DM.%26atitle%3DP2RX4%2520deficiency%2520in%2520mice%2520alleviates%2520allergen-induced%2520airway%2520inflammation%26jtitle%3DOncotarget%26date%3D2016%26volume%3D7%26spage%3D80288%26epage%3D80297%26doi%3D10.18632%2Foncotarget.13375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, X.</span></span> <span> </span><span class="NLM_article-title">Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice</span>. <i>Mol. Med. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">697</span>– <span class="NLM_lpage">704</span>, <span class="refDoi"> DOI: 10.3892/mmr.2015.4622</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.3892%2Fmmr.2015.4622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26648454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28XmsVyjsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2016&pages=697-704&author=H.+Chenauthor=Q.+Xiaauthor=X.+Fengauthor=F.+Caoauthor=H.+Yuauthor=Y.+Songauthor=X.+Ni&title=Effect+of+P2X4R+on+airway+inflammation+and+airway+remodeling+in+allergic+airway+challenge+in+mice&doi=10.3892%2Fmmr.2015.4622"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of P2X4R on airway inflammation and airway remodeling in allergic airway challenge in mice</span></div><div class="casAuthors">Chen, Hongxia; Xia, Qingqing; Feng, Xiaoqian; Cao, Fangyuan; Yu, Hang; Song, Yinli; Ni, Xiuqin</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Medicine Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">1, Pt. B</span>),
    <span class="NLM_cas:pages">697-704</span>CODEN:
                <span class="NLM_cas:coden">MMROA5</span>;
        ISSN:<span class="NLM_cas:issn">1791-2997</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">P2X4 receptor (P2X4R) is the most widely expressed subtype of the P2XRs in the purinergic receptor family.  ATP (ATP), a ligand for this receptor, has been implicated in the pathogenesis of asthma.  ATP-P2X4R signaling is involved in pulmonary vascular remodeling, and in the proliferation and differentiation of airway and alveolar epithelial cell lines.  However, the role of P2X4R in asthma remains to be elucidated.  This aim of the present study was to investigate the effects of P2X4R in a murine exptl. asthma model.  The asthmatic model was established by the inhalation of ovalbumin (OVA) in BALB/c mice.  The mice were treated with P2X4R-specific agonists and antagonists to investigate the role of this receptor in vivo.  Pathol. changes in the bronchi and lung tissues were examd. using hematoxylin and eosin staining, Masson's trichrome staining and Alcian blue staining.  The inflammatory cells in the bronchoalveolar lavage fluid were counted, and the expression levels of P2X4R, α-smooth muscle actin (α-SMA) and proliferating cell nuclear antigen (PCNA) were detected using western blotting.  In the OVA-challenged mice, inflammation, infiltration, collagen deposition, mucus prodn., and the expression levels of P2X4R and PCNA were all increased; however, the expression of α-SMA was decreased, compared with the mice in the control group.  Whereas treatment with the P2X4R agonist, ATP, enhanced the allergic reaction, treatment with the P2X4R antagonist, 5-BDBD, attenuated the allergic reaction.  The results suggested that ATP-P2X4R signaling may not only contribute to airway inflammation, but it may also contribute to airway remodeling in allergic asthma in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqeh4hfRqnMsbVg90H21EOLACvtfcHk0liwfe1plUZUdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmsVyjsLg%253D&md5=2c5689ddd5c0617a09440271e9d011cd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3892%2Fmmr.2015.4622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fmmr.2015.4622%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DXia%26aufirst%3DQ.%26aulast%3DFeng%26aufirst%3DX.%26aulast%3DCao%26aufirst%3DF.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DNi%26aufirst%3DX.%26atitle%3DEffect%2520of%2520P2X4R%2520on%2520airway%2520inflammation%2520and%2520airway%2520remodeling%2520in%2520allergic%2520airway%2520challenge%2520in%2520mice%26jtitle%3DMol.%2520Med.%2520Rep.%26date%3D2016%26volume%3D13%26spage%3D697%26epage%3D704%26doi%3D10.3892%2Fmmr.2015.4622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ralevic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunn, W. R.</span></span> <span> </span><span class="NLM_article-title">Purinergic transmission in blood vessels</span>. <i>Auton. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>191</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">66</span>, <span class="refDoi"> DOI: 10.1016/j.autneu.2015.04.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.autneu.2015.04.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26004513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOhu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=191&publication_year=2015&pages=48-66&author=V.+Ralevicauthor=W.+R.+Dunn&title=Purinergic+transmission+in+blood+vessels&doi=10.1016%2Fj.autneu.2015.04.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Purinergic transmission in blood vessels</span></div><div class="casAuthors">Ralevic, Vera; Dunn, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Autonomic Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">191</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">48-66</span>CODEN:
                <span class="NLM_cas:coden">ANUEB2</span>;
        ISSN:<span class="NLM_cas:issn">1566-0702</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  There are nineteen different receptor proteins for adenosine, adenine and uridine nucleotides, and nucleotide sugars, belonging to three families of G protein-coupled adenosine and P2Y receptors, and ionotropic P2X receptors.  The majority are functionally expressed in blood vessels, as purinergic receptors in perivascular nerves, smooth muscle and endothelial cells, and roles in regulation of vascular contractility, immune function and growth have been identified.  The endogenous ligands for purine receptors, ATP, ADP, UTP, UDP and adenosine, can be released from different cell types within the vasculature, as well as from circulating blood cells, including erythrocytes and platelets.  Many purine receptors can be activated by two or more of the endogenous ligands.  Further complexity arises because of interconversion between ligands, notably adenosine formation from the metab. of ATP, leading to complex integrated responses through activation of different subtypes of purine receptors.  The enzymes responsible for this conversion, ectonucleotidases, are present on the surface of smooth muscle and endothelial cells, and may be coreleased with neurotransmitters from nerves.  What selectivity there is for the actions of purines/pyrimidines comes from differential expression of their receptors within the vasculature.  P2X1 receptors mediate the vasocontractile actions of ATP released as a neurotransmitter with noradrenaline (NA) from sympathetic perivascular nerves, and are located on the vascular smooth muscle adjacent to the nerve varicosities, the sites of neurotransmitter release.  The relative contribution of ATP and NA as functional cotransmitters varies with species, type and size of blood vessel, neuronal firing pattern, the tone/pressure of the blood vessel, and in aging and disease.  ATP is also a neurotransmitter in non-adrenergic non-cholinergic perivascular nerves and mediates vasorelaxation via smooth muscle P2Y-like receptors.  ATP and adenosine can act as neuromodulators, with the most robust evidence being for prejunctional inhibition of neurotransmission via A1 adenosine receptors, but also prejunctional excitation and inhibition of neurotransmission via P2X and P2Y receptors, resp.  P2Y2, P2Y4 and P2Y6 receptors expressed on the vascular smooth muscle are coupled to vasocontraction, and may have a role in pathophysiol. conditions, when purines are released from damaged cells, or when there is damage to the protective barrier that is the endothelium.  Adenosine is released during hypoxia to increase blood flow via vasodilator A2A and A2B receptors expressed on the endothelium and smooth muscle.  ATP is released from endothelial cells during hypoxia and shear stress and can act at P2Y and P2X4 receptors expressed on the endothelium to increase local blood flow.  Activation of endothelial purine receptors leads to the release of nitric oxide, hyperpolarizing factors and prostacyclin, which inhibits platelet aggregation and thus ensures patent blood flow.  Vascular purine receptors also regulate endothelial and smooth muscle growth, and inflammation, and thus are involved in the underlying processes of a no. of cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbeULIrF09MrVg90H21EOLACvtfcHk0lg3agqi_QAotQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOhu7k%253D&md5=4093d360d3282fed51863bfe01de02ee</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.autneu.2015.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.autneu.2015.04.007%26sid%3Dliteratum%253Aachs%26aulast%3DRalevic%26aufirst%3DV.%26aulast%3DDunn%26aufirst%3DW.%2BR.%26atitle%3DPurinergic%2520transmission%2520in%2520blood%2520vessels%26jtitle%3DAuton.%2520Neurosci.%26date%3D2015%26volume%3D191%26spage%3D48%26epage%3D66%26doi%3D10.1016%2Fj.autneu.2015.04.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ledderose, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slubowski, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dertnig, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denicoló, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arbab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konrad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fakhari, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lederer, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visner, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junger, W. G.</span></span> <span> </span><span class="NLM_article-title">Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">3583</span>– <span class="NLM_lpage">3594</span>, <span class="refDoi"> DOI: 10.1172/JCI120972</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1172%2FJCI120972" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=29894310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC1MbmsFSmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=3583-3594&author=C.+Ledderoseauthor=K.+Liuauthor=Y.+Kondoauthor=C.+J.+Slubowskiauthor=T.+Dertnigauthor=S.+Denicol%C3%B3author=M.+Arbabauthor=J.+Hubnerauthor=K.+Konradauthor=M.+Fakhariauthor=J.+A.+Ledererauthor=S.+C.+Robsonauthor=G.+A.+Visnerauthor=W.+G.+Junger&title=Purinergic+P2X4+receptors+and+mitochondrial+ATP+production+regulate+T+cell+migration&doi=10.1172%2FJCI120972"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration</span></div><div class="casAuthors">Ledderose Carola; Kondo Yutaka; Slubowski Christian J; Dertnig Thomas; Denicolo Sara; Arbab Mona; Hubner Johannes; Konrad Kirstin; Fakhari Mahtab; Junger Wolfgang G; Liu Kaifeng; Visner Gary A; Lederer James A; Robson Simon C; Junger Wolfgang G</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3583-3594</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">T cells must migrate in order to encounter antigen-presenting cells (APCs) and to execute their varied functions in immune defense and inflammation.  ATP release and autocrine signaling through purinergic receptors contribute to T cell activation at the immune synapse that T cells form with APCs.  Here, we show that T cells also require ATP release and purinergic signaling for their migration to APCs.  We found that the chemokine stromal-derived factor-1α (SDF-1α) triggered mitochondrial ATP production, rapid bursts of ATP release, and increased migration of primary human CD4+ T cells.  This process depended on pannexin-1 ATP release channels and autocrine stimulation of P2X4 receptors.  SDF-1α stimulation caused localized accumulation of mitochondria with P2X4 receptors near the front of cells, resulting in a feed-forward signaling mechanism that promotes cellular Ca2+ influx and sustains mitochondrial ATP synthesis at levels needed for pseudopod protrusion, T cell polarization, and cell migration.  Inhibition of P2X4 receptors blocked the activation and migration of T cells in vitro.  In a mouse lung transplant model, P2X4 receptor antagonist treatment prevented the recruitment of T cells into allograft tissue and the rejection of lung transplants.  Our findings suggest that P2X4 receptors are therapeutic targets for immunomodulation in transplantation and inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ4HkcvkZTMrNts4TFFB11gfW6udTcc2eYWd4248RsMWLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MbmsFSmug%253D%253D&md5=de5d429950992944510b704e353bd52c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1172%2FJCI120972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI120972%26sid%3Dliteratum%253Aachs%26aulast%3DLedderose%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DK.%26aulast%3DKondo%26aufirst%3DY.%26aulast%3DSlubowski%26aufirst%3DC.%2BJ.%26aulast%3DDertnig%26aufirst%3DT.%26aulast%3DDenicol%25C3%25B3%26aufirst%3DS.%26aulast%3DArbab%26aufirst%3DM.%26aulast%3DHubner%26aufirst%3DJ.%26aulast%3DKonrad%26aufirst%3DK.%26aulast%3DFakhari%26aufirst%3DM.%26aulast%3DLederer%26aufirst%3DJ.%2BA.%26aulast%3DRobson%26aufirst%3DS.%2BC.%26aulast%3DVisner%26aufirst%3DG.%2BA.%26aulast%3DJunger%26aufirst%3DW.%2BG.%26atitle%3DPurinergic%2520P2X4%2520receptors%2520and%2520mitochondrial%2520ATP%2520production%2520regulate%2520T%2520cell%2520migration%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26spage%3D3583%26epage%3D3594%26doi%3D10.1172%2FJCI120972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ralevic, V.</span></span> <span> </span><span class="NLM_article-title">P2X receptors in the cardiovascular system and their potential as therapeutic targets in disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">865</span>, <span class="refDoi"> DOI: 10.2174/0929867321666141215094050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.2174%2F0929867321666141215094050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25515516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislelsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=851-865&author=V.+Ralevic&title=P2X+receptors+in+the+cardiovascular+system+and+their+potential+as+therapeutic+targets+in+disease&doi=10.2174%2F0929867321666141215094050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">P2X Receptors in the Cardiovascular System and their Potential as Therapeutic Targets in Disease</span></div><div class="casAuthors">Ralevic, Vera</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">851-865</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">This review considers the expression and roles of P2X receptors in the cardiovascular system in health and disease and their potential as therapeutic targets.  P2X receptors are ligand gated ion channels which are activated by the endogenous ligand ATP.  They are formed from the assembly of three P2X subunit proteins from the complement of seven (P2X1-7), which can assoc. to form homomeric or heteromeric P2X receptors.  The P2X1 receptor is widely expressed in the cardiovascular system, being located in the heart, in the smooth muscle of the majority of blood vessels and in platelets.  P2X1 receptors expressed in blood vessels can be activated by ATP coreleased with noradrenaline as a sympathetic neurotransmitter, leading to smooth muscle depolarisation and contraction.  There is evidence that the purinergic component of sympathetic neurotransmission is increased in hypertension, identifying P2X1 receptors as a possible therapeutic target in this disorder.  P2X3 and P2X2/3 receptors are expressed on cardiac sympathetic neurons and may, through pos. feedback of neuronal ATP at this prejunctional site, amplify sympathetic neurotransmission.  Activation of P2X receptors expressed in the heart increases cardiac myocyte contractility, and an important role of the P2X4 receptor in this has been identified.  Deletion of P2X4 receptors in the heart depresses contractile performance in models of heart failure, while overexpression of P2X4 receptors has been shown to be cardioprotective, thus P2X4 receptors may be therapeutic targets in the treatment of heart disease.  P2X receptors have been identified on endothelial cells.  Although immunoreactivity for all P2X1-7 receptor proteins has been shown on the endothelium, relatively little is known about their function, with the exception of the endothelial P2X4 receptor, which has been shown to mediate endothelium-dependent vasodilatation to ATP released during shear stress.  The potential of P2X receptors as therapeutic targets in the treatment of cardiovascular disease is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppU7eFgynPOrVg90H21EOLACvtfcHk0lg3agqi_QAotQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislelsr8%253D&md5=825263e596aff3a3588cc40cae14541d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F0929867321666141215094050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666141215094050%26sid%3Dliteratum%253Aachs%26aulast%3DRalevic%26aufirst%3DV.%26atitle%3DP2X%2520receptors%2520in%2520the%2520cardiovascular%2520system%2520and%2520their%2520potential%2520as%2520therapeutic%2520targets%2520in%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D851%26epage%3D865%26doi%3D10.2174%2F0929867321666141215094050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, R.</span>; <span class="NLM_string-name">Kalthof, B.</span>; <span class="NLM_string-name">Grützmann, R.</span>; <span class="NLM_string-name">Woltering, E.</span>; <span class="NLM_string-name">Stelte-Ludwig, B.</span>; <span class="NLM_string-name">Wuttke, M.</span></span> <span> </span><span class="NLM_article-title">Bayer Healthcare AG. Benzofuro-1,4-diazepin-2-one Derivatives</span>. <span class="NLM_patent">WO2004085440</span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+Fischer&author=B.+Kalthof&author=R.+Gr%C3%BCtzmann&author=E.+Woltering&author=B.+Stelte-Ludwig&author=M.+Wuttke&title=Bayer+Healthcare+AG.+Benzofuro-1%2C4-diazepin-2-one+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DR.%26atitle%3DBayer%2520Healthcare%2520AG.%2520Benzofuro-1%252C4-diazepin-2-one%2520Derivatives%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Emerging structures and ligands for P2X3 and P2X4 receptors – towards novel treatments of neuropathic pain</span>. <i>Purinergic Signalling</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">145</span>– <span class="NLM_lpage">148</span>, <span class="refDoi"> DOI: 10.1007/s11302-010-9182-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1007%2Fs11302-010-9182-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=20806006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsFSrtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=145-148&author=C.+E.+M%C3%BCller&title=Emerging+structures+and+ligands+for+P2X3+and+P2X4+receptors+%E2%80%93+towards+novel+treatments+of+neuropathic+pain&doi=10.1007%2Fs11302-010-9182-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Emerging structures and ligands for P2X3 and P2X4 receptors-towards novel treatments of neuropathic pain</span></div><div class="casAuthors">Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Purinergic Signalling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">145-148</span>CODEN:
                <span class="NLM_cas:coden">PSUIA9</span>;
        ISSN:<span class="NLM_cas:issn">1573-9538</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGQFjAaEKcybVg90H21EOLACvtfcHk0ljamW5Qce7jGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsFSrtrg%253D&md5=296b4340724c0c75160bde886b783255</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1007%2Fs11302-010-9182-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11302-010-9182-y%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DEmerging%2520structures%2520and%2520ligands%2520for%2520P2X3%2520and%2520P2X4%2520receptors%2520%25E2%2580%2593%2520towards%2520novel%2520treatments%2520of%2520neuropathic%2520pain%26jtitle%3DPurinergic%2520Signalling%26date%3D2010%26volume%3D6%26spage%3D145%26epage%3D148%26doi%3D10.1007%2Fs11302-010-9182-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gunosewoyo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassiou, M.</span></span> <span> </span><span class="NLM_article-title">P2X purinergic receptor ligands: recently patented compounds</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">625</span>– <span class="NLM_lpage">646</span>, <span class="refDoi"> DOI: 10.1517/13543771003702424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1517%2F13543771003702424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=20205618" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC3cXltlWhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=625-646&author=H.+Gunosewoyoauthor=M.+Kassiou&title=P2X+purinergic+receptor+ligands%3A+recently+patented+compounds&doi=10.1517%2F13543771003702424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">P2X purinergic receptor ligands: recently patented compounds</span></div><div class="casAuthors">Gunosewoyo, Hendra; Kassiou, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">625-646</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: P2X channels are ionotropic purinergic receptors that are currently under scrutiny as attractive targets for novel therapeutics in areas including chronic inflammation, pain and depression.  Their wide expression in the CNS, recent advances in the biochem. and pharmacol. properties as well as increasing nos. of patents published in this research domain demand a review in this field.  Areas covered in this review: The patent literature covering novel drug-like antagonists for each P2X receptor subtype (P2X1R to P2X7R) up to Dec. 2009 is described in this review article together with their recent highlights in pharmacol.  What the reader will gain: Readers will gain an up-to-date overview of patents covering drug-like antagonists for seven P2X receptor subtypes within the last 4 years.  Take home message: P2X7R antagonists and other P2X inhibitors will probably be on the market for combating rheumatoid arthritis and other diseases.  Some P2X7R antagonists are already in Phase I and II clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-8wN9lvn6XrVg90H21EOLACvtfcHk0ljamW5Qce7jGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXltlWhtro%253D&md5=368c6d47ee49616986f80db5be326ab0</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1517%2F13543771003702424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543771003702424%26sid%3Dliteratum%253Aachs%26aulast%3DGunosewoyo%26aufirst%3DH.%26aulast%3DKassiou%26aufirst%3DM.%26atitle%3DP2X%2520purinergic%2520receptor%2520ligands%253A%2520recently%2520patented%2520compounds%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D625%26epage%3D646%26doi%3D10.1517%2F13543771003702424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry of P2X receptors: allosteric modulators</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">929</span>– <span class="NLM_lpage">941</span>, <span class="refDoi"> DOI: 10.2174/0929867322666141210155610</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.2174%2F0929867322666141210155610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25524251" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXislemtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=929-941&author=C.+E.+M%C3%BCller&title=Medicinal+chemistry+of+P2X+receptors%3A+allosteric+modulators&doi=10.2174%2F0929867322666141210155610"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23cR"><div class="casContent"><span class="casTitleNuber">23c</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal Chemistry of P2X Receptors: Allosteric Modulators</span></div><div class="casAuthors">Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">929-941</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  P2X receptors are trimeric ligand-gated ion channels whose potential as novel drug targets for a no. of diseases has been recognized.  They are mainly involved in inflammatory processes, including neuroinflammation, and pain sensation.  The orthosteric binding site is lined by basic amino acid residues that bind the neg. charged agonist ATP.  Therefore it is not easy to develop orthosteric ligands that possess drug-like properties for such a highly polar binding site.  However, ligand-gated ion channels offer multiple addnl. binding sites for allosteric ligands, pos. or neg. allosteric modulators enhancing or blocking receptor function.  So far, the P2X3 (and P2X2/3), as well as the P2X7 receptor subtype have been the main focus of drug development efforts.  A no. of potent and selective allosteric antagonists have been developed to block these receptors.  We start to see the development of novel allosteric ligands also for the other P2X receptor subtypes, P2X1, P2X2 and esp. P2X4.  The times when only poor, non-selective, non-drug-like tools for studying P2X receptor function were available have been overcome.  The first clin. studies with allosteric P2X3 and P2X7 antagonists suggest that P2X therapeutics may soon become a reality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBp9rwzLCJ3bVg90H21EOLACvtfcHk0lgM7RJAqdFv_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXislemtbY%253D&md5=be1838c9ea9de083e946065f3c72650e</span></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.2174%2F0929867322666141210155610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867322666141210155610%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMedicinal%2520chemistry%2520of%2520P2X%2520receptors%253A%2520allosteric%2520modulators%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2015%26volume%3D22%26spage%3D929%26epage%3D941%26doi%3D10.2174%2F0929867322666141210155610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit23d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry of adenosine, P2Y and P2X receptors</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2015.12.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.neuropharm.2015.12.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26686393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2016&pages=31-49&author=K.+A.+Jacobsonauthor=C.+E.+M%C3%BCller&title=Medicinal+chemistry+of+adenosine%2C+P2Y+and+P2X+receptors&doi=10.1016%2Fj.neuropharm.2015.12.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23dR"><div class="casContent"><span class="casTitleNuber">23d</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine, P2Y and P2X receptors</span></div><div class="casAuthors">Jacobson, Kenneth A.; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31-49</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Pharmacol. tool compds. are now available to define action at the adenosine (ARs), P2Y and P2X receptors.  We present a selection of the most commonly used agents to study purines in the nervous system.  Some of these compds., including A1 and A3 AR agonists, P2Y1R and P2Y12R antagonists, and P2X3, P2X4 and P2X7 antagonists, are potentially of clin. use in treatment of disorders of the nervous system, such as chronic pain, neurodegeneration and brain injury.  Agonists of the A2AAR and P2Y2R are already used clin., P2Y12R antagonists are widely used antithrombotics and an antagonist of the A2AAR is approved in Japan for treating Parkinson's disease.  The selectivity defined for some of the previously introduced compds. has been revised with updated pharmacol. characterization, for example, various AR agonists and antagonists were deemed A1AR or A3AR selective based on human data, but species differences indicated a redn. in selectivity ratios in other species.  Also, many of the P2R ligands still lack bioavailability due to charged groups or hydrolytic (either enzymic or chem.) instability.  X-ray crystallog. structures of AR and P2YRs have shifted the mode of ligand discovery to structure-based approaches rather than previous empirical approaches.  The X-ray structures can be utilized either for in silico screening of chem. diverse libraries for the discovery of novel ligands or for enhancement of the properties of known ligands by chem. modification.  Although X-ray structures of the zebrafish P2X4R have been reported, there is scant structural information about ligand recognition in these trimeric ion channels.  In summary, there are definitive, selective agonists and antagonists for all of the ARs and some of the P2YRs; while the pharmacochem. of P2XRs is still in nascent stages.  The therapeutic potential of selectively modulating these receptors is continuing to gain interest in such fields as cancer, inflammation, pain, diabetes, ischemic protection and many other conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfj6lh6K1FbLVg90H21EOLACvtfcHk0lgM7RJAqdFv_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitV2rsrzF&md5=ffcb23c7e271df86ef6b24d88aef2d82</span></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2015.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2015.12.001%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMedicinal%2520chemistry%2520of%2520adenosine%252C%2520P2Y%2520and%2520P2X%2520receptors%26jtitle%3DNeuropharmacology%26date%3D2016%26volume%3D104%26spage%3D31%26epage%3D49%26doi%3D10.1016%2Fj.neuropharm.2015.12.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozaki-Saitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span> <span> </span><span class="NLM_article-title">Antidepressants inhibit P2X4 receptor function: a possible involvement in neuropathic pain relief</span>. <i>Mol. Pain</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1744</span>– <span class="NLM_lpage">8069</span>, <span class="refDoi"> DOI: 10.1186/1744-8069-5-20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1186%2F1744-8069-5-20" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=1744-8069&author=K.+Nagataauthor=T.+Imaiauthor=T.+Yamashitaauthor=M.+Tsudaauthor=H.+Tozaki-Saitohauthor=K.+Inoue&title=Antidepressants+inhibit+P2X4+receptor+function%3A+a+possible+involvement+in+neuropathic+pain+relief&doi=10.1186%2F1744-8069-5-20"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-5-20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-5-20%26sid%3Dliteratum%253Aachs%26aulast%3DNagata%26aufirst%3DK.%26aulast%3DImai%26aufirst%3DT.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DTozaki-Saitoh%26aufirst%3DH.%26aulast%3DInoue%26aufirst%3DK.%26atitle%3DAntidepressants%2520inhibit%2520P2X4%2520receptor%2520function%253A%2520a%2520possible%2520involvement%2520in%2520neuropathic%2520pain%2520relief%26jtitle%3DMol.%2520Pain%26date%3D2009%26volume%3D5%26spage%3D1744%26epage%3D8069%26doi%3D10.1186%2F1744-8069-5-20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez-Olmos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freudendahl, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinhausen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">N-Substituted phenoxazine and acridone derivatives: Structure-activity relationships of potent P2X4 receptor antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9576</span>– <span class="NLM_lpage">9588</span>, <span class="refDoi"> DOI: 10.1021/jm300845v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300845v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9576-9588&author=V.+Hernandez-Olmosauthor=A.+Abdelrahmanauthor=A.+El-Tayebauthor=D.+Freudendahlauthor=S.+Weinhausenauthor=C.+E.+M%C3%BCller&title=N-Substituted+phenoxazine+and+acridone+derivatives%3A+Structure-activity+relationships+of+potent+P2X4+receptor+antagonists&doi=10.1021%2Fjm300845v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">N-Substituted Phenoxazine and Acridone Derivatives: Structure-Activity Relationships of Potent P2X4 Receptor Antagonists</span></div><div class="casAuthors">Hernandez-Olmos, Victor; Abdelrahman, Aliaa; El-Tayeb, Ali; Freudendahl, Diana; Weinhausen, Stephanie; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9576-9588</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">P2X4 receptor antagonists have potential as drugs for the treatment of neuropathic pain and neurodegenerative diseases.  In the present study the discovery of phenoxazine derivs. as potent P2X4 antagonists is described.  N-Substituted phenoxazine and related acridone and benzoxazine derivs. were synthesized and optimized with regard to their potency to inhibit ATP-induced calcium influx in 1321N1 astrocytoma cells stably transfected with the human P2X4 receptor.  In addn., species selectivity (rat, mouse, human) and receptor subtype selectivity (vs. P2X1,2,3,7) were investigated.  The most potent P2X4 antagonist of the present series was N-(benzyloxycarbonyl)phenoxazine (PSB-12054) with an IC50 of 0.189 μM and good selectivity vs. the other human P2X receptor subtypes.  N-(p-Methylphenylsulfonyl)phenoxazine (PSB-12062) was identified as a selective P2X4 antagonist that was equally potent in all three species (IC50: 0.928-1.76 μM).  The compds. showed an allosteric mechanism of action.  The present study represents the first structure-activity relationship anal. of P2X4 antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxJVfTTe0warVg90H21EOLACvtfcHk0lgM7RJAqdFv_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFamtrrL&md5=44d6b170092e37329f9dd82cac8e3dfb</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm300845v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300845v%26sid%3Dliteratum%253Aachs%26aulast%3DHernandez-Olmos%26aufirst%3DV.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DFreudendahl%26aufirst%3DD.%26aulast%3DWeinhausen%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DN-Substituted%2520phenoxazine%2520and%2520acridone%2520derivatives%253A%2520Structure-activity%2520relationships%2520of%2520potent%2520P2X4%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9576%26epage%3D9588%26doi%3D10.1021%2Fjm300845v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdelrahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinhausen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weyer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dosa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Tayeb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, C. E.</span></span> <span> </span><span class="NLM_article-title">Carbamazepine derivatives with P2X4 receptor-blocking activity</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.12.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.bmc.2013.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=24411477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktFymtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=1077-1088&author=M.+Tianauthor=A.+Abdelrahmanauthor=S.+Weinhausenauthor=S.+Hinzauthor=S.+Weyerauthor=S.+Dosaauthor=A.+El-Tayebauthor=C.+E.+M%C3%BCller&title=Carbamazepine+derivatives+with+P2X4+receptor-blocking+activity&doi=10.1016%2Fj.bmc.2013.12.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Carbamazepine derivatives with P2X4 receptor-blocking activity</span></div><div class="casAuthors">Tian, Maoqun; Abdelrahman, Aliaa; Weinhausen, Stephanie; Hinz, Sonja; Weyer, Stefanie; Dosa, Stefan; El-Tayeb, Ali; Muller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1077-1088</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Antagonists for the P2 receptor subtype P2X4, an ATP-activated cation channel receptor, have potential as novel drugs for the treatment of neuropathic pain and other inflammatory diseases.  In the present study, a series of 47 carbamazepine derivs. including 32 novel compds. were designed, synthesized, and evaluated as P2X4 receptor antagonists.  Their potency to inhibit ATP-induced calcium influx in 1321N1 astrocytoma cells stably transfected with the human P2X4 receptor was detd.  Addnl., species selectivity (human, rat, mouse) and receptor subtype selectivity (P2X4 vs P2X1, 2, 3, 7) were investigated for selected derivs.  The most potent compd. of the present series, which exhibited an allosteric mechanism of P2X4 inhibition, was N,N-diisopropyl-5H-dibenz[b,f]azepine-5-carboxamide (34, IC50 of 3.44 μM).  The present study extends the so far very limited knowledge on structure-activity relationships of P2X4 receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlNUgOfw-YE7Vg90H21EOLACvtfcHk0lgYkIV5gKcvPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktFymtw%253D%253D&md5=2d9bd84b87ea809455af4d8fff8599ef</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DTian%26aufirst%3DM.%26aulast%3DAbdelrahman%26aufirst%3DA.%26aulast%3DWeinhausen%26aufirst%3DS.%26aulast%3DHinz%26aufirst%3DS.%26aulast%3DWeyer%26aufirst%3DS.%26aulast%3DDosa%26aufirst%3DS.%26aulast%3DEl-Tayeb%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DCarbamazepine%2520derivatives%2520with%2520P2X4%2520receptor-blocking%2520activity%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D1077%26epage%3D1088%26doi%3D10.1016%2Fj.bmc.2013.12.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ase, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honson, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaghdane, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Séguéla, P.</span></span> <span> </span><span class="NLM_article-title">Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">616</span>, <span class="refDoi"> DOI: 10.1124/mol.114.096222</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1124%2Fmol.114.096222" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25597706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXktlaksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2015&pages=606-616&author=A.+R.+Aseauthor=N.+S.+Honsonauthor=H.+Zaghdaneauthor=T.+A.+Pfeiferauthor=P.+S%C3%A9gu%C3%A9la&title=Identification+and+characterization+of+a+selective+allosteric+antagonist+of+human+P2X4+receptor+channels&doi=10.1124%2Fmol.114.096222"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and characterization of a selective allosteric antagonist of human P2X4 receptor channels</span></div><div class="casAuthors">Ase, Ariel R.; Honson, Nicolette S.; Zaghdane, Helmi; Pfeifer, Tom A.; Seguela, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">606-616</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P2X4 is an ATP-gated nonselective cation channel highly permeable to calcium.  There is increasing evidence that this homomeric purinoceptor, which is expressed in several neuronal and immune cell types, is involved in chronic pain and inflammation.  The current paucity of unambiguous pharmacol. tools available to interrogate or modulate P2X4 function led us to pursue the search for selective antagonists.  In the high-throughput screen of a compd. library, we identified the phenylurea BX430 (1-(2,6-dibromo-4-isopropyl-phenyl)-3-(3-pyridyl)urea, mol. wt. = 413), with antagonist properties on human P2X4-mediated calcium uptake.  Patch-clamp electrophysiol. confirmed direct inhibition of P2X4 currents by extracellular BX430, with submicromolar potency (IC50 = 0.54 μM).  BX430 is highly selective, having virtually no functional impact on all other P2X subtypes, namely, P2X1-P2X3, P2X5, and P2X7, at 10-100 times its IC50.  Unexpected species differences were noticed, as BX430 is a potent antagonist of zebrafish P2X4 but has no effect on rat andmouse P2X4 orthologs.  The concn.-response curve for ATP on human P2X4 in the presence of BX430 shows an insurmountable blockade, indicating a noncompetitive allosteric mechanism of action.  Using a fluorescent dye uptake assay, we obsd. that BX430 also effectively suppresses ATP-evoked and ivermectin-potentiated membrane permeabilization induced by P2X4 pore dilation.  Finally, in single-cell calcium imaging, we validated its selective inhibitory effects on native P2X4 channels at the surface of human THP-1 cells that were differentiated into macrophages.  In summary, this ligand provides a novel mol. probe to assess the specific role of P2X4 in inflammatory and neuropathic conditions, where ATP signaling has been shown to be dysfunctional.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWlqYNj9h6IrVg90H21EOLACvtfcHk0lgYkIV5gKcvPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXktlaksb0%253D&md5=5c3359c14f615d964142a61ad1bfad2f</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.096222&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.096222%26sid%3Dliteratum%253Aachs%26aulast%3DAse%26aufirst%3DA.%2BR.%26aulast%3DHonson%26aufirst%3DN.%2BS.%26aulast%3DZaghdane%26aufirst%3DH.%26aulast%3DPfeifer%26aufirst%3DT.%2BA.%26aulast%3DS%25C3%25A9gu%25C3%25A9la%26aufirst%3DP.%26atitle%3DIdentification%2520and%2520characterization%2520of%2520a%2520selective%2520allosteric%2520antagonist%2520of%2520human%2520P2X4%2520receptor%2520channels%26jtitle%3DMol.%2520Pharmacol.%26date%3D2015%26volume%3D87%26spage%3D606%26epage%3D616%26doi%3D10.1124%2Fmol.114.096222" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Ushioda, M.</span>; <span class="NLM_string-name">Kobayashi, K.</span>; <span class="NLM_string-name">Saito, D.</span>; <span class="NLM_string-name">Sakuma, S.</span>; <span class="NLM_string-name">Imai, T.</span>; <span class="NLM_string-name">Inoue, K.</span></span> <span> </span><span class="NLM_article-title">Preparation of Benzodiazepine Derivatives P2X4 Receptor Antagonists</span>. <span class="NLM_patent">WO2013105608</span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+Ushioda&author=K.+Kobayashi&author=D.+Saito&author=S.+Sakuma&author=T.+Imai&author=K.+Inoue&title=Preparation+of+Benzodiazepine+Derivatives+P2X4+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DUshioda%26aufirst%3DM.%26atitle%3DPreparation%2520of%2520Benzodiazepine%2520Derivatives%2520P2X4%2520Receptor%2520Antagonists%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakata, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohno, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tozaki-Saitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuraishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, K.</span></span> <span> </span><span class="NLM_article-title">A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">32461</span> <span class="refDoi"> DOI: 10.1038/srep32461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1038%2Fsrep32461" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=27576299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKjtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=Y.+Matsumuraauthor=T.+Yamashitaauthor=A.+Sasakiauthor=E.+Nakataauthor=K.+Kohnoauthor=T.+Masudaauthor=H.+Tozaki-Saitohauthor=T.+Imaiauthor=Y.+Kuraishiauthor=M.+Tsudaauthor=K.+Inoue&title=A+novel+P2X4+receptor-selective+antagonist+produces+anti-allodynic+effect+in+a+mouse+model+of+herpetic+pain&doi=10.1038%2Fsrep32461"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">A novel P2X4 receptor-selective antagonist produces anti-allodynic effect in a mouse model of herpetic pain</span></div><div class="casAuthors">Matsumura, Yuta; Yamashita, Tomohiro; Sasaki, Atsushi; Nakata, Eriko; Kohno, Keita; Masuda, Takahiro; Tozaki-Saitoh, Hidetoshi; Imai, Toshiyasu; Kuraishi, Yasushi; Tsuda, Makoto; Inoue, Kazuhide</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">32461</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Accumulating evidence indicates that purinergic P2X4 receptors (P2X4R: cation channels activated by extracellular ATP) expressed in spinal microglia are crucial for pathol. chronic pain caused by nerve damage, suggesting a potential target for drug discovery.  We identified NP-1815-PX (5-[3-(5-thioxo-4H-[1,2,4]oxadiazol-3-yl)phenyl]-1H-naphtho[1, 2-b][1,4]diazepine-2,4(3H,5H)-dione) as a novel antagonist selective for P2X4R with high potency and selectivity compared with other P2XR subtypes.  In in vivo assay for acute and chronic pain, intrathecal administration of NP-1815-PX produced an anti-allodynic effect in mice with traumatic nerve damage without affecting acute nociceptive pain and motor function (although its oral administration did not produce the effect).  Furthermore, in a mouse model of herpetic pain, P2X4R upregulation in the spinal cord exclusively occurred in microglia, and intrathecal NP-1815-PX suppressed induction of mech. allodynia.  This model also showed K+/Cl- cotransporter 2 (KCC2) downregulation, which is implicated in dorsal horn neuron hyperexcitability; this downregulation was restored by intrathecal treatment with NP-1815-PX or by interfering with brain-derived neurotrophic factor (BDNF) signaling, a P2X4R-activated microglial factor implicated in KCC2 downregulation.  Taken together, the newly developed P2X4R antagonist NP-1815-PX produces anti-allodynic effects in chronic pain models without altering acute pain sensitivity, suggesting that microglial P2X4R could be an attractive target for treating chronic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrs9wa0Z9o767Vg90H21EOLACvtfcHk0lgYkIV5gKcvPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKjtrzM&md5=e7f89cd6fd1c8eb45e95d61384ca9cea</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1038%2Fsrep32461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep32461%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DY.%26aulast%3DYamashita%26aufirst%3DT.%26aulast%3DSasaki%26aufirst%3DA.%26aulast%3DNakata%26aufirst%3DE.%26aulast%3DKohno%26aufirst%3DK.%26aulast%3DMasuda%26aufirst%3DT.%26aulast%3DTozaki-Saitoh%26aufirst%3DH.%26aulast%3DImai%26aufirst%3DT.%26aulast%3DKuraishi%26aufirst%3DY.%26aulast%3DTsuda%26aufirst%3DM.%26aulast%3DInoue%26aufirst%3DK.%26atitle%3DA%2520novel%2520P2X4%2520receptor-selective%2520antagonist%2520produces%2520anti-allodynic%2520effect%2520in%2520a%2520mouse%2520model%2520of%2520herpetic%2520pain%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fsrep32461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29a"><span><span class="NLM_label">(a) </span>Announcement see: <a href="https://adisinsight.springer.com/drugs/800038339" class="extLink">https://adisinsight.springer.com/drugs/800038339</a> (accessed Oct 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Announcement+see%3A+https%3A%2F%2Fadisinsight.springer.com%2Fdrugs%2F800038339+%28accessed+Oct+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit29b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Imai, T.</span>; <span class="NLM_string-name">Sakuma, S.</span>; <span class="NLM_string-name">Nakata, E.</span>; <span class="NLM_string-name">Kawasaki, T.</span>; <span class="NLM_string-name">Ogawa, T.</span>; <span class="NLM_string-name">Inoue, K.</span>; <span class="NLM_string-name">Yamakawa, T.</span></span> <i>Novel P2X4 Receptor Antagonist NC-2600 Attenuated Allodynia Induced by Sciatic Nerve Injury</i>, 16th World Congress on Pain, <span class="NLM_publisher-name">IASP</span>: <span class="NLM_publisher-loc">Yokohama</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=T.+Imai&author=S.+Sakuma&author=E.+Nakata&author=T.+Kawasaki&author=T.+Ogawa&author=K.+Inoue&author=T.+Yamakawa&title=Novel+P2X4+Receptor+Antagonist+NC-2600+Attenuated+Allodynia+Induced+by+Sciatic+Nerve+Injury"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DImai%26aufirst%3DT.%26jtitle%3DNovel%2520P2X4%2520Receptor%2520Antagonist%2520NC-2600%2520Attenuated%2520Allodynia%2520Induced%2520by%2520Sciatic%2520Nerve%2520Injury%26pub%3DIASP%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Newcom, J.</span>; <span class="NLM_string-name">Spear, K. L.</span></span> <span> </span><span class="NLM_article-title">Sunovion Pharmaceuticals Inc. P2X4 Receptor Modulating Compounds</span>. <span class="NLM_patent">WO2015088564</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Newcom&author=K.+L.+Spear&title=Sunovion+Pharmaceuticals+Inc.+P2X4+Receptor+Modulating+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNewcom%26aufirst%3DJ.%26atitle%3DSunovion%2520Pharmaceuticals%2520Inc.%2520P2X4%2520Receptor%2520Modulating%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit30b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Newcom, J.</span>; <span class="NLM_string-name">Spear, K. L.</span></span> <span> </span><span class="NLM_article-title">Sunovion Pharmaceuticals Inc. P2X4 Receptor Modulating Compounds and Methods of Use Thereof</span>. <span class="NLM_patent">WO2015088565</span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=J.+Newcom&author=K.+L.+Spear&title=Sunovion+Pharmaceuticals+Inc.+P2X4+Receptor+Modulating+Compounds+and+Methods+of+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNewcom%26aufirst%3DJ.%26atitle%3DSunovion%2520Pharmaceuticals%2520Inc.%2520P2X4%2520Receptor%2520Modulating%2520Compounds%2520and%2520Methods%2520of%2520Use%2520Thereof%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Werner, S.</span>; <span class="NLM_string-name">Mesch, S.</span>; <span class="NLM_string-name">Bräuer, N.</span>; <span class="NLM_string-name">Pook, E.</span>; <span class="NLM_string-name">Dahllöf, H.</span>; <span class="NLM_string-name">Nubbemeyer, R.</span>; <span class="NLM_string-name">Osmers, M.</span>; <span class="NLM_string-name">Kalthof, B.</span></span> <span> </span><span class="NLM_article-title">Aromatic Sulfonamide Derivatives</span>. <span class="NLM_patent">WO2016198374</span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+Werner&author=S.+Mesch&author=N.+Br%C3%A4uer&author=E.+Pook&author=H.+Dahll%C3%B6f&author=R.+Nubbemeyer&author=M.+Osmers&author=B.+Kalthof&title=Aromatic+Sulfonamide+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWerner%26aufirst%3DS.%26atitle%3DAromatic%2520Sulfonamide%2520Derivatives%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dernetz, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C. L.</span></span> <span> </span><span class="NLM_article-title">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span>. <i>Nurs. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1097/NNR.0000000000000082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1097%2FNNR.0000000000000082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25738619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=81-87&author=M.+A.+Griffioenauthor=V.+H.+Dernetzauthor=G.+S.+Yangauthor=K.+A.+Griffithauthor=S.+G.+Dorseyauthor=C.+L.+Renn&title=Evaluation+of+dynamic+weight+bearing+for+measuring+nonevoked+inflammatory+hyperalgesia+in+mice&doi=10.1097%2FNNR.0000000000000082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span></div><div class="casAuthors">Griffioen Mari A; Dernetz Valerie H; Yang Gee Su; Griffith Kathleen A; Dorsey Susan G; Renn Cynthia L</div><div class="citationInfo"><span class="NLM_cas:title">Nursing research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Animal models in pain research have suggested that inclusion of both evoked and nonevoked behavioral measures is needed to better reflect the human pain experience.  Individuals with chronic pain are known to experience spontaneous pain, in addition to pain after exposure to an external stimulus.  Recently, the dynamic weight bearing (DWB) apparatus was developed to assess for nonevoked hyperalgesia by capturing weight bearing and surface distribution in the paws of mice after acute inflammation.  OBJECTIVES:  The aim of this study was to evaluate the DWB test as a measure of nonevoked hyperalgesia.  METHODS:  The experimental group received an intraplantar injection in the left hind paw of the inflammatory agent--complete Freund's adjuvant (CFA)--whereas the vehicle control group received a saline injection and the naive control group had no treatment.  Calipers and a plethysmometer were used to verify inflammation and the hot-plate test was used as a measure for stimulus-evoked hyperalgesia.  Data were collected at baseline; 3 hours; and 1, 3, and 7 days after injection.  RESULTS:  Mice injected with CFA showed a statistically significant higher mean paw thickness and volume displacement compared with the vehicle and naive control groups.  In the hot-plate testing, CFA-treated mice showed lower response temperature at 7 days compared with the other groups.  On the DWB test, CFA-treated mice showed a reduction in the ipsilateral paw load and surface area compared with the contralateral paw load at Days 1, 3, and 7.  DISCUSSION:  Mice with inflammation showed alterations in weight bearing as well as increased thermal hyperalgesia in comparison with control groups.  These findings support the use of the DWB test as a tool for measuring nonevoked inflammatory hyperalgesia in a mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHfIzmZeNC_GhHGZei4OW9fW6udTcc2ea6RKa-SdYbQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D&md5=f9c78e7f44e84894440969c91f5d0554</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1097%2FNNR.0000000000000082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNNR.0000000000000082%26sid%3Dliteratum%253Aachs%26aulast%3DGriffioen%26aufirst%3DM.%2BA.%26aulast%3DDernetz%26aufirst%3DV.%2BH.%26aulast%3DYang%26aufirst%3DG.%2BS.%26aulast%3DGriffith%26aufirst%3DK.%2BA.%26aulast%3DDorsey%26aufirst%3DS.%2BG.%26aulast%3DRenn%26aufirst%3DC.%2BL.%26atitle%3DEvaluation%2520of%2520dynamic%2520weight%2520bearing%2520for%2520measuring%2520nonevoked%2520inflammatory%2520hyperalgesia%2520in%2520mice%26jtitle%3DNurs.%2520Res.%26date%3D2015%26volume%3D64%26spage%3D81%26epage%3D87%26doi%3D10.1097%2FNNR.0000000000000082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dernetz, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C. L.</span></span> <span> </span><span class="NLM_article-title">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span>. <i>Nurs. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1097/NNR.0000000000000082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1097%2FNNR.0000000000000082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25738619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=81-87&author=M.+A.+Griffioenauthor=V.+H.+Dernetzauthor=G.+S.+Yangauthor=K.+A.+Griffithauthor=S.+G.+Dorseyauthor=C.+L.+Renn&title=Evaluation+of+dynamic+weight+bearing+for+measuring+nonevoked+inflammatory+hyperalgesia+in+mice&doi=10.1097%2FNNR.0000000000000082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span></div><div class="casAuthors">Griffioen Mari A; Dernetz Valerie H; Yang Gee Su; Griffith Kathleen A; Dorsey Susan G; Renn Cynthia L</div><div class="citationInfo"><span class="NLM_cas:title">Nursing research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Animal models in pain research have suggested that inclusion of both evoked and nonevoked behavioral measures is needed to better reflect the human pain experience.  Individuals with chronic pain are known to experience spontaneous pain, in addition to pain after exposure to an external stimulus.  Recently, the dynamic weight bearing (DWB) apparatus was developed to assess for nonevoked hyperalgesia by capturing weight bearing and surface distribution in the paws of mice after acute inflammation.  OBJECTIVES:  The aim of this study was to evaluate the DWB test as a measure of nonevoked hyperalgesia.  METHODS:  The experimental group received an intraplantar injection in the left hind paw of the inflammatory agent--complete Freund's adjuvant (CFA)--whereas the vehicle control group received a saline injection and the naive control group had no treatment.  Calipers and a plethysmometer were used to verify inflammation and the hot-plate test was used as a measure for stimulus-evoked hyperalgesia.  Data were collected at baseline; 3 hours; and 1, 3, and 7 days after injection.  RESULTS:  Mice injected with CFA showed a statistically significant higher mean paw thickness and volume displacement compared with the vehicle and naive control groups.  In the hot-plate testing, CFA-treated mice showed lower response temperature at 7 days compared with the other groups.  On the DWB test, CFA-treated mice showed a reduction in the ipsilateral paw load and surface area compared with the contralateral paw load at Days 1, 3, and 7.  DISCUSSION:  Mice with inflammation showed alterations in weight bearing as well as increased thermal hyperalgesia in comparison with control groups.  These findings support the use of the DWB test as a tool for measuring nonevoked inflammatory hyperalgesia in a mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHfIzmZeNC_GhHGZei4OW9fW6udTcc2eZtjKqEyFlLHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D&md5=f9c78e7f44e84894440969c91f5d0554</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1097%2FNNR.0000000000000082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNNR.0000000000000082%26sid%3Dliteratum%253Aachs%26aulast%3DGriffioen%26aufirst%3DM.%2BA.%26aulast%3DDernetz%26aufirst%3DV.%2BH.%26aulast%3DYang%26aufirst%3DG.%2BS.%26aulast%3DGriffith%26aufirst%3DK.%2BA.%26aulast%3DDorsey%26aufirst%3DS.%2BG.%26aulast%3DRenn%26aufirst%3DC.%2BL.%26atitle%3DEvaluation%2520of%2520dynamic%2520weight%2520bearing%2520for%2520measuring%2520nonevoked%2520inflammatory%2520hyperalgesia%2520in%2520mice%26jtitle%3DNurs.%2520Res.%26date%3D2015%26volume%3D64%26spage%3D81%26epage%3D87%26doi%3D10.1097%2FNNR.0000000000000082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tétreault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dansereau, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré-Savard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarret, P.</span></span> <span> </span><span class="NLM_article-title">Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats</span>. <i>Physiol. Behav.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">495</span>– <span class="NLM_lpage">502</span>, <span class="refDoi"> DOI: 10.1016/j.physbeh.2011.05.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.physbeh.2011.05.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=21620878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFSqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2011&pages=495-502&author=P.+T%C3%A9treaultauthor=M.+A.+Dansereauauthor=L.+Dor%C3%A9-Savardauthor=N.+Beaudetauthor=P.+Sarret&title=Weight+bearing+evaluation+in+inflammatory%2C+neuropathic+and+cancer+chronic+pain+in+freely+moving+rats&doi=10.1016%2Fj.physbeh.2011.05.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Weight bearing evaluation in inflammatory, neuropathic and cancer chronic pain in freely moving rats</span></div><div class="casAuthors">Tetreault, Pascal; Dansereau, Marc-Andre; Dore-Savard, Louis; Beaudet, Nicolas; Sarret, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Physiology & Behavior</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">495-502</span>CODEN:
                <span class="NLM_cas:coden">PHBHA4</span>;
        ISSN:<span class="NLM_cas:issn">0031-9384</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Preclin. pain assessment remains a key step for the development of new and potent painkillers.  Significant progress in pain evaluation has been achieved with the development of non-reflexive tools.  Seeking efficient and clin. relevant devices for pain-related quality of life assessment, we evaluated a new Dynamic Wt. Bearing (DWB) device based on pressure captors in three different preclin. chronic pain models.  Inflammatory (CFA), neuropathic (CCI) and bone cancer pain (femoral tumor) models were evaluated in Sprague Dawley rats for mech. allodynia using dynamic von Frey for pain-related behaviors and DWB for discomfort.  We obsd. similar impairment patterns in all of the models for both von Frey (allodynia) and DWB (wt. balance) during the complete observation period, starting at day 3 in CCI- and CFA-affected limbs and at day 14 in bone cancer-afflicted rats, indicating that the DWB could be a useful tool for supporting pain assessment.  Interestingly, we demonstrated that the main compensation, when animals experienced pain, was seen in the forepaws, ranging from 46% to 69% of increased load compared to normal.  Other pain-related coping behaviors were also measured, such as the time spent on each paw and the contact surface.  Our results revealed that CFA, CCI and cancerous rats decreased the use of their ipsilateral hind paws by 30% and showed a 50% redn. in paw surface pressed against the floor.  In conclusion, this new device improves methods for preclin. evaluation of discomfort and quality of life proxies and could be helpful in screening putative analgesics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocZiNDP41SHbVg90H21EOLACvtfcHk0ljhB-l1hWOu1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFSqsr4%253D&md5=0c6181a0e82193f6632b3bbf52fb67b5</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.physbeh.2011.05.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.physbeh.2011.05.015%26sid%3Dliteratum%253Aachs%26aulast%3DT%25C3%25A9treault%26aufirst%3DP.%26aulast%3DDansereau%26aufirst%3DM.%2BA.%26aulast%3DDor%25C3%25A9-Savard%26aufirst%3DL.%26aulast%3DBeaudet%26aufirst%3DN.%26aulast%3DSarret%26aufirst%3DP.%26atitle%3DWeight%2520bearing%2520evaluation%2520in%2520inflammatory%252C%2520neuropathic%2520and%2520cancer%2520chronic%2520pain%2520in%2520freely%2520moving%2520rats%26jtitle%3DPhysiol.%2520Behav.%26date%3D2011%26volume%3D104%26spage%3D495%26epage%3D502%26doi%3D10.1016%2Fj.physbeh.2011.05.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laux-Biehlmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyken, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahllöf, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollner, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, J.</span></span> <span> </span><span class="NLM_article-title">Dynamic weight bearing as a non-reflexive method for the measurement of abdominal pain in mice</span>. <i>Eur. J. Pain.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">752</span>, <span class="refDoi"> DOI: 10.1002/ejp.800</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1002%2Fejp.800" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26684879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28Xltlajs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=742-752&author=A.+Laux-Biehlmannauthor=J.+Boykenauthor=H.+Dahll%C3%B6fauthor=N.+Schmidtauthor=T.+M.+Zollnerauthor=J.+Nagel&title=Dynamic+weight+bearing+as+a+non-reflexive+method+for+the+measurement+of+abdominal+pain+in+mice&doi=10.1002%2Fejp.800"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Dynamic weight bearing as a non-reflexive method for the measurement of abdominal pain in mice</span></div><div class="casAuthors">Laux-Biehlmann, A.; Boyken, J.; Dahlloef, H.; Schmidt, N.; Zollner, T. M.; Nagel, J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pain (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-752</span>CODEN:
                <span class="NLM_cas:coden">EJPAFJ</span>;
        ISSN:<span class="NLM_cas:issn">1532-2149</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background: Chronic pelvic pain (CPP) is a high burden for patients and society.  It affects 15-24% of women in reproductive age and is an area of high unmet medical need.  CPP can be caused by a wide range of visceral diseases such as abdominal infections, gastrointestinal or gynaecol. diseases like endometriosis.  Despite the high medical need for this condition, pharmacol. approaches are hampered by the limited no. of available methods for the behavioral evaluation of pain in inflammation-driven animal models of pelvic pain.  Methods: The dynamic wt. bearing (DWB) system was used for the evaluation of spontaneous behavior changes in the zymosan-induced peritonitis mouse model.  Inflammatory mediator levels were evaluated in peritoneal lavage and their correlation with the behavioral endpoints was assessed.  We evaluated the effect on behavioral endpoints of the selective cyclooxygenase-2 (COX-2) inhibitor celecoxib and the Nav1.8 blocker A-803467.  Results: The presence of a relief posture, characterized by a significantly increased wt. distribution towards the front paws, was obsd. following i.p. injection of zymosan.  A pos. correlation was detected between PGE2 levels in the peritoneal lavage and DWB endpoints.  In addn., zymosan-induced wt. bearing changes were reverted by celecoxib and A-803467.  Conclusions: This study described for the first time the use of DWB as a non-subjective and non-reflexive method for the evaluation of inflammatory-driven abdominal pain in a mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRgMcZqYylVrVg90H21EOLACvtfcHk0ljhB-l1hWOu1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xltlajs70%253D&md5=87b7aaddcd30b018ca7eb6cb157a1b0f</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fejp.800&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejp.800%26sid%3Dliteratum%253Aachs%26aulast%3DLaux-Biehlmann%26aufirst%3DA.%26aulast%3DBoyken%26aufirst%3DJ.%26aulast%3DDahll%25C3%25B6f%26aufirst%3DH.%26aulast%3DSchmidt%26aufirst%3DN.%26aulast%3DZollner%26aufirst%3DT.%2BM.%26aulast%3DNagel%26aufirst%3DJ.%26atitle%3DDynamic%2520weight%2520bearing%2520as%2520a%2520non-reflexive%2520method%2520for%2520the%2520measurement%2520of%2520abdominal%2520pain%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Pain.%26date%3D2016%26volume%3D20%26spage%3D742%26epage%3D752%26doi%3D10.1002%2Fejp.800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gruen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laux-Biehlmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zollner, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagel, J.</span></span> <span> </span><span class="NLM_article-title">Use of dynamic weight bearing as a novel end-point for the assessment of abdominal pain in the LPS-induced peritonitis model in the rat</span>. <i>J. Neurosci. Methods</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>232</i></span>,  <span class="NLM_fpage">118</span>– <span class="NLM_lpage">124</span>, <span class="refDoi"> DOI: 10.1016/j.jneumeth.2014.05.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.jneumeth.2014.05.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=24861422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC2cjlvF2huw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=232&publication_year=2014&pages=118-124&author=M.+Gruenauthor=A.+Laux-Biehlmannauthor=T.+M.+Zollnerauthor=J.+Nagel&title=Use+of+dynamic+weight+bearing+as+a+novel+end-point+for+the+assessment+of+abdominal+pain+in+the+LPS-induced+peritonitis+model+in+the+rat&doi=10.1016%2Fj.jneumeth.2014.05.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Use of dynamic weight bearing as a novel end-point for the assessment of abdominal pain in the LPS-induced peritonitis model in the rat</span></div><div class="casAuthors">Gruen Michael; Laux-Biehlmann Alexis; Zollner Thomas M; Nagel Jens</div><div class="citationInfo"><span class="NLM_cas:title">Journal of neuroscience methods</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">232</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">118-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Chronic pelvic pain (CPP) is defined as long-lasting and severe pelvic pain persisting over six months in cyclic or non-cyclic chronic manner.  Various pathologic conditions like endometriosis, abdominal infections, intra-peritoneal adhesions or infection, underlie CPP which is often the leading symptom of the associated diseases.  Pharmacological approaches addressing CPP are hampered by the absence of a straight-forward, objective, and reliable method for the assessment of CPP in rodents.  METHOD:  In the presented study, the dynamic weight bearing system (DWB) was employed for the first time for the evaluation of pelvic pain in a rat model of LPS-induced peritonitis.  Rats were pretreated with the COX-2 inhibitor rofecoxib and PGE2 levels were evaluated in peritoneal lavage.  RESULTS:  DWB analysis revealed that rats treated with LPS showed a relief posture by a significantly increased weight distribution to the front when compared to vehicle-treated animals.  This effect was prevented by rofecoxib treatment indicating the sensitivity of the model for pelvic pain related to peritonitis.  Analysis of the PGE2 levels in the peritoneal fluid indicated a correlation with the relief posture intensity.  COMPARISON WITH EXISTING METHOD(S):  In contrast to others weight bearing approaches, the use of DWB allows evaluation of spontaneous posture changes as a consequence of pelvic pain.  CONCLUSION:  Taken together, we were able to show, that DWB combined with LPS-induced peritonitis may deliver a new reliable animal model addressing pelvic pain with high construct validity (peritoneal inflammation), and face validity (pain related relief posture).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRGu7FAT6EqDCXXDYhVZBdlfW6udTcc2eafNGE9iVtLYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cjlvF2huw%253D%253D&md5=f27ca3eeb11072cc2551367ab8597617</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2014.05.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2014.05.017%26sid%3Dliteratum%253Aachs%26aulast%3DGruen%26aufirst%3DM.%26aulast%3DLaux-Biehlmann%26aufirst%3DA.%26aulast%3DZollner%26aufirst%3DT.%2BM.%26aulast%3DNagel%26aufirst%3DJ.%26atitle%3DUse%2520of%2520dynamic%2520weight%2520bearing%2520as%2520a%2520novel%2520end-point%2520for%2520the%2520assessment%2520of%2520abdominal%2520pain%2520in%2520the%2520LPS-induced%2520peritonitis%2520model%2520in%2520the%2520rat%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2014%26volume%3D232%26spage%3D118%26epage%3D124%26doi%3D10.1016%2Fj.jneumeth.2014.05.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span>SGC chemical
probes: <a href="https://www.thesgc.org/chemical-probes" class="extLink">https://www.thesgc.org/chemical-probes</a> (accessed Oct 29, <span class="NLM_year">2019</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=SGC+chemical%0Aprobes%3A+https%3A%2F%2Fwww.thesgc.org%2Fchemical-probes+%28accessed+Oct+29%2C+2019%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arrowsmith, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Austin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bountra, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennan, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bunnage, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buser-Doepner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlin, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanak, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederiksen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frye, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimshaw, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huber, K. V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotz, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruger, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mader, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsden, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller-Fahrnow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Hagan, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Overington, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owen, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenberg, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schapira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Superti-Furga, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taunton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toledo-Sherman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walpole, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willson, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuercher, W. J.</span></span> <span> </span><span class="NLM_article-title">The promise and peril of chemical probes</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">536</span>– <span class="NLM_lpage">541</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1867</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1038%2Fnchembio.1867" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=26196764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=536-541&author=C.+H.+Arrowsmithauthor=J.+E.+Audiaauthor=C.+Austinauthor=J.+Baellauthor=J.+Bennettauthor=J.+Blaggauthor=C.+Bountraauthor=P.+E.+Brennanauthor=P.+J.+Brownauthor=M.+E.+Bunnageauthor=C.+Buser-Doepnerauthor=R.+M.+Campbellauthor=A.+J.+Carterauthor=P.+Cohenauthor=R.+A.+Copelandauthor=B.+Cravattauthor=J.+L.+Dahlinauthor=D.+Dhanakauthor=A.+M.+Edwardsauthor=M.+Frederiksenauthor=S.+V.+Fryeauthor=N.+Grayauthor=C.+E.+Grimshawauthor=D.+Hepworthauthor=T.+Howeauthor=K.+V.+M.+Huberauthor=J.+Jinauthor=S.+Knappauthor=J.+D.+Kotzauthor=R.+G.+Krugerauthor=D.+Loweauthor=M.+M.+Maderauthor=B.+Marsdenauthor=A.+Mueller-Fahrnowauthor=S.+M%C3%BCllerauthor=R.+C.+O%E2%80%99Haganauthor=J.+P.+Overingtonauthor=D.+R.+Owenauthor=S.+H.+Rosenbergauthor=R.+Rossauthor=B.+Rothauthor=M.+Schapiraauthor=S.+L.+Schreiberauthor=B.+Shoichetauthor=M.+Sundstr%C3%B6mauthor=G.+Superti-Furgaauthor=J.+Tauntonauthor=L.+Toledo-Shermanauthor=C.+Walpoleauthor=M.+A.+Waltersauthor=T.+M.+Willsonauthor=P.+Workmanauthor=R.+N.+Youngauthor=W.+J.+Zuercher&title=The+promise+and+peril+of+chemical+probes&doi=10.1038%2Fnchembio.1867"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">The promise and peril of chemical probes</span></div><div class="casAuthors">Arrowsmith, Cheryl H.; Audia, James E.; Austin, Christopher; Baell, Jonathan; Bennett, Jonathan; Blagg, Julian; Bountra, Chas; Brennan, Paul E.; Brown, Peter J.; Bunnage, Mark E.; Buser-Doepner, Carolyn; Campbell, Robert M.; Carter, Adrian J.; Cohen, Philip; Copeland, Robert A.; Cravatt, Ben; Dahlin, Jayme L.; Dhanak, Dashyant; Edwards, Aled M.; Frye, Stephen V.; Gray, Nathanael; Grimshaw, Charles E.; Hepworth, David; Howe, Trevor; Huber, Kilian V. M.; Jin, Jian; Knapp, Stefan; Kotz, Joanne D.; Kruger, Ryan G.; Lowe, Derek; Mader, Mary M.; Marsden, Brian; Mueller-Fahrnow, Anke; Muller, Susanne; O'Hagan, Ronan C.; Overington, John P.; Owen, Dafydd R.; Rosenberg, Saul H.; Roth, Brian; Ross, Ruth; Schapira, Matthieu; Schreiber, Stuart L.; Shoichet, Brian; Sundstrom, Michael; Superti-Furga, Giulio; Taunton, Jack; Toledo-Sherman, Leticia; Walpole, Chris; Walters, Michael A.; Willson, Timothy M.; Workman, Paul; Young, Robert N.; Zuercher, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">536-541</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Chem. probes are powerful reagents with increasing impacts on biomedical research.  However, probes of poor quality or that are used incorrectly generate misleading results.  To help address these shortcomings, we will create a community-driven wiki resource to improve quality and convey current best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-li4dxq487rVg90H21EOLACvtfcHk0lhc333okzL2Kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1Wlu7zO&md5=d8c7a7af94921ab4cdcc871487cceadd</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1867%26sid%3Dliteratum%253Aachs%26aulast%3DArrowsmith%26aufirst%3DC.%2BH.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DAustin%26aufirst%3DC.%26aulast%3DBaell%26aufirst%3DJ.%26aulast%3DBennett%26aufirst%3DJ.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DBountra%26aufirst%3DC.%26aulast%3DBrennan%26aufirst%3DP.%2BE.%26aulast%3DBrown%26aufirst%3DP.%2BJ.%26aulast%3DBunnage%26aufirst%3DM.%2BE.%26aulast%3DBuser-Doepner%26aufirst%3DC.%26aulast%3DCampbell%26aufirst%3DR.%2BM.%26aulast%3DCarter%26aufirst%3DA.%2BJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DCravatt%26aufirst%3DB.%26aulast%3DDahlin%26aufirst%3DJ.%2BL.%26aulast%3DDhanak%26aufirst%3DD.%26aulast%3DEdwards%26aufirst%3DA.%2BM.%26aulast%3DFrederiksen%26aufirst%3DM.%26aulast%3DFrye%26aufirst%3DS.%2BV.%26aulast%3DGray%26aufirst%3DN.%26aulast%3DGrimshaw%26aufirst%3DC.%2BE.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHowe%26aufirst%3DT.%26aulast%3DHuber%26aufirst%3DK.%2BV.%2BM.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DKotz%26aufirst%3DJ.%2BD.%26aulast%3DKruger%26aufirst%3DR.%2BG.%26aulast%3DLowe%26aufirst%3DD.%26aulast%3DMader%26aufirst%3DM.%2BM.%26aulast%3DMarsden%26aufirst%3DB.%26aulast%3DMueller-Fahrnow%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Hagan%26aufirst%3DR.%2BC.%26aulast%3DOverington%26aufirst%3DJ.%2BP.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DR.%26aulast%3DRoth%26aufirst%3DB.%26aulast%3DSchapira%26aufirst%3DM.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DShoichet%26aufirst%3DB.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSuperti-Furga%26aufirst%3DG.%26aulast%3DTaunton%26aufirst%3DJ.%26aulast%3DToledo-Sherman%26aufirst%3DL.%26aulast%3DWalpole%26aufirst%3DC.%26aulast%3DWalters%26aufirst%3DM.%2BA.%26aulast%3DWillson%26aufirst%3DT.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DYoung%26aufirst%3DR.%2BN.%26aulast%3DZuercher%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520promise%2520and%2520peril%2520of%2520chemical%2520probes%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26spage%3D536%26epage%3D541%26doi%3D10.1038%2Fnchembio.1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cobos, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghasemlou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Araldi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolf, C. J.</span></span> <span> </span><span class="NLM_article-title">Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia</span>. <i>Pain</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>153</i></span>,  <span class="NLM_fpage">876</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1016/j.pain.2012.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2Fj.pain.2012.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=22341563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC38vjt1Kisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=153&publication_year=2012&pages=876-884&author=E.+J.+Cobosauthor=N.+Ghasemlouauthor=D.+Araldiauthor=D.+Segalauthor=K.+Duongauthor=C.+J.+Woolf&title=Inflammation-induced+decrease+in+voluntary+wheel+running+in+mice%3A+a+nonreflexive+test+for+evaluating+inflammatory+pain+and+analgesia&doi=10.1016%2Fj.pain.2012.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Inflammation-induced decrease in voluntary wheel running in mice: a nonreflexive test for evaluating inflammatory pain and analgesia</span></div><div class="casAuthors">Cobos Enrique J; Ghasemlou Nader; Araldi Dioneia; Segal David; Duong Kelly; Woolf Clifford J</div><div class="citationInfo"><span class="NLM_cas:title">Pain</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">153</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">876-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Inflammatory pain impacts adversely on the quality of life of patients, often resulting in motor disabilities.  Therefore, we studied the effect of peripheral inflammation induced by intraplantar administration of complete Freund's adjuvant (CFA) in mice on a particular form of voluntary locomotion, wheel running, as an index of mobility impairment produced by pain.  The distance traveled over 1 hour of free access to activity wheels decreased significantly in response to hind paw inflammation, peaking 24 hours after CFA administration.  Recovery of voluntary wheel running by day 3 correlated with the ability to support weight on the inflamed limb.  Inflammation-induced mechanical hypersensitivity, measured with von Frey hairs, lasted considerably longer than the impaired voluntary wheel running and is not driving; therefore, the change in voluntary behavior.  The CFA-induced decrease in voluntary wheel running was dose-dependently reversed by subcutaneous administration of antiinflammatory and analgesic drugs, including naproxen (10-80 mg/kg), ibuprofen (2.5-20mg/kg), diclofenac (1.25-10mg/kg), celecoxib (2.5-20mg/kg), prednisolone (0.62-5mg/kg), and morphine (0.06-0.5mg/kg), all at much lower doses than reported in most rodent models.  Furthermore, the doses that induced recovery in voluntary wheel running did not reduce CFA-induced mechanical allodynia, indicating a greater sensitivity of the former as a surrogate measure of inflammatory pain.  We conclude that monitoring changes in voluntary wheel running in mice during peripheral inflammation is a simple, observer-independent objective measure of functional changes produced by inflammation, likely more aligned to the global level of pain than reflexive measures, and much more sensitive to analgesic drug effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVTCC_7r7pdpPq5LRczm8ffW6udTcc2earlar12C3svLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vjt1Kisw%253D%253D&md5=68a247f50365e78ec921d17657f208ac</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.pain.2012.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pain.2012.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DCobos%26aufirst%3DE.%2BJ.%26aulast%3DGhasemlou%26aufirst%3DN.%26aulast%3DAraldi%26aufirst%3DD.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DDuong%26aufirst%3DK.%26aulast%3DWoolf%26aufirst%3DC.%2BJ.%26atitle%3DInflammation-induced%2520decrease%2520in%2520voluntary%2520wheel%2520running%2520in%2520mice%253A%2520a%2520nonreflexive%2520test%2520for%2520evaluating%2520inflammatory%2520pain%2520and%2520analgesia%26jtitle%3DPain%26date%3D2012%26volume%3D153%26spage%3D876%26epage%3D884%26doi%3D10.1016%2Fj.pain.2012.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griffioen, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dernetz, V. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffith, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renn, C. L.</span></span> <span> </span><span class="NLM_article-title">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span>. <i>Nurs Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">81</span>– <span class="NLM_lpage">87</span>, <span class="refDoi"> DOI: 10.1097/NNR.0000000000000082</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1097%2FNNR.0000000000000082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=25738619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2015&pages=81-87&author=M.+A.+Griffioenauthor=V.+H.+Dernetzauthor=G.+S.+Yangauthor=K.+A.+Griffithauthor=S.+G.+Dorseyauthor=C.+L.+Renn&title=Evaluation+of+dynamic+weight+bearing+for+measuring+nonevoked+inflammatory+hyperalgesia+in+mice&doi=10.1097%2FNNR.0000000000000082"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of dynamic weight bearing for measuring nonevoked inflammatory hyperalgesia in mice</span></div><div class="casAuthors">Griffioen Mari A; Dernetz Valerie H; Yang Gee Su; Griffith Kathleen A; Dorsey Susan G; Renn Cynthia L</div><div class="citationInfo"><span class="NLM_cas:title">Nursing research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">81-7</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Animal models in pain research have suggested that inclusion of both evoked and nonevoked behavioral measures is needed to better reflect the human pain experience.  Individuals with chronic pain are known to experience spontaneous pain, in addition to pain after exposure to an external stimulus.  Recently, the dynamic weight bearing (DWB) apparatus was developed to assess for nonevoked hyperalgesia by capturing weight bearing and surface distribution in the paws of mice after acute inflammation.  OBJECTIVES:  The aim of this study was to evaluate the DWB test as a measure of nonevoked hyperalgesia.  METHODS:  The experimental group received an intraplantar injection in the left hind paw of the inflammatory agent--complete Freund's adjuvant (CFA)--whereas the vehicle control group received a saline injection and the naive control group had no treatment.  Calipers and a plethysmometer were used to verify inflammation and the hot-plate test was used as a measure for stimulus-evoked hyperalgesia.  Data were collected at baseline; 3 hours; and 1, 3, and 7 days after injection.  RESULTS:  Mice injected with CFA showed a statistically significant higher mean paw thickness and volume displacement compared with the vehicle and naive control groups.  In the hot-plate testing, CFA-treated mice showed lower response temperature at 7 days compared with the other groups.  On the DWB test, CFA-treated mice showed a reduction in the ipsilateral paw load and surface area compared with the contralateral paw load at Days 1, 3, and 7.  DISCUSSION:  Mice with inflammation showed alterations in weight bearing as well as increased thermal hyperalgesia in comparison with control groups.  These findings support the use of the DWB test as a tool for measuring nonevoked inflammatory hyperalgesia in a mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTHfIzmZeNC_GhHGZei4OW9fW6udTcc2earlar12C3svLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnhtlGktg%253D%253D&md5=f9c78e7f44e84894440969c91f5d0554</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1097%2FNNR.0000000000000082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FNNR.0000000000000082%26sid%3Dliteratum%253Aachs%26aulast%3DGriffioen%26aufirst%3DM.%2BA.%26aulast%3DDernetz%26aufirst%3DV.%2BH.%26aulast%3DYang%26aufirst%3DG.%2BS.%26aulast%3DGriffith%26aufirst%3DK.%2BA.%26aulast%3DDorsey%26aufirst%3DS.%2BG.%26aulast%3DRenn%26aufirst%3DC.%2BL.%26atitle%3DEvaluation%2520of%2520dynamic%2520weight%2520bearing%2520for%2520measuring%2520nonevoked%2520inflammatory%2520hyperalgesia%2520in%2520mice%26jtitle%3DNurs%2520Res.%26date%3D2015%26volume%3D64%26spage%3D81%26epage%3D87%26doi%3D10.1097%2FNNR.0000000000000082" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prosise, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taremi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, H. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madison, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesburg, C. A.</span></span> <span> </span><span class="NLM_article-title">Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability</span>. <i>Protein Engineering, Design & Selection</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">433</span>, <span class="refDoi"> DOI: 10.1093/protein/gzn017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1093%2Fprotein%2Fgzn017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=18456871" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnt1Sks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2008&pages=425-433&author=W.+Wangauthor=W.+W.+Prosiseauthor=J.+Chenauthor=S.+S.+Taremiauthor=H.+V.+Leauthor=V.+Madisonauthor=X.+Cuiauthor=A.+Thomasauthor=K.+C.+Chengauthor=C.+A.+Lesburg&title=Construction+and+characterization+of+a+fully+active+PXR%2FSRC-1+tethered+protein+with+increased+stability&doi=10.1093%2Fprotein%2Fgzn017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Construction and characterization of a fully active PXR/SRC-1 tethered protein with increased stability</span></div><div class="casAuthors">Wang, Wenyan; Prosise, Winifred W.; Chen, Jun; Taremi, S. Shane; Le, Hung V.; Madison, Vincent; Cui, Xiaoming; Thomas, Ann; Cheng, K.-C.; Lesburg, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Protein Engineering, Design & Selection</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">425-433</span>CODEN:
                <span class="NLM_cas:coden">PEDSBR</span>;
        ISSN:<span class="NLM_cas:issn">1741-0126</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">The nuclear xenobiotic receptor PXR is a ligand-inducible transcription factor regulating drug-metabolizing enzymes and transporters and a master switch mediating potentially adverse drug-drug interactions.  In addn. to binding a coactivator protein such as SRC-1, the C-terminal ligand-binding domain (LBD) is solely responsible for ligand recognition and thus the ligand-dependent downstream effects.  In an effort to facilitate structural studies of PXR to understand and abolish the interactions between PXR and its ligands, several recombinant PXR/SRC-1 constructs were designed and evaluated for expression, stability and activity.  Expression strategies employing either dual expression or translationally coupled bicistronic expression were found to be unsuitable for producing stable PXR in a stoichiometric complex with a peptide derived from SRC-1 (SRC-1p).  A single polypeptide chain encompassing PXR and SRC-1p tethered with a peptidyl linker was designed to promote intramol. complex formation.  This tethered protein was overexpressed as a sol. protein and required no addnl. SRC-1p for further stabilization.  X-ray crystal structures in the presence and absence of the known PXR agonist SR-12813 were detd. to high resoln.  In addn., a CD-based binding assay was developed to allow rapid evaluation of PXR ligand affinity, making this tethered protein a convenient and effective reagent for the rational attenuation of drug-induced PXR-mediated metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaIAHYXZGyYLVg90H21EOLACvtfcHk0ljAulTKBet3jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnt1Sks7s%253D&md5=87a30decb4445d6b713b55eedc2b7038</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Fprotein%2Fgzn017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fprotein%252Fgzn017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DLe%26aufirst%3DH.%2BV.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DCheng%26aufirst%3DK.%2BC.%26aulast%3DLesburg%26aufirst%3DC.%2BA.%26atitle%3DConstruction%2520and%2520characterization%2520of%2520a%2520fully%2520active%2520PXR%252FSRC-1%2520tethered%2520protein%2520with%2520increased%2520stability%26jtitle%3DProtein%2520Engineering%252C%2520Design%2520%2526%2520Selection%26date%3D2008%26volume%3D21%26spage%3D425%26epage%3D433%26doi%3D10.1093%2Fprotein%2Fgzn017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellmig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huschmann, F. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kastner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malecki, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pühringer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Röwer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sparta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steffien, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ühlein, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. S.</span></span> <span> </span><span class="NLM_article-title">2015. The macromolecular crystallography beamlines at BESSY II of the Helmholtz-Zentrum Berlin: Current status and perspectives</span>. <i>Eur. Phys. J. Plus</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>130</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">150</span>, <span class="refDoi"> DOI: 10.1140/epjp/i2015-15141-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1140%2Fepjp%2Fi2015-15141-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2015&pages=141-150&author=U.+Muellerauthor=R.+F%C3%B6rsterauthor=M.+Hellmigauthor=F.+U.+Huschmannauthor=A.+Kastnerauthor=P.+Maleckiauthor=S.+P%C3%BChringerauthor=M.+R%C3%B6werauthor=K.+Spartaauthor=M.+Steffienauthor=M.+%C3%9Chleinauthor=P.+Wilkauthor=M.+S.+Weiss&title=2015.+The+macromolecular+crystallography+beamlines+at+BESSY+II+of+the+Helmholtz-Zentrum+Berlin%3A+Current+status+and+perspectives&doi=10.1140%2Fepjp%2Fi2015-15141-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1140%2Fepjp%2Fi2015-15141-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1140%252Fepjp%252Fi2015-15141-2%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DF%25C3%25B6rster%26aufirst%3DR.%26aulast%3DHellmig%26aufirst%3DM.%26aulast%3DHuschmann%26aufirst%3DF.%2BU.%26aulast%3DKastner%26aufirst%3DA.%26aulast%3DMalecki%26aufirst%3DP.%26aulast%3DP%25C3%25BChringer%26aufirst%3DS.%26aulast%3DR%25C3%25B6wer%26aufirst%3DM.%26aulast%3DSparta%26aufirst%3DK.%26aulast%3DSteffien%26aufirst%3DM.%26aulast%3D%25C3%259Chlein%26aufirst%3DM.%26aulast%3DWilk%26aufirst%3DP.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26atitle%3D2015.%2520The%2520macromolecular%2520crystallography%2520beamlines%2520at%2520BESSY%2520II%2520of%2520the%2520Helmholtz-Zentrum%2520Berlin%253A%2520Current%2520status%2520and%2520perspectives%26jtitle%3DEur.%2520Phys.%2520J.%2520Plus%26date%3D2015%26volume%3D130%26spage%3D141%26epage%3D150%26doi%3D10.1140%2Fepjp%2Fi2015-15141-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">XDS</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgSvJPMrClkcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sparta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krug, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinemann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, M. S.</span></span> <span> </span><span class="NLM_article-title">XDSAPP2.0</span>. <i>J. Appl. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1085</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1107/S1600576716004416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1107%2FS1600576716004416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC28Xosl2rtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2016&pages=1085-1092&author=K.+Spartaauthor=M.+Krugauthor=U.+Heinemannauthor=U.+Muellerauthor=M.+S.+Weiss&title=XDSAPP2.0&doi=10.1107%2FS1600576716004416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">XDSAPP2.0</span></div><div class="casAuthors">Sparta, Karine M.; Krug, Michael; Heinemann, Udo; Mueller, Uwe; Weiss, Manfred S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Applied Crystallography</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1085-1092</span>CODEN:
                <span class="NLM_cas:coden">JACGAR</span>;
        ISSN:<span class="NLM_cas:issn">1600-5767</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">XDSAPP is an expert system and graphical user interface (GUI) for the automated processing of diffraction images using the XDS program suite and other programs.  The latest major update and the extension of the program are presented here.  The update includes new features, as well as improvements in the GUI and the underlying decision-making system.  XDSAPP is freely available for academic users.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ-TX0JPxrKrVg90H21EOLACvtfcHk0lgSvJPMrClkcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xosl2rtLw%253D&md5=6f8dd41413be2d19cfee0e556da3cb0b</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1107%2FS1600576716004416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS1600576716004416%26sid%3Dliteratum%253Aachs%26aulast%3DSparta%26aufirst%3DK.%26aulast%3DKrug%26aufirst%3DM.%26aulast%3DHeinemann%26aufirst%3DU.%26aulast%3DMueller%26aufirst%3DU.%26aulast%3DWeiss%26aufirst%3DM.%2BS.%26atitle%3DXDSAPP2.0%26jtitle%3DJ.%2520Appl.%2520Crystallogr.%26date%3D2016%26volume%3D49%26spage%3D1085%26epage%3D1092%26doi%3D10.1107%2FS1600576716004416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papiz, M. Z.</span></span> <span> </span><span class="NLM_article-title">Macromolecular TLS refinement in REFMAC at moderate resolutions</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>374</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(03)74014-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1016%2FS0076-6879%2803%2974014-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=14696379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BD2cXotlynsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=374&publication_year=2003&pages=300-321&author=M.+D.+Winnauthor=G.+N.+Murshudovauthor=M.+Z.+Papiz&title=Macromolecular+TLS+refinement+in+REFMAC+at+moderate+resolutions&doi=10.1016%2FS0076-6879%2803%2974014-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Macromolecular TLS refinement in REFMAC at moderate resolutions</span></div><div class="casAuthors">Winn, Martyn D.; Murshudov, Garib N.; Papiz, Miroslav Z.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">374</span>
        (<span class="NLM_cas:issue">Macromolecular Crystallography, Part D</span>),
    <span class="NLM_cas:pages">300-321</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The translation, rotation, screw-rotation (TLS) model parameterization of anisotropic displacement parameters (ADPs) is described.  The phys. model applied is that the anisotropic displacements can be modeled as those of a set of rigid bodies.  For rigid groups of four atoms or larger, TLS parameterization represents a decrease in the no. of parameters over a full ADP description.  Some of the practical issues involved in running TLS refinement in refmac and its applications are discussed, as well as the anal. program tlsanl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpByvlfp34wMbVg90H21EOLACvtfcHk0lgSvJPMrClkcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXotlynsg%253D%253D&md5=8240b81ce1b8f6d53cd8d61183c9e007</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2803%2974014-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252803%252974014-2%26sid%3Dliteratum%253Aachs%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DPapiz%26aufirst%3DM.%2BZ.%26atitle%3DMacromolecular%2520TLS%2520refinement%2520in%2520REFMAC%2520at%2520moderate%2520resolutions%26jtitle%3DMethods%2520Enzymol.%26date%3D2003%26volume%3D374%26spage%3D300%26epage%3D321%26doi%3D10.1016%2FS0076-6879%2803%2974014-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohkamp, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Features and development of Coot</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lj55LYnnhHObA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schüttelkopf, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Aalten, D. M. F.</span></span> <span> </span><span class="NLM_article-title">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span>. <i>Acta Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1355</span>– <span class="NLM_lpage">1363</span>, <span class="refDoi"> DOI: 10.1107/S0907444904011679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=10.1107%2FS0907444904011679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=15272157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVegtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=1355-1363&author=A.+W.+Sch%C3%BCttelkopfauthor=D.+M.+F.+van+Aalten&title=PRODRG%3A+a+tool+for+high-throughput+crystallography+of+protein-ligand+complexes&doi=10.1107%2FS0907444904011679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">PRODRG: a tool for high-throughput crystallography of protein-ligand complexes</span></div><div class="casAuthors">Schuettelkopf, Alexander W.; van Aalten, Daan M. F.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1355-1363</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The small-mol. topol. generator PRODRG is described, which takes input from existing coordinates or various two-dimensional formats and automatically generates coordinates and mol. topologies suitable for x-ray refinement of protein-ligand complexes.  Test results are described for automatic generation of topologies followed by energy minimization for a subset of compds. from the Cambridge Structural Database, which shows that, within the limits of the empirical GROMOS87 force field used, structures with good geometries are generated.  X-ray refinement in X-PLOR/CNS, REFMAC and SHELX using PRODRG-generated topologies produces results comparable to refinement with topologies from the std. libraries.  However, tests with distorted starting coordinates show that PRODRG topologies perform better, both in terms of ligand geometry and of crystallog. R factors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbflrch0bs97Vg90H21EOLACvtfcHk0lj55LYnnhHObA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVegtbY%253D&md5=f9bfdb14be7b04ea5c0db67feb39f72a</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444904011679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904011679%26sid%3Dliteratum%253Aachs%26aulast%3DSch%25C3%25BCttelkopf%26aufirst%3DA.%2BW.%26aulast%3Dvan%2BAalten%26aufirst%3DD.%2BM.%2BF.%26atitle%3DPRODRG%253A%2520a%2520tool%2520for%2520high-throughput%2520crystallography%2520of%2520protein-ligand%2520complexes%26jtitle%3DActa%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D1355%26epage%3D1363%26doi%3D10.1107%2FS0907444904011679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HTY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HTY','PDB','6HTY'); return false;">PDB: 6HTY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HVL" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3HVL','PDB','3HVL'); return false;">PDB: 3HVL</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-4"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i112"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01304">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_37577"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01304?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01304</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Analytical LC-MS and UPLC-MS conditions; FLIPR methods for human, mouse, and rat P2X4 1321N1 astrocytoma cells; QPatch methods for hP2X4 1321N1 cells; Caco-2 Permeability Assay; inhibition of CYP450 metabolism; TSA assay; stability of compounds in solution (pH 10, 7, and 1 at 37 °C); stability of compounds in plasma (rat, human at 37 °C); LogD measurement; off-target assay panels; HPLC traces of lead compounds <b>10</b>, <b>71</b>, and <b>73</b>;and data collection and refinement statistics (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_001.pdf">jm9b01304_si_001.pdf (335.56 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01304/suppl_file/jm9b01304_si_002.csv">jm9b01304_si_002.csv (16.16 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">The coordinates and structure factors of the crystal structure of PXR in complex with compound <b>25</b> have been deposited to the protein data bank (PDB) with PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6HTY">6HTY</a>. The authors will release them upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01304&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-24%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01304%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01304" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679960632f883cfa","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
